data_5x3z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x3z _Structure_validation_residue.Date_analyzed 2017-12-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 122.413 1.101 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -150.71 147.61 27.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.937 2.495 . . . . 0.0 109.797 -168.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -108.65 152.2 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.837 . . . . 0.0 111.307 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -85.41 144.54 27.95 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 164.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.71 110.34 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.44 1.496 . . . . 0.0 109.74 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.65 150.94 18.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.421 1.01 . . . . 0.0 113.908 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.62 15.52 54.68 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.316 0.96 . . . . 0.0 114.51 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.87 134.86 55.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.655 1.182 . . . . 0.0 111.66 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -62.47 148.69 44.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.299 0.639 . . . . 0.0 111.842 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t -58.73 -25.76 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.504 1.122 . . . . 0.0 113.885 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -74.26 -27.83 60.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.274 1.03 . . . . 0.0 112.476 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.4 m -72.75 127.38 32.38 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -94.42 165.76 12.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.48 -34.52 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -73.84 -37.43 64.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.403 0.681 . . . . 0.0 111.878 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -54.08 -46.08 71.93 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.851 0.75 . . . . 0.0 112.795 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.61 -48.53 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.624 1.17 . . . . 0.0 109.801 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -61.34 -42.98 99.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.027 0.931 . . . . 0.0 112.715 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -72.98 -28.8 62.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -69.11 -50.49 47.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.317 67.3 m-85 -65.83 -20.27 66.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -56.57 -18.03 10.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 170.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.63 -29.32 69.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.958 -1.089 . . . . 0.0 112.817 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -87.32 -34.55 18.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.005 0.922 . . . . 0.0 112.609 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.02 171.58 35.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.027 2.251 . . . . 0.0 110.576 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -66.67 133.47 50.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.709 0.766 . . . . 0.0 112.282 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.65 127.02 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.286 1.834 . . . . 0.0 109.296 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.84 -52.61 16.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -164.24 173.85 11.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.672 0.789 . . . . 0.0 110.011 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -138.59 157.33 46.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.197 1.399 . . . . 0.0 111.899 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptm -150.53 133.42 15.97 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.01 1.324 . . . . 0.0 111.049 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.36 150.61 25.07 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.563 -0.711 . . . . 0.0 110.622 169.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.1 mmm . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 121.166 0.508 . . . . 0.0 111.904 -173.171 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.3 p80 . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 21.23 0.07 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.491 2.316 . . . . 0.0 113.428 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.66 6.23 71.04 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.045 -1.66 . . . . 0.0 115.25 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.76 167.35 24.08 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.887 1.344 . . . . 0.0 110.13 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.19 -165.33 22.32 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.223 1.392 . . . . 0.0 112.676 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.56 152.23 50.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.191 1.796 . . . . 0.0 114.92 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.54 119.08 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.075 1.35 . . . . 0.0 112.058 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -89.11 144.76 25.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.502 1.921 . . . . 0.0 113.763 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -116.6 162.33 17.8 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.53 -40.9 76.62 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.829 -0.544 . . . . 0.0 111.137 168.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t -139.51 144.39 37.89 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.262 1.425 . . . . 0.0 112.406 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -65.5 -18.12 65.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.44 -32.63 71.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.9 mm -75.87 -41.75 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.751 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.27 -44.56 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.085 0.857 . . . . 0.0 109.888 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -60.82 -49.91 75.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 113.165 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.32 -45.44 80.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 0.0 112.531 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.35 -46.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.611 1.565 . . . . 0.0 111.225 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.5 m -66.2 -31.15 71.8 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -63.93 -31.38 72.55 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.151 1.38 . . . . 0.0 112.834 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.7 mt -68.82 -33.79 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.286 1.034 . . . . 0.0 111.319 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 65.19 -58.51 0.27 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 128.547 2.739 . . . . 0.0 114.884 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 46.1 m-85 -102.25 116.37 32.52 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 170.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -109.57 173.61 6.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.148 2.179 . . . . 0.0 110.709 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -140.84 123.22 15.88 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.07 -1.019 . . . . 0.0 112.505 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -137.38 133.01 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.987 1.715 . . . . 0.0 108.983 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 50.6 41.51 25.73 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.894 1.278 . . . . 0.0 114.025 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.15 24.7 14.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.049 1.74 . . . . 0.0 114.163 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -129.35 153.18 48.12 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.467 1.507 . . . . 0.0 110.713 169.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.8 mtp -94.47 144.47 25.54 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.39 144.97 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.426 1.491 . . . . 0.0 111.677 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -95.36 121.57 37.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.205 1.002 . . . . 0.0 110.646 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 72.6 m -105.89 131.07 53.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.334 1.053 . . . . 0.0 111.809 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.356 1.862 . . . . 0.0 110.14 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.49 135.07 57.64 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.82 1.191 . . . . 0.0 111.094 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 121.274 0.559 . . . . 0.0 110.871 175.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -105.15 133.65 49.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.349 1.06 . . . . 0.0 112.772 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.8 pt -112.46 154.58 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.205 1.402 . . . . 0.0 111.359 169.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.66 142.31 28.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.281 2.232 . . . . 0.0 107.843 165.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 t -133.56 110.43 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.135 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.06 153.85 16.68 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.459 1.028 . . . . 0.0 113.921 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.47 9.4 56.68 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.225 1.393 . . . . 0.0 115.249 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.0 mt -63.39 141.16 58.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.998 1.319 . . . . 0.0 110.931 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 t -66.85 142.98 57.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.972 -0.455 . . . . 0.0 110.838 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.79 -11.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -86.37 -13.36 46.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.807 1.243 . . . . 0.0 114.151 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.5 m -73.88 132.82 42.9 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.59 1.156 . . . . 0.0 111.676 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.88 161.63 17.38 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 175.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -60.29 -33.65 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 169.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -74.22 -34.25 63.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.697 0.799 . . . . 0.0 112.068 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -56.25 -46.05 79.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.081 0.855 . . . . 0.0 112.135 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.64 -47.92 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.077 0.951 . . . . 0.0 110.649 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.11 -47.28 86.54 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.66 0.664 . . . . 0.0 111.735 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -62.87 -38.82 92.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.196 0.998 . . . . 0.0 112.992 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -64.68 -51.0 64.8 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 57.0 m-85 -64.44 -21.24 66.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -66.61 0.02 2.55 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 170.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.49 -29.47 63.66 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.389 -1.444 . . . . 0.0 111.862 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -88.95 -21.13 23.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.13 -158.3 25.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.681 2.086 . . . . 0.0 110.49 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -97.95 147.52 24.39 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.484 1.142 . . . . 0.0 110.791 170.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.32 129.92 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.412 1.485 . . . . 0.0 109.302 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -71.08 -47.09 60.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.774 1.63 . . . . 0.0 114.738 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -162.69 161.07 26.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.156 0.983 . . . . 0.0 110.241 -173.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.34 153.72 40.85 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.566 1.546 . . . . 0.0 111.271 170.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -152.75 132.35 13.06 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.425 1.09 . . . . 0.0 111.794 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.0 mt -103.98 146.97 27.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.71 0.804 . . . . 0.0 110.752 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.87 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.7 p80 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -68.69 5.94 0.96 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.59 18.62 67.95 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.751 -1.218 . . . . 0.0 114.286 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.2 161.66 38.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.289 1.045 . . . . 0.0 112.48 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.85 27.08 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.632 0.634 . . . . 0.0 113.451 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.61 150.63 39.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.235 1.814 . . . . 0.0 114.343 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.72 127.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.421 1.488 . . . . 0.0 111.527 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -110.26 125.92 53.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.321 1.449 . . . . 0.0 114.394 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -91.48 162.09 14.7 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -170.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -60.7 -45.41 94.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.246 1.018 . . . . 0.0 111.605 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -136.73 142.66 43.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.572 1.549 . . . . 0.0 111.612 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.04 -24.67 67.79 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.509 1.124 . . . . 0.0 112.039 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.01 -28.9 70.42 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 172.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.7 -42.48 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 121.954 -0.467 . . . . 0.0 110.539 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.09 -41.29 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.236 0.614 . . . . 0.0 110.359 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.47 -47.23 82.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.985 0.514 . . . . 0.0 112.364 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -64.35 -45.97 85.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.307 1.043 . . . . 0.0 112.157 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.26 -41.33 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.144 1.377 . . . . 0.0 111.405 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.31 -33.92 70.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.983 0.913 . . . . 0.0 112.716 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -26.94 68.03 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.8 mt -67.32 -36.62 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.421 -0.799 . . . . 0.0 110.313 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 65.19 -60.27 0.25 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 128.826 2.85 . . . . 0.0 114.233 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 64.9 m-85 -100.03 123.51 44.36 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -124.17 176.01 6.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.741 2.416 . . . . 0.0 110.124 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -139.6 129.24 24.48 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.426 -1.421 . . . . 0.0 112.783 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 39.5 mt -138.15 131.99 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.296 1.438 . . . . 0.0 109.278 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.7 41.17 25.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.177 1.391 . . . . 0.0 114.543 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.3 t30 60.55 33.19 20.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.032 1.733 . . . . 0.0 113.794 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -133.97 143.62 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.05 1.74 . . . . 0.0 111.456 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 7.2 ttm -85.17 133.58 34.19 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.785 0.834 . . . . 0.0 110.723 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.32 156.72 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.571 1.548 . . . . 0.0 112.787 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -118.42 112.3 19.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.812 0.845 . . . . 0.0 112.097 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 t -78.72 131.21 36.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.785 0.834 . . . . 0.0 111.458 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -150.18 146.77 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.927 1.691 . . . . 0.0 110.709 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.79 135.15 55.47 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.448 -0.783 . . . . 0.0 112.493 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.076 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.15 137.91 43.2 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.475 -1.391 . . . . 0.0 112.667 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.8 pt -123.58 148.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.94 1.296 . . . . 0.0 112.456 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -85.96 139.49 31.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.919 2.088 . . . . 0.0 109.908 164.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.1 t -127.32 113.66 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.945 1.298 . . . . 0.0 109.521 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.09 154.12 16.6 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.8 1.191 . . . . 0.0 114.115 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.88 13.31 75.3 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.458 1.028 . . . . 0.0 114.506 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.06 144.17 46.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -65.61 139.74 58.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.23 -13.04 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.877 . . . . 0.0 112.528 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -22.09 27.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.63 1.172 . . . . 0.0 111.954 171.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 82.9 m -75.44 139.95 42.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.88 1.272 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -114.8 163.85 14.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.405 1.482 . . . . 0.0 114.745 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.7 p -54.47 -36.65 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.37 -30.49 69.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.557 0.743 . . . . 0.0 112.619 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.59 -47.29 67.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.89 -42.54 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.46 0.704 . . . . 0.0 111.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -60.76 -48.16 83.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.545 0.738 . . . . 0.0 112.051 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -60.54 -39.08 86.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.444 1.098 . . . . 0.0 113.679 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -68.07 -39.22 82.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 47.9 m-85 -81.21 -24.9 37.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.513 2.783 . . . . 0.0 118.513 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -57.72 -29.25 64.58 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.62 -26.03 68.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.367 1.467 . . . . 0.0 112.712 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -75.22 -20.78 59.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 116.436 2.014 . . . . 0.0 116.436 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.54 -93.6 0.09 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.033 1.302 . . . . 0.0 111.439 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -157.65 137.53 12.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.312 1.445 . . . . 0.0 111.809 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.1 136.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.409 1.484 . . . . 0.0 108.457 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -92.64 -30.71 15.45 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -162.23 153.84 18.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.283 1.033 . . . . 0.0 110.273 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.51 152.78 44.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.005 1.322 . . . . 0.0 111.757 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.8 ptm -154.21 134.89 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.013 1.325 . . . . 0.0 112.004 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.4 mt -109.46 145.12 36.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.178 0.991 . . . . 0.0 111.26 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 47.7 mmm . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.018 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.0 p80 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.642 0.734 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -70.89 15.01 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.319 1.848 . . . . 0.0 115.246 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.9 12.6 82.49 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.431 1.015 . . . . 0.0 114.494 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -152.09 167.8 27.31 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.607 1.204 . . . . 0.0 110.457 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.84 27.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.383 1.468 . . . . 0.0 113.182 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.93 149.62 48.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.349 1.86 . . . . 0.0 115.256 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.7 t -135.77 130.61 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 111.404 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.8 m -107.83 138.17 44.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.548 1.939 . . . . 0.0 113.203 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.89 157.95 18.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -67.17 -32.09 72.95 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.437 0.695 . . . . 0.0 112.477 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.0 t -146.24 143.52 29.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.797 1.239 . . . . 0.0 112.428 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.82 -17.55 64.55 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.93 -24.94 67.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.7 mm -78.24 -45.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.4 -44.55 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.592 0.757 . . . . 0.0 110.935 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.0 -37.06 86.05 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.857 0.753 . . . . 0.0 112.564 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -67.84 -47.56 68.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.697 1.199 . . . . 0.0 111.73 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.97 -47.01 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.984 1.314 . . . . 0.0 110.525 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.4 t -69.19 -32.83 72.39 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.704 0.802 . . . . 0.0 112.116 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.74 -30.27 71.28 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.77 1.228 . . . . 0.0 113.296 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 69.0 mt -64.98 -33.52 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.647 0.779 . . . . 0.0 111.099 171.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 66.84 -56.22 0.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.69 2.796 . . . . 0.0 114.93 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.279 63.3 m-85 -106.57 125.25 50.77 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -125.21 161.53 26.7 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.903 1.681 . . . . 0.0 111.3 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -109.58 135.15 51.02 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.372 1.069 . . . . 0.0 111.49 172.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.5 mt -141.93 124.76 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.362 1.865 . . . . 0.0 108.509 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 51.06 34.66 11.27 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.316 1.046 . . . . 0.0 113.425 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.275 3.6 m120 63.62 3.88 1.65 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.683 2.393 . . . . 0.0 116.298 -172.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -86.71 142.3 28.28 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.416 1.486 . . . . 0.0 108.821 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 29.2 ttm -88.82 135.93 33.27 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.578 -0.701 . . . . 0.0 111.201 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.66 158.89 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.143 1.777 . . . . 0.0 112.329 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -110.54 133.04 53.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.43 1.092 . . . . 0.0 111.428 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -97.73 145.76 26.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.019 0.928 . . . . 0.0 112.204 168.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -143.37 152.1 41.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.044 1.738 . . . . 0.0 108.843 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.76 136.43 56.92 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.334 1.425 . . . . 0.0 110.818 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -171.515 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -130.59 137.55 49.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.626 1.17 . . . . 0.0 112.436 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 pt -113.24 152.68 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 111.024 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -86.04 144.04 27.78 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -127.04 106.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.556 1.542 . . . . 0.0 109.279 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -107.1 150.84 16.83 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.988 1.28 . . . . 0.0 114.225 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.79 65.57 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.376 0.988 . . . . 0.0 114.569 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.19 137.78 57.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.489 1.116 . . . . 0.0 111.391 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.8 t -69.35 142.42 54.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.751 0.82 . . . . 0.0 111.641 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 p -61.21 -17.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -73.02 -29.03 62.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.937 0.895 . . . . 0.0 112.331 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.4 m -73.12 137.15 45.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.587 1.555 . . . . 0.0 112.927 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t -112.11 161.99 15.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.05 1.34 . . . . 0.0 114.41 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.89 -34.92 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.4 -31.13 69.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.574 0.75 . . . . 0.0 112.837 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -66.41 -43.54 85.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.895 0.77 . . . . 0.0 109.425 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -45.73 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.614 1.165 . . . . 0.0 111.564 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.92 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.717 0.807 . . . . 0.0 111.776 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -57.52 -41.57 81.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.954 0.901 . . . . 0.0 112.942 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.87 -46.92 73.48 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -70.92 -23.72 62.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -59.68 -29.91 68.4 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 171.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -64.24 -26.9 68.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.934 0.894 . . . . 0.0 112.906 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -72.76 -26.67 61.64 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -175.89 -94.21 0.09 OUTLIER Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.04 1.305 . . . . 0.0 112.006 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -157.29 133.6 9.72 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.437 1.495 . . . . 0.0 111.667 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.51 134.91 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.351 1.46 . . . . 0.0 108.666 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.9 -44.74 17.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.992 1.317 . . . . 0.0 113.915 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -161.9 160.76 28.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.09 1.356 . . . . 0.0 109.915 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.05 148.88 39.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.184 1.394 . . . . 0.0 111.707 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -153.3 132.47 12.67 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 112.53 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.57 145.94 25.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.691 0.796 . . . . 0.0 110.042 169.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.47 0.559 0 O-C-N 122.118 -0.364 . . . . 0.0 110.049 -178.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 p80 . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 121.283 0.563 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -76.2 8.06 3.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.369 2.267 . . . . 0.0 114.695 -169.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.16 6.1 84.91 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.992 1.282 . . . . 0.0 114.46 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.33 168.56 26.68 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.413 1.106 . . . . 0.0 111.218 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.37 -167.73 23.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.808 1.194 . . . . 0.0 113.337 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.8 149.99 50.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.27 1.828 . . . . 0.0 114.77 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -136.76 123.05 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.918 1.287 . . . . 0.0 111.609 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.06 148.94 21.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.829 2.052 . . . . 0.0 114.168 175.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.9 155.63 35.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -66.1 -36.38 83.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.209 0.604 . . . . 0.0 112.201 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -141.25 144.25 34.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.053 1.341 . . . . 0.0 112.485 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -64.5 -20.7 66.36 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.39 0.676 . . . . 0.0 112.557 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -61.78 -33.72 74.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mm -72.5 -40.62 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.008 -0.433 . . . . 0.0 110.434 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.4 t -57.14 -43.8 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.073 0.851 . . . . 0.0 110.288 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -60.66 -48.43 81.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.328 0.651 . . . . 0.0 112.699 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.01 -47.55 80.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.321 1.448 . . . . 0.0 112.703 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.67 -43.5 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.916 1.686 . . . . 0.0 111.159 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.63 -35.75 79.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 112.482 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.15 -29.34 70.28 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.041 1.336 . . . . 0.0 113.161 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.83 -35.13 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.272 1.029 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 65.75 -55.04 0.36 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.739 2.816 . . . . 0.0 115.238 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.314 59.9 m-85 -105.93 124.55 49.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -126.61 171.18 11.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.205 2.202 . . . . 0.0 110.734 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -137.65 132.48 33.02 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.828 -1.17 . . . . 0.0 112.919 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mt -140.99 127.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.509 1.523 . . . . 0.0 108.762 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 50.9 38.81 21.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.65 1.18 . . . . 0.0 113.746 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.05 -0.66 1.01 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.465 2.306 . . . . 0.0 116.195 -173.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -85.31 131.1 34.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.843 1.257 . . . . 0.0 109.631 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.3 ttm -80.17 132.97 36.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.164 0.586 . . . . 0.0 110.196 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.64 159.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.78 1.632 . . . . 0.0 111.806 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -114.96 126.22 54.52 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.268 1.027 . . . . 0.0 111.639 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.1 p -87.17 147.8 25.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.389 0.614 . . . . 0.0 111.605 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -143.49 151.78 40.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.387 1.475 . . . . 0.0 108.169 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.24 132.74 48.37 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.913 1.233 . . . . 0.0 109.922 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-N 118.089 0.404 . . . . 0.0 110.603 177.779 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt . . . . . 0 CA--C 1.553 1.067 0 CA-C-O 121.707 0.765 . . . . 0.0 113.019 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -149.69 147.15 27.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.214 2.206 . . . . 0.0 110.024 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.8 pt -123.54 152.35 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.45 1.1 . . . . 0.0 111.91 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -87.8 140.93 29.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.749 2.02 . . . . 0.0 105.849 164.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.9 110.11 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.195 1.398 . . . . 0.0 110.038 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.15 147.65 18.2 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.958 1.266 . . . . 0.0 114.475 -172.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.19 14.55 58.78 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.784 1.183 . . . . 0.0 114.671 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.79 135.01 57.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.734 1.267 . . . . 0.0 110.321 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 150.79 48.69 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.275 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.01 -20.89 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.16 -27.49 42.73 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.899 1.28 . . . . 0.0 113.664 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 83.2 m -68.93 138.84 54.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.454 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 2.1 t -118.13 165.29 13.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.63 -34.75 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.76 -30.04 66.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 112.625 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.11 -47.37 71.35 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.02 -45.57 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.817 0.847 . . . . 0.0 110.144 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.72 -48.79 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.627 0.771 . . . . 0.0 111.937 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -59.33 -50.34 74.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.978 0.911 . . . . 0.0 113.035 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.25 26.4 m-85 -59.81 -31.91 70.15 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.342 51.3 m-85 -85.25 -24.28 27.86 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -63.95 -20.2 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -62.81 -34.64 77.72 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.071 0.948 . . . . 0.0 111.948 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -74.94 -25.67 59.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.67 -94.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.709 1.147 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -154.87 136.16 14.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.072 1.349 . . . . 0.0 112.239 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -87.31 137.18 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.593 1.557 . . . . 0.0 108.847 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.87 -46.32 12.28 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.019 1.328 . . . . 0.0 113.056 169.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -160.57 155.17 23.75 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.983 1.313 . . . . 0.0 109.929 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.97 47.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.538 1.535 . . . . 0.0 111.461 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -154.12 127.83 8.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.168 0.987 . . . . 0.0 113.014 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.6 mt -88.24 143.96 26.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.749 0.82 . . . . 0.0 110.929 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 36.6 mmt . . . . . 0 N--CA 1.473 0.716 0 C-N-CA 123.374 0.669 . . . . 0.0 112.207 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.8 p80 . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.317 0.58 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -77.2 10.92 2.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.356 1.862 . . . . 0.0 115.044 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.8 79.56 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 121.281 -0.887 . . . . 0.0 114.121 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -152.3 165.49 34.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.742 1.271 . . . . 0.0 110.317 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.64 176.7 37.26 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.022 0.82 . . . . 0.0 113.829 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.38 146.59 28.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.19 116.09 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.882 1.273 . . . . 0.0 111.779 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -89.25 144.34 26.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.777 1.631 . . . . 0.0 113.001 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.54 163.44 14.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -69.58 -40.37 76.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.274 0.63 . . . . 0.0 111.849 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.6 t -140.33 145.42 37.15 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.172 1.389 . . . . 0.0 112.861 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.69 -25.99 68.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.709 1.203 . . . . 0.0 111.897 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.71 -35.9 79.38 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.27 -42.41 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.22 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.4 t -54.55 -45.67 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.657 0.662 . . . . 0.0 110.301 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.34 -39.03 74.95 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.82 -48.3 75.67 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.624 1.102 . . . . 0.0 111.685 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.13 -49.45 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.104 1.762 . . . . 0.0 110.797 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 33.1 m -66.54 -30.52 70.85 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -67.99 -25.68 65.53 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.555 1.07 . . . . 0.0 113.587 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 70.2 mt -71.28 -32.9 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.77 0.828 . . . . 0.0 111.079 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 65.36 -59.65 0.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 128.5 2.72 . . . . 0.0 114.923 173.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 47.3 m-85 -100.41 123.12 44.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 171.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -121.04 147.32 45.68 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.676 1.59 . . . . 0.0 112.232 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -95.25 124.5 39.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.897 0.879 . . . . 0.0 110.738 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.67 129.38 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.828 1.651 . . . . 0.0 108.715 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 50.54 35.51 11.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.194 0.998 . . . . 0.0 113.223 -173.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 28.3 m120 59.37 26.46 15.34 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.595 1.958 . . . . 0.0 115.758 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -125.81 148.06 49.24 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.151 1.78 . . . . 0.0 110.223 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.9 mmm -90.75 134.37 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.837 0.855 . . . . 0.0 112.408 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.16 153.68 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.439 1.496 . . . . 0.0 112.245 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -102.06 122.05 43.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.306 1.043 . . . . 0.0 112.107 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 74.0 m -98.31 135.6 39.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.402 1.081 . . . . 0.0 112.318 173.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -140.04 145.83 38.23 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.724 1.609 . . . . 0.0 110.769 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.46 137.77 57.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.889 1.222 . . . . 0.0 111.06 171.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.796 0 CA-C-O 121.733 0.777 . . . . 0.0 113.091 -174.558 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 83.2 tttt -107.36 138.11 44.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.108 1.363 . . . . 0.0 112.082 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.0 pt -123.39 151.78 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.225 1.41 . . . . 0.0 111.826 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -87.18 143.66 27.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.594 1.958 . . . . 0.0 108.064 165.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.72 125.98 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.834 1.653 . . . . 0.0 109.995 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.56 156.79 23.77 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.057 0.844 . . . . 0.0 114.48 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.89 10.5 58.72 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.712 1.149 . . . . 0.0 114.373 -174.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.3 mt -66.2 140.2 58.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.351 1.46 . . . . 0.0 111.327 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.8 p -75.23 152.15 38.35 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.757 -0.589 . . . . 0.0 111.372 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -65.92 -16.72 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -73.65 -34.81 65.12 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.651 1.18 . . . . 0.0 112.168 169.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.0 m -67.09 136.36 55.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.165 0.986 . . . . 0.0 111.698 173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.0 163.79 16.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 p -53.65 -36.2 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.45 -31.26 68.35 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.34 -43.63 90.33 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.884 0.765 . . . . 0.0 109.078 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.15 -47.77 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.485 1.114 . . . . 0.0 111.141 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -60.36 -50.07 75.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.45 0.7 . . . . 0.0 112.07 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -61.43 -38.37 86.88 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.56 0.744 . . . . 0.0 112.964 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.58 -46.99 80.38 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.297 47.2 m-85 -67.83 -27.09 66.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -58.71 -19.5 40.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -61.93 -45.16 94.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.873 1.269 . . . . 0.0 112.881 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.01 -38.13 82.24 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.619 1.168 . . . . 0.0 112.802 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.44 158.64 14.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.2 2.333 . . . . 0.0 110.226 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.16 138.11 57.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.636 1.208 . . . . 0.0 112.885 -168.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.5 t -97.63 136.64 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.882 2.073 . . . . 0.0 109.222 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -78.89 -49.72 12.4 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.697 1.599 . . . . 0.0 112.471 173.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -159.3 159.94 34.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.335 1.054 . . . . 0.0 110.498 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.95 151.19 36.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.556 1.542 . . . . 0.0 111.464 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -153.94 133.73 13.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.468 1.107 . . . . 0.0 112.231 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.1 mt -102.41 143.23 32.41 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.083 0.953 . . . . 0.0 111.201 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.4 mmt . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.185 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.7 p80 . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 121.409 0.623 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -75.28 16.1 0.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.83 1.652 . . . . 0.0 114.825 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.47 13.11 83.89 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.462 1.029 . . . . 0.0 114.405 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -147.47 162.71 38.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.998 1.399 . . . . 0.0 111.594 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.85 -168.32 30.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.446 1.498 . . . . 0.0 113.538 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.477 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.0 m-85 -125.03 151.02 46.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.153 1.781 . . . . 0.0 115.124 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.8 t -137.0 134.17 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.497 1.519 . . . . 0.0 110.414 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -114.89 134.42 55.16 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.69 1.596 . . . . 0.0 114.087 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -103.51 159.79 15.28 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.961 1.704 . . . . 0.0 115.471 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -72.46 -29.02 63.29 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.0 t -139.76 145.3 38.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.473 1.109 . . . . 0.0 112.867 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -62.5 -28.65 69.98 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.181 0.993 . . . . 0.0 111.782 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.92 -31.73 72.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.5 -43.2 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 119.228 -0.415 . . . . 0.0 109.977 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.73 -42.39 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 118.636 0.653 . . . . 0.0 110.577 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.0 -48.5 81.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.755 0.707 . . . . 0.0 112.668 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -58.19 -44.85 88.28 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.526 1.13 . . . . 0.0 112.118 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.65 -48.1 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.024 1.729 . . . . 0.0 111.019 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.23 -34.17 77.49 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.51 -21.47 66.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.6 mt -74.81 -30.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.099 0.96 . . . . 0.0 111.703 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 64.61 -62.21 0.19 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.297 2.639 . . . . 0.0 114.609 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 47.6 m-85 -101.5 120.2 39.93 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -115.66 154.72 29.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 111.747 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -112.85 108.28 17.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.585 0.754 . . . . 0.0 111.996 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.31 123.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.554 1.141 . . . . 0.0 109.467 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 51.17 37.01 17.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.075 0.95 . . . . 0.0 113.031 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 61.99 4.25 1.12 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 127.291 2.236 . . . . 0.0 115.646 -170.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -83.82 140.91 31.73 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.64 128.49 34.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 110.547 171.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.81 150.77 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 112.497 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -104.98 123.83 48.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.869 1.267 . . . . 0.0 111.327 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -89.66 147.95 23.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.676 0.791 . . . . 0.0 111.896 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -147.08 151.09 36.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.733 1.613 . . . . 0.0 108.786 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -64.56 135.18 55.73 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.051 1.296 . . . . 0.0 110.739 168.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.436 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -118.03 143.53 46.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.902 1.281 . . . . 0.0 112.066 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.04 149.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.662 1.185 . . . . 0.0 110.51 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -86.63 141.75 28.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.744 2.018 . . . . 0.0 106.945 166.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.95 118.26 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.695 1.598 . . . . 0.0 109.529 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.69 146.69 16.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.139 0.876 . . . . 0.0 113.764 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.18 19.44 33.3 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.592 1.092 . . . . 0.0 114.493 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 mt -70.4 134.7 48.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 112.122 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.5 t -64.04 141.99 58.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.894 -0.504 . . . . 0.0 111.637 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 p -62.83 -16.87 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.44 -32.66 66.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.821 0.848 . . . . 0.0 112.071 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 m -69.29 135.43 50.45 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.552 1.541 . . . . 0.0 113.132 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -111.73 164.46 13.02 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.169 1.388 . . . . 0.0 114.598 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.35 -36.83 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.7 -33.89 75.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 112.417 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.98 -48.6 75.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.79 -43.2 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.376 0.671 . . . . 0.0 111.485 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.19 -50.64 72.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.801 0.84 . . . . 0.0 112.036 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.46 -38.76 92.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.13 -48.14 79.77 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 52.4 m-85 -69.18 -24.35 64.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -61.79 -14.23 30.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.85 -27.94 69.21 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.576 1.08 . . . . 0.0 112.4 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -85.54 -30.31 23.49 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.397 1.079 . . . . 0.0 113.647 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.55 173.05 32.77 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.917 2.199 . . . . 0.0 111.026 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.13 131.71 45.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.266 1.031 . . . . 0.0 113.011 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -99.27 133.67 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.63 1.972 . . . . 0.0 108.211 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.64 -48.67 16.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.172 1.389 . . . . 0.0 113.507 174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.43 163.4 27.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.483 1.113 . . . . 0.0 110.153 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.86 151.84 40.4 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.447 1.499 . . . . 0.0 111.553 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -153.77 134.18 13.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.198 0.999 . . . . 0.0 112.317 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.88 0.872 . . . . 0.0 110.556 172.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.4 mmt . . . . . 0 N--CA 1.47 0.572 0 C-N-CA 122.771 0.428 . . . . 0.0 111.358 179.762 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.4 p80 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.194 0.521 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -78.69 8.62 5.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.531 1.532 . . . . 0.0 114.872 -171.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.36 15.13 81.72 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.512 -0.742 . . . . 0.0 114.276 -174.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.76 163.68 38.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.444 1.116 . . . . 0.0 109.478 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.37 -162.81 24.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.988 1.28 . . . . 0.0 113.166 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.8 151.56 51.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.941 1.696 . . . . 0.0 115.241 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.66 123.74 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.243 1.417 . . . . 0.0 111.385 171.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -98.09 140.17 32.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.104 1.762 . . . . 0.0 114.066 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -111.84 151.77 28.69 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.047 1.339 . . . . 0.0 114.043 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -76.7 -40.57 48.35 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.0 t -110.73 135.21 51.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.327 1.051 . . . . 0.0 111.775 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.27 -23.67 66.44 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.196 0.998 . . . . 0.0 112.213 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.02 -31.48 71.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.4 mm -69.53 -38.21 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.843 -0.536 . . . . 0.0 110.574 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.05 -43.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 118.614 0.643 . . . . 0.0 110.883 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -64.01 -49.16 73.53 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.905 0.882 . . . . 0.0 112.232 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.75 -45.15 78.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.617 1.567 . . . . 0.0 112.587 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.48 -49.43 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.731 1.612 . . . . 0.0 110.918 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.84 -32.74 74.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.1 0.56 . . . . 0.0 112.462 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.47 -28.81 68.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.227 1.411 . . . . 0.0 113.453 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.05 -30.6 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.431 1.092 . . . . 0.0 111.78 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 66.65 -51.15 0.45 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.863 2.865 . . . . 0.0 115.77 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.31 39.2 m-85 -112.92 124.22 52.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -123.13 153.83 39.47 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.124 1.77 . . . . 0.0 111.271 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -105.71 128.81 53.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.184 0.994 . . . . 0.0 110.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.2 mt -139.4 123.76 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.733 1.613 . . . . 0.0 108.758 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 50.46 35.07 10.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.015 0.926 . . . . 0.0 113.358 -174.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.6 m120 63.17 1.58 0.93 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.596 2.358 . . . . 0.0 116.957 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -83.47 142.52 30.88 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.166 1.387 . . . . 0.0 109.416 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 94.2 mmm -86.52 137.27 32.66 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.753 -0.592 . . . . 0.0 111.094 172.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.06 150.55 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.25 1.42 . . . . 0.0 111.771 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.99 130.8 45.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.622 0.769 . . . . 0.0 111.282 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.39 139.19 31.42 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.361 0.664 . . . . 0.0 110.797 167.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -136.92 154.22 50.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.266 1.426 . . . . 0.0 108.653 170.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.7 137.05 57.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.723 1.147 . . . . 0.0 110.276 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 0.0 111.673 -175.285 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 91.1 mttt . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -137.78 139.04 39.83 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.89 -1.131 . . . . 0.0 112.159 -173.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 pt -117.24 151.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.81 1.244 . . . . 0.0 111.593 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -89.75 136.83 32.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.35 2.66 . . . . 0.0 108.119 165.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.54 110.3 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.415 . . . . 0.0 110.136 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.8 142.78 17.07 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.255 0.931 . . . . 0.0 114.366 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.3 13.5 28.46 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.487 1.518 . . . . 0.0 115.027 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.72 151.43 42.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.264 1.426 . . . . 0.0 112.478 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.4 t -68.81 139.83 55.26 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.052 -0.405 . . . . 0.0 110.453 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.4 -14.44 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.538 0.735 . . . . 0.0 112.331 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.64 -19.55 35.22 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.914 1.285 . . . . 0.0 113.11 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.9 m -69.37 134.37 48.96 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.806 1.242 . . . . 0.0 111.759 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.5 t -102.28 157.97 16.52 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.39 -33.67 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.223 1.409 . . . . 0.0 114.608 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -71.35 -29.58 65.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.69 -43.89 95.3 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.162 0.892 . . . . 0.0 109.466 172.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.54 -47.62 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.109 1.364 . . . . 0.0 110.96 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -60.99 -45.25 95.59 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.845 -0.534 . . . . 0.0 112.057 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -60.34 -43.71 96.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 112.273 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.01 -43.88 97.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 61.5 m-85 -72.54 -27.49 62.26 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -62.01 -14.75 38.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.74 -44.64 96.52 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.689 1.196 . . . . 0.0 112.711 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.675 1.19 . . . . 0.0 113.769 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.87 164.82 24.22 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.004 2.24 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.83 134.13 56.78 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.224 1.012 . . . . 0.0 113.258 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.97 127.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.599 1.96 . . . . 0.0 109.228 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -72.5 -50.0 29.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.916 1.287 . . . . 0.0 112.875 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -160.09 160.45 33.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.487 1.115 . . . . 0.0 109.91 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.6 153.67 42.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.473 1.509 . . . . 0.0 111.115 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -153.16 133.89 13.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.408 1.083 . . . . 0.0 111.991 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 19.2 mt -102.25 142.76 32.97 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.135 0.974 . . . . 0.0 110.448 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.438 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 30.2 mmt . . . . . 0 N--CA 1.47 0.541 0 O-C-N 121.956 -0.465 . . . . 0.0 111.554 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.0 p80 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.284 0.564 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -70.24 7.8 0.92 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.953 1.701 . . . . 0.0 115.245 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.66 15.96 76.62 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.551 1.072 . . . . 0.0 114.41 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 35.4 p90 -152.18 164.58 37.04 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.795 1.298 . . . . 0.0 110.977 176.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.42 32.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.365 0.983 . . . . 0.0 113.871 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -120.13 147.7 44.55 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.132 1.773 . . . . 0.0 114.675 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.66 124.09 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.016 1.326 . . . . 0.0 111.366 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -105.34 137.62 42.84 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.531 1.933 . . . . 0.0 114.459 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.62 155.87 23.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -67.15 -34.58 77.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.839 0.855 . . . . 0.0 112.197 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.3 t -141.39 143.15 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.827 1.251 . . . . 0.0 112.517 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -66.37 -20.16 66.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.44 0.696 . . . . 0.0 112.597 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.34 -31.32 71.93 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mm -73.89 -42.55 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.116 170.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.34 -44.02 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.801 0.728 . . . . 0.0 109.858 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -59.82 -48.18 82.73 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -57.0 -49.48 75.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.145 0.978 . . . . 0.0 112.285 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.4 -43.26 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.826 1.65 . . . . 0.0 110.987 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.2 m -69.23 -32.47 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -67.21 -27.79 67.54 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.239 0.927 . . . . 0.0 113.322 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.91 -36.36 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.569 0.748 . . . . 0.0 110.688 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 66.42 -53.36 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.796 2.838 . . . . 0.0 115.07 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.317 59.0 m-85 -106.19 125.89 51.54 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -127.92 169.36 14.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.716 2.007 . . . . 0.0 111.074 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -131.03 130.58 43.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.244 -0.91 . . . . 0.0 112.51 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 56.8 mt -139.77 127.45 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.396 1.478 . . . . 0.0 108.969 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 49.53 43.04 23.7 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.001 1.321 . . . . 0.0 113.784 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 66.29 0.03 1.6 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.544 2.338 . . . . 0.0 116.459 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.61 143.68 26.08 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.664 1.12 . . . . 0.0 111.551 168.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 17.5 ttm -89.05 136.36 33.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.674 0.79 . . . . 0.0 111.029 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.42 149.04 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.502 1.521 . . . . 0.0 112.559 -176.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -95.24 128.25 41.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.864 0.866 . . . . 0.0 110.39 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.02 129.6 55.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.639 1.176 . . . . 0.0 111.012 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -152.21 153.12 33.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 0.0 111.715 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.78 133.66 56.31 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.119 0.872 . . . . 0.0 112.58 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.592 0 C-N-CA 123.186 0.595 . . . . 0.0 111.438 -179.319 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.4 mttt . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -145.75 133.75 21.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 111.305 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.19 151.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.381 1.086 . . . . 0.0 111.168 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.73 136.17 34.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.238 2.615 . . . . 0.0 106.939 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 t -126.13 116.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.863 1.265 . . . . 0.0 110.478 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.29 148.29 18.89 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.666 1.127 . . . . 0.0 114.1 -173.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.91 58.94 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.256 1.408 . . . . 0.0 114.49 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.1 mt -65.47 135.69 55.5 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.699 1.2 . . . . 0.0 111.66 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -64.58 142.72 58.33 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.84 -0.538 . . . . 0.0 112.03 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.78 -14.67 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.42 -31.56 63.92 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.71 0.804 . . . . 0.0 112.169 169.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -71.91 125.47 27.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.476 . . . . 0.0 113.625 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.15 166.13 16.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.8 -32.6 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -73.08 -35.5 66.66 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.017 0.927 . . . . 0.0 111.545 174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.91 -49.19 78.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.498 0.59 . . . . 0.0 112.016 169.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -48.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 109.929 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.64 -49.16 77.36 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.665 0.666 . . . . 0.0 111.967 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -60.66 -46.67 89.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 113.037 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.26 19.0 m-85 -64.72 -21.97 66.87 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.321 61.0 m-85 -92.94 -23.58 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -62.6 -18.43 62.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -63.52 -28.95 70.3 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.359 -0.838 . . . . 0.0 113.058 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -83.75 -27.0 29.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.37 175.37 31.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.072 2.272 . . . . 0.0 110.973 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.89 132.64 49.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.453 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.11 133.72 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.633 1.973 . . . . 0.0 107.73 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.63 -46.58 14.18 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.786 1.234 . . . . 0.0 113.773 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -162.71 162.7 26.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 109.836 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.42 153.51 46.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.726 1.61 . . . . 0.0 111.482 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.6 ptm -155.52 151.0 27.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.505 1.122 . . . . 0.0 112.425 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.4 mt -119.29 144.52 46.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.539 1.536 . . . . 0.0 110.381 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 28.9 mmm . . . . . 0 N--CA 1.47 0.531 0 C-N-CA 122.786 0.435 . . . . 0.0 110.751 -179.729 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.4 p80 . . . . . 0 CA--C 1.544 0.73 0 CA-C-O 121.086 0.469 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 8.56 8.6 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.366 2.266 . . . . 0.0 114.108 -172.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.81 13.16 59.71 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.022 -1.049 . . . . 0.0 115.034 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -152.25 163.26 39.78 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.139 1.47 . . . . 0.0 110.004 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.04 -170.84 28.5 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.834 1.207 . . . . 0.0 112.954 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.45 153.71 47.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.68 127.6 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.088 1.355 . . . . 0.0 111.948 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -99.92 145.8 27.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.297 1.839 . . . . 0.0 113.558 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.38 154.5 37.62 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -67.91 -34.97 77.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.367 0.667 . . . . 0.0 112.299 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.7 t -140.24 143.37 35.94 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.017 1.327 . . . . 0.0 111.984 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.44 -19.19 64.56 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.093 -0.379 . . . . 0.0 111.364 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.07 -31.12 70.79 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.81 -42.85 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.938 -0.476 . . . . 0.0 110.195 170.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.28 -43.61 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.74 0.7 . . . . 0.0 110.025 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.849 0.859 . . . . 0.0 112.763 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.91 -48.5 79.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.443 1.097 . . . . 0.0 112.353 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.16 -45.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.778 1.631 . . . . 0.0 110.825 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 48.4 t -70.1 -31.27 68.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.192 -0.942 . . . . 0.0 112.925 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.8 -32.55 74.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.803 1.241 . . . . 0.0 112.818 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.22 -34.18 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.9 0.88 . . . . 0.0 111.064 171.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 66.22 -58.91 0.34 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.628 2.771 . . . . 0.0 115.026 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 56.0 m-85 -100.97 121.74 42.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -118.86 168.74 10.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.136 1.774 . . . . 0.0 111.118 -175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -126.68 135.65 51.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.229 1.012 . . . . 0.0 111.699 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.7 mt -140.78 129.08 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.877 1.671 . . . . 0.0 108.746 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 51.24 37.93 19.89 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.417 1.087 . . . . 0.0 113.799 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 64.74 1.15 1.31 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.519 2.328 . . . . 0.0 116.292 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -88.91 133.6 34.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.52 1.128 . . . . 0.0 110.473 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 27.1 ttm -84.1 137.53 33.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.686 0.794 . . . . 0.0 110.71 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 154.66 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.039 1.736 . . . . 0.0 111.589 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -102.93 131.73 49.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.408 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 78.5 m -111.87 134.8 53.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.014 1.326 . . . . 0.0 111.57 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.89 157.73 43.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.02 1.728 . . . . 0.0 110.228 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.92 138.7 58.62 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.168 1.349 . . . . 0.0 112.038 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 123.347 0.659 . . . . 0.0 111.959 178.622 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.8 mttt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -129.28 139.12 51.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.612 1.165 . . . . 0.0 113.846 -167.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -121.02 149.59 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.911 1.284 . . . . 0.0 112.081 173.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -87.11 139.43 30.58 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.054 2.542 . . . . 0.0 108.725 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.24 115.0 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.249 1.42 . . . . 0.0 109.452 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.07 147.63 16.62 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.278 0.942 . . . . 0.0 114.324 -173.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.81 18.34 48.06 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.054 1.312 . . . . 0.0 114.574 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.5 mt -58.44 144.44 42.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.948 1.299 . . . . 0.0 112.218 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 t -64.77 142.55 58.39 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.087 -0.383 . . . . 0.0 110.512 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.98 -14.83 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.64 -29.91 63.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.215 1.006 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.5 m -70.51 136.91 49.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.348 1.459 . . . . 0.0 114.753 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -116.84 164.08 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.516 1.527 . . . . 0.0 114.251 169.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -54.25 -35.5 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.23 -30.79 67.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.35 -44.67 86.94 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.824 0.738 . . . . 0.0 109.257 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.3 -47.03 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.963 1.305 . . . . 0.0 110.612 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.42 -51.02 71.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.694 0.798 . . . . 0.0 111.881 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -58.79 -43.95 90.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.843 0.857 . . . . 0.0 112.662 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.97 -42.7 94.33 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.349 63.6 m-85 -71.32 -28.25 63.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -59.88 -21.79 61.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.04 -33.92 74.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 112.199 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -72.0 -38.56 69.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 170.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.32 165.12 25.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 126.722 2.106 . . . . 0.0 111.497 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.13 134.28 52.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.277 1.037 . . . . 0.0 113.693 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.13 134.02 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.824 2.049 . . . . 0.0 108.237 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.17 -45.56 19.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.294 1.438 . . . . 0.0 113.419 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -161.81 158.82 26.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.426 1.091 . . . . 0.0 110.456 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.15 149.01 40.95 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.871 1.668 . . . . 0.0 111.346 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -154.95 130.76 10.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 0.0 112.513 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.5 mt -101.81 141.17 35.08 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.975 0.91 . . . . 0.0 110.488 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 34.8 mmt . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 121.248 0.547 . . . . 0.0 112.137 -170.583 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.3 p80 . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.532 0.682 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -70.93 13.12 0.21 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.75 12.36 80.09 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.153 0.882 . . . . 0.0 114.058 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -150.26 164.38 35.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.841 1.32 . . . . 0.0 110.837 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.55 -168.19 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.041 1.305 . . . . 0.0 113.417 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.89 149.3 50.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.271 1.828 . . . . 0.0 115.158 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.14 130.14 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.162 1.385 . . . . 0.0 111.563 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -108.09 140.99 40.46 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.058 1.743 . . . . 0.0 113.49 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.53 153.72 28.28 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -169.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.49 -34.83 70.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.526 0.73 . . . . 0.0 112.314 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.6 t -132.91 140.95 48.11 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.981 1.312 . . . . 0.0 112.15 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -65.11 -25.62 67.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.247 1.019 . . . . 0.0 111.781 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.5 mm -70.26 -40.78 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.002 -0.436 . . . . 0.0 110.325 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.69 -42.91 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.787 0.721 . . . . 0.0 110.842 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -63.23 -46.98 84.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.599 0.636 . . . . 0.0 112.586 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -56.64 -46.12 81.19 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.393 1.477 . . . . 0.0 112.602 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.84 -47.41 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.059 1.744 . . . . 0.0 110.876 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 67.4 m -66.12 -30.75 71.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.25 -31.0 72.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.897 1.279 . . . . 0.0 112.832 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.54 -33.37 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.363 1.065 . . . . 0.0 111.337 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 64.27 -59.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.611 2.764 . . . . 0.0 115.225 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.334 39.2 m-85 -99.05 119.85 38.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -114.83 170.32 8.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.729 2.012 . . . . 0.0 111.312 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.85 122.98 20.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.55 0.74 . . . . 0.0 112.331 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 34.1 mt -138.26 130.08 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.0 1.72 . . . . 0.0 108.954 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 50.73 47.19 24.89 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.886 1.274 . . . . 0.0 113.914 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.8 t30 59.09 30.63 20.47 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.927 1.691 . . . . 0.0 114.101 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -145.61 156.34 43.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.06 1.744 . . . . 0.0 110.38 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 50.3 mtp -105.48 148.82 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.3 147.15 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.566 1.547 . . . . 0.0 111.737 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -88.85 129.78 35.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.598 0.759 . . . . 0.0 110.305 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.65 132.05 55.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.354 1.062 . . . . 0.0 111.391 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -153.43 151.46 29.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.102 1.361 . . . . 0.0 112.073 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 130.35 45.15 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.608 0.763 . . . . 0.0 111.647 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -170.164 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.34 140.91 43.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.279 1.431 . . . . 0.0 111.125 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.8 pt -117.9 150.66 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.64 1.176 . . . . 0.0 110.925 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -86.23 142.83 28.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.055 2.142 . . . . 0.0 107.23 165.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.64 106.53 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.505 1.522 . . . . 0.0 109.722 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.1 141.58 15.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.521 1.058 . . . . 0.0 114.763 -170.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.33 17.54 58.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.783 1.183 . . . . 0.0 114.924 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.82 122.64 15.33 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.694 1.197 . . . . 0.0 110.394 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.3 t -62.84 140.89 58.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.785 0.434 . . . . 0.0 110.795 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.299 0.3 OUTLIER -66.35 -10.27 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -168.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -77.8 -19.19 55.44 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.659 1.184 . . . . 0.0 112.862 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.8 m -71.32 138.87 49.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.291 1.436 . . . . 0.0 112.24 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 t -113.81 162.93 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 173.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.61 -34.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.414 1.485 . . . . 0.0 114.252 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.56 -34.51 75.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.305 0.642 . . . . 0.0 112.279 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.86 -44.09 97.54 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.017 0.826 . . . . 0.0 109.503 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.15 -46.69 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 111.336 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.31 -50.6 73.35 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.059 0.944 . . . . 0.0 112.054 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -64.71 -34.85 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -63.85 -53.34 52.22 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 51.9 m-85 -65.02 -22.2 66.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -63.16 -12.99 31.78 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.31 -29.22 69.95 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.525 1.057 . . . . 0.0 112.546 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -86.18 -31.61 21.67 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.346 1.058 . . . . 0.0 112.82 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.31 168.49 28.57 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 127.729 2.585 . . . . 0.0 110.33 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.61 134.7 54.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.166 0.984 . . . . 0.0 112.082 -169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.0 t -97.63 134.08 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.034 1.733 . . . . 0.0 108.169 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.4 -45.73 15.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.792 1.237 . . . . 0.0 113.764 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -162.89 164.06 26.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.731 1.212 . . . . 0.0 109.866 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.76 153.27 43.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.276 1.43 . . . . 0.0 111.579 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptm -152.03 136.45 16.81 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.706 1.202 . . . . 0.0 111.618 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.1 mt -107.85 153.52 22.9 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.83 0.852 . . . . 0.0 110.303 168.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.8 mmm . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.924 0.869 . . . . 0.0 111.317 -176.065 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 p80 . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.243 0.544 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -67.33 2.42 1.69 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.13 68.37 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.432 1.015 . . . . 0.0 114.888 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -153.09 168.74 24.91 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.345 1.072 . . . . 0.0 110.139 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.94 -167.77 27.08 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.455 1.026 . . . . 0.0 113.085 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -126.7 150.12 49.19 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.085 1.754 . . . . 0.0 114.976 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.58 122.08 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.017 1.327 . . . . 0.0 111.153 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m -93.54 143.08 26.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.492 1.917 . . . . 0.0 113.78 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -115.41 155.69 26.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -66.95 -36.06 81.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.327 0.651 . . . . 0.0 111.608 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -142.95 141.83 31.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 0.0 112.837 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -61.5 -20.59 63.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.007 1.323 . . . . 0.0 113.004 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.9 -25.73 67.29 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.9 -40.86 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.749 -0.594 . . . . 0.0 110.193 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -58.01 -45.39 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 110.191 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -66.11 -35.78 81.41 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.832 0.742 . . . . 0.0 112.784 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.0 -46.29 85.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.586 1.555 . . . . 0.0 111.977 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.74 -47.61 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.608 1.563 . . . . 0.0 110.699 175.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.1 m -65.08 -30.71 71.68 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -64.9 -26.64 68.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.695 1.198 . . . . 0.0 113.402 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.47 -32.25 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.112 0.965 . . . . 0.0 111.119 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 67.69 -49.82 0.51 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.867 2.867 . . . . 0.0 115.488 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.33 49.2 m-85 -114.5 123.83 50.39 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -121.27 157.07 31.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.783 2.033 . . . . 0.0 110.885 -171.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -117.18 114.81 24.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.981 -174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 38.5 mt -131.33 125.39 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.51 1.124 . . . . 0.0 109.634 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 49.7 37.09 12.12 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.448 1.099 . . . . 0.0 112.971 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.251 33.7 m120 61.41 4.66 1.0 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.806 2.442 . . . . 0.0 116.864 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -86.61 138.81 31.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.473 1.109 . . . . 0.0 110.105 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.2 mmm -82.6 131.62 35.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.518 0.727 . . . . 0.0 110.537 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.04 148.22 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.099 1.359 . . . . 0.0 111.748 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -96.11 125.39 40.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.721 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -89.87 135.44 33.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.179 0.592 . . . . 0.0 110.801 168.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -142.09 149.79 40.35 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.01 1.324 . . . . 0.0 109.666 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -61.61 135.35 57.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.515 1.052 . . . . 0.0 110.522 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -132.64 138.13 47.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.843 1.257 . . . . 0.0 112.569 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.7 pt -117.26 149.82 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.783 1.233 . . . . 0.0 111.604 172.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -85.87 138.93 31.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.911 2.084 . . . . 0.0 108.257 163.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.86 108.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 109.609 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.07 147.43 17.78 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.4 9.98 58.58 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.647 1.117 . . . . 0.0 114.206 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.24 134.95 57.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.121 1.461 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.0 t -61.57 143.27 56.3 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.206 -0.309 . . . . 0.0 111.367 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -60.78 -18.43 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -75.42 -25.78 57.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.827 1.251 . . . . 0.0 113.295 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.8 m -70.94 134.16 46.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.221 1.408 . . . . 0.0 113.271 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -106.49 158.4 16.94 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.191 1.396 . . . . 0.0 113.613 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -56.54 -32.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.87 -30.02 67.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -65.17 -47.11 78.12 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.641 0.777 . . . . 0.0 111.459 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -60.77 -45.82 92.85 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.835 -0.541 . . . . 0.0 112.287 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -59.85 -44.27 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.116 0.871 . . . . 0.0 113.307 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -58.98 -33.94 71.26 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 55.9 m-85 -85.65 -24.97 26.85 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 174.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -60.82 -16.25 38.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -42.11 87.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 112.375 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -79.07 -29.66 43.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.91 -173.96 38.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.975 1.75 . . . . 0.0 111.949 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.11 107.34 3.62 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.638 -0.919 . . . . 0.0 112.645 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.07 130.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.308 1.443 . . . . 0.0 109.609 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.38 -57.38 3.9 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.12 0.968 . . . . 0.0 112.727 173.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -157.48 164.74 37.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.953 0.901 . . . . 0.0 110.467 -170.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.03 41.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.481 1.512 . . . . 0.0 111.404 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -154.44 129.71 9.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.182 0.993 . . . . 0.0 113.136 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.78 144.62 26.51 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.476 1.11 . . . . 0.0 111.209 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 32.6 mmt . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 122.065 0.936 . . . . 0.0 111.551 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.6 p80 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -73.75 11.09 0.91 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.6 13.89 83.02 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.112 -0.826 . . . . 0.0 114.367 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -145.2 161.78 38.7 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.215 1.507 . . . . 0.0 112.052 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.9 -179.19 34.53 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.868 1.223 . . . . 0.0 112.471 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -116.79 149.14 40.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.563 1.545 . . . . 0.0 114.922 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.0 124.17 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.87 1.268 . . . . 0.0 111.523 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.52 142.67 33.88 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.691 1.997 . . . . 0.0 114.068 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.13 149.79 40.45 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.0 113.998 -172.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.55 -40.93 48.34 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.03 -0.419 . . . . 0.0 111.721 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 12.9 m -110.71 132.05 54.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 112.144 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -63.18 -34.09 76.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.476 1.111 . . . . 0.0 112.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -58.76 -28.33 65.81 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.3 mm -70.9 -39.76 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.753 -0.592 . . . . 0.0 110.465 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.94 -42.18 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.569 0.622 . . . . 0.0 110.25 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.4 -47.71 80.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.629 0.772 . . . . 0.0 111.84 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -57.32 -50.59 72.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.664 1.186 . . . . 0.0 112.234 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.7 -45.0 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 111.062 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 35.2 t -71.21 -32.37 68.74 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.415 -0.803 . . . . 0.0 112.643 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.25 -32.71 74.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.61 1.164 . . . . 0.0 112.723 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.4 -35.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.982 0.913 . . . . 0.0 111.18 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 66.7 -51.84 0.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.525 2.73 . . . . 0.0 115.06 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.261 74.5 m-85 -108.71 125.84 52.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 176.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -132.24 155.87 47.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.407 1.483 . . . . 0.0 112.376 -169.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -107.96 127.6 53.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.228 1.011 . . . . 0.0 111.408 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 44.6 mt -137.05 124.36 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.737 1.615 . . . . 0.0 109.035 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.46 36.11 12.65 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.225 1.01 . . . . 0.0 113.223 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.82 6.19 1.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.609 2.363 . . . . 0.0 116.765 -171.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.02 143.96 26.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.001 1.721 . . . . 0.0 109.992 169.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 41.5 tpp -85.15 133.89 34.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.374 1.07 . . . . 0.0 110.876 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.83 152.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.871 1.669 . . . . 0.0 113.703 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -104.27 123.78 47.97 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.831 1.252 . . . . 0.0 110.591 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 83.7 m -104.88 130.94 52.93 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.063 1.345 . . . . 0.0 111.072 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -153.28 145.35 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.026 1.33 . . . . 0.0 111.582 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.42 137.31 57.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.15 0.886 . . . . 0.0 112.265 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 122.963 0.505 . . . . 0.0 112.258 -176.092 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HE2' ' CD1' ' A' ' 154' ' ' PHE . 85.1 tttt -115.72 139.66 49.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.219 1.407 . . . . 0.0 112.099 -169.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.2 pt -121.94 150.15 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.12 1.368 . . . . 0.0 111.202 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -84.3 145.84 28.06 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.924 2.09 . . . . 0.0 107.379 166.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.12 117.28 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.736 1.614 . . . . 0.0 110.153 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.0 149.73 17.34 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.356 0.979 . . . . 0.0 114.037 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.0 55.48 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 124.951 1.262 . . . . 0.0 114.913 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.6 mt -68.38 135.39 51.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.881 1.273 . . . . 0.0 111.508 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.9 p -69.48 151.1 46.46 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.341 -0.849 . . . . 0.0 111.849 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -65.17 -16.23 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -79.77 -28.55 40.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.609 1.164 . . . . 0.0 112.941 171.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.8 m -71.22 136.99 48.31 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.486 1.115 . . . . 0.0 110.763 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.02 163.35 17.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.86 -36.58 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -173.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.06 -35.81 80.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.518 0.727 . . . . 0.0 112.468 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.14 -47.76 75.96 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.38 -42.25 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.049 0.539 . . . . 0.0 111.844 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -59.35 -53.05 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.603 0.638 . . . . 0.0 111.803 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -60.11 -38.74 83.87 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.282 33.3 m-85 -66.22 -16.48 64.03 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 52.5 m-85 -99.37 -26.76 14.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.55 -22.3 43.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.575 1.55 . . . . 0.0 114.234 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -62.77 -29.46 70.71 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -83.45 -27.44 29.5 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.82 169.19 21.92 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.355 2.407 . . . . 0.0 110.491 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -61.61 132.17 52.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.077 0.942 . . . . 0.0 113.279 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.45 124.46 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.667 1.987 . . . . 0.0 109.342 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.04 -56.25 7.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -146.54 160.01 42.69 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.24 40.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.777 1.231 . . . . 0.0 110.466 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptm -153.49 124.63 7.44 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.748 1.219 . . . . 0.0 111.159 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.8 mt -103.62 153.37 20.69 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.595 0.758 . . . . 0.0 111.413 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.411 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 37.6 mmt . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 125.072 1.349 . . . . 0.0 113.502 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 p80 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -68.62 3.38 1.88 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.59 14.55 75.66 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.217 -0.927 . . . . 0.0 114.712 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.411 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 32.1 p90 -148.6 168.09 23.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.051 0.926 . . . . 0.0 110.441 174.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -172.57 -166.62 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.984 1.278 . . . . 0.0 113.189 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.455 ' CD1' ' HE2' ' A' ' 110' ' ' LYS . 94.6 m-85 -128.6 154.05 46.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 115.186 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.95 140.31 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.756 1.622 . . . . 0.0 110.854 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -123.05 136.89 55.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.848 2.059 . . . . 0.0 114.358 -174.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -110.87 156.65 20.85 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -168.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -63.97 -41.72 97.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.271 1.028 . . . . 0.0 112.302 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.4 t -137.78 143.04 40.89 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.624 1.17 . . . . 0.0 112.414 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -62.62 -26.29 68.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.299 1.04 . . . . 0.0 111.903 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.08 -32.92 71.4 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.51 -42.02 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.389 171.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.16 -43.52 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.843 0.747 . . . . 0.0 110.697 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.95 -47.99 80.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.395 0.678 . . . . 0.0 112.828 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.83 -47.07 81.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.734 1.213 . . . . 0.0 112.345 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.46 -48.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.705 1.602 . . . . 0.0 110.617 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.54 -34.73 78.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -61.66 -27.22 68.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.997 1.319 . . . . 0.0 113.652 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.41 -33.15 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 0.0 111.321 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 65.73 -53.22 0.37 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 128.886 2.875 . . . . 0.0 115.32 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 57.3 m-85 -108.14 122.2 46.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -123.67 151.04 43.51 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.359 1.464 . . . . 0.0 112.606 -169.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -101.64 126.05 48.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.998 0.919 . . . . 0.0 110.903 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 10.4 mt -138.03 125.61 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.74 1.616 . . . . 0.0 108.811 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.27 37.01 13.97 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.395 1.078 . . . . 0.0 113.463 -173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 61.96 7.1 1.93 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.044 2.138 . . . . 0.0 116.003 -171.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -95.34 163.01 13.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.87 1.668 . . . . 0.0 111.421 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -95.37 129.38 42.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.362 1.465 . . . . 0.0 111.061 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.1 165.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.589 1.556 . . . . 0.0 113.151 173.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -123.22 130.32 52.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.388 1.075 . . . . 0.0 111.762 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.72 144.44 25.51 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.982 0.913 . . . . 0.0 111.92 168.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -140.08 149.6 43.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.969 1.307 . . . . 0.0 108.591 170.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -64.56 131.18 46.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.983 1.265 . . . . 0.0 110.732 170.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.555 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.4 mttp . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.555 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 81.3 tttt -105.86 132.73 51.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.278 1.831 . . . . 0.0 111.583 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -120.3 150.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.918 1.287 . . . . 0.0 111.339 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -85.99 142.64 28.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.462 1.905 . . . . 0.0 109.441 165.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -126.6 100.55 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.519 1.528 . . . . 0.0 109.943 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.43 144.38 17.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.501 1.048 . . . . 0.0 113.952 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 19.72 54.09 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.41 1.005 . . . . 0.0 115.181 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.6 135.57 55.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.519 1.159 . . . . 0.0 111.379 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -66.81 144.0 56.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.024 0.53 . . . . 0.0 111.295 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 m -59.54 -16.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.98 -27.78 62.01 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.484 1.114 . . . . 0.0 113.303 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -77.11 131.24 38.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.637 1.575 . . . . 0.0 113.608 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.96 165.54 15.15 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.01 -34.98 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -71.46 -36.69 71.3 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 111.595 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -55.84 -51.67 66.69 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.411 0.551 . . . . 0.0 111.949 169.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.67 -42.58 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.9 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -57.59 -52.96 63.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.814 0.734 . . . . 0.0 111.123 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -62.48 -39.83 94.72 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.259 22.5 m-85 -63.67 -20.01 65.36 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 60.6 m-85 -97.3 -27.23 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 169.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.4 -23.51 38.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.223 1.409 . . . . 0.0 114.532 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -62.86 -29.78 71.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -85.75 -35.81 20.54 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.665 0.786 . . . . 0.0 111.628 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.69 163.04 24.97 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.179 2.799 . . . . 0.0 109.328 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -66.88 155.66 37.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -169.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.97 121.29 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.195 -1.82 . . . . 0.0 108.649 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -73.2 -39.6 65.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.746 1.218 . . . . 0.0 111.244 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.13 144.33 18.65 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.924 2.09 . . . . 0.0 115.206 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -132.16 148.17 52.46 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.621 1.168 . . . . 0.0 110.66 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -148.66 138.38 22.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.34 1.056 . . . . 0.0 111.564 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 46.1 mt -100.18 139.61 35.61 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.686 0.795 . . . . 0.0 110.444 170.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.7 mmm . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 122.892 0.477 . . . . 0.0 110.09 -179.48 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 121.578 0.704 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -79.16 11.8 2.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.594 2.358 . . . . 0.0 113.598 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.931 -1.106 . . . . 0.0 115.466 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.34 166.36 32.1 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.652 1.226 . . . . 0.0 112.329 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.25 -179.71 35.21 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.12 0.867 . . . . 0.0 113.529 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.555 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 95.7 m-85 -117.94 148.15 42.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.069 1.748 . . . . 0.0 115.248 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.8 t -137.03 126.83 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.918 1.287 . . . . 0.0 111.961 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -106.14 131.91 52.83 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.101 2.161 . . . . 0.0 114.479 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -102.54 159.49 15.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 120.33 3.455 . . . . 0.0 120.33 -167.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -58.32 -38.76 77.75 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.22 2.208 . . . . 0.0 113.501 170.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.9 t -155.26 153.42 30.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.408 1.483 . . . . 0.0 111.337 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -60.17 -32.3 70.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 111.25 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -61.96 -34.18 75.65 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.02 -42.93 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.179 -0.439 . . . . 0.0 110.195 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.95 -43.88 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.814 0.734 . . . . 0.0 110.511 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.31 -46.45 88.69 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.45 -45.5 88.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.59 1.156 . . . . 0.0 112.418 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.14 -48.91 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.002 1.721 . . . . 0.0 110.646 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.96 -30.58 71.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -64.55 -27.92 69.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 113.276 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.02 -33.27 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.208 1.003 . . . . 0.0 111.256 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 65.34 -58.84 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.543 2.737 . . . . 0.0 114.667 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 54.1 m-85 -104.3 116.97 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -112.15 152.69 28.04 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.91 1.684 . . . . 0.0 111.47 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.69 125.15 48.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.748 0.819 . . . . 0.0 110.495 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.04 122.46 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.545 1.538 . . . . 0.0 108.901 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 50.2 35.84 11.23 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.0 m120 63.03 2.12 0.98 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.427 2.291 . . . . 0.0 116.611 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -83.52 138.67 33.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.444 1.498 . . . . 0.0 109.112 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.8 mmm -86.43 129.82 34.72 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.833 -0.542 . . . . 0.0 110.78 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.13 152.2 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.526 1.53 . . . . 0.0 112.605 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -105.51 120.41 41.55 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.082 0.953 . . . . 0.0 111.654 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.33 141.86 28.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.151 0.58 . . . . 0.0 111.415 168.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -148.28 146.29 28.54 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 109.006 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.88 137.25 58.23 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.753 1.161 . . . . 0.0 110.155 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.577 0.703 . . . . 0.0 112.164 -174.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -142.08 138.92 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.789 -1.194 . . . . 0.0 113.041 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.69 151.91 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.932 1.293 . . . . 0.0 111.159 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.27 144.52 27.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.316 2.246 . . . . 0.0 106.546 165.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.08 108.9 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.806 1.642 . . . . 0.0 108.899 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.44 147.96 18.61 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.444 1.021 . . . . 0.0 114.531 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.56 19.96 36.25 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.896 1.236 . . . . 0.0 114.734 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.17 134.98 53.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.774 1.23 . . . . 0.0 111.466 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 t -63.24 152.39 37.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.928 0.891 . . . . 0.0 112.488 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 m -59.61 -20.08 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.625 1.17 . . . . 0.0 113.535 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -79.56 -25.91 41.51 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.572 1.149 . . . . 0.0 112.893 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 36.2 m -73.78 140.96 46.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.077 1.351 . . . . 0.0 113.713 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -122.87 164.13 19.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.736 1.614 . . . . 0.0 114.903 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.08 -35.84 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.17 -29.83 67.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.593 0.757 . . . . 0.0 112.775 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.41 -48.93 68.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.67 -43.01 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.821 0.848 . . . . 0.0 111.742 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.98 -46.54 90.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.156 0.582 . . . . 0.0 111.801 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -59.38 -45.26 91.95 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.986 0.914 . . . . 0.0 113.088 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -63.69 -35.33 80.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.346 62.3 m-85 -84.03 -25.82 29.58 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -59.37 -21.13 59.39 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.82 -31.81 73.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.119 1.367 . . . . 0.0 112.322 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -80.89 -26.54 36.78 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.0 165.0 15.18 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.993 2.235 . . . . 0.0 110.974 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.99 133.43 56.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.958 0.885 . . . . 0.0 112.638 -171.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.97 125.23 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.96 1.704 . . . . 0.0 108.093 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.99 -35.43 59.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -163.87 157.48 18.81 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.17 0.988 . . . . 0.0 110.435 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.9 150.49 43.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 111.218 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptm -153.88 133.73 13.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.633 1.173 . . . . 0.0 111.883 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.6 mt -103.9 147.66 27.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 170.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.9 mmm . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -171.506 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.0 p80 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 -72.76 9.85 1.02 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.42 22.16 77.83 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.122 -0.986 . . . . 0.0 113.853 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -150.34 166.27 30.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.518 1.151 . . . . 0.0 108.222 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.92 -170.33 23.35 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.79 1.186 . . . . 0.0 113.088 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.47 152.68 36.51 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.677 1.591 . . . . 0.0 114.486 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.79 127.41 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.13 1.372 . . . . 0.0 110.835 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.09 139.1 38.16 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.854 2.062 . . . . 0.0 113.759 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -112.09 155.34 24.02 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -66.87 -34.86 78.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.454 0.702 . . . . 0.0 112.087 172.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.5 t -141.64 143.51 33.67 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 112.206 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -67.01 -20.42 65.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.747 0.819 . . . . 0.0 111.976 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.62 -31.44 71.52 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.8 mm -72.84 -40.8 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.283 171.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.18 -44.85 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.941 0.791 . . . . 0.0 109.957 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -63.95 -45.0 91.11 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -56.91 -46.38 82.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.367 1.067 . . . . 0.0 111.868 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.88 -49.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.885 1.674 . . . . 0.0 110.651 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.15 -33.29 75.15 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.88 -27.38 68.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.462 1.105 . . . . 0.0 113.459 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.1 mt -72.56 -31.66 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.743 1.217 . . . . 0.0 111.754 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 66.04 -48.89 0.41 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 128.87 2.868 . . . . 0.0 115.607 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 51.8 m-85 -117.51 122.46 43.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -120.89 149.4 42.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 111.899 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -87.57 131.77 34.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.327 0.651 . . . . 0.0 111.846 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.8 mt -141.23 125.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.488 1.915 . . . . 0.0 108.74 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 51.27 41.36 27.88 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.726 1.211 . . . . 0.0 114.255 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 64.5 t30 60.27 21.13 10.57 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.13 1.772 . . . . 0.0 114.654 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -120.4 167.18 12.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.203 2.201 . . . . 0.0 110.318 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 95.9 mmm -105.52 141.19 37.43 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.928 0.891 . . . . 0.0 112.448 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.68 149.62 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.838 1.655 . . . . 0.0 112.29 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -94.78 127.76 41.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.023 0.929 . . . . 0.0 111.391 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.67 135.0 35.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.712 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -138.63 149.7 45.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.599 1.559 . . . . 0.0 109.585 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -61.15 136.29 58.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.959 1.254 . . . . 0.0 110.685 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 122.758 0.423 . . . . 0.0 110.838 -177.789 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -118.89 137.96 53.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.805 1.242 . . . . 0.0 112.761 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.3 pt -118.17 152.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.871 1.268 . . . . 0.0 111.065 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.437 ' CD1' ' HE2' ' A' ' 182' ' ' LYS . 49.8 t80 -87.62 141.44 28.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.745 2.018 . . . . 0.0 108.098 165.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.81 114.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.227 1.411 . . . . 0.0 109.347 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.11 144.37 18.41 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.423 1.011 . . . . 0.0 114.334 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.59 20.56 50.9 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.523 1.058 . . . . 0.0 114.562 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.0 mt -61.91 141.42 58.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.6 1.2 . . . . 0.0 111.103 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.32 141.7 58.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.888 -0.508 . . . . 0.0 111.128 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.01 -17.34 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.44 -25.85 50.99 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.543 1.137 . . . . 0.0 112.876 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 140.06 55.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.112 1.365 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -113.67 161.1 17.88 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.004 1.322 . . . . 0.0 114.42 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -54.7 -34.51 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.48 -31.35 68.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -64.6 -42.19 95.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.897 0.772 . . . . 0.0 109.25 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.7 -48.83 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.585 1.154 . . . . 0.0 111.3 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -60.26 -48.29 82.37 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.629 0.65 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -58.53 -41.17 84.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.672 0.789 . . . . 0.0 112.796 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.7 -47.01 82.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 57.5 m-85 -70.2 -25.89 63.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -60.48 -43.66 96.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.622 1.169 . . . . 0.0 112.784 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.46 -35.63 70.94 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 113.04 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.62 166.12 26.17 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.123 2.297 . . . . 0.0 110.731 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.072 0.939 . . . . 0.0 112.978 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.6 t -106.79 129.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.556 1.943 . . . . 0.0 108.395 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.89 -56.59 5.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 112.163 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -155.46 161.46 40.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.048 0.939 . . . . 0.0 110.319 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.44 152.63 38.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.47 1.508 . . . . 0.0 111.044 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -154.17 132.0 11.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.975 0.91 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.5 mt -100.59 137.49 38.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.27 1.028 . . . . 0.0 111.087 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.3 mmt . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 122.885 0.474 . . . . 0.0 112.264 -174.803 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.2 p80 . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.277 0.561 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -77.78 19.22 0.4 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.218 1.407 . . . . 0.0 114.709 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.42 22.52 76.44 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.128 -0.982 . . . . 0.0 113.824 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -151.7 164.0 37.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.559 1.179 . . . . 0.0 109.224 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.34 -167.57 29.18 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.279 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.62 150.1 44.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.916 1.686 . . . . 0.0 114.337 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.95 128.66 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.191 1.397 . . . . 0.0 110.815 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -108.54 134.22 51.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.209 1.803 . . . . 0.0 114.079 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -105.82 160.04 15.55 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -69.12 -33.68 73.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.933 0.893 . . . . 0.0 112.753 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t -142.66 147.07 35.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.707 1.203 . . . . 0.0 112.316 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.21 -30.09 67.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.517 1.127 . . . . 0.0 111.765 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.75 -35.27 72.46 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.65 -40.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.562 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.95 -44.21 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.994 0.816 . . . . 0.0 110.138 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -62.15 -48.07 81.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.44 -46.46 76.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.023 1.329 . . . . 0.0 112.547 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.85 -45.14 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.358 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.9 t -67.62 -36.13 80.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.699 0.799 . . . . 0.0 112.846 -176.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.54 -22.64 67.02 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.8 -33.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.803 0.841 . . . . 0.0 111.051 172.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 67.11 -51.32 0.48 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.838 2.855 . . . . 0.0 115.42 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.332 59.2 m-85 -110.28 123.57 50.06 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -123.86 170.36 10.64 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.281 2.232 . . . . 0.0 110.578 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -142.47 122.54 13.71 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.816 -1.178 . . . . 0.0 112.939 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.88 128.84 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.77 1.628 . . . . 0.0 108.989 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.72 39.64 18.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.65 1.18 . . . . 0.0 113.294 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 62.22 9.02 2.97 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.118 2.167 . . . . 0.0 116.231 -174.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -98.68 134.06 42.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.16 1.384 . . . . 0.0 110.42 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 18.7 ttm -82.53 137.24 34.65 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.757 0.823 . . . . 0.0 110.784 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.17 157.52 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.171 1.788 . . . . 0.0 112.259 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -106.47 128.77 54.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.065 0.946 . . . . 0.0 111.913 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.1 p -90.7 138.62 31.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.093 0.557 . . . . 0.0 110.632 167.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.437 ' HE2' ' CD1' ' A' ' 112' ' ' PHE . 46.6 mtmt -140.36 146.44 38.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.828 1.251 . . . . 0.0 109.518 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -62.79 128.1 34.36 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.218 0.917 . . . . 0.0 110.781 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 120.867 0.365 . . . . 0.0 111.945 -172.578 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.2 mttp . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.174 0.035 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -133.55 139.8 46.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -167.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 pt -121.07 153.07 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.192 1.397 . . . . 0.0 111.032 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.55 143.9 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.211 2.604 . . . . 0.0 105.009 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.58 103.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.949 1.7 . . . . 0.0 109.263 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -104.29 142.44 15.49 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.568 1.08 . . . . 0.0 114.264 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.13 54.69 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.747 1.165 . . . . 0.0 114.997 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 mt -62.54 145.16 55.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.757 1.223 . . . . 0.0 112.475 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 t -66.93 137.69 56.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 110.719 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.76 -9.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.28 -20.29 28.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.098 0.959 . . . . 0.0 113.071 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.8 m -72.22 129.92 39.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.725 1.21 . . . . 0.0 111.37 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -103.01 163.95 11.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.72 -38.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.56 -29.64 68.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.276 0.63 . . . . 0.0 112.616 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -65.75 -45.73 81.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.308 0.958 . . . . 0.0 110.172 173.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.52 -48.21 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.576 1.15 . . . . 0.0 110.812 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -56.64 -51.13 69.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.149 1.38 . . . . 0.0 112.377 173.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -62.42 -36.86 83.7 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.872 0.869 . . . . 0.0 112.934 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -65.97 -45.38 81.92 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 58.3 m-85 -71.14 -25.51 62.6 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 176.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -56.83 -22.38 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.532 1.533 . . . . 0.0 114.631 170.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.79 -43.53 97.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.57 -33.28 68.94 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.52 170.8 30.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.336 1.922 . . . . 0.0 112.049 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -60.62 132.08 52.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.22 1.008 . . . . 0.0 112.188 -171.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.62 134.95 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.161 1.784 . . . . 0.0 108.431 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.93 -45.6 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.437 1.095 . . . . 0.0 113.703 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.73 162.35 23.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.911 1.285 . . . . 0.0 109.73 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.43 153.09 42.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.287 1.435 . . . . 0.0 111.71 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -156.33 134.72 11.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.53 1.132 . . . . 0.0 112.276 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 18.4 mt -101.49 147.07 26.81 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.864 0.866 . . . . 0.0 110.839 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.445 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 33.4 mmt . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 112.91 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.6 p80 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 121.624 0.726 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 ttp85 -72.88 17.41 0.12 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.88 2.072 . . . . 0.0 114.489 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.29 15.35 69.34 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.198 1.38 . . . . 0.0 114.766 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.445 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 27.4 p90 -156.02 168.47 27.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.219 1.51 . . . . 0.0 111.237 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.87 -167.74 25.92 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.829 1.204 . . . . 0.0 113.573 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.71 150.83 50.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.268 1.827 . . . . 0.0 115.014 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.48 128.52 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.29 1.436 . . . . 0.0 111.498 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -100.72 146.51 27.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.735 2.014 . . . . 0.0 113.687 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.8 151.94 38.97 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.41 -27.76 63.53 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.926 0.891 . . . . 0.0 112.948 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.8 t -141.68 142.34 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.995 1.318 . . . . 0.0 112.148 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -64.23 -26.52 68.54 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.125 . . . . 0.0 111.754 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.76 -32.82 72.1 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.9 -42.34 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.336 172.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.56 -44.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.666 0.666 . . . . 0.0 110.514 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -64.23 -47.3 80.19 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.84 -46.58 74.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.403 1.081 . . . . 0.0 111.946 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.91 -49.62 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.827 1.651 . . . . 0.0 110.872 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.61 -33.31 75.63 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -65.67 -21.6 66.56 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.68 -31.77 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.021 0.928 . . . . 0.0 111.304 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 66.1 -52.75 0.4 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.828 2.851 . . . . 0.0 115.535 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.337 49.6 m-85 -111.41 121.5 45.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 173.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -118.42 165.65 13.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.117 2.167 . . . . 0.0 110.849 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -131.14 113.9 14.46 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.276 -0.89 . . . . 0.0 112.14 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.75 129.24 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.776 1.23 . . . . 0.0 109.314 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 48.1 45.12 19.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.648 1.179 . . . . 0.0 112.686 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.297 0.9 OUTLIER 52.81 31.79 11.18 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.448 2.299 . . . . 0.0 115.748 -174.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -130.84 142.2 50.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.78 1.632 . . . . 0.0 110.344 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.3 mmm -84.11 135.1 34.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.312 1.045 . . . . 0.0 111.79 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.71 153.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.834 1.254 . . . . 0.0 111.892 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.38 127.63 46.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.651 0.78 . . . . 0.0 111.933 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -89.79 136.38 33.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.846 0.458 . . . . 0.0 110.432 167.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -140.76 148.11 40.17 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.974 1.309 . . . . 0.0 108.744 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.45 135.5 55.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.897 1.226 . . . . 0.0 110.879 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 122.742 0.417 . . . . 0.0 111.29 -175.676 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.2 mttp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.546 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 80.2 tttt -136.63 138.33 41.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.346 1.458 . . . . 0.0 111.72 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.0 149.29 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.592 1.157 . . . . 0.0 111.333 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -83.97 145.22 28.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.251 1.82 . . . . 0.0 107.534 165.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.82 108.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.977 1.711 . . . . 0.0 109.984 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.74 147.63 18.66 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.594 1.092 . . . . 0.0 114.5 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.8 17.42 63.57 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.243 0.925 . . . . 0.0 114.61 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.1 mt -61.66 144.68 54.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.841 1.256 . . . . 0.0 111.494 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.5 t -69.36 137.0 52.49 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.061 -0.399 . . . . 0.0 110.133 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.4 m -64.52 -12.2 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -27.63 42.11 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.75 1.22 . . . . 0.0 113.145 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.2 m -67.4 132.39 47.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 111.974 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.49 161.46 20.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -35.02 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -71.6 -37.35 70.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.489 0.716 . . . . 0.0 111.685 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.51 -50.26 72.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.539 0.609 . . . . 0.0 111.787 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.81 -43.49 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.84 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.94 -52.57 64.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.053 0.842 . . . . 0.0 111.647 174.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -59.55 -39.79 85.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.27 24.4 m-85 -64.32 -16.24 61.82 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 118.309 2.707 . . . . 0.0 118.309 170.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 58.3 m-85 -101.5 -25.61 13.85 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.72 -21.87 56.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.159 1.384 . . . . 0.0 113.824 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.19 -29.92 71.17 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.31 -28.55 31.61 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.72 169.19 24.7 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.496 2.474 . . . . 0.0 110.079 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -63.27 130.23 43.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.843 0.83 . . . . 0.0 112.589 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.44 132.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.193 1.797 . . . . 0.0 108.938 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.94 -57.91 3.6 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.174 0.989 . . . . 0.0 112.743 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -157.47 166.99 31.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.271 1.029 . . . . 0.0 109.883 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.39 157.72 43.66 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.398 1.479 . . . . 0.0 111.315 174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -152.16 125.02 8.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.421 1.088 . . . . 0.0 111.391 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.36 146.97 25.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.305 0.642 . . . . 0.0 110.568 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.408 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 36.8 mmt . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 112.114 -172.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.4 p80 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -70.7 -15.67 62.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.303 1.441 . . . . 0.0 114.081 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 114.9 22.27 5.04 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.509 1.052 . . . . 0.0 114.841 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.408 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 41.6 p90 -153.46 166.04 33.93 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.778 1.289 . . . . 0.0 111.237 171.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.3 -169.58 33.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.614 1.102 . . . . 0.0 114.289 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.546 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 92.8 m-85 -124.11 152.57 42.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.875 2.07 . . . . 0.0 115.979 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -137.86 133.65 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.412 1.485 . . . . 0.0 111.807 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.58 140.89 39.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.328 2.251 . . . . 0.0 114.934 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -117.2 155.61 29.12 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -168.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -72.24 -31.29 65.68 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.866 0.866 . . . . 0.0 113.095 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.7 t -144.37 145.99 32.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.65 1.18 . . . . 0.0 112.633 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.32 -25.07 66.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.88 0.872 . . . . 0.0 111.872 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.12 -32.52 72.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.7 mm -72.33 -42.56 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.312 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.51 -44.68 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.772 0.715 . . . . 0.0 110.23 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.75 -49.7 76.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -55.76 -47.39 77.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.513 1.125 . . . . 0.0 112.301 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.32 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.749 1.62 . . . . 0.0 110.725 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 61.6 m -65.7 -33.27 75.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.24 -23.03 66.95 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.8 mt -72.98 -33.03 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.914 0.885 . . . . 0.0 111.251 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 65.7 -48.94 0.39 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.032 2.933 . . . . 0.0 115.531 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.301 46.9 m-85 -115.7 124.14 50.1 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -123.56 139.32 54.12 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.665 1.586 . . . . 0.0 111.816 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -86.05 124.62 32.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.072 0.949 . . . . 0.0 111.222 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.1 mt -138.76 124.75 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.213 1.805 . . . . 0.0 108.729 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 48.29 44.72 20.04 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.313 0.8 OUTLIER 53.45 29.22 8.58 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.688 1.995 . . . . 0.0 115.947 -172.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -127.53 136.06 51.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.318 2.247 . . . . 0.0 109.819 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 88.0 mtp -86.25 132.72 33.93 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.776 -0.578 . . . . 0.0 111.207 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.2 m -127.37 153.27 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.625 1.57 . . . . 0.0 112.712 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -101.25 125.98 47.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.781 0.833 . . . . 0.0 111.982 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.11 139.31 30.75 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.392 0.677 . . . . 0.0 111.462 167.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -136.37 145.3 45.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.72 1.208 . . . . 0.0 109.237 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.72 130.28 45.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.367 0.985 . . . . 0.0 109.758 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -172.699 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.0 mttt . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.515 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 84.0 tttt -137.86 140.1 40.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.877 1.271 . . . . 0.0 111.178 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt -124.82 150.62 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.489 1.116 . . . . 0.0 111.922 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -85.12 144.14 28.39 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.09 117.09 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.613 1.565 . . . . 0.0 109.762 172.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.0 145.81 16.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.269 0.938 . . . . 0.0 114.267 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.02 11.9 58.26 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.855 1.217 . . . . 0.0 115.121 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -59.63 142.78 52.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 111.275 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t -67.83 144.71 55.21 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.63 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.25 1.4 p -65.07 -13.57 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -72.75 -26.85 61.71 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 112.545 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.2 m -72.22 135.37 46.06 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 112.832 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 t -106.15 160.05 15.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 171.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.89 -34.42 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.435 1.494 . . . . 0.0 114.564 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.29 -34.88 75.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.235 0.614 . . . . 0.0 112.598 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -61.2 -42.37 98.47 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.222 0.919 . . . . 0.0 109.85 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.85 -47.81 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.74 1.216 . . . . 0.0 111.244 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -60.85 -48.48 81.61 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.664 0.665 . . . . 0.0 112.156 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -59.83 -37.02 78.04 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.67 -48.37 72.32 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 54.4 m-85 -68.99 -25.0 64.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -59.79 -18.65 45.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -59.43 -45.0 92.8 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.633 1.173 . . . . 0.0 112.82 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -73.01 -36.85 67.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.963 1.305 . . . . 0.0 112.535 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.68 165.88 29.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.097 1.808 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -59.09 126.22 26.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.963 0.905 . . . . 0.0 112.432 -169.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.97 128.67 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.756 1.622 . . . . 0.0 108.593 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.37 -57.2 4.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.195 0.998 . . . . 0.0 113.093 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -156.19 165.56 36.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 110.039 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.8 155.81 41.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.571 1.549 . . . . 0.0 111.272 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -154.86 134.88 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.373 1.069 . . . . 0.0 112.347 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.2 mt -103.25 142.45 34.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 111.236 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.3 mmt . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 121.863 0.84 . . . . 0.0 111.611 -175.009 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.7 p80 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.763 0.316 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.06 2.65 6.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.03 58.27 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.059 -1.025 . . . . 0.0 113.952 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.39 165.15 35.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.562 1.181 . . . . 0.0 109.234 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.65 -167.88 33.94 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.477 1.037 . . . . 0.0 113.668 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.515 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.5 m-85 -124.79 151.73 44.78 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.988 1.715 . . . . 0.0 114.974 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.15 132.91 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.288 1.435 . . . . 0.0 111.526 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.14 142.76 37.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.942 2.097 . . . . 0.0 114.647 -178.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.21 156.88 30.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -168.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.37 -32.92 73.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.796 0.838 . . . . 0.0 112.99 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.9 t -144.41 145.96 32.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.795 1.238 . . . . 0.0 112.377 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -60.18 -31.13 69.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.838 0.855 . . . . 0.0 111.638 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -59.69 -30.34 68.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.3 mm -72.36 -44.66 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 122.06 -0.4 . . . . 0.0 110.086 169.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.25 -41.33 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.639 0.654 . . . . 0.0 110.504 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -58.19 -51.37 70.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.291 0.636 . . . . 0.0 112.631 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.17 -46.38 88.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.639 1.176 . . . . 0.0 112.435 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.33 -46.87 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.806 1.642 . . . . 0.0 110.791 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.48 -38.52 91.46 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.622 0.769 . . . . 0.0 112.988 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -63.45 -19.46 64.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 73.4 mt -71.87 -33.71 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.28 -0.888 . . . . 0.0 111.464 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 65.08 -55.39 0.31 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.851 2.86 . . . . 0.0 115.179 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.359 46.3 m-85 -107.6 109.55 21.22 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -100.15 168.95 9.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.602 2.361 . . . . 0.0 111.353 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -132.45 118.41 19.28 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.362 -0.836 . . . . 0.0 111.889 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.91 127.95 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.787 1.235 . . . . 0.0 109.262 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.5 43.21 19.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.758 1.223 . . . . 0.0 112.939 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.301 0.7 OUTLIER 53.92 20.58 2.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.76 2.424 . . . . 0.0 116.352 -173.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -106.43 138.74 42.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.697 1.599 . . . . 0.0 110.24 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.1 mmm -80.7 133.56 35.71 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.896 0.878 . . . . 0.0 110.457 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.86 147.67 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.792 1.237 . . . . 0.0 112.84 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -97.35 124.63 41.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.225 1.01 . . . . 0.0 111.987 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.2 p -90.55 147.64 23.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.05 0.54 . . . . 0.0 111.426 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -143.34 151.02 39.98 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.927 1.291 . . . . 0.0 109.128 170.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.49 126.81 29.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.016 0.825 . . . . 0.0 109.149 168.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 121.435 0.636 . . . . 0.0 112.161 -175.99 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.8 mttt . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -124.0 138.49 54.45 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.543 1.065 . . . . 0.0 113.027 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.5 pt -118.66 153.04 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.894 1.278 . . . . 0.0 111.537 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -88.54 139.46 30.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.783 2.433 . . . . 0.0 108.12 165.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.4 t -130.73 111.13 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.31 1.444 . . . . 0.0 109.809 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.58 17.6 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.536 1.065 . . . . 0.0 113.807 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.52 12.76 37.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.917 1.246 . . . . 0.0 114.534 -177.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.02 139.23 58.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.429 1.092 . . . . 0.0 110.876 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -66.85 142.12 57.44 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.868 -0.52 . . . . 0.0 110.029 169.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.92 -14.61 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -74.18 -21.7 59.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.303 1.441 . . . . 0.0 113.744 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -71.24 145.48 49.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.404 1.481 . . . . 0.0 112.448 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -118.59 159.36 23.72 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.897 1.279 . . . . 0.0 114.113 169.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.54 -34.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.269 1.427 . . . . 0.0 114.847 -173.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.57 -28.82 65.19 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.56 0.744 . . . . 0.0 112.942 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -64.88 -51.59 61.14 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 t -58.83 -44.81 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.148 0.979 . . . . 0.0 111.489 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -59.21 -48.01 83.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.929 0.492 . . . . 0.0 111.952 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -62.71 -40.08 96.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -58.57 -30.38 67.12 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.262 59.7 m-85 -88.42 -24.1 23.13 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.13 -14.07 22.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -59.19 -42.58 91.19 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 112.523 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -80.51 -32.98 36.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.06 172.87 35.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.39 1.948 . . . . 0.0 111.058 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.16 125.5 24.08 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.134 0.967 . . . . 0.0 112.391 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 38.3 t -97.66 128.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.516 1.527 . . . . 0.0 110.107 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -75.05 -50.68 15.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.973 1.309 . . . . 0.0 112.906 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -160.9 164.25 31.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.18 0.992 . . . . 0.0 110.471 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.62 154.56 39.88 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.546 1.539 . . . . 0.0 111.383 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -151.71 136.71 17.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.697 1.199 . . . . 0.0 111.67 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.75 146.83 34.28 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 111.396 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 124.287 1.035 . . . . 0.0 112.363 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.8 p80 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -67.23 7.96 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.204 1.802 . . . . 0.0 115.751 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.84 65.73 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.581 1.086 . . . . 0.0 114.208 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -153.7 167.6 29.04 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.719 1.26 . . . . 0.0 111.21 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.78 -164.7 22.88 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.102 0.858 . . . . 0.0 113.41 170.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -120.89 150.58 40.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.104 1.762 . . . . 0.0 114.892 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.17 127.77 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.066 1.346 . . . . 0.0 111.159 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.66 136.34 48.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.432 1.893 . . . . 0.0 114.62 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -109.76 158.68 17.88 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.141 1.776 . . . . 0.0 115.643 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.32 -28.44 63.07 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.2 t -141.85 144.84 34.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.169 1.388 . . . . 0.0 112.459 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -60.58 -31.67 70.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 111.684 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.62 -31.46 70.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.75 -42.04 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 110.134 171.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.9 -43.19 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.834 0.743 . . . . 0.0 110.248 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -59.94 -47.15 86.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 173.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -58.67 -51.21 70.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.189 0.995 . . . . 0.0 112.466 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.0 t -64.19 -43.18 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.703 1.601 . . . . 0.0 110.809 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 46.7 t -70.23 -35.52 73.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -64.28 -26.58 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.923 -1.111 . . . . 0.0 113.781 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.5 mt -71.07 -39.43 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.844 0.858 . . . . 0.0 110.874 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 65.45 -43.15 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.973 2.909 . . . . 0.0 115.969 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.283 53.2 m-85 -111.69 123.36 50.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 174.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -129.52 159.84 35.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.502 1.521 . . . . 0.0 112.356 -169.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -106.41 127.08 53.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.129 0.972 . . . . 0.0 111.282 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.74 123.79 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.327 1.451 . . . . 0.0 108.998 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.58 37.48 16.28 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.279 1.032 . . . . 0.0 113.298 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.83 12.92 4.07 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 127.339 2.256 . . . . 0.0 115.7 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -97.86 145.57 26.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.082 1.753 . . . . 0.0 110.584 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.67 128.96 34.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.368 1.467 . . . . 0.0 110.205 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.39 147.31 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.702 1.201 . . . . 0.0 113.318 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -94.18 129.18 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.549 1.139 . . . . 0.0 110.187 171.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.85 126.58 54.14 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.754 1.222 . . . . 0.0 110.388 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -148.88 148.69 30.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.025 1.33 . . . . 0.0 111.296 -171.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.31 138.94 58.25 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.411 -0.806 . . . . 0.0 111.817 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.382 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.8 m -66.61 -23.54 66.2 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -148.84 153.44 38.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.755 1.622 . . . . 0.0 111.66 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 50.1 tpp -86.36 157.33 19.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.833 0.853 . . . . 0.0 110.41 168.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -75.76 46.48 0.37 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.522 1.529 . . . . 0.0 112.048 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -150.71 147.61 27.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.937 2.495 . . . . 0.0 109.797 -168.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -108.65 152.2 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.837 . . . . 0.0 111.307 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -85.41 144.54 27.95 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 164.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.71 110.34 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.44 1.496 . . . . 0.0 109.74 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.65 150.94 18.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.421 1.01 . . . . 0.0 113.908 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.62 15.52 54.68 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.316 0.96 . . . . 0.0 114.51 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.87 134.86 55.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.655 1.182 . . . . 0.0 111.66 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -62.47 148.69 44.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.299 0.639 . . . . 0.0 111.842 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t -58.73 -25.76 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.504 1.122 . . . . 0.0 113.885 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -74.26 -27.83 60.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.274 1.03 . . . . 0.0 112.476 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.4 m -72.75 127.38 32.38 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -94.42 165.76 12.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.48 -34.52 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -73.84 -37.43 64.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.403 0.681 . . . . 0.0 111.878 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -54.08 -46.08 71.93 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.851 0.75 . . . . 0.0 112.795 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.61 -48.53 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.624 1.17 . . . . 0.0 109.801 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -61.34 -42.98 99.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.027 0.931 . . . . 0.0 112.715 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -72.98 -28.8 62.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -69.11 -50.49 47.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.317 67.3 m-85 -65.83 -20.27 66.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -56.57 -18.03 10.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 170.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.63 -29.32 69.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.958 -1.089 . . . . 0.0 112.817 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -87.32 -34.55 18.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.005 0.922 . . . . 0.0 112.609 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.02 171.58 35.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.027 2.251 . . . . 0.0 110.576 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -66.67 133.47 50.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.709 0.766 . . . . 0.0 112.282 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.65 127.02 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.286 1.834 . . . . 0.0 109.296 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.84 -52.61 16.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -164.24 173.85 11.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.672 0.789 . . . . 0.0 110.011 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -138.59 157.33 46.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.197 1.399 . . . . 0.0 111.899 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptm -150.53 133.42 15.97 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.01 1.324 . . . . 0.0 111.049 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.36 150.61 25.07 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.563 -0.711 . . . . 0.0 110.622 169.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.1 mmm -80.39 72.72 7.28 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.166 0.508 . . . . 0.0 111.904 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.287 53.4 m-85 -61.85 137.99 58.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -118.81 112.04 19.2 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.967 1.707 . . . . 0.0 113.181 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -64.31 -18.08 64.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -25.38 64.94 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 170.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.3 p -130.56 -14.79 3.63 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 65.68 11.65 7.68 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.125 2.17 . . . . 0.0 114.444 -171.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.28 167.77 9.77 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.907 1.683 . . . . 0.0 111.716 169.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -91.97 156.65 17.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.969 0.908 . . . . 0.0 113.064 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 21.23 0.07 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.491 2.316 . . . . 0.0 113.428 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.66 6.23 71.04 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.045 -1.66 . . . . 0.0 115.25 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.76 167.35 24.08 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.887 1.344 . . . . 0.0 110.13 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.19 -165.33 22.32 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.223 1.392 . . . . 0.0 112.676 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.56 152.23 50.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.191 1.796 . . . . 0.0 114.92 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.54 119.08 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.075 1.35 . . . . 0.0 112.058 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -89.11 144.76 25.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.502 1.921 . . . . 0.0 113.763 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -116.6 162.33 17.8 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.53 -40.9 76.62 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.829 -0.544 . . . . 0.0 111.137 168.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t -139.51 144.39 37.89 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.262 1.425 . . . . 0.0 112.406 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -65.5 -18.12 65.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.44 -32.63 71.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.9 mm -75.87 -41.75 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.751 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.27 -44.56 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.085 0.857 . . . . 0.0 109.888 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -60.82 -49.91 75.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 113.165 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.32 -45.44 80.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 0.0 112.531 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.35 -46.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.611 1.565 . . . . 0.0 111.225 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.5 m -66.2 -31.15 71.8 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -63.93 -31.38 72.55 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.151 1.38 . . . . 0.0 112.834 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.7 mt -68.82 -33.79 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.286 1.034 . . . . 0.0 111.319 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 65.19 -58.51 0.27 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 128.547 2.739 . . . . 0.0 114.884 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 46.1 m-85 -102.25 116.37 32.52 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 170.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -109.57 173.61 6.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.148 2.179 . . . . 0.0 110.709 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -140.84 123.22 15.88 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.07 -1.019 . . . . 0.0 112.505 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -137.38 133.01 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.987 1.715 . . . . 0.0 108.983 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 50.6 41.51 25.73 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.894 1.278 . . . . 0.0 114.025 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.15 24.7 14.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.049 1.74 . . . . 0.0 114.163 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -129.35 153.18 48.12 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.467 1.507 . . . . 0.0 110.713 169.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.8 mtp -94.47 144.47 25.54 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.39 144.97 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.426 1.491 . . . . 0.0 111.677 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -95.36 121.57 37.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.205 1.002 . . . . 0.0 110.646 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 72.6 m -105.89 131.07 53.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.334 1.053 . . . . 0.0 111.809 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.356 1.862 . . . . 0.0 110.14 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.49 135.07 57.64 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.82 1.191 . . . . 0.0 111.094 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.51 118.08 12.86 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.274 0.559 . . . . 0.0 110.871 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -66.82 147.66 99.0 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.676 1.191 . . . . 0.0 111.479 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.78 36.13 0.47 Allowed 'Trans proline' 0 CA--C 1.547 1.16 1 C-N-CA 125.713 4.275 . . . . 0.0 117.948 -166.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 59.98 -15.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 129.409 3.084 . . . . 0.0 118.32 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.27 -31.02 71.55 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.016 -1.053 . . . . 0.0 111.617 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.4 m -67.99 -5.03 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.124 1.77 . . . . 0.0 115.173 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 81.3 mtp -70.25 -12.18 61.41 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.177 0.898 . . . . 0.0 112.825 169.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.2 t -56.9 148.92 46.61 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.925 1.29 . . . . 0.0 112.068 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -54.83 -20.97 24.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.474 2.783 . . . . 0.0 115.345 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.7 p -70.11 -15.95 63.05 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 171.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.47 -11.54 0.99 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.023 1.297 . . . . 0.0 116.157 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 89.1 p -62.06 -21.17 64.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.777 1.788 . . . . 0.0 114.53 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.62 54.66 1.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.283 1.433 . . . . 0.0 111.87 169.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 48.65 32.74 3.69 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.941 2.496 . . . . 0.0 114.681 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.04 171.71 48.81 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.493 1.521 . . . . 0.0 115.334 -171.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 149.81 49.79 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.916 2.086 . . . . 0.0 111.222 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.547 1.539 . . . . 0.0 113.748 -178.844 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.154 1 O4'-C1'-N19 112.946 4.746 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.434 1 O4'-C1'-N19 112.623 4.423 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.308 1 O4'-C1'-N19 112.606 4.406 . 0.089 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.205 1 O4'-C1'-N19 113.181 4.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.171 0 O4'-C1'-N19 111.702 3.502 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.076 -0.409 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.2 p -153.46 163.08 40.57 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.163 1.385 . . . . 0.0 112.362 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -153.07 175.05 13.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.693 1.597 . . . . 0.0 111.632 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.65 35.92 4.74 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.576 1.55 . . . . 0.0 111.324 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -75.0 -1.64 23.62 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -174.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -105.15 133.65 49.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.349 1.06 . . . . 0.0 112.772 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.8 pt -112.46 154.58 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.205 1.402 . . . . 0.0 111.359 169.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.66 142.31 28.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.281 2.232 . . . . 0.0 107.843 165.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 t -133.56 110.43 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.135 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.06 153.85 16.68 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.459 1.028 . . . . 0.0 113.921 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.47 9.4 56.68 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.225 1.393 . . . . 0.0 115.249 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.0 mt -63.39 141.16 58.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.998 1.319 . . . . 0.0 110.931 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 t -66.85 142.98 57.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.972 -0.455 . . . . 0.0 110.838 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.79 -11.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -86.37 -13.36 46.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.807 1.243 . . . . 0.0 114.151 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.5 m -73.88 132.82 42.9 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.59 1.156 . . . . 0.0 111.676 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.88 161.63 17.38 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 175.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -60.29 -33.65 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 169.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -74.22 -34.25 63.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.697 0.799 . . . . 0.0 112.068 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -56.25 -46.05 79.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.081 0.855 . . . . 0.0 112.135 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.64 -47.92 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.077 0.951 . . . . 0.0 110.649 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.11 -47.28 86.54 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.66 0.664 . . . . 0.0 111.735 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -62.87 -38.82 92.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.196 0.998 . . . . 0.0 112.992 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -64.68 -51.0 64.8 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 57.0 m-85 -64.44 -21.24 66.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -66.61 0.02 2.55 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 170.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.49 -29.47 63.66 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.389 -1.444 . . . . 0.0 111.862 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -88.95 -21.13 23.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.13 -158.3 25.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.681 2.086 . . . . 0.0 110.49 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -97.95 147.52 24.39 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.484 1.142 . . . . 0.0 110.791 170.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.32 129.92 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.412 1.485 . . . . 0.0 109.302 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -71.08 -47.09 60.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.774 1.63 . . . . 0.0 114.738 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -162.69 161.07 26.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.156 0.983 . . . . 0.0 110.241 -173.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.34 153.72 40.85 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.566 1.546 . . . . 0.0 111.271 170.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -152.75 132.35 13.06 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.425 1.09 . . . . 0.0 111.794 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.0 mt -103.98 146.97 27.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.71 0.804 . . . . 0.0 110.752 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.1 mmt -87.15 85.24 7.2 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -69.61 136.63 51.45 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 118.41 2.744 . . . . 0.0 118.41 174.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -94.17 129.39 40.78 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.218 1.407 . . . . 0.0 113.414 168.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.5 -38.01 89.51 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -171.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -76.99 -52.5 9.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.063 1.345 . . . . 0.0 109.028 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 p -69.32 -19.67 63.87 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.322 9.1 p30 51.2 26.66 3.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.109 2.163 . . . . 0.0 114.841 -172.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -131.64 160.91 34.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.3 2.24 . . . . 0.0 111.119 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -86.43 157.88 19.72 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -68.69 5.94 0.96 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.59 18.62 67.95 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.751 -1.218 . . . . 0.0 114.286 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.2 161.66 38.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.289 1.045 . . . . 0.0 112.48 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.85 27.08 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.632 0.634 . . . . 0.0 113.451 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.61 150.63 39.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.235 1.814 . . . . 0.0 114.343 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.72 127.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.421 1.488 . . . . 0.0 111.527 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -110.26 125.92 53.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.321 1.449 . . . . 0.0 114.394 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -91.48 162.09 14.7 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -170.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -60.7 -45.41 94.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.246 1.018 . . . . 0.0 111.605 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -136.73 142.66 43.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.572 1.549 . . . . 0.0 111.612 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.04 -24.67 67.79 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.509 1.124 . . . . 0.0 112.039 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.01 -28.9 70.42 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 172.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.7 -42.48 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 121.954 -0.467 . . . . 0.0 110.539 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.09 -41.29 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.236 0.614 . . . . 0.0 110.359 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.47 -47.23 82.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.985 0.514 . . . . 0.0 112.364 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -64.35 -45.97 85.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.307 1.043 . . . . 0.0 112.157 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.26 -41.33 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.144 1.377 . . . . 0.0 111.405 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.31 -33.92 70.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.983 0.913 . . . . 0.0 112.716 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -26.94 68.03 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.8 mt -67.32 -36.62 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.421 -0.799 . . . . 0.0 110.313 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 65.19 -60.27 0.25 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 128.826 2.85 . . . . 0.0 114.233 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 64.9 m-85 -100.03 123.51 44.36 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -124.17 176.01 6.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.741 2.416 . . . . 0.0 110.124 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -139.6 129.24 24.48 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.426 -1.421 . . . . 0.0 112.783 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 39.5 mt -138.15 131.99 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.296 1.438 . . . . 0.0 109.278 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.7 41.17 25.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.177 1.391 . . . . 0.0 114.543 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.3 t30 60.55 33.19 20.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.032 1.733 . . . . 0.0 113.794 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -133.97 143.62 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.05 1.74 . . . . 0.0 111.456 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 7.2 ttm -85.17 133.58 34.19 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.785 0.834 . . . . 0.0 110.723 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.32 156.72 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.571 1.548 . . . . 0.0 112.787 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -118.42 112.3 19.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.812 0.845 . . . . 0.0 112.097 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 t -78.72 131.21 36.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.785 0.834 . . . . 0.0 111.458 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -150.18 146.77 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.927 1.691 . . . . 0.0 110.709 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.79 135.15 55.47 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.448 -0.783 . . . . 0.0 112.493 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.0 122.5 18.81 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -129.67 155.63 80.05 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 126.407 1.883 . . . . 0.0 111.896 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.84 151.05 86.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.3 2.667 . . . . 0.0 114.237 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -66.05 -16.43 63.91 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -65.61 -41.66 92.46 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.858 1.263 . . . . 0.0 112.487 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.268 1.0 OUTLIER -77.12 -31.86 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 178.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 22.4 mmt -79.46 -17.05 55.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.712 1.205 . . . . 0.0 113.489 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.0 t 63.86 133.7 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.876 2.87 . . . . 0.0 114.316 -168.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.33 -21.35 54.39 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.873 2.382 . . . . 0.0 113.565 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.268 1.0 OUTLIER -81.99 158.46 23.85 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -177.43 167.99 39.4 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.419 1.009 . . . . 0.0 113.608 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 91.9 p -156.21 163.71 39.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.547 1.539 . . . . 0.0 111.915 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 54.83 31.75 16.29 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.73 1.612 . . . . 0.0 114.939 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -62.44 141.42 58.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.319 1.448 . . . . 0.0 111.505 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.67 -10.51 50.14 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 116.541 1.376 . . . . 0.0 116.541 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -113.89 9.26 17.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.499 1.92 . . . . 0.0 114.014 174.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.254 1.337 0 C-N-CA 125.407 1.483 . . . . 0.0 112.217 178.137 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.38 0 O4'-C1'-N19 110.497 2.297 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 0 O4'-C1'-N19 111.557 3.357 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.123 0 O4'-C4'-C3' 109.314 2.725 . 0.55 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.375 0 O4'-C1'-N19 111.464 3.264 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.498 2 O4'-C1'-N19 113.574 5.374 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.4 p -153.1 160.27 42.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.183 1.393 . . . . 0.0 112.691 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -76.7 177.75 7.3 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.078 1.351 . . . . 0.0 113.09 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 20.7 ptp -130.12 41.23 3.44 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.952 1.301 . . . . 0.0 112.811 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -71.08 30.19 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.15 137.91 43.2 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.475 -1.391 . . . . 0.0 112.667 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.8 pt -123.58 148.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.94 1.296 . . . . 0.0 112.456 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -85.96 139.49 31.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.919 2.088 . . . . 0.0 109.908 164.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.1 t -127.32 113.66 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.945 1.298 . . . . 0.0 109.521 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.09 154.12 16.6 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.8 1.191 . . . . 0.0 114.115 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.88 13.31 75.3 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.458 1.028 . . . . 0.0 114.506 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.06 144.17 46.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -65.61 139.74 58.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.23 -13.04 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.877 . . . . 0.0 112.528 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -22.09 27.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.63 1.172 . . . . 0.0 111.954 171.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 82.9 m -75.44 139.95 42.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.88 1.272 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -114.8 163.85 14.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.405 1.482 . . . . 0.0 114.745 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.7 p -54.47 -36.65 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.37 -30.49 69.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.557 0.743 . . . . 0.0 112.619 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.59 -47.29 67.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.89 -42.54 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.46 0.704 . . . . 0.0 111.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -60.76 -48.16 83.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.545 0.738 . . . . 0.0 112.051 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -60.54 -39.08 86.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.444 1.098 . . . . 0.0 113.679 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -68.07 -39.22 82.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 47.9 m-85 -81.21 -24.9 37.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.513 2.783 . . . . 0.0 118.513 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -57.72 -29.25 64.58 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.62 -26.03 68.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.367 1.467 . . . . 0.0 112.712 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -75.22 -20.78 59.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 116.436 2.014 . . . . 0.0 116.436 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.54 -93.6 0.09 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.033 1.302 . . . . 0.0 111.439 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -157.65 137.53 12.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.312 1.445 . . . . 0.0 111.809 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.1 136.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.409 1.484 . . . . 0.0 108.457 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -92.64 -30.71 15.45 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -162.23 153.84 18.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.283 1.033 . . . . 0.0 110.273 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.51 152.78 44.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.005 1.322 . . . . 0.0 111.757 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.8 ptm -154.21 134.89 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.013 1.325 . . . . 0.0 112.004 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.4 mt -109.46 145.12 36.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.178 0.991 . . . . 0.0 111.26 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 47.7 mmm -85.79 74.91 10.13 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.287 40.9 m-85 -58.49 137.43 57.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 171.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.09 119.17 33.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.567 1.547 . . . . 0.0 113.341 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -57.07 -26.31 60.15 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.316 1.446 . . . . 0.0 113.321 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.42 -24.91 67.79 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.499 2.036 . . . . 0.0 116.499 173.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 p -128.71 -16.98 4.13 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.6 t30 56.58 30.96 18.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.079 1.752 . . . . 0.0 113.116 -172.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -135.35 163.75 29.3 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.192 2.197 . . . . 0.0 110.11 172.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -79.36 154.47 29.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.642 0.734 . . . . 0.0 112.368 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -70.89 15.01 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.319 1.848 . . . . 0.0 115.246 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.9 12.6 82.49 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.431 1.015 . . . . 0.0 114.494 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -152.09 167.8 27.31 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.607 1.204 . . . . 0.0 110.457 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.84 27.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.383 1.468 . . . . 0.0 113.182 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.93 149.62 48.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.349 1.86 . . . . 0.0 115.256 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.7 t -135.77 130.61 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 111.404 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.8 m -107.83 138.17 44.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.548 1.939 . . . . 0.0 113.203 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.89 157.95 18.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -67.17 -32.09 72.95 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.437 0.695 . . . . 0.0 112.477 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.0 t -146.24 143.52 29.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.797 1.239 . . . . 0.0 112.428 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.82 -17.55 64.55 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.93 -24.94 67.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.7 mm -78.24 -45.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.4 -44.55 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.592 0.757 . . . . 0.0 110.935 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.0 -37.06 86.05 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.857 0.753 . . . . 0.0 112.564 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -67.84 -47.56 68.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.697 1.199 . . . . 0.0 111.73 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.97 -47.01 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.984 1.314 . . . . 0.0 110.525 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.4 t -69.19 -32.83 72.39 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.704 0.802 . . . . 0.0 112.116 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.74 -30.27 71.28 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.77 1.228 . . . . 0.0 113.296 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 69.0 mt -64.98 -33.52 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.647 0.779 . . . . 0.0 111.099 171.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 66.84 -56.22 0.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.69 2.796 . . . . 0.0 114.93 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.279 63.3 m-85 -106.57 125.25 50.77 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -125.21 161.53 26.7 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.903 1.681 . . . . 0.0 111.3 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -109.58 135.15 51.02 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.372 1.069 . . . . 0.0 111.49 172.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.5 mt -141.93 124.76 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.362 1.865 . . . . 0.0 108.509 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 51.06 34.66 11.27 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.316 1.046 . . . . 0.0 113.425 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.275 3.6 m120 63.62 3.88 1.65 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.683 2.393 . . . . 0.0 116.298 -172.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -86.71 142.3 28.28 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.416 1.486 . . . . 0.0 108.821 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 29.2 ttm -88.82 135.93 33.27 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.578 -0.701 . . . . 0.0 111.201 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.66 158.89 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.143 1.777 . . . . 0.0 112.329 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -110.54 133.04 53.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.43 1.092 . . . . 0.0 111.428 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -97.73 145.76 26.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.019 0.928 . . . . 0.0 112.204 168.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -143.37 152.1 41.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.044 1.738 . . . . 0.0 108.843 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.76 136.43 56.92 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.334 1.425 . . . . 0.0 110.818 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -77.99 104.68 8.71 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -90.61 149.8 41.36 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.471 1.508 . . . . 0.0 110.859 169.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.25 151.46 71.96 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.473 2.115 . . . . 0.0 111.619 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -61.56 -14.71 32.15 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -59.75 -29.54 68.23 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.579 1.551 . . . . 0.0 113.514 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.255 1.4 m -76.15 -4.9 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 24.3 mmt -122.97 115.27 21.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.954 1.702 . . . . 0.0 109.798 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.2 m -57.02 146.54 59.69 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.183 1.393 . . . . 0.0 113.439 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -64.23 -26.68 64.36 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.972 2.448 . . . . 0.0 115.658 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.251 1.5 t -71.27 144.97 49.84 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.34 179.07 21.72 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.99 1.281 . . . . 0.0 114.888 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 79.9 p -159.22 150.2 19.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.044 1.338 . . . . 0.0 112.218 177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.15 149.72 40.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.172 0.589 . . . . 0.0 111.56 170.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 155.8 30.19 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.478 1.511 . . . . 0.0 111.737 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 170.8 -166.86 40.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.39 1.472 . . . . 0.0 112.128 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.6 133.92 16.29 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.082 1.353 . . . . 0.0 111.549 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 126.049 1.74 . . . . 0.0 113.741 179.152 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.572 0 O4'-C1'-N19 111.015 2.815 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.291 0 O4'-C1'-N19 111.868 3.668 . 0.062 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.596 0 O4'-C1'-N19 111.828 3.628 . 0.166 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 C4'-C3'-C2' 99.5 -3.2 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.098 1 O4'-C1'-N19 112.465 4.265 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.0 m -64.45 149.85 47.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.889 1.275 . . . . 0.0 113.91 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -80.42 169.33 17.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.869 0.868 . . . . 0.0 110.909 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 77.5 mtm -60.1 125.48 23.81 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.235 -0.915 . . . . 0.0 110.945 173.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -74.98 37.52 0.12 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.981 1.312 . . . . 0.0 114.46 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -130.59 137.55 49.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.626 1.17 . . . . 0.0 112.436 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 pt -113.24 152.68 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 111.024 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -86.04 144.04 27.78 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -127.04 106.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.556 1.542 . . . . 0.0 109.279 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -107.1 150.84 16.83 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.988 1.28 . . . . 0.0 114.225 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.79 65.57 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.376 0.988 . . . . 0.0 114.569 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.19 137.78 57.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.489 1.116 . . . . 0.0 111.391 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.8 t -69.35 142.42 54.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.751 0.82 . . . . 0.0 111.641 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 p -61.21 -17.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -73.02 -29.03 62.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.937 0.895 . . . . 0.0 112.331 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.4 m -73.12 137.15 45.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.587 1.555 . . . . 0.0 112.927 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t -112.11 161.99 15.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.05 1.34 . . . . 0.0 114.41 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.89 -34.92 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.4 -31.13 69.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.574 0.75 . . . . 0.0 112.837 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -66.41 -43.54 85.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.895 0.77 . . . . 0.0 109.425 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -45.73 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.614 1.165 . . . . 0.0 111.564 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.92 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.717 0.807 . . . . 0.0 111.776 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -57.52 -41.57 81.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.954 0.901 . . . . 0.0 112.942 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.87 -46.92 73.48 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -70.92 -23.72 62.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -59.68 -29.91 68.4 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 171.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -64.24 -26.9 68.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.934 0.894 . . . . 0.0 112.906 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -72.76 -26.67 61.64 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -175.89 -94.21 0.09 OUTLIER Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.04 1.305 . . . . 0.0 112.006 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -157.29 133.6 9.72 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.437 1.495 . . . . 0.0 111.667 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.51 134.91 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.351 1.46 . . . . 0.0 108.666 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.9 -44.74 17.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.992 1.317 . . . . 0.0 113.915 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -161.9 160.76 28.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.09 1.356 . . . . 0.0 109.915 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.05 148.88 39.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.184 1.394 . . . . 0.0 111.707 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -153.3 132.47 12.67 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 112.53 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.57 145.94 25.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.691 0.796 . . . . 0.0 110.042 169.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.9 mmt -83.33 127.34 33.58 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.118 -0.364 . . . . 0.0 110.049 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.288 64.2 m-85 -103.64 139.69 38.58 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -174.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -96.86 110.0 22.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.381 1.472 . . . . 0.0 113.567 171.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.12 -16.07 58.81 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -35.97 82.2 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 174.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.281 0.7 OUTLIER -136.55 -2.98 2.14 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 65.08 12.59 8.07 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.974 2.11 . . . . 0.0 114.638 -171.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -71.35 156.48 39.45 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.75 1.22 . . . . 0.0 110.937 168.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -87.08 156.14 19.85 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.283 0.563 . . . . 0.0 110.506 167.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -76.2 8.06 3.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.369 2.267 . . . . 0.0 114.695 -169.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.16 6.1 84.91 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.992 1.282 . . . . 0.0 114.46 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.33 168.56 26.68 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.413 1.106 . . . . 0.0 111.218 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.37 -167.73 23.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.808 1.194 . . . . 0.0 113.337 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.8 149.99 50.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.27 1.828 . . . . 0.0 114.77 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -136.76 123.05 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.918 1.287 . . . . 0.0 111.609 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.06 148.94 21.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.829 2.052 . . . . 0.0 114.168 175.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.9 155.63 35.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -66.1 -36.38 83.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.209 0.604 . . . . 0.0 112.201 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -141.25 144.25 34.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.053 1.341 . . . . 0.0 112.485 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -64.5 -20.7 66.36 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.39 0.676 . . . . 0.0 112.557 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -61.78 -33.72 74.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mm -72.5 -40.62 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.008 -0.433 . . . . 0.0 110.434 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.4 t -57.14 -43.8 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.073 0.851 . . . . 0.0 110.288 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -60.66 -48.43 81.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.328 0.651 . . . . 0.0 112.699 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.01 -47.55 80.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.321 1.448 . . . . 0.0 112.703 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.67 -43.5 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.916 1.686 . . . . 0.0 111.159 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.63 -35.75 79.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 112.482 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.15 -29.34 70.28 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.041 1.336 . . . . 0.0 113.161 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.83 -35.13 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.272 1.029 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 65.75 -55.04 0.36 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.739 2.816 . . . . 0.0 115.238 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.314 59.9 m-85 -105.93 124.55 49.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -126.61 171.18 11.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.205 2.202 . . . . 0.0 110.734 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -137.65 132.48 33.02 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.828 -1.17 . . . . 0.0 112.919 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mt -140.99 127.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.509 1.523 . . . . 0.0 108.762 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 50.9 38.81 21.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.65 1.18 . . . . 0.0 113.746 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.05 -0.66 1.01 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.465 2.306 . . . . 0.0 116.195 -173.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -85.31 131.1 34.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.843 1.257 . . . . 0.0 109.631 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.3 ttm -80.17 132.97 36.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.164 0.586 . . . . 0.0 110.196 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.64 159.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.78 1.632 . . . . 0.0 111.806 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -114.96 126.22 54.52 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.268 1.027 . . . . 0.0 111.639 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.1 p -87.17 147.8 25.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.389 0.614 . . . . 0.0 111.605 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -143.49 151.78 40.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.387 1.475 . . . . 0.0 108.169 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.24 132.74 48.37 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.913 1.233 . . . . 0.0 109.922 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.94 136.38 48.48 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.089 0.404 . . . . 0.0 110.603 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -137.18 158.19 72.99 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.435 1.094 . . . . 0.0 111.8 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.97 156.12 51.26 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.667 2.911 . . . . 0.0 114.354 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -61.78 -20.65 63.81 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 59.8 mp0 -63.73 -21.92 66.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.87 1.668 . . . . 0.0 113.189 170.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.256 1.0 OUTLIER -118.31 -9.36 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.265 1.826 . . . . 0.0 115.209 175.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 26.2 mmt -127.26 103.27 7.31 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.837 2.055 . . . . 0.0 110.862 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.7 t -144.09 135.25 12.52 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.917 1.287 . . . . 0.0 110.982 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.65 165.08 27.45 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.822 3.014 . . . . 0.0 113.239 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.267 0.6 OUTLIER -69.63 161.0 30.53 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 169.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -77.21 -0.95 72.81 Favored Glycine 0 CA--C 1.54 1.594 0 N-CA-C 115.335 0.894 . . . . 0.0 115.335 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.1 t -71.76 133.33 45.5 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 118.977 1.389 . . . . 0.0 112.693 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.97 158.87 26.47 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.737 1.215 . . . . 0.0 112.723 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 32.1 ttt-85 -65.44 141.57 58.47 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.937 0.895 . . . . 0.0 111.057 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.28 138.55 34.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.35 0.5 . . . . 0.0 112.692 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 53.2 tpt85 -84.22 -27.63 27.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.242 1.417 . . . . 0.0 113.652 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.6 1.96 . . . . 0.0 112.403 -173.352 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 0 O4'-C1'-N19 111.765 3.565 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 O4'-C1'-N19 112.01 3.81 . 0.071 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 111.07 2.87 . 0.041 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.49 1 O4'-C1'-N19 112.967 4.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.411 0 O4'-C1'-N19 111.662 3.462 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.1 p -76.35 166.98 22.66 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.231 1.012 . . . . 0.0 113.085 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -71.14 -6.29 38.22 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 86.5 mtp -76.89 39.21 0.22 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.103 1.761 . . . . 0.0 113.954 -174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -76.89 38.65 0.21 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.464 1.506 . . . . 0.0 113.019 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -149.69 147.15 27.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.214 2.206 . . . . 0.0 110.024 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.8 pt -123.54 152.35 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.45 1.1 . . . . 0.0 111.91 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -87.8 140.93 29.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.749 2.02 . . . . 0.0 105.849 164.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.9 110.11 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.195 1.398 . . . . 0.0 110.038 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.15 147.65 18.2 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.958 1.266 . . . . 0.0 114.475 -172.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.19 14.55 58.78 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.784 1.183 . . . . 0.0 114.671 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.79 135.01 57.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.734 1.267 . . . . 0.0 110.321 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 150.79 48.69 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.275 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.01 -20.89 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.16 -27.49 42.73 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.899 1.28 . . . . 0.0 113.664 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 83.2 m -68.93 138.84 54.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.454 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 2.1 t -118.13 165.29 13.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.63 -34.75 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.76 -30.04 66.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 112.625 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.11 -47.37 71.35 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.02 -45.57 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.817 0.847 . . . . 0.0 110.144 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.72 -48.79 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.627 0.771 . . . . 0.0 111.937 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -59.33 -50.34 74.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.978 0.911 . . . . 0.0 113.035 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.25 26.4 m-85 -59.81 -31.91 70.15 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.342 51.3 m-85 -85.25 -24.28 27.86 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -63.95 -20.2 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -62.81 -34.64 77.72 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.071 0.948 . . . . 0.0 111.948 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -74.94 -25.67 59.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.67 -94.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.709 1.147 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -154.87 136.16 14.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.072 1.349 . . . . 0.0 112.239 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -87.31 137.18 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.593 1.557 . . . . 0.0 108.847 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.87 -46.32 12.28 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.019 1.328 . . . . 0.0 113.056 169.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -160.57 155.17 23.75 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.983 1.313 . . . . 0.0 109.929 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.97 47.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.538 1.535 . . . . 0.0 111.461 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -154.12 127.83 8.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.168 0.987 . . . . 0.0 113.014 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.6 mt -88.24 143.96 26.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.749 0.82 . . . . 0.0 110.929 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 36.6 mmt -91.43 141.92 28.23 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.374 0.669 . . . . 0.0 112.207 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.305 40.2 m-85 -109.2 142.31 40.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 118.768 2.877 . . . . 0.0 118.768 -169.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.61 118.93 23.18 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.58 1.552 . . . . 0.0 114.272 169.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -67.07 -19.44 65.66 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -43.82 55.48 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 p -126.18 -0.31 7.09 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 60.76 22.42 12.39 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.522 1.929 . . . . 0.0 115.546 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -101.2 162.76 12.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.27 1.828 . . . . 0.0 111.063 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -74.36 150.52 40.04 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.614 -0.679 . . . . 0.0 111.69 174.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -77.2 10.92 2.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.356 1.862 . . . . 0.0 115.044 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.8 79.56 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 121.281 -0.887 . . . . 0.0 114.121 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -152.3 165.49 34.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.742 1.271 . . . . 0.0 110.317 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.64 176.7 37.26 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.022 0.82 . . . . 0.0 113.829 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.38 146.59 28.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.19 116.09 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.882 1.273 . . . . 0.0 111.779 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -89.25 144.34 26.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.777 1.631 . . . . 0.0 113.001 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.54 163.44 14.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -69.58 -40.37 76.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.274 0.63 . . . . 0.0 111.849 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.6 t -140.33 145.42 37.15 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.172 1.389 . . . . 0.0 112.861 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.69 -25.99 68.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.709 1.203 . . . . 0.0 111.897 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.71 -35.9 79.38 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.27 -42.41 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.22 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.4 t -54.55 -45.67 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.657 0.662 . . . . 0.0 110.301 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.34 -39.03 74.95 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.82 -48.3 75.67 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.624 1.102 . . . . 0.0 111.685 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.13 -49.45 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.104 1.762 . . . . 0.0 110.797 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 33.1 m -66.54 -30.52 70.85 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -67.99 -25.68 65.53 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.555 1.07 . . . . 0.0 113.587 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 70.2 mt -71.28 -32.9 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.77 0.828 . . . . 0.0 111.079 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 65.36 -59.65 0.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 128.5 2.72 . . . . 0.0 114.923 173.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 47.3 m-85 -100.41 123.12 44.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 171.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -121.04 147.32 45.68 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.676 1.59 . . . . 0.0 112.232 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -95.25 124.5 39.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.897 0.879 . . . . 0.0 110.738 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.67 129.38 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.828 1.651 . . . . 0.0 108.715 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 50.54 35.51 11.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.194 0.998 . . . . 0.0 113.223 -173.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 28.3 m120 59.37 26.46 15.34 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.595 1.958 . . . . 0.0 115.758 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -125.81 148.06 49.24 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.151 1.78 . . . . 0.0 110.223 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.9 mmm -90.75 134.37 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.837 0.855 . . . . 0.0 112.408 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.16 153.68 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.439 1.496 . . . . 0.0 112.245 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -102.06 122.05 43.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.306 1.043 . . . . 0.0 112.107 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 74.0 m -98.31 135.6 39.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.402 1.081 . . . . 0.0 112.318 173.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -140.04 145.83 38.23 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.724 1.609 . . . . 0.0 110.769 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.46 137.77 57.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.889 1.222 . . . . 0.0 111.06 171.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.01 94.43 0.86 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.733 0.777 . . . . 0.0 113.091 -174.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -80.86 156.35 72.55 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.516 1.926 . . . . 0.0 111.334 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.96 -179.93 4.3 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.475 3.45 . . . . 0.0 114.411 -169.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -68.85 66.53 0.14 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.611 1.565 . . . . 0.0 111.764 168.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -146.16 -41.54 0.21 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.767 2.427 . . . . 0.0 110.32 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 15.4 m -76.9 34.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 127.005 2.122 . . . . 0.0 113.531 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 69.2 mtm -71.05 -4.74 26.61 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -167.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.2 m -59.83 127.67 85.65 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.9 0.88 . . . . 0.0 112.179 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.73 147.65 45.29 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.198 2.599 . . . . 0.0 112.261 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.1 p -77.97 158.94 29.11 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -67.43 129.39 28.28 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 121.501 -0.749 . . . . 0.0 113.675 -175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.4 p -138.57 -1.92 1.82 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.174 1.39 . . . . 0.0 114.66 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.63 -7.13 52.22 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -173.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.84 134.64 20.06 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.719 1.208 . . . . 0.0 111.596 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.63 -155.45 30.74 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.986 1.279 . . . . 0.0 113.353 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -23.16 67.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.604 1.161 . . . . 0.0 113.126 173.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 C--O 1.253 1.239 0 C-N-CA 127.011 2.124 . . . . 0.0 110.056 174.033 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.223 0 O4'-C1'-N19 111.032 2.832 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.232 0 O5'-C5'-C4' 113.715 2.511 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.4 0 C1'-O4'-C4' 106.43 -3.522 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.611 0 O4'-C1'-N19 111.083 2.883 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.014 1 O4'-C1'-N19 112.241 4.041 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.0 m -59.75 -22.55 62.25 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -61.2 -23.49 65.64 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.173 0.989 . . . . 0.0 113.168 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 53.2 tpp -63.08 -21.04 65.91 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.225 1.01 . . . . 0.0 112.778 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -77.61 -0.98 28.58 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 83.2 tttt -107.36 138.11 44.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.108 1.363 . . . . 0.0 112.082 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.0 pt -123.39 151.78 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.225 1.41 . . . . 0.0 111.826 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -87.18 143.66 27.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.594 1.958 . . . . 0.0 108.064 165.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.72 125.98 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.834 1.653 . . . . 0.0 109.995 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.56 156.79 23.77 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.057 0.844 . . . . 0.0 114.48 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.89 10.5 58.72 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.712 1.149 . . . . 0.0 114.373 -174.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.3 mt -66.2 140.2 58.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.351 1.46 . . . . 0.0 111.327 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.8 p -75.23 152.15 38.35 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.757 -0.589 . . . . 0.0 111.372 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -65.92 -16.72 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -73.65 -34.81 65.12 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.651 1.18 . . . . 0.0 112.168 169.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.0 m -67.09 136.36 55.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.165 0.986 . . . . 0.0 111.698 173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.0 163.79 16.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 p -53.65 -36.2 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.45 -31.26 68.35 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.34 -43.63 90.33 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.884 0.765 . . . . 0.0 109.078 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.15 -47.77 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.485 1.114 . . . . 0.0 111.141 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -60.36 -50.07 75.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.45 0.7 . . . . 0.0 112.07 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -61.43 -38.37 86.88 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.56 0.744 . . . . 0.0 112.964 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.58 -46.99 80.38 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.297 47.2 m-85 -67.83 -27.09 66.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -58.71 -19.5 40.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -61.93 -45.16 94.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.873 1.269 . . . . 0.0 112.881 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.01 -38.13 82.24 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.619 1.168 . . . . 0.0 112.802 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.44 158.64 14.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.2 2.333 . . . . 0.0 110.226 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.16 138.11 57.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.636 1.208 . . . . 0.0 112.885 -168.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.5 t -97.63 136.64 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.882 2.073 . . . . 0.0 109.222 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -78.89 -49.72 12.4 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.697 1.599 . . . . 0.0 112.471 173.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -159.3 159.94 34.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.335 1.054 . . . . 0.0 110.498 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.95 151.19 36.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.556 1.542 . . . . 0.0 111.464 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -153.94 133.73 13.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.468 1.107 . . . . 0.0 112.231 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.1 mt -102.41 143.23 32.41 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.083 0.953 . . . . 0.0 111.201 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.4 mmt -87.6 103.96 16.06 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.334 32.8 m-85 -72.17 147.21 46.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 118.589 2.811 . . . . 0.0 118.589 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -117.73 111.74 19.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.349 1.46 . . . . 0.0 111.488 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.1 mttp -64.6 -21.53 66.73 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 m -70.85 -27.6 63.97 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.5 p -106.59 -19.06 13.78 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.8 t30 56.75 32.83 21.92 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.139 1.775 . . . . 0.0 112.985 -172.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -136.15 165.68 25.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.048 2.139 . . . . 0.0 110.447 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -74.65 152.64 39.17 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.409 0.623 . . . . 0.0 111.554 169.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -75.28 16.1 0.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.83 1.652 . . . . 0.0 114.825 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.47 13.11 83.89 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.462 1.029 . . . . 0.0 114.405 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -147.47 162.71 38.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.998 1.399 . . . . 0.0 111.594 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.85 -168.32 30.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.446 1.498 . . . . 0.0 113.538 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.477 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.0 m-85 -125.03 151.02 46.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.153 1.781 . . . . 0.0 115.124 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.8 t -137.0 134.17 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.497 1.519 . . . . 0.0 110.414 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -114.89 134.42 55.16 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.69 1.596 . . . . 0.0 114.087 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -103.51 159.79 15.28 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.961 1.704 . . . . 0.0 115.471 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -72.46 -29.02 63.29 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.0 t -139.76 145.3 38.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.473 1.109 . . . . 0.0 112.867 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -62.5 -28.65 69.98 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.181 0.993 . . . . 0.0 111.782 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.92 -31.73 72.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.5 -43.2 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 119.228 -0.415 . . . . 0.0 109.977 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.73 -42.39 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 118.636 0.653 . . . . 0.0 110.577 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.0 -48.5 81.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.755 0.707 . . . . 0.0 112.668 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -58.19 -44.85 88.28 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.526 1.13 . . . . 0.0 112.118 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.65 -48.1 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.024 1.729 . . . . 0.0 111.019 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.23 -34.17 77.49 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.51 -21.47 66.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.6 mt -74.81 -30.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.099 0.96 . . . . 0.0 111.703 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 64.61 -62.21 0.19 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.297 2.639 . . . . 0.0 114.609 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 47.6 m-85 -101.5 120.2 39.93 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -115.66 154.72 29.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 111.747 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -112.85 108.28 17.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.585 0.754 . . . . 0.0 111.996 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.31 123.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.554 1.141 . . . . 0.0 109.467 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 51.17 37.01 17.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.075 0.95 . . . . 0.0 113.031 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 61.99 4.25 1.12 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 127.291 2.236 . . . . 0.0 115.646 -170.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -83.82 140.91 31.73 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.64 128.49 34.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 110.547 171.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.81 150.77 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 112.497 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -104.98 123.83 48.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.869 1.267 . . . . 0.0 111.327 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -89.66 147.95 23.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.676 0.791 . . . . 0.0 111.896 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -147.08 151.09 36.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.733 1.613 . . . . 0.0 108.786 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -64.56 135.18 55.73 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.051 1.296 . . . . 0.0 110.739 168.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.51 137.14 42.29 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.2 152.78 80.14 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.428 1.491 . . . . 0.0 111.645 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.95 150.89 84.48 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.558 2.839 . . . . 0.0 114.247 -171.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -64.28 -20.6 66.17 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -69.0 -22.55 64.07 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.518 1.927 . . . . 0.0 113.041 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.3 m -107.98 -36.01 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.406 1.483 . . . . 0.0 113.832 170.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 86.9 mmm -91.53 71.91 5.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.086 1.754 . . . . 0.0 110.83 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.7 p -81.29 144.24 53.56 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.644 0.778 . . . . 0.0 111.334 169.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.59 149.72 74.24 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.181 2.588 . . . . 0.0 113.038 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.9 p -78.98 -2.97 42.7 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 82.53 -152.34 30.47 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.73 1.157 . . . . 0.0 112.702 -172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.8 p -66.04 130.83 44.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.775 0.83 . . . . 0.0 112.554 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.02 156.94 38.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.23 1.412 . . . . 0.0 112.186 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -76.78 -23.1 52.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.943 1.297 . . . . 0.0 114.086 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 118.39 -145.87 18.41 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.758 1.647 . . . . 0.0 112.023 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -68.01 149.36 49.8 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.817 0.809 . . . . 0.0 111.707 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.73 1.612 . . . . 0.0 113.678 -178.638 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.242 0 O4'-C1'-N19 111.692 3.492 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . 0.435 HO2' ' P ' ' B' ' 203' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.427 -2.166 1 O4'-C1'-N19 112.336 4.136 . 0.342 2[ . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . 0.435 ' P ' HO2' ' B' ' 202' ' ' ' U' . . . . . . . . 0 C5'--C4' 1.544 2.644 0 O4'-C1'-N19 110.996 2.796 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 C4'-C3'-C2' 99.932 -2.768 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.289 0 O4'-C1'-N19 112.083 3.883 . 0.06 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.4 m 52.98 29.61 8.15 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 m80 56.96 22.44 7.22 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.163 1.785 . . . . 0.0 115.54 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.1 mmt -64.0 -26.8 68.73 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -83.89 8.35 15.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -118.03 143.53 46.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.902 1.281 . . . . 0.0 112.066 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.04 149.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.662 1.185 . . . . 0.0 110.51 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -86.63 141.75 28.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.744 2.018 . . . . 0.0 106.945 166.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.95 118.26 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.695 1.598 . . . . 0.0 109.529 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.69 146.69 16.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.139 0.876 . . . . 0.0 113.764 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.18 19.44 33.3 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.592 1.092 . . . . 0.0 114.493 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 mt -70.4 134.7 48.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 112.122 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.5 t -64.04 141.99 58.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.894 -0.504 . . . . 0.0 111.637 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 p -62.83 -16.87 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.44 -32.66 66.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.821 0.848 . . . . 0.0 112.071 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 m -69.29 135.43 50.45 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.552 1.541 . . . . 0.0 113.132 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -111.73 164.46 13.02 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.169 1.388 . . . . 0.0 114.598 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.35 -36.83 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.7 -33.89 75.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 112.417 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.98 -48.6 75.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.79 -43.2 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.376 0.671 . . . . 0.0 111.485 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.19 -50.64 72.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.801 0.84 . . . . 0.0 112.036 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.46 -38.76 92.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.13 -48.14 79.77 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 52.4 m-85 -69.18 -24.35 64.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -61.79 -14.23 30.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.85 -27.94 69.21 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.576 1.08 . . . . 0.0 112.4 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -85.54 -30.31 23.49 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.397 1.079 . . . . 0.0 113.647 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.55 173.05 32.77 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.917 2.199 . . . . 0.0 111.026 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.13 131.71 45.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.266 1.031 . . . . 0.0 113.011 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -99.27 133.67 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.63 1.972 . . . . 0.0 108.211 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.64 -48.67 16.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.172 1.389 . . . . 0.0 113.507 174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.43 163.4 27.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.483 1.113 . . . . 0.0 110.153 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.86 151.84 40.4 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.447 1.499 . . . . 0.0 111.553 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -153.77 134.18 13.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.198 0.999 . . . . 0.0 112.317 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.88 0.872 . . . . 0.0 110.556 172.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.4 mmt -85.05 140.89 30.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.771 0.428 . . . . 0.0 111.358 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.334 42.9 m-85 -106.15 150.3 25.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 118.734 2.864 . . . . 0.0 118.734 -173.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.63 120.33 37.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.009 1.724 . . . . 0.0 113.325 168.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -74.25 -14.05 60.86 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -42.47 68.56 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.2 p -123.23 -4.63 8.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.062 1.745 . . . . 0.0 115.703 -175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 60.65 13.51 4.33 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.748 2.019 . . . . 0.0 115.297 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -85.45 159.43 19.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.299 1.84 . . . . 0.0 111.492 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -75.15 153.17 38.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.723 -0.61 . . . . 0.0 111.004 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -78.69 8.62 5.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.531 1.532 . . . . 0.0 114.872 -171.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.36 15.13 81.72 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.512 -0.742 . . . . 0.0 114.276 -174.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.76 163.68 38.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.444 1.116 . . . . 0.0 109.478 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.37 -162.81 24.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.988 1.28 . . . . 0.0 113.166 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.8 151.56 51.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.941 1.696 . . . . 0.0 115.241 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.66 123.74 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.243 1.417 . . . . 0.0 111.385 171.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -98.09 140.17 32.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.104 1.762 . . . . 0.0 114.066 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -111.84 151.77 28.69 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.047 1.339 . . . . 0.0 114.043 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -76.7 -40.57 48.35 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.0 t -110.73 135.21 51.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.327 1.051 . . . . 0.0 111.775 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.27 -23.67 66.44 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.196 0.998 . . . . 0.0 112.213 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.02 -31.48 71.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.4 mm -69.53 -38.21 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.843 -0.536 . . . . 0.0 110.574 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.05 -43.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 118.614 0.643 . . . . 0.0 110.883 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -64.01 -49.16 73.53 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.905 0.882 . . . . 0.0 112.232 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.75 -45.15 78.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.617 1.567 . . . . 0.0 112.587 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.48 -49.43 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.731 1.612 . . . . 0.0 110.918 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.84 -32.74 74.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.1 0.56 . . . . 0.0 112.462 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.47 -28.81 68.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.227 1.411 . . . . 0.0 113.453 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.05 -30.6 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.431 1.092 . . . . 0.0 111.78 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 66.65 -51.15 0.45 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.863 2.865 . . . . 0.0 115.77 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.31 39.2 m-85 -112.92 124.22 52.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -123.13 153.83 39.47 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.124 1.77 . . . . 0.0 111.271 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -105.71 128.81 53.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.184 0.994 . . . . 0.0 110.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.2 mt -139.4 123.76 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.733 1.613 . . . . 0.0 108.758 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 50.46 35.07 10.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.015 0.926 . . . . 0.0 113.358 -174.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.6 m120 63.17 1.58 0.93 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.596 2.358 . . . . 0.0 116.957 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -83.47 142.52 30.88 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.166 1.387 . . . . 0.0 109.416 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 94.2 mmm -86.52 137.27 32.66 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.753 -0.592 . . . . 0.0 111.094 172.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.06 150.55 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.25 1.42 . . . . 0.0 111.771 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.99 130.8 45.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.622 0.769 . . . . 0.0 111.282 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.39 139.19 31.42 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.361 0.664 . . . . 0.0 110.797 167.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -136.92 154.22 50.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.266 1.426 . . . . 0.0 108.653 170.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.7 137.05 57.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.723 1.147 . . . . 0.0 110.276 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.81 114.18 12.96 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 0.0 111.673 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -66.25 148.97 98.27 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 166.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -60.36 151.3 75.3 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.843 2.362 . . . . 0.0 112.849 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -60.12 -17.38 39.82 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -78.57 -17.0 56.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.505 1.522 . . . . 0.0 114.052 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.0 p -65.61 -45.91 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -171.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.2 mmt 50.64 48.87 21.95 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.351 2.261 . . . . 0.0 112.868 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.7 m -60.83 151.14 74.34 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.443 1.097 . . . . 0.0 112.515 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -57.4 139.82 91.27 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.12 2.547 . . . . 0.0 113.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.8 p -71.98 157.44 37.81 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -174.5 126.29 1.18 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.301 0.953 . . . . 0.0 112.629 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 52.5 p -70.9 149.39 46.79 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -160.56 138.23 9.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.799 1.64 . . . . 0.0 111.209 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -81.34 -30.53 33.77 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.194 -0.941 . . . . 0.0 113.349 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.94 -169.79 40.8 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.974 1.273 . . . . 0.0 113.414 -169.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.5 mmm-85 -70.11 -18.99 63.26 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.1 p . . . . . 0 C--O 1.254 1.304 0 C-N-CA 126.46 1.904 . . . . 0.0 112.998 174.227 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.118 0 O4'-C1'-N19 112.058 3.858 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.132 0 O4'-C1'-N19 112.192 3.992 . 0.24 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.921 0 O4'-C1'-N19 110.113 1.913 . 0.352 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.455 1 O4'-C1'-N19 113.284 5.084 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.245 1 O4'-C1'-N19 112.225 4.025 . 0.184 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.2 t -155.79 -48.28 0.08 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.454 1.102 . . . . 0.0 112.781 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -71.15 94.01 1.11 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.694 1.198 . . . . 0.0 112.622 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 50.0 ttm -78.41 53.51 1.29 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.265 1.426 . . . . 0.0 111.48 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -75.92 30.57 0.11 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.541 1.536 . . . . 0.0 114.474 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -137.78 139.04 39.83 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.89 -1.131 . . . . 0.0 112.159 -173.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 pt -117.24 151.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.81 1.244 . . . . 0.0 111.593 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -89.75 136.83 32.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.35 2.66 . . . . 0.0 108.119 165.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.54 110.3 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.415 . . . . 0.0 110.136 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.8 142.78 17.07 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.255 0.931 . . . . 0.0 114.366 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.3 13.5 28.46 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.487 1.518 . . . . 0.0 115.027 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.72 151.43 42.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.264 1.426 . . . . 0.0 112.478 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.4 t -68.81 139.83 55.26 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.052 -0.405 . . . . 0.0 110.453 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.4 -14.44 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.538 0.735 . . . . 0.0 112.331 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.64 -19.55 35.22 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.914 1.285 . . . . 0.0 113.11 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.9 m -69.37 134.37 48.96 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.806 1.242 . . . . 0.0 111.759 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.5 t -102.28 157.97 16.52 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.39 -33.67 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.223 1.409 . . . . 0.0 114.608 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -71.35 -29.58 65.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.69 -43.89 95.3 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.162 0.892 . . . . 0.0 109.466 172.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.54 -47.62 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.109 1.364 . . . . 0.0 110.96 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -60.99 -45.25 95.59 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.845 -0.534 . . . . 0.0 112.057 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -60.34 -43.71 96.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 112.273 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.01 -43.88 97.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 61.5 m-85 -72.54 -27.49 62.26 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -62.01 -14.75 38.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.74 -44.64 96.52 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.689 1.196 . . . . 0.0 112.711 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.675 1.19 . . . . 0.0 113.769 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.87 164.82 24.22 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.004 2.24 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.83 134.13 56.78 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.224 1.012 . . . . 0.0 113.258 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.97 127.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.599 1.96 . . . . 0.0 109.228 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -72.5 -50.0 29.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.916 1.287 . . . . 0.0 112.875 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -160.09 160.45 33.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.487 1.115 . . . . 0.0 109.91 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.6 153.67 42.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.473 1.509 . . . . 0.0 111.115 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -153.16 133.89 13.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.408 1.083 . . . . 0.0 111.991 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 19.2 mt -102.25 142.76 32.97 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.135 0.974 . . . . 0.0 110.448 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.438 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 30.2 mmt -80.67 86.53 5.89 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.956 -0.465 . . . . 0.0 111.554 -169.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.349 53.5 m-85 -61.76 123.84 19.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -76.01 -43.11 45.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.971 0.891 . . . . 0.0 110.938 168.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -152.59 123.02 7.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.053 2.141 . . . . 0.0 108.255 168.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.3 p -63.25 -30.11 71.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.466 1.506 . . . . 0.0 111.876 -169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 p -75.68 -8.21 56.25 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -127.37 -71.56 0.67 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.08 1.352 . . . . 0.0 114.399 -169.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -163.29 159.9 23.19 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -169.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -103.86 167.33 9.85 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.842 1.657 . . . . 0.0 112.01 169.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -70.24 7.8 0.92 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.953 1.701 . . . . 0.0 115.245 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.66 15.96 76.62 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.551 1.072 . . . . 0.0 114.41 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 35.4 p90 -152.18 164.58 37.04 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.795 1.298 . . . . 0.0 110.977 176.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.42 32.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.365 0.983 . . . . 0.0 113.871 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -120.13 147.7 44.55 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.132 1.773 . . . . 0.0 114.675 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.66 124.09 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.016 1.326 . . . . 0.0 111.366 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -105.34 137.62 42.84 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.531 1.933 . . . . 0.0 114.459 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.62 155.87 23.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -67.15 -34.58 77.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.839 0.855 . . . . 0.0 112.197 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.3 t -141.39 143.15 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.827 1.251 . . . . 0.0 112.517 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -66.37 -20.16 66.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.44 0.696 . . . . 0.0 112.597 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.34 -31.32 71.93 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mm -73.89 -42.55 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.116 170.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.34 -44.02 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.801 0.728 . . . . 0.0 109.858 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -59.82 -48.18 82.73 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -57.0 -49.48 75.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.145 0.978 . . . . 0.0 112.285 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.4 -43.26 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.826 1.65 . . . . 0.0 110.987 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.2 m -69.23 -32.47 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -67.21 -27.79 67.54 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.239 0.927 . . . . 0.0 113.322 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.91 -36.36 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.569 0.748 . . . . 0.0 110.688 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 66.42 -53.36 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.796 2.838 . . . . 0.0 115.07 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.317 59.0 m-85 -106.19 125.89 51.54 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -127.92 169.36 14.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.716 2.007 . . . . 0.0 111.074 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -131.03 130.58 43.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.244 -0.91 . . . . 0.0 112.51 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 56.8 mt -139.77 127.45 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.396 1.478 . . . . 0.0 108.969 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 49.53 43.04 23.7 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.001 1.321 . . . . 0.0 113.784 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 66.29 0.03 1.6 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.544 2.338 . . . . 0.0 116.459 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.61 143.68 26.08 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.664 1.12 . . . . 0.0 111.551 168.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 17.5 ttm -89.05 136.36 33.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.674 0.79 . . . . 0.0 111.029 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.42 149.04 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.502 1.521 . . . . 0.0 112.559 -176.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -95.24 128.25 41.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.864 0.866 . . . . 0.0 110.39 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.02 129.6 55.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.639 1.176 . . . . 0.0 111.012 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -152.21 153.12 33.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 0.0 111.715 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.78 133.66 56.31 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.119 0.872 . . . . 0.0 112.58 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.72 127.48 32.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.186 0.595 . . . . 0.0 111.438 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -130.01 156.74 78.68 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.343 1.457 . . . . 0.0 112.339 -175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.16 141.03 81.17 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.022 2.481 . . . . 0.0 112.345 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -62.97 -21.29 66.01 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -63.54 -29.76 70.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.231 1.413 . . . . 0.0 113.439 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.259 0.9 OUTLIER -77.2 -27.24 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 173.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 25.5 mmt -86.67 -29.72 22.27 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.059 1.344 . . . . 0.0 113.077 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.7 t 51.43 57.08 16.84 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 126.369 1.868 . . . . 0.0 113.621 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.43 -13.91 20.39 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.149 3.232 . . . . 0.0 114.497 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.52 130.27 42.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 -170.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -77.39 168.28 54.43 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.507 1.051 . . . . 0.0 114.449 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.2 p -67.78 153.95 42.6 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.945 1.298 . . . . 0.0 113.405 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.37 134.2 56.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.181 0.992 . . . . 0.0 112.186 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -152.39 29.27 0.55 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.107 1.363 . . . . 0.0 114.028 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -170.19 -175.08 38.81 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.049 1.309 . . . . 0.0 113.429 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -148.68 164.39 34.47 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.688 1.595 . . . . 0.0 112.789 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.808 1.643 . . . . 0.0 112.784 171.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 1 O4'-C1'-N19 113.432 5.232 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.082 1 O4'-C1'-N19 112.396 4.196 . 0.084 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 0 O4'-C1'-N19 111.103 2.903 . 0.189 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . 0.434 " H1'" ' SD ' ' A' ' 141' ' ' MET . . . . . . . . 0 O4'--C4' 1.416 -3.089 0 O4'-C1'-N19 111.61 3.41 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.389 0 O4'-C1'-N19 111.356 3.156 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 112.109 -0.396 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.0 p -76.54 -28.99 56.52 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.434 1.094 . . . . 0.0 112.932 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -73.55 161.53 30.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.176 1.791 . . . . 0.0 112.542 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 57.4 21.59 7.03 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -70.69 33.2 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.151 1.38 . . . . 0.0 114.342 170.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -145.75 133.75 21.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 111.305 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.19 151.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.381 1.086 . . . . 0.0 111.168 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.73 136.17 34.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.238 2.615 . . . . 0.0 106.939 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 t -126.13 116.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.863 1.265 . . . . 0.0 110.478 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.29 148.29 18.89 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.666 1.127 . . . . 0.0 114.1 -173.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.91 58.94 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.256 1.408 . . . . 0.0 114.49 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.1 mt -65.47 135.69 55.5 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.699 1.2 . . . . 0.0 111.66 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -64.58 142.72 58.33 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.84 -0.538 . . . . 0.0 112.03 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.78 -14.67 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.42 -31.56 63.92 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.71 0.804 . . . . 0.0 112.169 169.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -71.91 125.47 27.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.476 . . . . 0.0 113.625 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.15 166.13 16.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.8 -32.6 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -73.08 -35.5 66.66 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.017 0.927 . . . . 0.0 111.545 174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.91 -49.19 78.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.498 0.59 . . . . 0.0 112.016 169.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -48.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 109.929 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.64 -49.16 77.36 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.665 0.666 . . . . 0.0 111.967 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -60.66 -46.67 89.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 113.037 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.26 19.0 m-85 -64.72 -21.97 66.87 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.321 61.0 m-85 -92.94 -23.58 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -62.6 -18.43 62.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -63.52 -28.95 70.3 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.359 -0.838 . . . . 0.0 113.058 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -83.75 -27.0 29.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.37 175.37 31.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.072 2.272 . . . . 0.0 110.973 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.89 132.64 49.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.453 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.11 133.72 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.633 1.973 . . . . 0.0 107.73 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.63 -46.58 14.18 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.786 1.234 . . . . 0.0 113.773 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -162.71 162.7 26.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 109.836 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.42 153.51 46.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.726 1.61 . . . . 0.0 111.482 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.6 ptm -155.52 151.0 27.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.505 1.122 . . . . 0.0 112.425 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.4 mt -119.29 144.52 46.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.539 1.536 . . . . 0.0 110.381 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 28.9 mmm -95.98 127.61 42.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.786 0.435 . . . . 0.0 110.751 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.426 62.1 m-85 -83.0 143.76 30.42 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 119.503 3.149 . . . . 0.0 119.503 -169.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -97.32 -52.43 3.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.78 0.832 . . . . 0.0 109.871 168.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -135.12 108.37 7.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.928 2.091 . . . . 0.0 108.071 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -28.5 65.09 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 -169.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.4 p -81.63 -6.61 59.17 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -135.61 -54.66 0.78 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -157.93 151.04 23.07 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.194 1.361 . . . . 0.0 113.742 -172.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -84.45 161.45 20.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.084 0.954 . . . . 0.0 112.063 170.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 8.56 8.6 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.366 2.266 . . . . 0.0 114.108 -172.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.81 13.16 59.71 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.022 -1.049 . . . . 0.0 115.034 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -152.25 163.26 39.78 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.139 1.47 . . . . 0.0 110.004 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.04 -170.84 28.5 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.834 1.207 . . . . 0.0 112.954 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.45 153.71 47.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.68 127.6 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.088 1.355 . . . . 0.0 111.948 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -99.92 145.8 27.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.297 1.839 . . . . 0.0 113.558 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.38 154.5 37.62 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -67.91 -34.97 77.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.367 0.667 . . . . 0.0 112.299 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.7 t -140.24 143.37 35.94 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.017 1.327 . . . . 0.0 111.984 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.44 -19.19 64.56 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.093 -0.379 . . . . 0.0 111.364 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.07 -31.12 70.79 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.81 -42.85 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.938 -0.476 . . . . 0.0 110.195 170.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.28 -43.61 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.74 0.7 . . . . 0.0 110.025 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.849 0.859 . . . . 0.0 112.763 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.91 -48.5 79.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.443 1.097 . . . . 0.0 112.353 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.16 -45.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.778 1.631 . . . . 0.0 110.825 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 48.4 t -70.1 -31.27 68.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.192 -0.942 . . . . 0.0 112.925 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.8 -32.55 74.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.803 1.241 . . . . 0.0 112.818 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.22 -34.18 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.9 0.88 . . . . 0.0 111.064 171.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 66.22 -58.91 0.34 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.628 2.771 . . . . 0.0 115.026 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 56.0 m-85 -100.97 121.74 42.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -118.86 168.74 10.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.136 1.774 . . . . 0.0 111.118 -175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -126.68 135.65 51.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.229 1.012 . . . . 0.0 111.699 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.7 mt -140.78 129.08 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.877 1.671 . . . . 0.0 108.746 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 51.24 37.93 19.89 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.417 1.087 . . . . 0.0 113.799 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 64.74 1.15 1.31 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.519 2.328 . . . . 0.0 116.292 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -88.91 133.6 34.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.52 1.128 . . . . 0.0 110.473 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 27.1 ttm -84.1 137.53 33.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.686 0.794 . . . . 0.0 110.71 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 154.66 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.039 1.736 . . . . 0.0 111.589 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -102.93 131.73 49.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.408 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 78.5 m -111.87 134.8 53.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.014 1.326 . . . . 0.0 111.57 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.89 157.73 43.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.02 1.728 . . . . 0.0 110.228 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.92 138.7 58.62 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.168 1.349 . . . . 0.0 112.038 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.99 133.24 41.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.347 0.659 . . . . 0.0 111.959 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -64.61 146.53 98.25 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 122.992 0.517 . . . . 0.0 109.988 168.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.73 -36.85 10.11 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.688 2.259 . . . . 0.0 116.853 -165.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -156.05 44.94 0.44 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -169.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 55.32 48.8 18.42 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.823 1.297 . . . . 0.0 110.752 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.16 -1.78 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -168.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 20.4 mmt -62.02 -33.8 75.03 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.03 1.332 . . . . 0.0 112.428 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.4 t -162.76 139.7 5.98 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 111.458 169.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.62 -14.3 43.41 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.074 2.516 . . . . 0.0 113.164 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.341 0.2 OUTLIER -116.97 19.44 14.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.944 2.098 . . . . 0.0 115.999 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 78.78 -20.33 4.52 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.835 1.683 . . . . 0.0 115.899 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 91.2 p -155.03 157.69 37.99 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.938 1.695 . . . . 0.0 111.04 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.67 132.12 48.8 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.546 -0.721 . . . . 0.0 111.756 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 156.17 39.71 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.519 1.128 . . . . 0.0 112.322 174.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -172.9 175.22 45.92 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.487 1.041 . . . . 0.0 113.732 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 95.0 mtm-85 -69.96 154.69 41.63 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.901 1.28 . . . . 0.0 113.045 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.7 p . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.762 1.625 . . . . 0.0 114.433 174.574 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.332 1 O4'-C1'-N19 114.637 6.437 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.138 0 O4'-C1'-N19 111.53 3.33 . 0.666 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.018 0 N19-C1'-C2' 116.561 1.976 . 0.221 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.511 1 O4'-C1'-N19 114.463 6.263 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.12 0 O4'-C1'-N19 111.123 2.923 . 0.143 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.1 m -139.45 147.89 41.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.699 1.6 . . . . 0.0 111.806 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -149.9 -51.57 0.14 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.11 0.964 . . . . 0.0 113.166 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 98.4 mmm -69.41 -11.56 60.92 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -76.33 46.08 0.4 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.464 1.906 . . . . 0.0 112.285 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -129.28 139.12 51.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.612 1.165 . . . . 0.0 113.846 -167.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -121.02 149.59 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.911 1.284 . . . . 0.0 112.081 173.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -87.11 139.43 30.58 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.054 2.542 . . . . 0.0 108.725 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.24 115.0 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.249 1.42 . . . . 0.0 109.452 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.07 147.63 16.62 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.278 0.942 . . . . 0.0 114.324 -173.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.81 18.34 48.06 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.054 1.312 . . . . 0.0 114.574 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.5 mt -58.44 144.44 42.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.948 1.299 . . . . 0.0 112.218 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 t -64.77 142.55 58.39 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.087 -0.383 . . . . 0.0 110.512 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.98 -14.83 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.64 -29.91 63.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.215 1.006 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.5 m -70.51 136.91 49.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.348 1.459 . . . . 0.0 114.753 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -116.84 164.08 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.516 1.527 . . . . 0.0 114.251 169.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -54.25 -35.5 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.23 -30.79 67.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.35 -44.67 86.94 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.824 0.738 . . . . 0.0 109.257 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.3 -47.03 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.963 1.305 . . . . 0.0 110.612 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.42 -51.02 71.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.694 0.798 . . . . 0.0 111.881 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -58.79 -43.95 90.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.843 0.857 . . . . 0.0 112.662 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.97 -42.7 94.33 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.349 63.6 m-85 -71.32 -28.25 63.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -59.88 -21.79 61.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.04 -33.92 74.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 112.199 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -72.0 -38.56 69.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 170.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.32 165.12 25.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 126.722 2.106 . . . . 0.0 111.497 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.13 134.28 52.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.277 1.037 . . . . 0.0 113.693 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.13 134.02 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.824 2.049 . . . . 0.0 108.237 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.17 -45.56 19.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.294 1.438 . . . . 0.0 113.419 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -161.81 158.82 26.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.426 1.091 . . . . 0.0 110.456 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.15 149.01 40.95 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.871 1.668 . . . . 0.0 111.346 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -154.95 130.76 10.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 0.0 112.513 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.5 mt -101.81 141.17 35.08 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.975 0.91 . . . . 0.0 110.488 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 34.8 mmt -84.18 86.54 7.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.248 0.547 . . . . 0.0 112.137 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.26 37.4 m-85 -66.9 136.23 55.05 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 118.275 2.694 . . . . 0.0 118.275 174.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -97.03 121.55 39.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.6 1.16 . . . . 0.0 113.193 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -63.04 -33.62 75.82 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.25 -50.94 16.89 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -23.86 65.91 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.254 30.7 m-80 58.54 33.02 22.77 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.7 1.6 . . . . 0.0 114.219 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -150.25 164.11 36.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.29 2.236 . . . . 0.0 110.74 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -77.35 153.47 33.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.532 0.682 . . . . 0.0 112.099 169.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -70.93 13.12 0.21 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.75 12.36 80.09 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.153 0.882 . . . . 0.0 114.058 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -150.26 164.38 35.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.841 1.32 . . . . 0.0 110.837 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.55 -168.19 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.041 1.305 . . . . 0.0 113.417 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.89 149.3 50.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.271 1.828 . . . . 0.0 115.158 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.14 130.14 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.162 1.385 . . . . 0.0 111.563 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -108.09 140.99 40.46 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.058 1.743 . . . . 0.0 113.49 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.53 153.72 28.28 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -169.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.49 -34.83 70.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.526 0.73 . . . . 0.0 112.314 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.6 t -132.91 140.95 48.11 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.981 1.312 . . . . 0.0 112.15 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -65.11 -25.62 67.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.247 1.019 . . . . 0.0 111.781 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.5 mm -70.26 -40.78 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.002 -0.436 . . . . 0.0 110.325 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.69 -42.91 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.787 0.721 . . . . 0.0 110.842 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -63.23 -46.98 84.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.599 0.636 . . . . 0.0 112.586 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -56.64 -46.12 81.19 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.393 1.477 . . . . 0.0 112.602 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.84 -47.41 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.059 1.744 . . . . 0.0 110.876 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 67.4 m -66.12 -30.75 71.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.25 -31.0 72.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.897 1.279 . . . . 0.0 112.832 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.54 -33.37 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.363 1.065 . . . . 0.0 111.337 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 64.27 -59.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.611 2.764 . . . . 0.0 115.225 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.334 39.2 m-85 -99.05 119.85 38.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -114.83 170.32 8.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.729 2.012 . . . . 0.0 111.312 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.85 122.98 20.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.55 0.74 . . . . 0.0 112.331 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 34.1 mt -138.26 130.08 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.0 1.72 . . . . 0.0 108.954 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 50.73 47.19 24.89 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.886 1.274 . . . . 0.0 113.914 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.8 t30 59.09 30.63 20.47 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.927 1.691 . . . . 0.0 114.101 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -145.61 156.34 43.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.06 1.744 . . . . 0.0 110.38 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 50.3 mtp -105.48 148.82 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.3 147.15 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.566 1.547 . . . . 0.0 111.737 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -88.85 129.78 35.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.598 0.759 . . . . 0.0 110.305 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.65 132.05 55.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.354 1.062 . . . . 0.0 111.391 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -153.43 151.46 29.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.102 1.361 . . . . 0.0 112.073 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 130.35 45.15 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.608 0.763 . . . . 0.0 111.647 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.04 130.94 42.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -170.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -129.75 151.55 78.32 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 126.774 2.03 . . . . 0.0 111.303 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.11 142.53 38.32 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.852 2.368 . . . . 0.0 112.971 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -60.25 -22.85 63.56 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.7 -27.41 68.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.565 1.546 . . . . 0.0 113.1 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.7 m -98.1 -24.9 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 25.9 mmt -73.57 -27.78 61.5 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.9 t 52.0 56.19 15.62 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.32 1.848 . . . . 0.0 113.848 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.77 0.87 8.25 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.216 3.277 . . . . 0.0 114.356 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.5 p -65.36 -16.77 63.95 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.117 2.266 . . . . 0.0 117.117 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -77.93 -174.77 43.17 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.7 1.143 . . . . 0.0 114.518 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 53.3 m -69.75 -3.72 16.68 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.25 -4.87 32.08 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -57.89 149.45 22.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.992 1.317 . . . . 0.0 114.225 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -85.23 -99.58 0.69 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.173 1.368 . . . . 0.0 112.097 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 56.71 39.33 29.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.288 2.235 . . . . 0.0 113.858 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.794 0.838 . . . . 0.0 111.784 168.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.43 0 O5'-C5'-C4' 113.621 2.444 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.043 0 O4'-C1'-N19 111.612 3.412 . 0.568 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.648 0 O4'-C1'-N19 110.501 2.301 . 0.081 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 1 O4'-C1'-N19 112.831 4.631 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 0 O4'-C1'-N19 111.381 3.181 . 0.149 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.2 m -76.83 -18.12 58.58 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -83.44 168.63 16.35 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.658 1.183 . . . . 0.0 112.548 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.66 154.25 34.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.142 1.377 . . . . 0.0 109.406 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -105.59 6.27 32.01 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 170.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.34 140.91 43.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.279 1.431 . . . . 0.0 111.125 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.8 pt -117.9 150.66 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.64 1.176 . . . . 0.0 110.925 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -86.23 142.83 28.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.055 2.142 . . . . 0.0 107.23 165.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.64 106.53 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.505 1.522 . . . . 0.0 109.722 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.1 141.58 15.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.521 1.058 . . . . 0.0 114.763 -170.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.33 17.54 58.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.783 1.183 . . . . 0.0 114.924 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.82 122.64 15.33 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.694 1.197 . . . . 0.0 110.394 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.3 t -62.84 140.89 58.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.785 0.434 . . . . 0.0 110.795 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.299 0.3 OUTLIER -66.35 -10.27 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -168.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -77.8 -19.19 55.44 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.659 1.184 . . . . 0.0 112.862 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.8 m -71.32 138.87 49.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.291 1.436 . . . . 0.0 112.24 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 t -113.81 162.93 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 173.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.61 -34.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.414 1.485 . . . . 0.0 114.252 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.56 -34.51 75.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.305 0.642 . . . . 0.0 112.279 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.86 -44.09 97.54 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.017 0.826 . . . . 0.0 109.503 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.15 -46.69 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 111.336 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.31 -50.6 73.35 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.059 0.944 . . . . 0.0 112.054 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -64.71 -34.85 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -63.85 -53.34 52.22 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 51.9 m-85 -65.02 -22.2 66.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -63.16 -12.99 31.78 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.31 -29.22 69.95 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.525 1.057 . . . . 0.0 112.546 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -86.18 -31.61 21.67 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.346 1.058 . . . . 0.0 112.82 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.31 168.49 28.57 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 127.729 2.585 . . . . 0.0 110.33 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.61 134.7 54.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.166 0.984 . . . . 0.0 112.082 -169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.0 t -97.63 134.08 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.034 1.733 . . . . 0.0 108.169 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.4 -45.73 15.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.792 1.237 . . . . 0.0 113.764 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -162.89 164.06 26.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.731 1.212 . . . . 0.0 109.866 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.76 153.27 43.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.276 1.43 . . . . 0.0 111.579 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptm -152.03 136.45 16.81 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.706 1.202 . . . . 0.0 111.618 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.1 mt -107.85 153.52 22.9 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.83 0.852 . . . . 0.0 110.303 168.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.8 mmm -82.47 71.67 9.54 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.924 0.869 . . . . 0.0 111.317 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -70.6 155.48 40.67 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -172.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -119.66 105.07 10.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.417 2.287 . . . . 0.0 110.976 167.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.06 -9.38 21.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -33.7 76.02 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 169.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -139.4 -3.53 1.52 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.277 76.4 m-20 62.16 12.61 5.19 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.097 2.159 . . . . 0.0 115.497 -170.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.27 169.39 16.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.793 1.237 . . . . 0.0 110.182 167.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -142.76 168.54 19.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.192 0.997 . . . . 0.0 112.446 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -67.33 2.42 1.69 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.13 68.37 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.432 1.015 . . . . 0.0 114.888 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -153.09 168.74 24.91 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.345 1.072 . . . . 0.0 110.139 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.94 -167.77 27.08 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.455 1.026 . . . . 0.0 113.085 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -126.7 150.12 49.19 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.085 1.754 . . . . 0.0 114.976 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.58 122.08 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.017 1.327 . . . . 0.0 111.153 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m -93.54 143.08 26.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.492 1.917 . . . . 0.0 113.78 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -115.41 155.69 26.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -66.95 -36.06 81.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.327 0.651 . . . . 0.0 111.608 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -142.95 141.83 31.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 0.0 112.837 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -61.5 -20.59 63.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.007 1.323 . . . . 0.0 113.004 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.9 -25.73 67.29 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.9 -40.86 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.749 -0.594 . . . . 0.0 110.193 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -58.01 -45.39 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 110.191 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -66.11 -35.78 81.41 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.832 0.742 . . . . 0.0 112.784 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.0 -46.29 85.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.586 1.555 . . . . 0.0 111.977 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.74 -47.61 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.608 1.563 . . . . 0.0 110.699 175.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.1 m -65.08 -30.71 71.68 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -64.9 -26.64 68.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.695 1.198 . . . . 0.0 113.402 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.47 -32.25 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.112 0.965 . . . . 0.0 111.119 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 67.69 -49.82 0.51 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.867 2.867 . . . . 0.0 115.488 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.33 49.2 m-85 -114.5 123.83 50.39 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -121.27 157.07 31.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.783 2.033 . . . . 0.0 110.885 -171.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -117.18 114.81 24.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.981 -174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 38.5 mt -131.33 125.39 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.51 1.124 . . . . 0.0 109.634 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 49.7 37.09 12.12 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.448 1.099 . . . . 0.0 112.971 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.251 33.7 m120 61.41 4.66 1.0 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.806 2.442 . . . . 0.0 116.864 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -86.61 138.81 31.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.473 1.109 . . . . 0.0 110.105 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.2 mmm -82.6 131.62 35.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.518 0.727 . . . . 0.0 110.537 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.04 148.22 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.099 1.359 . . . . 0.0 111.748 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -96.11 125.39 40.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.721 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -89.87 135.44 33.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.179 0.592 . . . . 0.0 110.801 168.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -142.09 149.79 40.35 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.01 1.324 . . . . 0.0 109.666 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -61.61 135.35 57.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.515 1.052 . . . . 0.0 110.522 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.95 137.51 49.24 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -134.82 148.91 69.06 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.968 1.307 . . . . 0.0 111.604 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.33 149.48 88.27 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.327 2.685 . . . . 0.0 113.862 -172.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -67.14 -16.64 64.44 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 173.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -72.6 -22.78 60.92 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.987 1.315 . . . . 0.0 112.894 169.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.63 -49.2 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.381 1.473 . . . . 0.0 110.602 169.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 70.7 mtp -82.37 60.22 4.95 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.034 1.734 . . . . 0.0 112.02 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.1 m -59.78 -37.06 45.73 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.58 137.17 53.45 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.224 2.616 . . . . 0.0 113.134 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.23 -14.43 62.96 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 75.03 -34.1 1.07 Allowed Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.789 1.662 . . . . 0.0 115.591 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.6 t -64.65 153.52 39.23 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.547 1.539 . . . . 0.0 113.091 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.37 151.42 37.44 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.702 1.601 . . . . 0.0 112.091 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -81.16 -8.25 59.72 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.99 154.2 52.82 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 124.38 0.991 . . . . 0.0 114.349 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -149.87 135.71 18.59 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.901 1.68 . . . . 0.0 110.942 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.201 1.4 . . . . 0.0 111.369 174.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.724 0 O5'-C5'-C4' 114.314 2.938 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.339 0 O4'-C1'-N19 112.095 3.895 . 0.024 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.503 0 O4'-C1'-N19 111.803 3.603 . 0.241 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.429 0 C4'-C3'-C2' 99.517 -3.183 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.431 -1.851 1 O4'-C1'-N19 113.857 5.657 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.6 p -72.37 160.66 31.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.74 1.216 . . . . 0.0 113.908 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -66.2 163.37 17.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.881 1.673 . . . . 0.0 112.817 171.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 77.7 mtm -59.24 142.1 52.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.57 0.748 . . . . 0.0 112.081 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -75.93 39.87 0.19 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.476 1.11 . . . . 0.0 112.848 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -132.64 138.13 47.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.843 1.257 . . . . 0.0 112.569 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.7 pt -117.26 149.82 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.783 1.233 . . . . 0.0 111.604 172.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -85.87 138.93 31.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.911 2.084 . . . . 0.0 108.257 163.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.86 108.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 109.609 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.07 147.43 17.78 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.4 9.98 58.58 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.647 1.117 . . . . 0.0 114.206 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.24 134.95 57.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.121 1.461 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.0 t -61.57 143.27 56.3 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.206 -0.309 . . . . 0.0 111.367 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -60.78 -18.43 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -75.42 -25.78 57.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.827 1.251 . . . . 0.0 113.295 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.8 m -70.94 134.16 46.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.221 1.408 . . . . 0.0 113.271 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -106.49 158.4 16.94 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.191 1.396 . . . . 0.0 113.613 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -56.54 -32.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.87 -30.02 67.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -65.17 -47.11 78.12 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.641 0.777 . . . . 0.0 111.459 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -60.77 -45.82 92.85 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.835 -0.541 . . . . 0.0 112.287 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -59.85 -44.27 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.116 0.871 . . . . 0.0 113.307 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -58.98 -33.94 71.26 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 55.9 m-85 -85.65 -24.97 26.85 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 174.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -60.82 -16.25 38.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -42.11 87.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 112.375 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -79.07 -29.66 43.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.91 -173.96 38.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.975 1.75 . . . . 0.0 111.949 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.11 107.34 3.62 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.638 -0.919 . . . . 0.0 112.645 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.07 130.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.308 1.443 . . . . 0.0 109.609 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.38 -57.38 3.9 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.12 0.968 . . . . 0.0 112.727 173.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -157.48 164.74 37.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.953 0.901 . . . . 0.0 110.467 -170.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.03 41.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.481 1.512 . . . . 0.0 111.404 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -154.44 129.71 9.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.182 0.993 . . . . 0.0 113.136 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.78 144.62 26.51 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.476 1.11 . . . . 0.0 111.209 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 32.6 mmt -93.96 82.63 4.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.065 0.936 . . . . 0.0 111.551 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.294 50.9 m-85 -60.2 137.45 58.11 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -81.08 -54.32 5.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.712 0.805 . . . . 0.0 110.839 168.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.2 114.72 11.09 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.624 1.97 . . . . 0.0 107.608 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -27.71 66.62 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.287 2.329 . . . . 0.0 117.287 -169.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 t -76.56 -9.99 59.06 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -129.25 -64.01 0.92 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -169.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -157.41 156.27 31.92 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -168.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -113.54 161.64 17.15 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.231 1.413 . . . . 0.0 112.848 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -73.75 11.09 0.91 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.6 13.89 83.02 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.112 -0.826 . . . . 0.0 114.367 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -145.2 161.78 38.7 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.215 1.507 . . . . 0.0 112.052 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.9 -179.19 34.53 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.868 1.223 . . . . 0.0 112.471 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -116.79 149.14 40.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.563 1.545 . . . . 0.0 114.922 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.0 124.17 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.87 1.268 . . . . 0.0 111.523 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.52 142.67 33.88 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.691 1.997 . . . . 0.0 114.068 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.13 149.79 40.45 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.0 113.998 -172.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.55 -40.93 48.34 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.03 -0.419 . . . . 0.0 111.721 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 12.9 m -110.71 132.05 54.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 112.144 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -63.18 -34.09 76.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.476 1.111 . . . . 0.0 112.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -58.76 -28.33 65.81 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.3 mm -70.9 -39.76 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.753 -0.592 . . . . 0.0 110.465 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.94 -42.18 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.569 0.622 . . . . 0.0 110.25 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.4 -47.71 80.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.629 0.772 . . . . 0.0 111.84 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -57.32 -50.59 72.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.664 1.186 . . . . 0.0 112.234 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.7 -45.0 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 111.062 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 35.2 t -71.21 -32.37 68.74 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.415 -0.803 . . . . 0.0 112.643 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.25 -32.71 74.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.61 1.164 . . . . 0.0 112.723 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.4 -35.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.982 0.913 . . . . 0.0 111.18 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 66.7 -51.84 0.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.525 2.73 . . . . 0.0 115.06 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.261 74.5 m-85 -108.71 125.84 52.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 176.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -132.24 155.87 47.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.407 1.483 . . . . 0.0 112.376 -169.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -107.96 127.6 53.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.228 1.011 . . . . 0.0 111.408 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 44.6 mt -137.05 124.36 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.737 1.615 . . . . 0.0 109.035 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.46 36.11 12.65 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.225 1.01 . . . . 0.0 113.223 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.82 6.19 1.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.609 2.363 . . . . 0.0 116.765 -171.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.02 143.96 26.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.001 1.721 . . . . 0.0 109.992 169.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 41.5 tpp -85.15 133.89 34.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.374 1.07 . . . . 0.0 110.876 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.83 152.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.871 1.669 . . . . 0.0 113.703 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -104.27 123.78 47.97 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.831 1.252 . . . . 0.0 110.591 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 83.7 m -104.88 130.94 52.93 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.063 1.345 . . . . 0.0 111.072 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -153.28 145.35 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.026 1.33 . . . . 0.0 111.582 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.42 137.31 57.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.15 0.886 . . . . 0.0 112.265 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.01 131.38 45.73 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 122.963 0.505 . . . . 0.0 112.258 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -129.68 155.49 80.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.911 1.685 . . . . 0.0 111.834 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -62.6 145.0 95.22 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.311 2.674 . . . . 0.0 115.318 -170.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -61.74 -28.28 69.32 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -78.9 -27.92 43.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.531 1.532 . . . . 0.0 113.315 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.71 -28.5 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 58.3 mtp -99.93 17.14 21.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.772 1.629 . . . . 0.0 114.539 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.4 p -60.55 145.87 86.43 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 121.108 -0.995 . . . . 0.0 113.138 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.96 143.78 61.73 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.287 2.658 . . . . 0.0 112.775 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 p -79.72 -17.42 53.59 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 168.8 -162.06 35.8 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.106 1.336 . . . . 0.0 113.177 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.2 t -65.9 155.36 36.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.259 1.024 . . . . 0.0 112.668 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.69 -15.17 63.51 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.819 1.248 . . . . 0.0 114.178 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -148.99 156.24 41.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.781 1.632 . . . . 0.0 112.417 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 169.33 174.05 37.45 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.712 1.149 . . . . 0.0 113.555 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -70.04 124.09 23.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.064 1.346 . . . . 0.0 111.403 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.917 1.687 . . . . 0.0 113.179 178.625 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.27 0 C5'-C4'-C3' 110.101 -3.599 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.665 1 C5'-C4'-C3' 108.207 -4.862 . 0.432 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.325 0 O4'-C1'-N19 112.191 3.991 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.162 1 O4'-C1'-N19 113.277 5.077 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.525 1 O4'-C1'-N19 113.297 5.097 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.36 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.2 t -67.24 120.62 14.08 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.683 1.193 . . . . 0.0 112.673 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -75.32 -28.99 59.87 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.875 0.87 . . . . 0.0 111.783 169.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 96.4 mtp -66.94 -36.08 81.42 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.463 1.105 . . . . 0.0 113.301 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt 50.61 39.59 21.78 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.36 1.464 . . . . 0.0 113.732 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HE2' ' CD1' ' A' ' 154' ' ' PHE . 85.1 tttt -115.72 139.66 49.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.219 1.407 . . . . 0.0 112.099 -169.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.2 pt -121.94 150.15 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.12 1.368 . . . . 0.0 111.202 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -84.3 145.84 28.06 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.924 2.09 . . . . 0.0 107.379 166.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.12 117.28 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.736 1.614 . . . . 0.0 110.153 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.0 149.73 17.34 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.356 0.979 . . . . 0.0 114.037 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.0 55.48 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 124.951 1.262 . . . . 0.0 114.913 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.6 mt -68.38 135.39 51.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.881 1.273 . . . . 0.0 111.508 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.9 p -69.48 151.1 46.46 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.341 -0.849 . . . . 0.0 111.849 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -65.17 -16.23 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -79.77 -28.55 40.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.609 1.164 . . . . 0.0 112.941 171.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.8 m -71.22 136.99 48.31 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.486 1.115 . . . . 0.0 110.763 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.02 163.35 17.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.86 -36.58 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -173.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.06 -35.81 80.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.518 0.727 . . . . 0.0 112.468 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.14 -47.76 75.96 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.38 -42.25 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.049 0.539 . . . . 0.0 111.844 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -59.35 -53.05 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.603 0.638 . . . . 0.0 111.803 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -60.11 -38.74 83.87 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.282 33.3 m-85 -66.22 -16.48 64.03 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 52.5 m-85 -99.37 -26.76 14.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.55 -22.3 43.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.575 1.55 . . . . 0.0 114.234 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -62.77 -29.46 70.71 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -83.45 -27.44 29.5 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.82 169.19 21.92 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.355 2.407 . . . . 0.0 110.491 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -61.61 132.17 52.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.077 0.942 . . . . 0.0 113.279 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.45 124.46 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.667 1.987 . . . . 0.0 109.342 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.04 -56.25 7.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -146.54 160.01 42.69 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.24 40.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.777 1.231 . . . . 0.0 110.466 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptm -153.49 124.63 7.44 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.748 1.219 . . . . 0.0 111.159 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.8 mt -103.62 153.37 20.69 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.595 0.758 . . . . 0.0 111.413 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.411 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 37.6 mmt -76.71 62.47 2.0 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.072 1.349 . . . . 0.0 113.502 -173.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -65.78 136.53 56.34 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -99.25 113.19 25.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.178 1.391 . . . . 0.0 112.423 169.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -59.16 -18.67 38.21 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -25.13 63.57 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 172.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -134.84 -16.45 1.98 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 -173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 61.3 12.8 4.45 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.718 2.007 . . . . 0.0 115.318 -170.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -94.65 163.48 13.36 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.276 1.43 . . . . 0.0 109.994 168.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -114.6 163.84 14.85 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.857 0.863 . . . . 0.0 113.13 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -68.62 3.38 1.88 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.59 14.55 75.66 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.217 -0.927 . . . . 0.0 114.712 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.411 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 32.1 p90 -148.6 168.09 23.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.051 0.926 . . . . 0.0 110.441 174.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -172.57 -166.62 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.984 1.278 . . . . 0.0 113.189 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.455 ' CD1' ' HE2' ' A' ' 110' ' ' LYS . 94.6 m-85 -128.6 154.05 46.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 115.186 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.95 140.31 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.756 1.622 . . . . 0.0 110.854 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -123.05 136.89 55.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.848 2.059 . . . . 0.0 114.358 -174.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -110.87 156.65 20.85 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -168.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -63.97 -41.72 97.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.271 1.028 . . . . 0.0 112.302 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.4 t -137.78 143.04 40.89 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.624 1.17 . . . . 0.0 112.414 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -62.62 -26.29 68.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.299 1.04 . . . . 0.0 111.903 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.08 -32.92 71.4 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.51 -42.02 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.389 171.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.16 -43.52 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.843 0.747 . . . . 0.0 110.697 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.95 -47.99 80.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.395 0.678 . . . . 0.0 112.828 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.83 -47.07 81.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.734 1.213 . . . . 0.0 112.345 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.46 -48.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.705 1.602 . . . . 0.0 110.617 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.54 -34.73 78.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -61.66 -27.22 68.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.997 1.319 . . . . 0.0 113.652 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.41 -33.15 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 0.0 111.321 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 65.73 -53.22 0.37 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 128.886 2.875 . . . . 0.0 115.32 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 57.3 m-85 -108.14 122.2 46.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -123.67 151.04 43.51 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.359 1.464 . . . . 0.0 112.606 -169.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -101.64 126.05 48.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.998 0.919 . . . . 0.0 110.903 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 10.4 mt -138.03 125.61 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.74 1.616 . . . . 0.0 108.811 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.27 37.01 13.97 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.395 1.078 . . . . 0.0 113.463 -173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 61.96 7.1 1.93 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.044 2.138 . . . . 0.0 116.003 -171.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -95.34 163.01 13.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.87 1.668 . . . . 0.0 111.421 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -95.37 129.38 42.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.362 1.465 . . . . 0.0 111.061 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.1 165.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.589 1.556 . . . . 0.0 113.151 173.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -123.22 130.32 52.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.388 1.075 . . . . 0.0 111.762 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.72 144.44 25.51 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.982 0.913 . . . . 0.0 111.92 168.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -140.08 149.6 43.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.969 1.307 . . . . 0.0 108.591 170.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -64.56 131.18 46.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.983 1.265 . . . . 0.0 110.732 170.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.83 150.62 37.64 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -144.78 150.66 47.32 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.504 1.521 . . . . 0.0 110.313 170.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.83 159.18 38.85 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.169 2.579 . . . . 0.0 115.832 -169.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -54.69 -28.82 50.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.408 2.283 . . . . 0.0 114.898 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -78.2 -25.63 47.16 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.707 1.603 . . . . 0.0 113.743 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.84 -34.02 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -169.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -158.18 163.03 37.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.706 1.602 . . . . 0.0 110.847 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 90.3 p -144.71 159.67 50.0 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 128.463 2.705 . . . . 0.0 111.003 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.73 147.93 45.8 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.67 2.247 . . . . 0.0 112.225 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.5 t -151.24 157.49 42.65 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 162.69 -173.39 38.92 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.41 1.481 . . . . 0.0 113.168 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.0 p -65.46 148.91 50.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.311 1.044 . . . . 0.0 112.995 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.69 -19.04 62.12 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -60.77 151.23 30.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.106 1.762 . . . . 0.0 113.008 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.63 161.43 54.1 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.094 0.854 . . . . 0.0 113.609 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 -72.14 139.81 48.5 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.605 1.162 . . . . 0.0 111.633 174.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.539 1.936 . . . . 0.0 112.493 -178.794 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.103 1 O4'-C1'-N19 112.419 4.219 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.204 0 O4'-C1'-N19 111.224 3.024 . 0.605 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 111.591 3.391 . 0.282 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.733 0 C5'-C4'-C3' 110.109 -3.594 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.219 0 O4'-C1'-N19 111.376 3.176 . 0.497 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 m -76.18 68.73 2.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.949 1.3 . . . . 0.0 113.089 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.79 -32.26 73.43 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.865 1.266 . . . . 0.0 113.295 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.39 144.37 57.12 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.776 1.231 . . . . 0.0 111.617 175.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -116.88 17.46 15.04 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -170.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.555 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 81.3 tttt -105.86 132.73 51.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.278 1.831 . . . . 0.0 111.583 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -120.3 150.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.918 1.287 . . . . 0.0 111.339 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -85.99 142.64 28.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.462 1.905 . . . . 0.0 109.441 165.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -126.6 100.55 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.519 1.528 . . . . 0.0 109.943 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.43 144.38 17.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.501 1.048 . . . . 0.0 113.952 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 19.72 54.09 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.41 1.005 . . . . 0.0 115.181 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.6 135.57 55.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.519 1.159 . . . . 0.0 111.379 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -66.81 144.0 56.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.024 0.53 . . . . 0.0 111.295 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 m -59.54 -16.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.98 -27.78 62.01 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.484 1.114 . . . . 0.0 113.303 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -77.11 131.24 38.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.637 1.575 . . . . 0.0 113.608 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.96 165.54 15.15 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.01 -34.98 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -71.46 -36.69 71.3 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 111.595 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -55.84 -51.67 66.69 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.411 0.551 . . . . 0.0 111.949 169.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.67 -42.58 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.9 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -57.59 -52.96 63.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.814 0.734 . . . . 0.0 111.123 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -62.48 -39.83 94.72 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.259 22.5 m-85 -63.67 -20.01 65.36 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 60.6 m-85 -97.3 -27.23 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 169.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.4 -23.51 38.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.223 1.409 . . . . 0.0 114.532 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -62.86 -29.78 71.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -85.75 -35.81 20.54 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.665 0.786 . . . . 0.0 111.628 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.69 163.04 24.97 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.179 2.799 . . . . 0.0 109.328 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -66.88 155.66 37.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -169.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.97 121.29 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.195 -1.82 . . . . 0.0 108.649 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -73.2 -39.6 65.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.746 1.218 . . . . 0.0 111.244 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.13 144.33 18.65 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.924 2.09 . . . . 0.0 115.206 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -132.16 148.17 52.46 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.621 1.168 . . . . 0.0 110.66 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -148.66 138.38 22.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.34 1.056 . . . . 0.0 111.564 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 46.1 mt -100.18 139.61 35.61 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.686 0.795 . . . . 0.0 110.444 170.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.7 mmm -89.49 138.9 31.05 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 122.892 0.477 . . . . 0.0 110.09 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.321 22.4 m-85 -102.46 145.35 29.68 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -175.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -69.83 126.82 30.86 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 168.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -70.1 3.22 2.9 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -169.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.7 p -70.76 -20.59 62.6 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.963 1.705 . . . . 0.0 109.057 164.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.522 0.3 OUTLIER 71.3 22.54 4.28 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.97 2.508 . . . . 0.0 116.277 -168.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.58 -59.43 2.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -149.02 168.98 21.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.723 2.009 . . . . 0.0 111.437 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -68.34 147.74 51.7 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.578 0.704 . . . . 0.0 110.987 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -79.16 11.8 2.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.594 2.358 . . . . 0.0 113.598 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.931 -1.106 . . . . 0.0 115.466 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.34 166.36 32.1 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.652 1.226 . . . . 0.0 112.329 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.25 -179.71 35.21 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.12 0.867 . . . . 0.0 113.529 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.555 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 95.7 m-85 -117.94 148.15 42.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.069 1.748 . . . . 0.0 115.248 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.8 t -137.03 126.83 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.918 1.287 . . . . 0.0 111.961 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -106.14 131.91 52.83 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.101 2.161 . . . . 0.0 114.479 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -102.54 159.49 15.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 120.33 3.455 . . . . 0.0 120.33 -167.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -58.32 -38.76 77.75 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.22 2.208 . . . . 0.0 113.501 170.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.9 t -155.26 153.42 30.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.408 1.483 . . . . 0.0 111.337 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -60.17 -32.3 70.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 111.25 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -61.96 -34.18 75.65 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.02 -42.93 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.179 -0.439 . . . . 0.0 110.195 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.95 -43.88 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.814 0.734 . . . . 0.0 110.511 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.31 -46.45 88.69 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.45 -45.5 88.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.59 1.156 . . . . 0.0 112.418 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.14 -48.91 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.002 1.721 . . . . 0.0 110.646 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.96 -30.58 71.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -64.55 -27.92 69.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 113.276 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.02 -33.27 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.208 1.003 . . . . 0.0 111.256 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 65.34 -58.84 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.543 2.737 . . . . 0.0 114.667 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 54.1 m-85 -104.3 116.97 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -112.15 152.69 28.04 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.91 1.684 . . . . 0.0 111.47 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.69 125.15 48.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.748 0.819 . . . . 0.0 110.495 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.04 122.46 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.545 1.538 . . . . 0.0 108.901 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 50.2 35.84 11.23 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.0 m120 63.03 2.12 0.98 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.427 2.291 . . . . 0.0 116.611 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -83.52 138.67 33.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.444 1.498 . . . . 0.0 109.112 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.8 mmm -86.43 129.82 34.72 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.833 -0.542 . . . . 0.0 110.78 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.13 152.2 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.526 1.53 . . . . 0.0 112.605 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -105.51 120.41 41.55 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.082 0.953 . . . . 0.0 111.654 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.33 141.86 28.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.151 0.58 . . . . 0.0 111.415 168.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -148.28 146.29 28.54 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 109.006 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.88 137.25 58.23 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.753 1.161 . . . . 0.0 110.155 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.12 133.81 49.53 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.577 0.703 . . . . 0.0 112.164 -174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -142.49 156.63 63.51 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.312 2.245 . . . . 0.0 111.855 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.0 167.87 26.15 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.276 2.651 . . . . 0.0 112.522 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -57.59 -12.15 2.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.321 1.848 . . . . 0.0 115.086 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -62.88 -26.46 68.79 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.155 1.382 . . . . 0.0 113.374 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.334 2.2 m -81.88 15.98 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -177.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 91.6 mtp -75.19 46.53 0.32 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.691 1.596 . . . . 0.0 113.568 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.6 p -68.79 152.86 96.52 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.441 1.096 . . . . 0.0 112.094 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.68 138.69 38.69 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.069 2.513 . . . . 0.0 112.703 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.306 1.3 p -130.67 15.62 5.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.33 1.852 . . . . 0.0 115.905 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 83.89 172.89 49.37 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.752 1.168 . . . . 0.0 113.372 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 39.7 t -68.97 -40.78 78.66 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.71 168.04 27.91 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.652 1.581 . . . . 0.0 111.791 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -67.01 -16.45 64.37 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 79.98 173.82 46.16 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.308 1.432 . . . . 0.0 114.389 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -78.86 91.66 4.79 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.169 1.387 . . . . 0.0 111.786 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.785 1.634 . . . . 0.0 112.37 169.589 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.124 0 O4'-C1'-N19 111.524 3.324 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.419 0 O5'-C5'-C4' 113.624 2.445 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.369 1 C1'-O4'-C4' 105.286 -4.793 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.626 0 C5'-C4'-C3' 109.855 -3.763 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.28 0 O4'-C1'-N19 110.967 2.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 54.5 p -69.21 159.05 33.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.916 1.286 . . . . 0.0 113.694 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -136.36 -73.04 0.44 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.548 1.539 . . . . 0.0 112.002 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 52.8 tpp -164.49 145.47 8.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.878 1.271 . . . . 0.0 111.687 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -74.79 36.28 0.11 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.367 1.467 . . . . 0.0 114.714 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -142.08 138.92 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.789 -1.194 . . . . 0.0 113.041 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.69 151.91 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.932 1.293 . . . . 0.0 111.159 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.27 144.52 27.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.316 2.246 . . . . 0.0 106.546 165.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.08 108.9 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.806 1.642 . . . . 0.0 108.899 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.44 147.96 18.61 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.444 1.021 . . . . 0.0 114.531 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.56 19.96 36.25 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.896 1.236 . . . . 0.0 114.734 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.17 134.98 53.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.774 1.23 . . . . 0.0 111.466 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 t -63.24 152.39 37.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.928 0.891 . . . . 0.0 112.488 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 m -59.61 -20.08 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.625 1.17 . . . . 0.0 113.535 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -79.56 -25.91 41.51 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.572 1.149 . . . . 0.0 112.893 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 36.2 m -73.78 140.96 46.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.077 1.351 . . . . 0.0 113.713 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -122.87 164.13 19.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.736 1.614 . . . . 0.0 114.903 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.08 -35.84 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.17 -29.83 67.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.593 0.757 . . . . 0.0 112.775 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.41 -48.93 68.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.67 -43.01 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.821 0.848 . . . . 0.0 111.742 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.98 -46.54 90.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.156 0.582 . . . . 0.0 111.801 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -59.38 -45.26 91.95 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.986 0.914 . . . . 0.0 113.088 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -63.69 -35.33 80.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.346 62.3 m-85 -84.03 -25.82 29.58 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -59.37 -21.13 59.39 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.82 -31.81 73.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.119 1.367 . . . . 0.0 112.322 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -80.89 -26.54 36.78 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.0 165.0 15.18 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.993 2.235 . . . . 0.0 110.974 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.99 133.43 56.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.958 0.885 . . . . 0.0 112.638 -171.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.97 125.23 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.96 1.704 . . . . 0.0 108.093 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.99 -35.43 59.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -163.87 157.48 18.81 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.17 0.988 . . . . 0.0 110.435 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.9 150.49 43.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 111.218 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptm -153.88 133.73 13.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.633 1.173 . . . . 0.0 111.883 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.6 mt -103.9 147.66 27.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 170.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.9 mmm -97.94 108.17 20.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -171.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.287 53.9 m-85 -80.84 149.4 29.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -90.7 169.05 11.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.042 1.737 . . . . 0.0 114.048 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -69.22 5.29 1.29 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 18.4 p -66.36 -21.88 66.25 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.395 1.078 . . . . 0.0 108.702 164.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.434 0.8 OUTLIER 62.91 14.23 7.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.322 2.249 . . . . 0.0 114.765 -169.54 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -140.8 -18.28 0.84 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -167.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -127.87 144.44 51.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.958 1.303 . . . . 0.0 112.148 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -101.26 159.57 15.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.612 1.165 . . . . 0.0 112.633 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 -72.76 9.85 1.02 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.42 22.16 77.83 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.122 -0.986 . . . . 0.0 113.853 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -150.34 166.27 30.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.518 1.151 . . . . 0.0 108.222 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.92 -170.33 23.35 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.79 1.186 . . . . 0.0 113.088 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.47 152.68 36.51 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.677 1.591 . . . . 0.0 114.486 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.79 127.41 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.13 1.372 . . . . 0.0 110.835 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.09 139.1 38.16 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.854 2.062 . . . . 0.0 113.759 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -112.09 155.34 24.02 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -66.87 -34.86 78.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.454 0.702 . . . . 0.0 112.087 172.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.5 t -141.64 143.51 33.67 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 112.206 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -67.01 -20.42 65.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.747 0.819 . . . . 0.0 111.976 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.62 -31.44 71.52 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.8 mm -72.84 -40.8 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.283 171.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.18 -44.85 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.941 0.791 . . . . 0.0 109.957 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -63.95 -45.0 91.11 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -56.91 -46.38 82.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.367 1.067 . . . . 0.0 111.868 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.88 -49.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.885 1.674 . . . . 0.0 110.651 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.15 -33.29 75.15 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.88 -27.38 68.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.462 1.105 . . . . 0.0 113.459 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.1 mt -72.56 -31.66 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.743 1.217 . . . . 0.0 111.754 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 66.04 -48.89 0.41 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 128.87 2.868 . . . . 0.0 115.607 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 51.8 m-85 -117.51 122.46 43.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -120.89 149.4 42.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 111.899 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -87.57 131.77 34.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.327 0.651 . . . . 0.0 111.846 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.8 mt -141.23 125.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.488 1.915 . . . . 0.0 108.74 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 51.27 41.36 27.88 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.726 1.211 . . . . 0.0 114.255 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 64.5 t30 60.27 21.13 10.57 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.13 1.772 . . . . 0.0 114.654 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -120.4 167.18 12.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.203 2.201 . . . . 0.0 110.318 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 95.9 mmm -105.52 141.19 37.43 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.928 0.891 . . . . 0.0 112.448 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.68 149.62 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.838 1.655 . . . . 0.0 112.29 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -94.78 127.76 41.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.023 0.929 . . . . 0.0 111.391 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.67 135.0 35.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.712 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -138.63 149.7 45.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.599 1.559 . . . . 0.0 109.585 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -61.15 136.29 58.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.959 1.254 . . . . 0.0 110.685 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -72.89 115.65 12.44 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.758 0.423 . . . . 0.0 110.838 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -102.68 153.48 38.17 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.546 1.138 . . . . 0.0 111.517 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.21 147.79 93.66 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.164 2.576 . . . . 0.0 112.903 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -66.28 -20.36 66.08 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.213 -0.93 . . . . 0.0 113.466 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -67.98 -28.57 67.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.92 1.688 . . . . 0.0 112.779 169.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.14 -46.32 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.249 1.42 . . . . 0.0 111.09 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 93.1 mmm -74.66 -19.64 60.19 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.8 t 65.52 126.51 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 128.431 2.692 . . . . 0.0 113.022 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.0 132.85 38.53 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.666 2.244 . . . . 0.0 111.414 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.7 t -161.71 176.0 11.41 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -169.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -169.79 156.0 26.45 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.592 1.091 . . . . 0.0 112.665 172.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -58.08 133.67 55.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.359 0.664 . . . . 0.0 112.325 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.32 -29.85 64.22 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -155.99 142.67 18.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.509 1.524 . . . . 0.0 111.427 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -168.38 168.0 40.63 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.13 1.347 . . . . 0.0 112.451 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.04 -55.81 0.17 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 128.434 2.693 . . . . 0.0 115.277 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 C--O 1.252 1.205 0 C-N-CA 126.585 1.954 . . . . 0.0 113.135 176.178 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.562 0 O5'-C5'-C4' 114.012 2.723 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.179 0 O4'-C1'-N19 111.639 3.439 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.142 0 O4'-C1'-N19 111.727 3.527 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.276 0 O4'-C1'-N19 111.689 3.489 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.067 1 O4'-C1'-N19 112.437 4.237 . 0.019 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.7 t -153.95 146.14 23.77 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.968 1.307 . . . . 0.0 111.583 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 64.67 -31.15 0.12 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.082 2.953 . . . . 0.0 116.606 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 35.3 mmt -73.72 53.99 0.46 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.807 2.043 . . . . 0.0 112.984 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.07 32.19 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.192 2.197 . . . . 0.0 114.736 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -118.89 137.96 53.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.805 1.242 . . . . 0.0 112.761 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.3 pt -118.17 152.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.871 1.268 . . . . 0.0 111.065 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.437 ' CD1' ' HE2' ' A' ' 182' ' ' LYS . 49.8 t80 -87.62 141.44 28.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.745 2.018 . . . . 0.0 108.098 165.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.81 114.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.227 1.411 . . . . 0.0 109.347 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.11 144.37 18.41 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.423 1.011 . . . . 0.0 114.334 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.59 20.56 50.9 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.523 1.058 . . . . 0.0 114.562 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.0 mt -61.91 141.42 58.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.6 1.2 . . . . 0.0 111.103 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.32 141.7 58.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.888 -0.508 . . . . 0.0 111.128 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.01 -17.34 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.44 -25.85 50.99 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.543 1.137 . . . . 0.0 112.876 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 140.06 55.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.112 1.365 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -113.67 161.1 17.88 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.004 1.322 . . . . 0.0 114.42 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -54.7 -34.51 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.48 -31.35 68.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -64.6 -42.19 95.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.897 0.772 . . . . 0.0 109.25 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.7 -48.83 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.585 1.154 . . . . 0.0 111.3 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -60.26 -48.29 82.37 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.629 0.65 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -58.53 -41.17 84.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.672 0.789 . . . . 0.0 112.796 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.7 -47.01 82.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 57.5 m-85 -70.2 -25.89 63.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -60.48 -43.66 96.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.622 1.169 . . . . 0.0 112.784 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.46 -35.63 70.94 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 113.04 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.62 166.12 26.17 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.123 2.297 . . . . 0.0 110.731 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.072 0.939 . . . . 0.0 112.978 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.6 t -106.79 129.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.556 1.943 . . . . 0.0 108.395 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.89 -56.59 5.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 112.163 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -155.46 161.46 40.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.048 0.939 . . . . 0.0 110.319 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.44 152.63 38.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.47 1.508 . . . . 0.0 111.044 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -154.17 132.0 11.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.975 0.91 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.5 mt -100.59 137.49 38.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.27 1.028 . . . . 0.0 111.087 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.3 mmt -87.42 121.8 30.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.885 0.474 . . . . 0.0 112.264 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.378 25.2 m-85 -83.87 145.28 28.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -68.28 136.83 54.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.492 1.517 . . . . 0.0 109.067 169.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -64.38 -18.2 64.46 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -168.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -3.48 9.56 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 167.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.475 0.7 OUTLIER 63.67 19.19 11.59 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.723 2.009 . . . . 0.0 115.28 -169.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -77.94 -51.8 9.84 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -168.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.3 167.45 25.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.467 1.907 . . . . 0.0 111.405 -172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -79.58 150.7 30.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.56 0.618 . . . . 0.0 110.779 168.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -77.78 19.22 0.4 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.218 1.407 . . . . 0.0 114.709 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.42 22.52 76.44 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.128 -0.982 . . . . 0.0 113.824 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -151.7 164.0 37.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.559 1.179 . . . . 0.0 109.224 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.34 -167.57 29.18 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.279 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.62 150.1 44.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.916 1.686 . . . . 0.0 114.337 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.95 128.66 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.191 1.397 . . . . 0.0 110.815 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -108.54 134.22 51.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.209 1.803 . . . . 0.0 114.079 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -105.82 160.04 15.55 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -69.12 -33.68 73.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.933 0.893 . . . . 0.0 112.753 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t -142.66 147.07 35.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.707 1.203 . . . . 0.0 112.316 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.21 -30.09 67.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.517 1.127 . . . . 0.0 111.765 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.75 -35.27 72.46 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.65 -40.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.562 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.95 -44.21 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.994 0.816 . . . . 0.0 110.138 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -62.15 -48.07 81.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.44 -46.46 76.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.023 1.329 . . . . 0.0 112.547 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.85 -45.14 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.358 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.9 t -67.62 -36.13 80.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.699 0.799 . . . . 0.0 112.846 -176.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.54 -22.64 67.02 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.8 -33.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.803 0.841 . . . . 0.0 111.051 172.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 67.11 -51.32 0.48 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.838 2.855 . . . . 0.0 115.42 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.332 59.2 m-85 -110.28 123.57 50.06 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -123.86 170.36 10.64 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.281 2.232 . . . . 0.0 110.578 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -142.47 122.54 13.71 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.816 -1.178 . . . . 0.0 112.939 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.88 128.84 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.77 1.628 . . . . 0.0 108.989 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.72 39.64 18.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.65 1.18 . . . . 0.0 113.294 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 62.22 9.02 2.97 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.118 2.167 . . . . 0.0 116.231 -174.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -98.68 134.06 42.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.16 1.384 . . . . 0.0 110.42 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 18.7 ttm -82.53 137.24 34.65 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.757 0.823 . . . . 0.0 110.784 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.17 157.52 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.171 1.788 . . . . 0.0 112.259 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -106.47 128.77 54.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.065 0.946 . . . . 0.0 111.913 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.1 p -90.7 138.62 31.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.093 0.557 . . . . 0.0 110.632 167.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.437 ' HE2' ' CD1' ' A' ' 112' ' ' PHE . 46.6 mtmt -140.36 146.44 38.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.828 1.251 . . . . 0.0 109.518 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -62.79 128.1 34.36 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.218 0.917 . . . . 0.0 110.781 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.71 125.24 26.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.867 0.365 . . . . 0.0 111.945 -172.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -126.11 134.85 26.35 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.496 1.519 . . . . 0.0 110.922 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.47 138.66 81.88 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.001 2.468 . . . . 0.0 112.807 174.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -60.66 -21.93 63.32 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -67.76 -21.24 65.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.457 1.903 . . . . 0.0 113.797 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.77 -30.5 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' MET . . . . . 0.425 ' HG3' ' H ' ' A' ' 191' ' ' SER . 6.3 ptm -84.8 -70.69 0.56 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.051 0.841 . . . . 0.0 112.923 173.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.425 ' H ' ' HG3' ' A' ' 190' ' ' MET . 32.5 t -166.23 136.53 2.71 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.507 1.523 . . . . 0.0 110.773 176.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.77 149.91 78.72 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.118 2.545 . . . . 0.0 112.299 175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.9 t -68.34 156.74 37.15 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -145.39 16.89 1.87 Allowed Glycine 0 CA--C 1.538 1.475 0 C-N-CA 126.041 1.782 . . . . 0.0 113.658 172.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.0 t -66.46 131.97 47.24 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.307 1.054 . . . . 0.0 112.366 -175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.02 154.19 38.12 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.519 1.127 . . . . 0.0 113.519 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -74.38 -21.79 59.49 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.55 1.14 . . . . 0.0 113.583 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.45 -98.63 0.07 OUTLIER Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.911 1.719 . . . . 0.0 112.936 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 50.31 56.33 8.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.407 1.483 . . . . 0.0 111.477 177.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.924 2.09 . . . . 0.0 113.129 -169.668 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.282 1 O4'-C1'-N19 112.233 4.033 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.057 0 O4'-C1'-N19 111.757 3.557 . 0.264 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 111.619 3.419 . 0.093 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 C5'-C4'-C3' 111.858 -2.428 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.746 0 O5'-C5'-C4' 106.933 -2.333 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.1 t -68.31 144.93 54.63 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.123 0.969 . . . . 0.0 113.029 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -80.9 14.17 2.33 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.808 1.643 . . . . 0.0 113.855 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -58.89 152.19 19.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.438 1.495 . . . . 0.0 113.59 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.15 60.55 1.7 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.937 1.695 . . . . 0.0 111.026 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -133.55 139.8 46.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -167.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 pt -121.07 153.07 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.192 1.397 . . . . 0.0 111.032 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.55 143.9 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.211 2.604 . . . . 0.0 105.009 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.58 103.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.949 1.7 . . . . 0.0 109.263 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -104.29 142.44 15.49 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.568 1.08 . . . . 0.0 114.264 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.13 54.69 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.747 1.165 . . . . 0.0 114.997 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 mt -62.54 145.16 55.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.757 1.223 . . . . 0.0 112.475 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 t -66.93 137.69 56.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 110.719 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.76 -9.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.28 -20.29 28.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.098 0.959 . . . . 0.0 113.071 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.8 m -72.22 129.92 39.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.725 1.21 . . . . 0.0 111.37 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -103.01 163.95 11.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.72 -38.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.56 -29.64 68.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.276 0.63 . . . . 0.0 112.616 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -65.75 -45.73 81.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.308 0.958 . . . . 0.0 110.172 173.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.52 -48.21 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.576 1.15 . . . . 0.0 110.812 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -56.64 -51.13 69.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.149 1.38 . . . . 0.0 112.377 173.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -62.42 -36.86 83.7 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.872 0.869 . . . . 0.0 112.934 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -65.97 -45.38 81.92 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 58.3 m-85 -71.14 -25.51 62.6 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 176.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -56.83 -22.38 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.532 1.533 . . . . 0.0 114.631 170.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.79 -43.53 97.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.57 -33.28 68.94 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.52 170.8 30.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.336 1.922 . . . . 0.0 112.049 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -60.62 132.08 52.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.22 1.008 . . . . 0.0 112.188 -171.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.62 134.95 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.161 1.784 . . . . 0.0 108.431 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.93 -45.6 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.437 1.095 . . . . 0.0 113.703 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.73 162.35 23.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.911 1.285 . . . . 0.0 109.73 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.43 153.09 42.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.287 1.435 . . . . 0.0 111.71 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -156.33 134.72 11.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.53 1.132 . . . . 0.0 112.276 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 18.4 mt -101.49 147.07 26.81 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.864 0.866 . . . . 0.0 110.839 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.445 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 33.4 mmt -81.45 75.89 8.4 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 112.91 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.271 53.4 m-85 -62.94 141.68 58.62 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -103.02 123.49 46.71 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.873 1.669 . . . . 0.0 113.349 168.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -62.06 -25.95 67.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.479 1.112 . . . . 0.0 113.362 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -67.86 0.5 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 175.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -19.9 62.31 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 177.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.269 37.9 m-80 57.66 32.89 22.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.506 1.522 . . . . 0.0 113.684 -174.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -132.09 159.11 39.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.49 2.716 . . . . 0.0 109.633 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -84.18 156.29 22.13 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.624 0.726 . . . . 0.0 112.427 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 ttp85 -72.88 17.41 0.12 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.88 2.072 . . . . 0.0 114.489 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.29 15.35 69.34 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.198 1.38 . . . . 0.0 114.766 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.445 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 27.4 p90 -156.02 168.47 27.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.219 1.51 . . . . 0.0 111.237 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.87 -167.74 25.92 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.829 1.204 . . . . 0.0 113.573 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.71 150.83 50.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.268 1.827 . . . . 0.0 115.014 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.48 128.52 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.29 1.436 . . . . 0.0 111.498 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -100.72 146.51 27.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.735 2.014 . . . . 0.0 113.687 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.8 151.94 38.97 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.41 -27.76 63.53 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.926 0.891 . . . . 0.0 112.948 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.8 t -141.68 142.34 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.995 1.318 . . . . 0.0 112.148 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -64.23 -26.52 68.54 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.125 . . . . 0.0 111.754 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.76 -32.82 72.1 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.9 -42.34 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.336 172.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.56 -44.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.666 0.666 . . . . 0.0 110.514 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -64.23 -47.3 80.19 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.84 -46.58 74.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.403 1.081 . . . . 0.0 111.946 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.91 -49.62 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.827 1.651 . . . . 0.0 110.872 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.61 -33.31 75.63 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -65.67 -21.6 66.56 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.68 -31.77 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.021 0.928 . . . . 0.0 111.304 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 66.1 -52.75 0.4 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.828 2.851 . . . . 0.0 115.535 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.337 49.6 m-85 -111.41 121.5 45.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 173.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -118.42 165.65 13.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.117 2.167 . . . . 0.0 110.849 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -131.14 113.9 14.46 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.276 -0.89 . . . . 0.0 112.14 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.75 129.24 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.776 1.23 . . . . 0.0 109.314 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 48.1 45.12 19.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.648 1.179 . . . . 0.0 112.686 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.297 0.9 OUTLIER 52.81 31.79 11.18 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.448 2.299 . . . . 0.0 115.748 -174.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -130.84 142.2 50.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.78 1.632 . . . . 0.0 110.344 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.3 mmm -84.11 135.1 34.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.312 1.045 . . . . 0.0 111.79 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.71 153.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.834 1.254 . . . . 0.0 111.892 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.38 127.63 46.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.651 0.78 . . . . 0.0 111.933 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -89.79 136.38 33.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.846 0.458 . . . . 0.0 110.432 167.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -140.76 148.11 40.17 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.974 1.309 . . . . 0.0 108.744 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.45 135.5 55.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.897 1.226 . . . . 0.0 110.879 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.52 117.36 15.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.742 0.417 . . . . 0.0 111.29 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -73.51 149.53 88.67 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.323 0.649 . . . . 0.0 111.56 170.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.59 148.65 92.52 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.929 2.419 . . . . 0.0 112.915 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -60.73 -22.87 64.45 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.366 -0.834 . . . . 0.0 113.21 169.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -66.03 -26.57 67.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.732 1.613 . . . . 0.0 113.509 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.269 1.2 m -87.37 -7.64 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 7.1 ptm -156.39 76.0 0.88 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.335 1.454 . . . . 0.0 112.353 -171.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.8 p -147.52 150.94 38.51 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.154 1.381 . . . . 0.0 112.328 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.93 161.14 45.8 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.645 2.897 . . . . 0.0 113.459 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.75 138.63 44.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.741 1.616 . . . . 0.0 115.351 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 76.43 174.57 38.73 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.624 1.106 . . . . 0.0 114.805 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.6 t -76.82 160.18 29.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.547 1.139 . . . . 0.0 112.384 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.17 154.19 40.39 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.662 1.185 . . . . 0.0 112.963 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -149.75 147.75 28.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.639 1.576 . . . . 0.0 111.342 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.07 53.19 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.256 0.932 . . . . 0.0 113.985 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -133.45 155.62 49.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.154 1.782 . . . . 0.0 112.385 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.933 1.693 . . . . 0.0 113.581 179.159 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.173 1 O4'-C1'-N19 112.891 4.691 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.343 0 O4'-C1'-N19 111.66 3.46 . 0.266 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 C4'-C3'-C2' 100.679 -2.021 . 0.282 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.303 1 O4'-C1'-N19 114.004 5.804 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.225 0 O4'-C1'-N19 111.553 3.353 . 0.035 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -65.92 157.17 31.38 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.756 1.222 . . . . 0.0 113.28 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -144.5 170.43 16.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.916 1.286 . . . . 0.0 112.391 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 73.3 mtm -55.41 137.29 48.44 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.697 0.799 . . . . 0.0 111.522 171.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -77.01 43.22 0.35 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.33 1.452 . . . . 0.0 112.86 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.546 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 80.2 tttt -136.63 138.33 41.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.346 1.458 . . . . 0.0 111.72 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.0 149.29 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.592 1.157 . . . . 0.0 111.333 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -83.97 145.22 28.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.251 1.82 . . . . 0.0 107.534 165.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.82 108.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.977 1.711 . . . . 0.0 109.984 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.74 147.63 18.66 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.594 1.092 . . . . 0.0 114.5 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.8 17.42 63.57 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.243 0.925 . . . . 0.0 114.61 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.1 mt -61.66 144.68 54.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.841 1.256 . . . . 0.0 111.494 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.5 t -69.36 137.0 52.49 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.061 -0.399 . . . . 0.0 110.133 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.4 m -64.52 -12.2 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -27.63 42.11 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.75 1.22 . . . . 0.0 113.145 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.2 m -67.4 132.39 47.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 111.974 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.49 161.46 20.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -35.02 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -71.6 -37.35 70.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.489 0.716 . . . . 0.0 111.685 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.51 -50.26 72.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.539 0.609 . . . . 0.0 111.787 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.81 -43.49 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.84 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.94 -52.57 64.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.053 0.842 . . . . 0.0 111.647 174.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -59.55 -39.79 85.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.27 24.4 m-85 -64.32 -16.24 61.82 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 118.309 2.707 . . . . 0.0 118.309 170.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 58.3 m-85 -101.5 -25.61 13.85 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.72 -21.87 56.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.159 1.384 . . . . 0.0 113.824 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.19 -29.92 71.17 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.31 -28.55 31.61 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.72 169.19 24.7 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.496 2.474 . . . . 0.0 110.079 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -63.27 130.23 43.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.843 0.83 . . . . 0.0 112.589 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.44 132.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.193 1.797 . . . . 0.0 108.938 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.94 -57.91 3.6 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.174 0.989 . . . . 0.0 112.743 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -157.47 166.99 31.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.271 1.029 . . . . 0.0 109.883 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.39 157.72 43.66 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.398 1.479 . . . . 0.0 111.315 174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -152.16 125.02 8.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.421 1.088 . . . . 0.0 111.391 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.36 146.97 25.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.305 0.642 . . . . 0.0 110.568 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.408 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 36.8 mmt -82.29 82.33 7.83 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 112.114 -172.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.363 10.8 m-85 -54.68 138.71 41.0 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 118.221 2.675 . . . . 0.0 118.221 174.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -75.61 148.75 38.54 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -1.77 11.69 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 116.183 1.919 . . . . 0.0 116.183 -169.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.2 p -69.23 -17.87 63.82 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.394 1.477 . . . . 0.0 109.305 166.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.501 0.5 OUTLIER 67.18 17.81 10.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.339 2.256 . . . . 0.0 114.967 -168.677 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -84.88 -58.44 2.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.025 0.93 . . . . 0.0 113.066 -170.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -148.64 166.76 27.35 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 128.038 2.535 . . . . 0.0 111.507 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -87.23 161.59 17.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.281 1.032 . . . . 0.0 112.954 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -70.7 -15.67 62.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.303 1.441 . . . . 0.0 114.081 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 114.9 22.27 5.04 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.509 1.052 . . . . 0.0 114.841 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.408 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 41.6 p90 -153.46 166.04 33.93 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.778 1.289 . . . . 0.0 111.237 171.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.3 -169.58 33.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.614 1.102 . . . . 0.0 114.289 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.546 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 92.8 m-85 -124.11 152.57 42.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.875 2.07 . . . . 0.0 115.979 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -137.86 133.65 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.412 1.485 . . . . 0.0 111.807 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.58 140.89 39.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.328 2.251 . . . . 0.0 114.934 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -117.2 155.61 29.12 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -168.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -72.24 -31.29 65.68 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.866 0.866 . . . . 0.0 113.095 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.7 t -144.37 145.99 32.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.65 1.18 . . . . 0.0 112.633 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.32 -25.07 66.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.88 0.872 . . . . 0.0 111.872 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.12 -32.52 72.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.7 mm -72.33 -42.56 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.312 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.51 -44.68 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.772 0.715 . . . . 0.0 110.23 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.75 -49.7 76.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -55.76 -47.39 77.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.513 1.125 . . . . 0.0 112.301 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.32 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.749 1.62 . . . . 0.0 110.725 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 61.6 m -65.7 -33.27 75.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.24 -23.03 66.95 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.8 mt -72.98 -33.03 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.914 0.885 . . . . 0.0 111.251 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 65.7 -48.94 0.39 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.032 2.933 . . . . 0.0 115.531 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.301 46.9 m-85 -115.7 124.14 50.1 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -123.56 139.32 54.12 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.665 1.586 . . . . 0.0 111.816 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -86.05 124.62 32.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.072 0.949 . . . . 0.0 111.222 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.1 mt -138.76 124.75 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.213 1.805 . . . . 0.0 108.729 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 48.29 44.72 20.04 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.313 0.8 OUTLIER 53.45 29.22 8.58 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.688 1.995 . . . . 0.0 115.947 -172.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -127.53 136.06 51.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.318 2.247 . . . . 0.0 109.819 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 88.0 mtp -86.25 132.72 33.93 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.776 -0.578 . . . . 0.0 111.207 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.2 m -127.37 153.27 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.625 1.57 . . . . 0.0 112.712 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -101.25 125.98 47.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.781 0.833 . . . . 0.0 111.982 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.11 139.31 30.75 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.392 0.677 . . . . 0.0 111.462 167.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -136.37 145.3 45.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.72 1.208 . . . . 0.0 109.237 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.72 130.28 45.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.367 0.985 . . . . 0.0 109.758 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.87 140.9 53.25 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -139.31 154.33 71.8 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.533 1.933 . . . . 0.0 110.941 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.85 153.88 73.06 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.063 2.509 . . . . 0.0 114.622 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -62.04 -19.65 63.11 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -71.61 -33.63 69.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.398 1.479 . . . . 0.0 112.415 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.14 -36.59 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.762 1.225 . . . . 0.0 111.221 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 19.7 mmt -80.55 83.2 6.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.747 1.219 . . . . 0.0 111.79 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.1 m -54.68 144.25 45.91 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.066 1.346 . . . . 0.0 114.211 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.91 -8.43 17.84 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.964 3.109 . . . . 0.0 114.902 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.273 1.2 p -65.14 153.8 39.82 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 75.01 -177.72 47.7 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.502 1.048 . . . . 0.0 114.116 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.3 t -157.4 156.17 31.78 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.896 1.278 . . . . 0.0 111.58 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.23 157.3 37.92 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.636 1.174 . . . . 0.0 113.066 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -150.21 162.94 39.5 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.704 1.601 . . . . 0.0 112.194 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -176.34 -171.79 40.43 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.929 1.252 . . . . 0.0 113.406 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -63.5 139.26 58.75 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.841 1.256 . . . . 0.0 112.055 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.973 1.709 . . . . 0.0 114.281 178.533 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.308 0 C4'-C3'-C2' 99.432 -3.268 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.247 0 O4'-C1'-N19 111.682 3.482 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.015 0 C3'-C2'-C1' 98.221 -3.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.991 1 O4'-C1'-N19 114.009 5.809 . 0.011 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.331 0 O4'-C1'-N19 111.515 3.315 . 0.181 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -86.06 -9.52 56.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.8 m80 60.14 34.8 21.17 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.194 1.798 . . . . 0.0 115.273 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.26 88.54 0.45 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.196 -0.94 . . . . 0.0 112.251 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -96.36 22.03 8.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.861 1.664 . . . . 0.0 113.405 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.515 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 84.0 tttt -137.86 140.1 40.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.877 1.271 . . . . 0.0 111.178 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt -124.82 150.62 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.489 1.116 . . . . 0.0 111.922 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -85.12 144.14 28.39 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.09 117.09 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.613 1.565 . . . . 0.0 109.762 172.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.0 145.81 16.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.269 0.938 . . . . 0.0 114.267 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.02 11.9 58.26 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.855 1.217 . . . . 0.0 115.121 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -59.63 142.78 52.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 111.275 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t -67.83 144.71 55.21 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.63 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.25 1.4 p -65.07 -13.57 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -72.75 -26.85 61.71 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 112.545 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.2 m -72.22 135.37 46.06 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 112.832 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 t -106.15 160.05 15.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 171.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.89 -34.42 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.435 1.494 . . . . 0.0 114.564 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.29 -34.88 75.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.235 0.614 . . . . 0.0 112.598 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -61.2 -42.37 98.47 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.222 0.919 . . . . 0.0 109.85 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.85 -47.81 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.74 1.216 . . . . 0.0 111.244 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -60.85 -48.48 81.61 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.664 0.665 . . . . 0.0 112.156 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -59.83 -37.02 78.04 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.67 -48.37 72.32 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 54.4 m-85 -68.99 -25.0 64.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -59.79 -18.65 45.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -59.43 -45.0 92.8 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.633 1.173 . . . . 0.0 112.82 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -73.01 -36.85 67.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.963 1.305 . . . . 0.0 112.535 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.68 165.88 29.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.097 1.808 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -59.09 126.22 26.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.963 0.905 . . . . 0.0 112.432 -169.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.97 128.67 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.756 1.622 . . . . 0.0 108.593 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.37 -57.2 4.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.195 0.998 . . . . 0.0 113.093 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -156.19 165.56 36.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 110.039 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.8 155.81 41.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.571 1.549 . . . . 0.0 111.272 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -154.86 134.88 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.373 1.069 . . . . 0.0 112.347 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.2 mt -103.25 142.45 34.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 111.236 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.3 mmt -83.7 90.08 7.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.863 0.84 . . . . 0.0 111.611 -175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.308 57.9 m-85 -61.23 138.32 58.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 175.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -88.06 -47.21 8.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.735 1.214 . . . . 0.0 110.538 168.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.97 112.17 8.04 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.924 2.089 . . . . 0.0 108.355 168.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.54 -27.05 64.18 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 -169.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.3 p -80.6 -10.04 59.75 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.786 1.634 . . . . 0.0 114.71 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -138.03 -58.99 0.65 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -168.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -144.8 149.59 35.73 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -168.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -123.1 159.97 27.39 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.045 1.738 . . . . 0.0 111.832 169.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.06 2.65 6.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.03 58.27 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.059 -1.025 . . . . 0.0 113.952 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.39 165.15 35.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.562 1.181 . . . . 0.0 109.234 172.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.65 -167.88 33.94 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.477 1.037 . . . . 0.0 113.668 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.515 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.5 m-85 -124.79 151.73 44.78 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.988 1.715 . . . . 0.0 114.974 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.15 132.91 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.288 1.435 . . . . 0.0 111.526 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.14 142.76 37.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.942 2.097 . . . . 0.0 114.647 -178.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.21 156.88 30.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -168.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.37 -32.92 73.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.796 0.838 . . . . 0.0 112.99 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.9 t -144.41 145.96 32.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.795 1.238 . . . . 0.0 112.377 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -60.18 -31.13 69.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.838 0.855 . . . . 0.0 111.638 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -59.69 -30.34 68.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.3 mm -72.36 -44.66 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 122.06 -0.4 . . . . 0.0 110.086 169.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.25 -41.33 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.639 0.654 . . . . 0.0 110.504 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -58.19 -51.37 70.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.291 0.636 . . . . 0.0 112.631 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.17 -46.38 88.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.639 1.176 . . . . 0.0 112.435 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.33 -46.87 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.806 1.642 . . . . 0.0 110.791 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.48 -38.52 91.46 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.622 0.769 . . . . 0.0 112.988 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -63.45 -19.46 64.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 73.4 mt -71.87 -33.71 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.28 -0.888 . . . . 0.0 111.464 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 65.08 -55.39 0.31 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.851 2.86 . . . . 0.0 115.179 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.359 46.3 m-85 -107.6 109.55 21.22 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -100.15 168.95 9.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.602 2.361 . . . . 0.0 111.353 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -132.45 118.41 19.28 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.362 -0.836 . . . . 0.0 111.889 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.91 127.95 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.787 1.235 . . . . 0.0 109.262 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.5 43.21 19.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.758 1.223 . . . . 0.0 112.939 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.301 0.7 OUTLIER 53.92 20.58 2.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.76 2.424 . . . . 0.0 116.352 -173.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -106.43 138.74 42.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.697 1.599 . . . . 0.0 110.24 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.1 mmm -80.7 133.56 35.71 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.896 0.878 . . . . 0.0 110.457 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.86 147.67 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.792 1.237 . . . . 0.0 112.84 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -97.35 124.63 41.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.225 1.01 . . . . 0.0 111.987 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.2 p -90.55 147.64 23.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.05 0.54 . . . . 0.0 111.426 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -143.34 151.02 39.98 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.927 1.291 . . . . 0.0 109.128 170.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.49 126.81 29.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.016 0.825 . . . . 0.0 109.149 168.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.66 141.67 36.25 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.435 0.636 . . . . 0.0 112.161 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -63.22 157.66 61.63 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.787 0.835 . . . . 0.0 111.085 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.27 -23.36 17.9 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.019 1.813 . . . . 0.0 113.214 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -162.6 -155.02 0.33 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.045 2.538 . . . . 0.0 107.783 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -74.82 28.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.944 2.098 . . . . 0.0 114.606 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.5 m -60.77 -12.47 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 95.4 mmm -66.24 -25.53 66.94 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.468 1.507 . . . . 0.0 112.327 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 t -153.77 85.8 3.96 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.701 1.2 . . . . 0.0 111.138 173.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.4 157.61 53.71 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.573 2.849 . . . . 0.0 113.36 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.0 t -149.5 162.02 40.96 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 168.24 -145.79 9.92 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.309 1.433 . . . . 0.0 112.446 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.0 m -68.33 -8.04 36.42 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -143.61 174.87 10.4 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.976 2.111 . . . . 0.0 111.045 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -60.46 163.35 5.34 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.752 1.221 . . . . 0.0 113.135 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.4 130.09 48.21 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 123.911 0.767 . . . . 0.0 113.287 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -157.49 161.79 38.87 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.004 1.722 . . . . 0.0 111.455 -176.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.247 1.819 . . . . 0.0 112.556 -177.222 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.127 2.927 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 0 O4'-C4'-C3' 108.893 2.424 . 0.113 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.939 0 O4'-C1'-N19 110.061 1.861 . 0.364 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.615 2.153 1 O4'-C1'-N19 115.453 7.253 . 0.062 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.329 0 O4'-C1'-N19 111.76 3.56 . 0.173 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.9 m 61.13 164.61 0.08 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.507 1.923 . . . . 0.0 115.282 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -76.67 37.51 0.18 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.117 1.767 . . . . 0.0 114.371 -174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 47.5 tpp -70.9 115.21 9.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.864 -1.148 . . . . 0.0 111.777 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -114.0 12.01 17.9 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -124.0 138.49 54.45 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.543 1.065 . . . . 0.0 113.027 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.5 pt -118.66 153.04 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.894 1.278 . . . . 0.0 111.537 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -88.54 139.46 30.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.783 2.433 . . . . 0.0 108.12 165.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.4 t -130.73 111.13 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.31 1.444 . . . . 0.0 109.809 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.58 17.6 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.536 1.065 . . . . 0.0 113.807 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.52 12.76 37.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.917 1.246 . . . . 0.0 114.534 -177.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.02 139.23 58.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.429 1.092 . . . . 0.0 110.876 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -66.85 142.12 57.44 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.868 -0.52 . . . . 0.0 110.029 169.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.92 -14.61 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -74.18 -21.7 59.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.303 1.441 . . . . 0.0 113.744 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -71.24 145.48 49.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.404 1.481 . . . . 0.0 112.448 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -118.59 159.36 23.72 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.897 1.279 . . . . 0.0 114.113 169.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.54 -34.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.269 1.427 . . . . 0.0 114.847 -173.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.57 -28.82 65.19 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.56 0.744 . . . . 0.0 112.942 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -64.88 -51.59 61.14 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 t -58.83 -44.81 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.148 0.979 . . . . 0.0 111.489 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -59.21 -48.01 83.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.929 0.492 . . . . 0.0 111.952 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -62.71 -40.08 96.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -58.57 -30.38 67.12 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.262 59.7 m-85 -88.42 -24.1 23.13 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.13 -14.07 22.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -59.19 -42.58 91.19 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 112.523 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -80.51 -32.98 36.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.06 172.87 35.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.39 1.948 . . . . 0.0 111.058 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.16 125.5 24.08 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.134 0.967 . . . . 0.0 112.391 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 38.3 t -97.66 128.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.516 1.527 . . . . 0.0 110.107 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -75.05 -50.68 15.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.973 1.309 . . . . 0.0 112.906 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -160.9 164.25 31.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.18 0.992 . . . . 0.0 110.471 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.62 154.56 39.88 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.546 1.539 . . . . 0.0 111.383 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -151.71 136.71 17.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.697 1.199 . . . . 0.0 111.67 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.75 146.83 34.28 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 111.396 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.25 78.48 8.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.287 1.035 . . . . 0.0 112.363 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.285 53.6 m-85 -64.26 134.5 54.85 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.32 121.19 14.26 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.592 1.157 . . . . 0.0 112.57 169.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.46 -16.05 53.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.097 1.359 . . . . 0.0 114.304 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -1.87 7.89 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 167.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.497 0.2 OUTLIER 70.33 31.81 2.97 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -177.264 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.83 -78.87 0.26 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.017 0.927 . . . . 0.0 113.364 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.69 166.46 20.0 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.097 2.559 . . . . 0.0 110.266 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -74.99 158.36 33.38 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -67.23 7.96 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.204 1.802 . . . . 0.0 115.751 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.84 65.73 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.581 1.086 . . . . 0.0 114.208 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -153.7 167.6 29.04 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.719 1.26 . . . . 0.0 111.21 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.78 -164.7 22.88 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.102 0.858 . . . . 0.0 113.41 170.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -120.89 150.58 40.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.104 1.762 . . . . 0.0 114.892 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.17 127.77 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.066 1.346 . . . . 0.0 111.159 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.66 136.34 48.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.432 1.893 . . . . 0.0 114.62 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -109.76 158.68 17.88 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.141 1.776 . . . . 0.0 115.643 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.32 -28.44 63.07 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.2 t -141.85 144.84 34.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.169 1.388 . . . . 0.0 112.459 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -60.58 -31.67 70.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 111.684 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.62 -31.46 70.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.75 -42.04 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 110.134 171.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.9 -43.19 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.834 0.743 . . . . 0.0 110.248 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -59.94 -47.15 86.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 173.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -58.67 -51.21 70.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.189 0.995 . . . . 0.0 112.466 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.0 t -64.19 -43.18 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.703 1.601 . . . . 0.0 110.809 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 46.7 t -70.23 -35.52 73.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -64.28 -26.58 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.923 -1.111 . . . . 0.0 113.781 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.5 mt -71.07 -39.43 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.844 0.858 . . . . 0.0 110.874 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 65.45 -43.15 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.973 2.909 . . . . 0.0 115.969 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.283 53.2 m-85 -111.69 123.36 50.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 174.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -129.52 159.84 35.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.502 1.521 . . . . 0.0 112.356 -169.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -106.41 127.08 53.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.129 0.972 . . . . 0.0 111.282 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.74 123.79 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.327 1.451 . . . . 0.0 108.998 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.58 37.48 16.28 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.279 1.032 . . . . 0.0 113.298 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.83 12.92 4.07 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 127.339 2.256 . . . . 0.0 115.7 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -97.86 145.57 26.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.082 1.753 . . . . 0.0 110.584 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.67 128.96 34.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.368 1.467 . . . . 0.0 110.205 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.39 147.31 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.702 1.201 . . . . 0.0 113.318 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -94.18 129.18 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.549 1.139 . . . . 0.0 110.187 171.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.85 126.58 54.14 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.754 1.222 . . . . 0.0 110.388 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -148.88 148.69 30.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.025 1.33 . . . . 0.0 111.296 -171.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.31 138.94 58.25 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.411 -0.806 . . . . 0.0 111.817 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.05 134.98 51.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -123.55 150.39 61.1 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.429 1.492 . . . . 0.0 111.365 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -57.08 149.04 65.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.391 2.727 . . . . 0.0 115.751 -171.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -58.55 -28.12 65.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.101 1.76 . . . . 0.0 113.778 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -70.56 -26.84 63.72 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.204 1.802 . . . . 0.0 113.565 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.3 m -114.0 4.54 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -172.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 27.2 mmt -122.55 113.13 18.88 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.448 1.899 . . . . 0.0 110.674 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.6 t -129.2 137.83 31.85 Favored Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 126.124 1.77 . . . . 0.0 111.282 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.46 -13.78 18.34 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.129 2.552 . . . . 0.0 113.209 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.422 0.2 OUTLIER 61.47 -21.11 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 119.132 3.012 . . . . 0.0 119.132 -176.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -165.01 141.52 7.11 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.055 1.788 . . . . 0.0 111.935 171.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.4 m -85.97 129.21 34.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.18 -27.57 48.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.183 0.993 . . . . 0.0 112.828 169.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.0 mtm105 -64.82 170.96 3.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.21 2.204 . . . . 0.0 112.864 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 89.37 27.44 22.73 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.014 0.816 . . . . 0.0 114.666 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.03 161.73 36.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.466 1.906 . . . . 0.0 112.32 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.08 1.752 . . . . 0.0 113.53 -175.862 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.671 0 O4'-C4'-C3' 108.587 2.205 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 0 O5'-C5'-C4' 113.915 2.654 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.819 0 C4'-C3'-C2' 99.563 -3.137 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.274 2 O4'-C1'-N19 112.564 4.364 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.054 2 O4'-C1'-N19 113.851 5.651 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 122.413 1.101 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -150.71 147.61 27.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.937 2.495 . . . . 0.0 109.797 -168.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -108.65 152.2 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.837 . . . . 0.0 111.307 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -85.41 144.54 27.95 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 164.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.71 110.34 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.44 1.496 . . . . 0.0 109.74 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.65 150.94 18.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.421 1.01 . . . . 0.0 113.908 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.62 15.52 54.68 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.316 0.96 . . . . 0.0 114.51 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.87 134.86 55.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.655 1.182 . . . . 0.0 111.66 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -62.47 148.69 44.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.299 0.639 . . . . 0.0 111.842 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t -58.73 -25.76 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.504 1.122 . . . . 0.0 113.885 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -74.26 -27.83 60.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.274 1.03 . . . . 0.0 112.476 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.4 m -72.75 127.38 32.38 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -94.42 165.76 12.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.48 -34.52 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -73.84 -37.43 64.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.403 0.681 . . . . 0.0 111.878 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -54.08 -46.08 71.93 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.851 0.75 . . . . 0.0 112.795 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.61 -48.53 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.624 1.17 . . . . 0.0 109.801 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -61.34 -42.98 99.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.027 0.931 . . . . 0.0 112.715 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -72.98 -28.8 62.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -69.11 -50.49 47.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.317 67.3 m-85 -65.83 -20.27 66.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -56.57 -18.03 10.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 170.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.63 -29.32 69.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.958 -1.089 . . . . 0.0 112.817 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -87.32 -34.55 18.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.005 0.922 . . . . 0.0 112.609 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.02 171.58 35.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.027 2.251 . . . . 0.0 110.576 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -66.67 133.47 50.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.709 0.766 . . . . 0.0 112.282 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.65 127.02 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.286 1.834 . . . . 0.0 109.296 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.84 -52.61 16.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -164.24 173.85 11.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.672 0.789 . . . . 0.0 110.011 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -138.59 157.33 46.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.197 1.399 . . . . 0.0 111.899 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptm -150.53 133.42 15.97 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.01 1.324 . . . . 0.0 111.049 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.36 150.61 25.07 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.563 -0.711 . . . . 0.0 110.622 169.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.1 mmm . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 121.166 0.508 . . . . 0.0 111.904 -173.171 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.3 p80 . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 21.23 0.07 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.491 2.316 . . . . 0.0 113.428 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.66 6.23 71.04 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.045 -1.66 . . . . 0.0 115.25 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.76 167.35 24.08 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.887 1.344 . . . . 0.0 110.13 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.19 -165.33 22.32 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.223 1.392 . . . . 0.0 112.676 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.56 152.23 50.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.191 1.796 . . . . 0.0 114.92 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.54 119.08 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.075 1.35 . . . . 0.0 112.058 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -89.11 144.76 25.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.502 1.921 . . . . 0.0 113.763 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -116.6 162.33 17.8 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.53 -40.9 76.62 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.829 -0.544 . . . . 0.0 111.137 168.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t -139.51 144.39 37.89 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.262 1.425 . . . . 0.0 112.406 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -65.5 -18.12 65.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.44 -32.63 71.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.9 mm -75.87 -41.75 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.751 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.27 -44.56 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.085 0.857 . . . . 0.0 109.888 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -60.82 -49.91 75.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 113.165 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.32 -45.44 80.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 0.0 112.531 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.35 -46.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.611 1.565 . . . . 0.0 111.225 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.5 m -66.2 -31.15 71.8 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -63.93 -31.38 72.55 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.151 1.38 . . . . 0.0 112.834 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.7 mt -68.82 -33.79 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.286 1.034 . . . . 0.0 111.319 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 65.19 -58.51 0.27 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 128.547 2.739 . . . . 0.0 114.884 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 46.1 m-85 -102.25 116.37 32.52 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 170.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -109.57 173.61 6.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.148 2.179 . . . . 0.0 110.709 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -140.84 123.22 15.88 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.07 -1.019 . . . . 0.0 112.505 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -137.38 133.01 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.987 1.715 . . . . 0.0 108.983 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 50.6 41.51 25.73 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.894 1.278 . . . . 0.0 114.025 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.15 24.7 14.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.049 1.74 . . . . 0.0 114.163 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -129.35 153.18 48.12 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.467 1.507 . . . . 0.0 110.713 169.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.8 mtp -94.47 144.47 25.54 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.39 144.97 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.426 1.491 . . . . 0.0 111.677 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -95.36 121.57 37.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.205 1.002 . . . . 0.0 110.646 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 72.6 m -105.89 131.07 53.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.334 1.053 . . . . 0.0 111.809 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.356 1.862 . . . . 0.0 110.14 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.49 135.07 57.64 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.82 1.191 . . . . 0.0 111.094 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 121.274 0.559 . . . . 0.0 110.871 175.944 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -105.15 133.65 49.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.349 1.06 . . . . 0.0 112.772 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.8 pt -112.46 154.58 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.205 1.402 . . . . 0.0 111.359 169.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.66 142.31 28.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.281 2.232 . . . . 0.0 107.843 165.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 t -133.56 110.43 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.135 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.06 153.85 16.68 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.459 1.028 . . . . 0.0 113.921 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.47 9.4 56.68 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.225 1.393 . . . . 0.0 115.249 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.0 mt -63.39 141.16 58.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.998 1.319 . . . . 0.0 110.931 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 t -66.85 142.98 57.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.972 -0.455 . . . . 0.0 110.838 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.79 -11.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -86.37 -13.36 46.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.807 1.243 . . . . 0.0 114.151 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.5 m -73.88 132.82 42.9 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.59 1.156 . . . . 0.0 111.676 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.88 161.63 17.38 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 175.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -60.29 -33.65 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 169.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -74.22 -34.25 63.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.697 0.799 . . . . 0.0 112.068 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -56.25 -46.05 79.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.081 0.855 . . . . 0.0 112.135 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.64 -47.92 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.077 0.951 . . . . 0.0 110.649 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.11 -47.28 86.54 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.66 0.664 . . . . 0.0 111.735 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -62.87 -38.82 92.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.196 0.998 . . . . 0.0 112.992 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -64.68 -51.0 64.8 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 57.0 m-85 -64.44 -21.24 66.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -66.61 0.02 2.55 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 170.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.49 -29.47 63.66 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.389 -1.444 . . . . 0.0 111.862 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -88.95 -21.13 23.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.13 -158.3 25.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.681 2.086 . . . . 0.0 110.49 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -97.95 147.52 24.39 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.484 1.142 . . . . 0.0 110.791 170.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.32 129.92 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.412 1.485 . . . . 0.0 109.302 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -71.08 -47.09 60.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.774 1.63 . . . . 0.0 114.738 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -162.69 161.07 26.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.156 0.983 . . . . 0.0 110.241 -173.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.34 153.72 40.85 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.566 1.546 . . . . 0.0 111.271 170.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -152.75 132.35 13.06 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.425 1.09 . . . . 0.0 111.794 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.0 mt -103.98 146.97 27.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.71 0.804 . . . . 0.0 110.752 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.87 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.7 p80 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -68.69 5.94 0.96 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.59 18.62 67.95 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.751 -1.218 . . . . 0.0 114.286 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.2 161.66 38.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.289 1.045 . . . . 0.0 112.48 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.85 27.08 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.632 0.634 . . . . 0.0 113.451 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.61 150.63 39.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.235 1.814 . . . . 0.0 114.343 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.72 127.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.421 1.488 . . . . 0.0 111.527 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -110.26 125.92 53.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.321 1.449 . . . . 0.0 114.394 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -91.48 162.09 14.7 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -170.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -60.7 -45.41 94.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.246 1.018 . . . . 0.0 111.605 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -136.73 142.66 43.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.572 1.549 . . . . 0.0 111.612 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.04 -24.67 67.79 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.509 1.124 . . . . 0.0 112.039 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.01 -28.9 70.42 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 172.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.7 -42.48 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 121.954 -0.467 . . . . 0.0 110.539 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.09 -41.29 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.236 0.614 . . . . 0.0 110.359 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.47 -47.23 82.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.985 0.514 . . . . 0.0 112.364 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -64.35 -45.97 85.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.307 1.043 . . . . 0.0 112.157 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.26 -41.33 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.144 1.377 . . . . 0.0 111.405 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.31 -33.92 70.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.983 0.913 . . . . 0.0 112.716 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -26.94 68.03 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.8 mt -67.32 -36.62 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.421 -0.799 . . . . 0.0 110.313 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 65.19 -60.27 0.25 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 128.826 2.85 . . . . 0.0 114.233 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 64.9 m-85 -100.03 123.51 44.36 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -124.17 176.01 6.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.741 2.416 . . . . 0.0 110.124 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -139.6 129.24 24.48 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.426 -1.421 . . . . 0.0 112.783 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 39.5 mt -138.15 131.99 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.296 1.438 . . . . 0.0 109.278 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.7 41.17 25.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.177 1.391 . . . . 0.0 114.543 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.3 t30 60.55 33.19 20.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.032 1.733 . . . . 0.0 113.794 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -133.97 143.62 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.05 1.74 . . . . 0.0 111.456 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 7.2 ttm -85.17 133.58 34.19 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.785 0.834 . . . . 0.0 110.723 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.32 156.72 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.571 1.548 . . . . 0.0 112.787 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -118.42 112.3 19.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.812 0.845 . . . . 0.0 112.097 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 t -78.72 131.21 36.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.785 0.834 . . . . 0.0 111.458 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -150.18 146.77 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.927 1.691 . . . . 0.0 110.709 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.79 135.15 55.47 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.448 -0.783 . . . . 0.0 112.493 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.076 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.15 137.91 43.2 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.475 -1.391 . . . . 0.0 112.667 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.8 pt -123.58 148.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.94 1.296 . . . . 0.0 112.456 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -85.96 139.49 31.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.919 2.088 . . . . 0.0 109.908 164.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.1 t -127.32 113.66 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.945 1.298 . . . . 0.0 109.521 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.09 154.12 16.6 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.8 1.191 . . . . 0.0 114.115 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.88 13.31 75.3 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.458 1.028 . . . . 0.0 114.506 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.06 144.17 46.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -65.61 139.74 58.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.23 -13.04 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.877 . . . . 0.0 112.528 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -22.09 27.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.63 1.172 . . . . 0.0 111.954 171.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 82.9 m -75.44 139.95 42.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.88 1.272 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -114.8 163.85 14.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.405 1.482 . . . . 0.0 114.745 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.7 p -54.47 -36.65 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.37 -30.49 69.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.557 0.743 . . . . 0.0 112.619 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.59 -47.29 67.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.89 -42.54 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.46 0.704 . . . . 0.0 111.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -60.76 -48.16 83.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.545 0.738 . . . . 0.0 112.051 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -60.54 -39.08 86.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.444 1.098 . . . . 0.0 113.679 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -68.07 -39.22 82.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 47.9 m-85 -81.21 -24.9 37.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.513 2.783 . . . . 0.0 118.513 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -57.72 -29.25 64.58 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.62 -26.03 68.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.367 1.467 . . . . 0.0 112.712 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -75.22 -20.78 59.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 116.436 2.014 . . . . 0.0 116.436 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.54 -93.6 0.09 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.033 1.302 . . . . 0.0 111.439 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -157.65 137.53 12.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.312 1.445 . . . . 0.0 111.809 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.1 136.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.409 1.484 . . . . 0.0 108.457 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -92.64 -30.71 15.45 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -162.23 153.84 18.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.283 1.033 . . . . 0.0 110.273 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.51 152.78 44.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.005 1.322 . . . . 0.0 111.757 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.8 ptm -154.21 134.89 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.013 1.325 . . . . 0.0 112.004 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.4 mt -109.46 145.12 36.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.178 0.991 . . . . 0.0 111.26 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 47.7 mmm . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.018 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.0 p80 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.642 0.734 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -70.89 15.01 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.319 1.848 . . . . 0.0 115.246 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.9 12.6 82.49 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.431 1.015 . . . . 0.0 114.494 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -152.09 167.8 27.31 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.607 1.204 . . . . 0.0 110.457 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.84 27.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.383 1.468 . . . . 0.0 113.182 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.93 149.62 48.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.349 1.86 . . . . 0.0 115.256 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.7 t -135.77 130.61 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 111.404 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.8 m -107.83 138.17 44.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.548 1.939 . . . . 0.0 113.203 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.89 157.95 18.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -67.17 -32.09 72.95 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.437 0.695 . . . . 0.0 112.477 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.0 t -146.24 143.52 29.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.797 1.239 . . . . 0.0 112.428 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.82 -17.55 64.55 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.93 -24.94 67.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.7 mm -78.24 -45.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.4 -44.55 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.592 0.757 . . . . 0.0 110.935 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.0 -37.06 86.05 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.857 0.753 . . . . 0.0 112.564 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -67.84 -47.56 68.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.697 1.199 . . . . 0.0 111.73 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.97 -47.01 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.984 1.314 . . . . 0.0 110.525 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.4 t -69.19 -32.83 72.39 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.704 0.802 . . . . 0.0 112.116 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.74 -30.27 71.28 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.77 1.228 . . . . 0.0 113.296 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 69.0 mt -64.98 -33.52 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.647 0.779 . . . . 0.0 111.099 171.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 66.84 -56.22 0.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.69 2.796 . . . . 0.0 114.93 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.279 63.3 m-85 -106.57 125.25 50.77 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -125.21 161.53 26.7 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.903 1.681 . . . . 0.0 111.3 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -109.58 135.15 51.02 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.372 1.069 . . . . 0.0 111.49 172.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.5 mt -141.93 124.76 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.362 1.865 . . . . 0.0 108.509 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 51.06 34.66 11.27 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.316 1.046 . . . . 0.0 113.425 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.275 3.6 m120 63.62 3.88 1.65 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.683 2.393 . . . . 0.0 116.298 -172.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -86.71 142.3 28.28 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.416 1.486 . . . . 0.0 108.821 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 29.2 ttm -88.82 135.93 33.27 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.578 -0.701 . . . . 0.0 111.201 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.66 158.89 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.143 1.777 . . . . 0.0 112.329 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -110.54 133.04 53.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.43 1.092 . . . . 0.0 111.428 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -97.73 145.76 26.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.019 0.928 . . . . 0.0 112.204 168.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -143.37 152.1 41.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.044 1.738 . . . . 0.0 108.843 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.76 136.43 56.92 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.334 1.425 . . . . 0.0 110.818 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -171.515 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -130.59 137.55 49.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.626 1.17 . . . . 0.0 112.436 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 pt -113.24 152.68 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 111.024 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -86.04 144.04 27.78 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -127.04 106.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.556 1.542 . . . . 0.0 109.279 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -107.1 150.84 16.83 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.988 1.28 . . . . 0.0 114.225 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.79 65.57 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.376 0.988 . . . . 0.0 114.569 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.19 137.78 57.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.489 1.116 . . . . 0.0 111.391 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.8 t -69.35 142.42 54.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.751 0.82 . . . . 0.0 111.641 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 p -61.21 -17.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -73.02 -29.03 62.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.937 0.895 . . . . 0.0 112.331 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.4 m -73.12 137.15 45.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.587 1.555 . . . . 0.0 112.927 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t -112.11 161.99 15.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.05 1.34 . . . . 0.0 114.41 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.89 -34.92 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.4 -31.13 69.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.574 0.75 . . . . 0.0 112.837 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -66.41 -43.54 85.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.895 0.77 . . . . 0.0 109.425 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -45.73 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.614 1.165 . . . . 0.0 111.564 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.92 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.717 0.807 . . . . 0.0 111.776 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -57.52 -41.57 81.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.954 0.901 . . . . 0.0 112.942 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.87 -46.92 73.48 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -70.92 -23.72 62.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -59.68 -29.91 68.4 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 171.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -64.24 -26.9 68.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.934 0.894 . . . . 0.0 112.906 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -72.76 -26.67 61.64 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -175.89 -94.21 0.09 OUTLIER Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.04 1.305 . . . . 0.0 112.006 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -157.29 133.6 9.72 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.437 1.495 . . . . 0.0 111.667 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.51 134.91 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.351 1.46 . . . . 0.0 108.666 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.9 -44.74 17.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.992 1.317 . . . . 0.0 113.915 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -161.9 160.76 28.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.09 1.356 . . . . 0.0 109.915 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.05 148.88 39.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.184 1.394 . . . . 0.0 111.707 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -153.3 132.47 12.67 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 112.53 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.57 145.94 25.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.691 0.796 . . . . 0.0 110.042 169.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.47 0.559 0 O-C-N 122.118 -0.364 . . . . 0.0 110.049 -178.98 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 p80 . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 121.283 0.563 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -76.2 8.06 3.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.369 2.267 . . . . 0.0 114.695 -169.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.16 6.1 84.91 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.992 1.282 . . . . 0.0 114.46 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.33 168.56 26.68 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.413 1.106 . . . . 0.0 111.218 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.37 -167.73 23.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.808 1.194 . . . . 0.0 113.337 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.8 149.99 50.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.27 1.828 . . . . 0.0 114.77 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -136.76 123.05 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.918 1.287 . . . . 0.0 111.609 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.06 148.94 21.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.829 2.052 . . . . 0.0 114.168 175.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.9 155.63 35.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -66.1 -36.38 83.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.209 0.604 . . . . 0.0 112.201 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -141.25 144.25 34.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.053 1.341 . . . . 0.0 112.485 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -64.5 -20.7 66.36 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.39 0.676 . . . . 0.0 112.557 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -61.78 -33.72 74.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mm -72.5 -40.62 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.008 -0.433 . . . . 0.0 110.434 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.4 t -57.14 -43.8 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.073 0.851 . . . . 0.0 110.288 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -60.66 -48.43 81.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.328 0.651 . . . . 0.0 112.699 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.01 -47.55 80.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.321 1.448 . . . . 0.0 112.703 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.67 -43.5 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.916 1.686 . . . . 0.0 111.159 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.63 -35.75 79.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 112.482 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.15 -29.34 70.28 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.041 1.336 . . . . 0.0 113.161 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.83 -35.13 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.272 1.029 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 65.75 -55.04 0.36 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.739 2.816 . . . . 0.0 115.238 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.314 59.9 m-85 -105.93 124.55 49.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -126.61 171.18 11.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.205 2.202 . . . . 0.0 110.734 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -137.65 132.48 33.02 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.828 -1.17 . . . . 0.0 112.919 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mt -140.99 127.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.509 1.523 . . . . 0.0 108.762 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 50.9 38.81 21.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.65 1.18 . . . . 0.0 113.746 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.05 -0.66 1.01 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.465 2.306 . . . . 0.0 116.195 -173.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -85.31 131.1 34.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.843 1.257 . . . . 0.0 109.631 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.3 ttm -80.17 132.97 36.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.164 0.586 . . . . 0.0 110.196 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.64 159.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.78 1.632 . . . . 0.0 111.806 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -114.96 126.22 54.52 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.268 1.027 . . . . 0.0 111.639 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.1 p -87.17 147.8 25.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.389 0.614 . . . . 0.0 111.605 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -143.49 151.78 40.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.387 1.475 . . . . 0.0 108.169 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.24 132.74 48.37 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.913 1.233 . . . . 0.0 109.922 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-N 118.089 0.404 . . . . 0.0 110.603 177.779 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt . . . . . 0 CA--C 1.553 1.067 0 CA-C-O 121.707 0.765 . . . . 0.0 113.019 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -149.69 147.15 27.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.214 2.206 . . . . 0.0 110.024 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.8 pt -123.54 152.35 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.45 1.1 . . . . 0.0 111.91 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -87.8 140.93 29.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.749 2.02 . . . . 0.0 105.849 164.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.9 110.11 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.195 1.398 . . . . 0.0 110.038 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.15 147.65 18.2 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.958 1.266 . . . . 0.0 114.475 -172.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.19 14.55 58.78 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.784 1.183 . . . . 0.0 114.671 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.79 135.01 57.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.734 1.267 . . . . 0.0 110.321 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 150.79 48.69 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.275 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.01 -20.89 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.16 -27.49 42.73 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.899 1.28 . . . . 0.0 113.664 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 83.2 m -68.93 138.84 54.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.454 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 2.1 t -118.13 165.29 13.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.63 -34.75 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.76 -30.04 66.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 112.625 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.11 -47.37 71.35 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.02 -45.57 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.817 0.847 . . . . 0.0 110.144 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.72 -48.79 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.627 0.771 . . . . 0.0 111.937 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -59.33 -50.34 74.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.978 0.911 . . . . 0.0 113.035 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.25 26.4 m-85 -59.81 -31.91 70.15 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.342 51.3 m-85 -85.25 -24.28 27.86 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -63.95 -20.2 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -62.81 -34.64 77.72 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.071 0.948 . . . . 0.0 111.948 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -74.94 -25.67 59.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.67 -94.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.709 1.147 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -154.87 136.16 14.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.072 1.349 . . . . 0.0 112.239 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -87.31 137.18 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.593 1.557 . . . . 0.0 108.847 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.87 -46.32 12.28 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.019 1.328 . . . . 0.0 113.056 169.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -160.57 155.17 23.75 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.983 1.313 . . . . 0.0 109.929 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.97 47.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.538 1.535 . . . . 0.0 111.461 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -154.12 127.83 8.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.168 0.987 . . . . 0.0 113.014 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.6 mt -88.24 143.96 26.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.749 0.82 . . . . 0.0 110.929 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 36.6 mmt . . . . . 0 N--CA 1.473 0.716 0 C-N-CA 123.374 0.669 . . . . 0.0 112.207 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.8 p80 . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.317 0.58 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -77.2 10.92 2.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.356 1.862 . . . . 0.0 115.044 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.8 79.56 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 121.281 -0.887 . . . . 0.0 114.121 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -152.3 165.49 34.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.742 1.271 . . . . 0.0 110.317 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.64 176.7 37.26 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.022 0.82 . . . . 0.0 113.829 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.38 146.59 28.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.19 116.09 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.882 1.273 . . . . 0.0 111.779 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -89.25 144.34 26.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.777 1.631 . . . . 0.0 113.001 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.54 163.44 14.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -69.58 -40.37 76.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.274 0.63 . . . . 0.0 111.849 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.6 t -140.33 145.42 37.15 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.172 1.389 . . . . 0.0 112.861 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.69 -25.99 68.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.709 1.203 . . . . 0.0 111.897 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.71 -35.9 79.38 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.27 -42.41 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.22 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.4 t -54.55 -45.67 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.657 0.662 . . . . 0.0 110.301 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.34 -39.03 74.95 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.82 -48.3 75.67 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.624 1.102 . . . . 0.0 111.685 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.13 -49.45 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.104 1.762 . . . . 0.0 110.797 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 33.1 m -66.54 -30.52 70.85 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -67.99 -25.68 65.53 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.555 1.07 . . . . 0.0 113.587 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 70.2 mt -71.28 -32.9 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.77 0.828 . . . . 0.0 111.079 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 65.36 -59.65 0.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 128.5 2.72 . . . . 0.0 114.923 173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 47.3 m-85 -100.41 123.12 44.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 171.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -121.04 147.32 45.68 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.676 1.59 . . . . 0.0 112.232 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -95.25 124.5 39.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.897 0.879 . . . . 0.0 110.738 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.67 129.38 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.828 1.651 . . . . 0.0 108.715 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 50.54 35.51 11.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.194 0.998 . . . . 0.0 113.223 -173.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 28.3 m120 59.37 26.46 15.34 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.595 1.958 . . . . 0.0 115.758 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -125.81 148.06 49.24 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.151 1.78 . . . . 0.0 110.223 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.9 mmm -90.75 134.37 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.837 0.855 . . . . 0.0 112.408 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.16 153.68 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.439 1.496 . . . . 0.0 112.245 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -102.06 122.05 43.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.306 1.043 . . . . 0.0 112.107 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 74.0 m -98.31 135.6 39.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.402 1.081 . . . . 0.0 112.318 173.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -140.04 145.83 38.23 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.724 1.609 . . . . 0.0 110.769 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.46 137.77 57.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.889 1.222 . . . . 0.0 111.06 171.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.796 0 CA-C-O 121.733 0.777 . . . . 0.0 113.091 -174.558 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.476 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 83.2 tttt -107.36 138.11 44.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.108 1.363 . . . . 0.0 112.082 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.0 pt -123.39 151.78 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.225 1.41 . . . . 0.0 111.826 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -87.18 143.66 27.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.594 1.958 . . . . 0.0 108.064 165.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.72 125.98 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.834 1.653 . . . . 0.0 109.995 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.56 156.79 23.77 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.057 0.844 . . . . 0.0 114.48 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.89 10.5 58.72 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.712 1.149 . . . . 0.0 114.373 -174.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.3 mt -66.2 140.2 58.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.351 1.46 . . . . 0.0 111.327 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.8 p -75.23 152.15 38.35 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.757 -0.589 . . . . 0.0 111.372 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -65.92 -16.72 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -73.65 -34.81 65.12 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.651 1.18 . . . . 0.0 112.168 169.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.0 m -67.09 136.36 55.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.165 0.986 . . . . 0.0 111.698 173.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.0 163.79 16.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 p -53.65 -36.2 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.45 -31.26 68.35 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.34 -43.63 90.33 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.884 0.765 . . . . 0.0 109.078 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.15 -47.77 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.485 1.114 . . . . 0.0 111.141 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -60.36 -50.07 75.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.45 0.7 . . . . 0.0 112.07 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -61.43 -38.37 86.88 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.56 0.744 . . . . 0.0 112.964 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.58 -46.99 80.38 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.297 47.2 m-85 -67.83 -27.09 66.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -58.71 -19.5 40.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -61.93 -45.16 94.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.873 1.269 . . . . 0.0 112.881 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.01 -38.13 82.24 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.619 1.168 . . . . 0.0 112.802 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.44 158.64 14.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.2 2.333 . . . . 0.0 110.226 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.16 138.11 57.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.636 1.208 . . . . 0.0 112.885 -168.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.5 t -97.63 136.64 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.882 2.073 . . . . 0.0 109.222 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -78.89 -49.72 12.4 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.697 1.599 . . . . 0.0 112.471 173.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -159.3 159.94 34.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.335 1.054 . . . . 0.0 110.498 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.95 151.19 36.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.556 1.542 . . . . 0.0 111.464 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -153.94 133.73 13.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.468 1.107 . . . . 0.0 112.231 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.1 mt -102.41 143.23 32.41 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.083 0.953 . . . . 0.0 111.201 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.4 mmt . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.185 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.7 p80 . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 121.409 0.623 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -75.28 16.1 0.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.83 1.652 . . . . 0.0 114.825 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.47 13.11 83.89 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.462 1.029 . . . . 0.0 114.405 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -147.47 162.71 38.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.998 1.399 . . . . 0.0 111.594 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.85 -168.32 30.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.446 1.498 . . . . 0.0 113.538 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.0 m-85 -125.03 151.02 46.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.153 1.781 . . . . 0.0 115.124 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.8 t -137.0 134.17 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.497 1.519 . . . . 0.0 110.414 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -114.89 134.42 55.16 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.69 1.596 . . . . 0.0 114.087 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -103.51 159.79 15.28 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.961 1.704 . . . . 0.0 115.471 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -72.46 -29.02 63.29 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.0 t -139.76 145.3 38.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.473 1.109 . . . . 0.0 112.867 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -62.5 -28.65 69.98 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.181 0.993 . . . . 0.0 111.782 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.92 -31.73 72.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.5 -43.2 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 119.228 -0.415 . . . . 0.0 109.977 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.73 -42.39 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 118.636 0.653 . . . . 0.0 110.577 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.0 -48.5 81.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.755 0.707 . . . . 0.0 112.668 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -58.19 -44.85 88.28 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.526 1.13 . . . . 0.0 112.118 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.65 -48.1 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.024 1.729 . . . . 0.0 111.019 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.23 -34.17 77.49 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.51 -21.47 66.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.6 mt -74.81 -30.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.099 0.96 . . . . 0.0 111.703 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 64.61 -62.21 0.19 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.297 2.639 . . . . 0.0 114.609 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 47.6 m-85 -101.5 120.2 39.93 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -115.66 154.72 29.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 111.747 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -112.85 108.28 17.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.585 0.754 . . . . 0.0 111.996 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.31 123.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.554 1.141 . . . . 0.0 109.467 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 51.17 37.01 17.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.075 0.95 . . . . 0.0 113.031 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 61.99 4.25 1.12 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 127.291 2.236 . . . . 0.0 115.646 -170.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -83.82 140.91 31.73 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.64 128.49 34.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 110.547 171.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.81 150.77 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 112.497 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -104.98 123.83 48.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.869 1.267 . . . . 0.0 111.327 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -89.66 147.95 23.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.676 0.791 . . . . 0.0 111.896 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -147.08 151.09 36.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.733 1.613 . . . . 0.0 108.786 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -64.56 135.18 55.73 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.051 1.296 . . . . 0.0 110.739 168.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.436 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -118.03 143.53 46.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.902 1.281 . . . . 0.0 112.066 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.04 149.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.662 1.185 . . . . 0.0 110.51 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -86.63 141.75 28.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.744 2.018 . . . . 0.0 106.945 166.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.95 118.26 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.695 1.598 . . . . 0.0 109.529 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.69 146.69 16.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.139 0.876 . . . . 0.0 113.764 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.18 19.44 33.3 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.592 1.092 . . . . 0.0 114.493 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 mt -70.4 134.7 48.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 112.122 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.5 t -64.04 141.99 58.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.894 -0.504 . . . . 0.0 111.637 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 p -62.83 -16.87 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.44 -32.66 66.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.821 0.848 . . . . 0.0 112.071 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 m -69.29 135.43 50.45 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.552 1.541 . . . . 0.0 113.132 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -111.73 164.46 13.02 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.169 1.388 . . . . 0.0 114.598 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.35 -36.83 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.7 -33.89 75.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 112.417 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.98 -48.6 75.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.79 -43.2 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.376 0.671 . . . . 0.0 111.485 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.19 -50.64 72.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.801 0.84 . . . . 0.0 112.036 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.46 -38.76 92.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.13 -48.14 79.77 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 52.4 m-85 -69.18 -24.35 64.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -61.79 -14.23 30.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.85 -27.94 69.21 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.576 1.08 . . . . 0.0 112.4 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -85.54 -30.31 23.49 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.397 1.079 . . . . 0.0 113.647 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.55 173.05 32.77 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.917 2.199 . . . . 0.0 111.026 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.13 131.71 45.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.266 1.031 . . . . 0.0 113.011 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -99.27 133.67 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.63 1.972 . . . . 0.0 108.211 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.64 -48.67 16.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.172 1.389 . . . . 0.0 113.507 174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.43 163.4 27.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.483 1.113 . . . . 0.0 110.153 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.86 151.84 40.4 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.447 1.499 . . . . 0.0 111.553 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -153.77 134.18 13.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.198 0.999 . . . . 0.0 112.317 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.88 0.872 . . . . 0.0 110.556 172.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.4 mmt . . . . . 0 N--CA 1.47 0.572 0 C-N-CA 122.771 0.428 . . . . 0.0 111.358 179.762 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.4 p80 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.194 0.521 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -78.69 8.62 5.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.531 1.532 . . . . 0.0 114.872 -171.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.36 15.13 81.72 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.512 -0.742 . . . . 0.0 114.276 -174.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.76 163.68 38.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.444 1.116 . . . . 0.0 109.478 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.37 -162.81 24.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.988 1.28 . . . . 0.0 113.166 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.8 151.56 51.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.941 1.696 . . . . 0.0 115.241 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.66 123.74 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.243 1.417 . . . . 0.0 111.385 171.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -98.09 140.17 32.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.104 1.762 . . . . 0.0 114.066 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -111.84 151.77 28.69 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.047 1.339 . . . . 0.0 114.043 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -76.7 -40.57 48.35 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.0 t -110.73 135.21 51.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.327 1.051 . . . . 0.0 111.775 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.27 -23.67 66.44 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.196 0.998 . . . . 0.0 112.213 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.02 -31.48 71.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.4 mm -69.53 -38.21 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.843 -0.536 . . . . 0.0 110.574 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.05 -43.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 118.614 0.643 . . . . 0.0 110.883 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -64.01 -49.16 73.53 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.905 0.882 . . . . 0.0 112.232 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.75 -45.15 78.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.617 1.567 . . . . 0.0 112.587 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.48 -49.43 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.731 1.612 . . . . 0.0 110.918 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.84 -32.74 74.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.1 0.56 . . . . 0.0 112.462 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.47 -28.81 68.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.227 1.411 . . . . 0.0 113.453 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.05 -30.6 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.431 1.092 . . . . 0.0 111.78 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 66.65 -51.15 0.45 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.863 2.865 . . . . 0.0 115.77 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.31 39.2 m-85 -112.92 124.22 52.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -123.13 153.83 39.47 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.124 1.77 . . . . 0.0 111.271 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -105.71 128.81 53.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.184 0.994 . . . . 0.0 110.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.2 mt -139.4 123.76 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.733 1.613 . . . . 0.0 108.758 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 50.46 35.07 10.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.015 0.926 . . . . 0.0 113.358 -174.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.6 m120 63.17 1.58 0.93 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.596 2.358 . . . . 0.0 116.957 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -83.47 142.52 30.88 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.166 1.387 . . . . 0.0 109.416 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 94.2 mmm -86.52 137.27 32.66 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.753 -0.592 . . . . 0.0 111.094 172.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.06 150.55 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.25 1.42 . . . . 0.0 111.771 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.99 130.8 45.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.622 0.769 . . . . 0.0 111.282 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.39 139.19 31.42 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.361 0.664 . . . . 0.0 110.797 167.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -136.92 154.22 50.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.266 1.426 . . . . 0.0 108.653 170.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.7 137.05 57.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.723 1.147 . . . . 0.0 110.276 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 0.0 111.673 -175.285 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 91.1 mttt . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -137.78 139.04 39.83 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.89 -1.131 . . . . 0.0 112.159 -173.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 pt -117.24 151.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.81 1.244 . . . . 0.0 111.593 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -89.75 136.83 32.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.35 2.66 . . . . 0.0 108.119 165.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.54 110.3 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.415 . . . . 0.0 110.136 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.8 142.78 17.07 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.255 0.931 . . . . 0.0 114.366 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.3 13.5 28.46 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.487 1.518 . . . . 0.0 115.027 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.72 151.43 42.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.264 1.426 . . . . 0.0 112.478 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.4 t -68.81 139.83 55.26 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.052 -0.405 . . . . 0.0 110.453 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.4 -14.44 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.538 0.735 . . . . 0.0 112.331 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.64 -19.55 35.22 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.914 1.285 . . . . 0.0 113.11 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.9 m -69.37 134.37 48.96 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.806 1.242 . . . . 0.0 111.759 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.5 t -102.28 157.97 16.52 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.39 -33.67 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.223 1.409 . . . . 0.0 114.608 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -71.35 -29.58 65.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.69 -43.89 95.3 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.162 0.892 . . . . 0.0 109.466 172.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.54 -47.62 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.109 1.364 . . . . 0.0 110.96 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -60.99 -45.25 95.59 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.845 -0.534 . . . . 0.0 112.057 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -60.34 -43.71 96.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 112.273 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.01 -43.88 97.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 61.5 m-85 -72.54 -27.49 62.26 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -62.01 -14.75 38.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.74 -44.64 96.52 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.689 1.196 . . . . 0.0 112.711 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.675 1.19 . . . . 0.0 113.769 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.87 164.82 24.22 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.004 2.24 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.83 134.13 56.78 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.224 1.012 . . . . 0.0 113.258 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.97 127.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.599 1.96 . . . . 0.0 109.228 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -72.5 -50.0 29.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.916 1.287 . . . . 0.0 112.875 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -160.09 160.45 33.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.487 1.115 . . . . 0.0 109.91 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.6 153.67 42.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.473 1.509 . . . . 0.0 111.115 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -153.16 133.89 13.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.408 1.083 . . . . 0.0 111.991 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 19.2 mt -102.25 142.76 32.97 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.135 0.974 . . . . 0.0 110.448 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.487 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 30.2 mmt . . . . . 0 N--CA 1.47 0.541 0 O-C-N 121.956 -0.465 . . . . 0.0 111.554 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.0 p80 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.284 0.564 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -70.24 7.8 0.92 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.953 1.701 . . . . 0.0 115.245 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.66 15.96 76.62 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.551 1.072 . . . . 0.0 114.41 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.487 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 35.4 p90 -152.18 164.58 37.04 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.795 1.298 . . . . 0.0 110.977 176.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.42 32.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.365 0.983 . . . . 0.0 113.871 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -120.13 147.7 44.55 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.132 1.773 . . . . 0.0 114.675 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.66 124.09 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.016 1.326 . . . . 0.0 111.366 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -105.34 137.62 42.84 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.531 1.933 . . . . 0.0 114.459 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.62 155.87 23.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -67.15 -34.58 77.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.839 0.855 . . . . 0.0 112.197 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.3 t -141.39 143.15 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.827 1.251 . . . . 0.0 112.517 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -66.37 -20.16 66.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.44 0.696 . . . . 0.0 112.597 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.34 -31.32 71.93 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mm -73.89 -42.55 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.116 170.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.34 -44.02 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.801 0.728 . . . . 0.0 109.858 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -59.82 -48.18 82.73 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -57.0 -49.48 75.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.145 0.978 . . . . 0.0 112.285 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.4 -43.26 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.826 1.65 . . . . 0.0 110.987 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.2 m -69.23 -32.47 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -67.21 -27.79 67.54 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.239 0.927 . . . . 0.0 113.322 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.91 -36.36 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.569 0.748 . . . . 0.0 110.688 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 66.42 -53.36 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.796 2.838 . . . . 0.0 115.07 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.317 59.0 m-85 -106.19 125.89 51.54 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -127.92 169.36 14.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.716 2.007 . . . . 0.0 111.074 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -131.03 130.58 43.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.244 -0.91 . . . . 0.0 112.51 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 56.8 mt -139.77 127.45 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.396 1.478 . . . . 0.0 108.969 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 49.53 43.04 23.7 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.001 1.321 . . . . 0.0 113.784 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 66.29 0.03 1.6 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.544 2.338 . . . . 0.0 116.459 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.61 143.68 26.08 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.664 1.12 . . . . 0.0 111.551 168.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 17.5 ttm -89.05 136.36 33.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.674 0.79 . . . . 0.0 111.029 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.42 149.04 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.502 1.521 . . . . 0.0 112.559 -176.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -95.24 128.25 41.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.864 0.866 . . . . 0.0 110.39 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.02 129.6 55.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.639 1.176 . . . . 0.0 111.012 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -152.21 153.12 33.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 0.0 111.715 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.78 133.66 56.31 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.119 0.872 . . . . 0.0 112.58 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.592 0 C-N-CA 123.186 0.595 . . . . 0.0 111.438 -179.319 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.4 mttt . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -145.75 133.75 21.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 111.305 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.19 151.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.381 1.086 . . . . 0.0 111.168 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.73 136.17 34.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.238 2.615 . . . . 0.0 106.939 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 t -126.13 116.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.863 1.265 . . . . 0.0 110.478 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.29 148.29 18.89 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.666 1.127 . . . . 0.0 114.1 -173.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.91 58.94 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.256 1.408 . . . . 0.0 114.49 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.1 mt -65.47 135.69 55.5 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.699 1.2 . . . . 0.0 111.66 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -64.58 142.72 58.33 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.84 -0.538 . . . . 0.0 112.03 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.78 -14.67 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.42 -31.56 63.92 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.71 0.804 . . . . 0.0 112.169 169.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -71.91 125.47 27.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.476 . . . . 0.0 113.625 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.15 166.13 16.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.8 -32.6 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -73.08 -35.5 66.66 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.017 0.927 . . . . 0.0 111.545 174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.91 -49.19 78.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.498 0.59 . . . . 0.0 112.016 169.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -48.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 109.929 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.64 -49.16 77.36 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.665 0.666 . . . . 0.0 111.967 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -60.66 -46.67 89.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 113.037 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.26 19.0 m-85 -64.72 -21.97 66.87 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.321 61.0 m-85 -92.94 -23.58 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -62.6 -18.43 62.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -63.52 -28.95 70.3 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.359 -0.838 . . . . 0.0 113.058 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -83.75 -27.0 29.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.37 175.37 31.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.072 2.272 . . . . 0.0 110.973 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.89 132.64 49.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.453 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.11 133.72 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.633 1.973 . . . . 0.0 107.73 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.63 -46.58 14.18 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.786 1.234 . . . . 0.0 113.773 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -162.71 162.7 26.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 109.836 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.42 153.51 46.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.726 1.61 . . . . 0.0 111.482 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.6 ptm -155.52 151.0 27.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.505 1.122 . . . . 0.0 112.425 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.4 mt -119.29 144.52 46.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.539 1.536 . . . . 0.0 110.381 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 28.9 mmm . . . . . 0 N--CA 1.47 0.531 0 C-N-CA 122.786 0.435 . . . . 0.0 110.751 -179.729 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.4 p80 . . . . . 0 CA--C 1.544 0.73 0 CA-C-O 121.086 0.469 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 8.56 8.6 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.366 2.266 . . . . 0.0 114.108 -172.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.81 13.16 59.71 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.022 -1.049 . . . . 0.0 115.034 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -152.25 163.26 39.78 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.139 1.47 . . . . 0.0 110.004 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.04 -170.84 28.5 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.834 1.207 . . . . 0.0 112.954 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.45 153.71 47.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.68 127.6 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.088 1.355 . . . . 0.0 111.948 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -99.92 145.8 27.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.297 1.839 . . . . 0.0 113.558 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.38 154.5 37.62 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -67.91 -34.97 77.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.367 0.667 . . . . 0.0 112.299 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.7 t -140.24 143.37 35.94 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.017 1.327 . . . . 0.0 111.984 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.44 -19.19 64.56 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.093 -0.379 . . . . 0.0 111.364 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.07 -31.12 70.79 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.81 -42.85 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.938 -0.476 . . . . 0.0 110.195 170.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.28 -43.61 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.74 0.7 . . . . 0.0 110.025 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.849 0.859 . . . . 0.0 112.763 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.91 -48.5 79.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.443 1.097 . . . . 0.0 112.353 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.16 -45.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.778 1.631 . . . . 0.0 110.825 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 48.4 t -70.1 -31.27 68.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.192 -0.942 . . . . 0.0 112.925 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.8 -32.55 74.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.803 1.241 . . . . 0.0 112.818 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.22 -34.18 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.9 0.88 . . . . 0.0 111.064 171.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 66.22 -58.91 0.34 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.628 2.771 . . . . 0.0 115.026 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 56.0 m-85 -100.97 121.74 42.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -118.86 168.74 10.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.136 1.774 . . . . 0.0 111.118 -175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -126.68 135.65 51.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.229 1.012 . . . . 0.0 111.699 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.7 mt -140.78 129.08 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.877 1.671 . . . . 0.0 108.746 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 51.24 37.93 19.89 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.417 1.087 . . . . 0.0 113.799 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 64.74 1.15 1.31 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.519 2.328 . . . . 0.0 116.292 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -88.91 133.6 34.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.52 1.128 . . . . 0.0 110.473 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 27.1 ttm -84.1 137.53 33.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.686 0.794 . . . . 0.0 110.71 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 154.66 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.039 1.736 . . . . 0.0 111.589 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -102.93 131.73 49.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.408 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 78.5 m -111.87 134.8 53.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.014 1.326 . . . . 0.0 111.57 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.89 157.73 43.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.02 1.728 . . . . 0.0 110.228 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.92 138.7 58.62 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.168 1.349 . . . . 0.0 112.038 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 123.347 0.659 . . . . 0.0 111.959 178.622 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.8 mttt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -129.28 139.12 51.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.612 1.165 . . . . 0.0 113.846 -167.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -121.02 149.59 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.911 1.284 . . . . 0.0 112.081 173.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -87.11 139.43 30.58 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.054 2.542 . . . . 0.0 108.725 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.24 115.0 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.249 1.42 . . . . 0.0 109.452 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.07 147.63 16.62 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.278 0.942 . . . . 0.0 114.324 -173.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.81 18.34 48.06 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.054 1.312 . . . . 0.0 114.574 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.5 mt -58.44 144.44 42.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.948 1.299 . . . . 0.0 112.218 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 t -64.77 142.55 58.39 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.087 -0.383 . . . . 0.0 110.512 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.98 -14.83 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.64 -29.91 63.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.215 1.006 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.5 m -70.51 136.91 49.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.348 1.459 . . . . 0.0 114.753 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -116.84 164.08 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.516 1.527 . . . . 0.0 114.251 169.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -54.25 -35.5 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.23 -30.79 67.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.35 -44.67 86.94 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.824 0.738 . . . . 0.0 109.257 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.3 -47.03 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.963 1.305 . . . . 0.0 110.612 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.42 -51.02 71.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.694 0.798 . . . . 0.0 111.881 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -58.79 -43.95 90.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.843 0.857 . . . . 0.0 112.662 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.97 -42.7 94.33 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.349 63.6 m-85 -71.32 -28.25 63.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -59.88 -21.79 61.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.04 -33.92 74.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 112.199 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -72.0 -38.56 69.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 170.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.32 165.12 25.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 126.722 2.106 . . . . 0.0 111.497 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.13 134.28 52.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.277 1.037 . . . . 0.0 113.693 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.13 134.02 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.824 2.049 . . . . 0.0 108.237 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.17 -45.56 19.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.294 1.438 . . . . 0.0 113.419 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -161.81 158.82 26.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.426 1.091 . . . . 0.0 110.456 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.15 149.01 40.95 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.871 1.668 . . . . 0.0 111.346 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -154.95 130.76 10.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 0.0 112.513 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.5 mt -101.81 141.17 35.08 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.975 0.91 . . . . 0.0 110.488 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 34.8 mmt . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 121.248 0.547 . . . . 0.0 112.137 -170.583 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.3 p80 . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.532 0.682 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -70.93 13.12 0.21 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.75 12.36 80.09 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.153 0.882 . . . . 0.0 114.058 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -150.26 164.38 35.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.841 1.32 . . . . 0.0 110.837 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.55 -168.19 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.041 1.305 . . . . 0.0 113.417 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.89 149.3 50.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.271 1.828 . . . . 0.0 115.158 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.14 130.14 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.162 1.385 . . . . 0.0 111.563 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -108.09 140.99 40.46 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.058 1.743 . . . . 0.0 113.49 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.53 153.72 28.28 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -169.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.49 -34.83 70.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.526 0.73 . . . . 0.0 112.314 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.6 t -132.91 140.95 48.11 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.981 1.312 . . . . 0.0 112.15 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -65.11 -25.62 67.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.247 1.019 . . . . 0.0 111.781 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.5 mm -70.26 -40.78 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.002 -0.436 . . . . 0.0 110.325 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.69 -42.91 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.787 0.721 . . . . 0.0 110.842 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -63.23 -46.98 84.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.599 0.636 . . . . 0.0 112.586 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -56.64 -46.12 81.19 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.393 1.477 . . . . 0.0 112.602 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.84 -47.41 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.059 1.744 . . . . 0.0 110.876 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 67.4 m -66.12 -30.75 71.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.25 -31.0 72.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.897 1.279 . . . . 0.0 112.832 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.54 -33.37 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.363 1.065 . . . . 0.0 111.337 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 64.27 -59.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.611 2.764 . . . . 0.0 115.225 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.334 39.2 m-85 -99.05 119.85 38.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -114.83 170.32 8.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.729 2.012 . . . . 0.0 111.312 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.85 122.98 20.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.55 0.74 . . . . 0.0 112.331 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 34.1 mt -138.26 130.08 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.0 1.72 . . . . 0.0 108.954 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 50.73 47.19 24.89 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.886 1.274 . . . . 0.0 113.914 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.8 t30 59.09 30.63 20.47 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.927 1.691 . . . . 0.0 114.101 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -145.61 156.34 43.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.06 1.744 . . . . 0.0 110.38 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 50.3 mtp -105.48 148.82 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.3 147.15 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.566 1.547 . . . . 0.0 111.737 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -88.85 129.78 35.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.598 0.759 . . . . 0.0 110.305 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.65 132.05 55.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.354 1.062 . . . . 0.0 111.391 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -153.43 151.46 29.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.102 1.361 . . . . 0.0 112.073 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 130.35 45.15 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.608 0.763 . . . . 0.0 111.647 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -170.164 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.34 140.91 43.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.279 1.431 . . . . 0.0 111.125 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.8 pt -117.9 150.66 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.64 1.176 . . . . 0.0 110.925 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -86.23 142.83 28.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.055 2.142 . . . . 0.0 107.23 165.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.64 106.53 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.505 1.522 . . . . 0.0 109.722 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.1 141.58 15.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.521 1.058 . . . . 0.0 114.763 -170.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.33 17.54 58.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.783 1.183 . . . . 0.0 114.924 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.82 122.64 15.33 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.694 1.197 . . . . 0.0 110.394 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.3 t -62.84 140.89 58.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.785 0.434 . . . . 0.0 110.795 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.299 0.3 OUTLIER -66.35 -10.27 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -168.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -77.8 -19.19 55.44 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.659 1.184 . . . . 0.0 112.862 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.8 m -71.32 138.87 49.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.291 1.436 . . . . 0.0 112.24 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 t -113.81 162.93 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 173.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.61 -34.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.414 1.485 . . . . 0.0 114.252 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.56 -34.51 75.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.305 0.642 . . . . 0.0 112.279 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.86 -44.09 97.54 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.017 0.826 . . . . 0.0 109.503 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.15 -46.69 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 111.336 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.31 -50.6 73.35 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.059 0.944 . . . . 0.0 112.054 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -64.71 -34.85 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -63.85 -53.34 52.22 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 51.9 m-85 -65.02 -22.2 66.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -63.16 -12.99 31.78 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.31 -29.22 69.95 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.525 1.057 . . . . 0.0 112.546 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -86.18 -31.61 21.67 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.346 1.058 . . . . 0.0 112.82 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.31 168.49 28.57 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 127.729 2.585 . . . . 0.0 110.33 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.61 134.7 54.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.166 0.984 . . . . 0.0 112.082 -169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.0 t -97.63 134.08 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.034 1.733 . . . . 0.0 108.169 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.4 -45.73 15.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.792 1.237 . . . . 0.0 113.764 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -162.89 164.06 26.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.731 1.212 . . . . 0.0 109.866 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.76 153.27 43.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.276 1.43 . . . . 0.0 111.579 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptm -152.03 136.45 16.81 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.706 1.202 . . . . 0.0 111.618 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.1 mt -107.85 153.52 22.9 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.83 0.852 . . . . 0.0 110.303 168.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.8 mmm . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.924 0.869 . . . . 0.0 111.317 -176.065 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 p80 . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.243 0.544 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -67.33 2.42 1.69 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.13 68.37 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.432 1.015 . . . . 0.0 114.888 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -153.09 168.74 24.91 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.345 1.072 . . . . 0.0 110.139 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.94 -167.77 27.08 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.455 1.026 . . . . 0.0 113.085 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -126.7 150.12 49.19 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.085 1.754 . . . . 0.0 114.976 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.58 122.08 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.017 1.327 . . . . 0.0 111.153 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m -93.54 143.08 26.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.492 1.917 . . . . 0.0 113.78 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -115.41 155.69 26.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -66.95 -36.06 81.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.327 0.651 . . . . 0.0 111.608 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -142.95 141.83 31.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 0.0 112.837 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -61.5 -20.59 63.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.007 1.323 . . . . 0.0 113.004 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.9 -25.73 67.29 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.9 -40.86 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.749 -0.594 . . . . 0.0 110.193 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -58.01 -45.39 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 110.191 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -66.11 -35.78 81.41 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.832 0.742 . . . . 0.0 112.784 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.0 -46.29 85.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.586 1.555 . . . . 0.0 111.977 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.74 -47.61 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.608 1.563 . . . . 0.0 110.699 175.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.1 m -65.08 -30.71 71.68 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -64.9 -26.64 68.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.695 1.198 . . . . 0.0 113.402 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.47 -32.25 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.112 0.965 . . . . 0.0 111.119 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 67.69 -49.82 0.51 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.867 2.867 . . . . 0.0 115.488 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.33 49.2 m-85 -114.5 123.83 50.39 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -121.27 157.07 31.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.783 2.033 . . . . 0.0 110.885 -171.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -117.18 114.81 24.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.981 -174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 38.5 mt -131.33 125.39 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.51 1.124 . . . . 0.0 109.634 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 49.7 37.09 12.12 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.448 1.099 . . . . 0.0 112.971 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.251 33.7 m120 61.41 4.66 1.0 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.806 2.442 . . . . 0.0 116.864 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -86.61 138.81 31.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.473 1.109 . . . . 0.0 110.105 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.2 mmm -82.6 131.62 35.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.518 0.727 . . . . 0.0 110.537 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.04 148.22 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.099 1.359 . . . . 0.0 111.748 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -96.11 125.39 40.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.721 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -89.87 135.44 33.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.179 0.592 . . . . 0.0 110.801 168.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -142.09 149.79 40.35 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.01 1.324 . . . . 0.0 109.666 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -61.61 135.35 57.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.515 1.052 . . . . 0.0 110.522 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -132.64 138.13 47.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.843 1.257 . . . . 0.0 112.569 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.7 pt -117.26 149.82 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.783 1.233 . . . . 0.0 111.604 172.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -85.87 138.93 31.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.911 2.084 . . . . 0.0 108.257 163.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.86 108.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 109.609 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.07 147.43 17.78 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.4 9.98 58.58 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.647 1.117 . . . . 0.0 114.206 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.24 134.95 57.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.121 1.461 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.0 t -61.57 143.27 56.3 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.206 -0.309 . . . . 0.0 111.367 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -60.78 -18.43 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -75.42 -25.78 57.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.827 1.251 . . . . 0.0 113.295 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.8 m -70.94 134.16 46.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.221 1.408 . . . . 0.0 113.271 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -106.49 158.4 16.94 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.191 1.396 . . . . 0.0 113.613 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -56.54 -32.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.87 -30.02 67.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -65.17 -47.11 78.12 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.641 0.777 . . . . 0.0 111.459 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -60.77 -45.82 92.85 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.835 -0.541 . . . . 0.0 112.287 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -59.85 -44.27 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.116 0.871 . . . . 0.0 113.307 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -58.98 -33.94 71.26 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 55.9 m-85 -85.65 -24.97 26.85 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 174.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -60.82 -16.25 38.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -42.11 87.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 112.375 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -79.07 -29.66 43.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.91 -173.96 38.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.975 1.75 . . . . 0.0 111.949 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.11 107.34 3.62 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.638 -0.919 . . . . 0.0 112.645 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.07 130.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.308 1.443 . . . . 0.0 109.609 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.38 -57.38 3.9 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.12 0.968 . . . . 0.0 112.727 173.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -157.48 164.74 37.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.953 0.901 . . . . 0.0 110.467 -170.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.03 41.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.481 1.512 . . . . 0.0 111.404 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -154.44 129.71 9.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.182 0.993 . . . . 0.0 113.136 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.78 144.62 26.51 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.476 1.11 . . . . 0.0 111.209 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 32.6 mmt . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 122.065 0.936 . . . . 0.0 111.551 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.6 p80 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -73.75 11.09 0.91 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.6 13.89 83.02 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.112 -0.826 . . . . 0.0 114.367 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -145.2 161.78 38.7 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.215 1.507 . . . . 0.0 112.052 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.9 -179.19 34.53 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.868 1.223 . . . . 0.0 112.471 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -116.79 149.14 40.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.563 1.545 . . . . 0.0 114.922 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.0 124.17 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.87 1.268 . . . . 0.0 111.523 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.52 142.67 33.88 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.691 1.997 . . . . 0.0 114.068 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.13 149.79 40.45 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.0 113.998 -172.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.55 -40.93 48.34 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.03 -0.419 . . . . 0.0 111.721 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 12.9 m -110.71 132.05 54.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 112.144 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -63.18 -34.09 76.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.476 1.111 . . . . 0.0 112.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -58.76 -28.33 65.81 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.3 mm -70.9 -39.76 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.753 -0.592 . . . . 0.0 110.465 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.94 -42.18 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.569 0.622 . . . . 0.0 110.25 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.4 -47.71 80.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.629 0.772 . . . . 0.0 111.84 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -57.32 -50.59 72.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.664 1.186 . . . . 0.0 112.234 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.7 -45.0 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 111.062 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 35.2 t -71.21 -32.37 68.74 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.415 -0.803 . . . . 0.0 112.643 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.25 -32.71 74.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.61 1.164 . . . . 0.0 112.723 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.4 -35.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.982 0.913 . . . . 0.0 111.18 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 66.7 -51.84 0.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.525 2.73 . . . . 0.0 115.06 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.261 74.5 m-85 -108.71 125.84 52.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 176.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -132.24 155.87 47.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.407 1.483 . . . . 0.0 112.376 -169.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -107.96 127.6 53.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.228 1.011 . . . . 0.0 111.408 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 44.6 mt -137.05 124.36 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.737 1.615 . . . . 0.0 109.035 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.46 36.11 12.65 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.225 1.01 . . . . 0.0 113.223 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.82 6.19 1.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.609 2.363 . . . . 0.0 116.765 -171.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.02 143.96 26.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.001 1.721 . . . . 0.0 109.992 169.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 41.5 tpp -85.15 133.89 34.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.374 1.07 . . . . 0.0 110.876 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.83 152.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.871 1.669 . . . . 0.0 113.703 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -104.27 123.78 47.97 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.831 1.252 . . . . 0.0 110.591 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 83.7 m -104.88 130.94 52.93 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.063 1.345 . . . . 0.0 111.072 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -153.28 145.35 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.026 1.33 . . . . 0.0 111.582 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.42 137.31 57.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.15 0.886 . . . . 0.0 112.265 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 122.963 0.505 . . . . 0.0 112.258 -176.092 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HE2' ' CD1' ' A' ' 154' ' ' PHE . 85.1 tttt -115.72 139.66 49.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.219 1.407 . . . . 0.0 112.099 -169.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.2 pt -121.94 150.15 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.12 1.368 . . . . 0.0 111.202 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -84.3 145.84 28.06 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.924 2.09 . . . . 0.0 107.379 166.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.12 117.28 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.736 1.614 . . . . 0.0 110.153 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.0 149.73 17.34 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.356 0.979 . . . . 0.0 114.037 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.0 55.48 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 124.951 1.262 . . . . 0.0 114.913 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.6 mt -68.38 135.39 51.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.881 1.273 . . . . 0.0 111.508 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.9 p -69.48 151.1 46.46 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.341 -0.849 . . . . 0.0 111.849 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -65.17 -16.23 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -79.77 -28.55 40.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.609 1.164 . . . . 0.0 112.941 171.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.8 m -71.22 136.99 48.31 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.486 1.115 . . . . 0.0 110.763 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.02 163.35 17.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.86 -36.58 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -173.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.06 -35.81 80.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.518 0.727 . . . . 0.0 112.468 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.14 -47.76 75.96 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.38 -42.25 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.049 0.539 . . . . 0.0 111.844 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -59.35 -53.05 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.603 0.638 . . . . 0.0 111.803 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -60.11 -38.74 83.87 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.282 33.3 m-85 -66.22 -16.48 64.03 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 52.5 m-85 -99.37 -26.76 14.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.55 -22.3 43.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.575 1.55 . . . . 0.0 114.234 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -62.77 -29.46 70.71 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -83.45 -27.44 29.5 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.82 169.19 21.92 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.355 2.407 . . . . 0.0 110.491 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -61.61 132.17 52.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.077 0.942 . . . . 0.0 113.279 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.45 124.46 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.667 1.987 . . . . 0.0 109.342 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.04 -56.25 7.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -146.54 160.01 42.69 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.24 40.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.777 1.231 . . . . 0.0 110.466 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptm -153.49 124.63 7.44 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.748 1.219 . . . . 0.0 111.159 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.8 mt -103.62 153.37 20.69 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.595 0.758 . . . . 0.0 111.413 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.438 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 37.6 mmt . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 125.072 1.349 . . . . 0.0 113.502 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 p80 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -68.62 3.38 1.88 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.59 14.55 75.66 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.217 -0.927 . . . . 0.0 114.712 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 32.1 p90 -148.6 168.09 23.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.051 0.926 . . . . 0.0 110.441 174.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -172.57 -166.62 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.984 1.278 . . . . 0.0 113.189 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.452 ' CD1' ' HE2' ' A' ' 110' ' ' LYS . 94.6 m-85 -128.6 154.05 46.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 115.186 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.95 140.31 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.756 1.622 . . . . 0.0 110.854 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -123.05 136.89 55.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.848 2.059 . . . . 0.0 114.358 -174.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -110.87 156.65 20.85 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -168.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -63.97 -41.72 97.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.271 1.028 . . . . 0.0 112.302 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.4 t -137.78 143.04 40.89 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.624 1.17 . . . . 0.0 112.414 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -62.62 -26.29 68.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.299 1.04 . . . . 0.0 111.903 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.08 -32.92 71.4 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.51 -42.02 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.389 171.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.16 -43.52 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.843 0.747 . . . . 0.0 110.697 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.95 -47.99 80.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.395 0.678 . . . . 0.0 112.828 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.83 -47.07 81.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.734 1.213 . . . . 0.0 112.345 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.46 -48.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.705 1.602 . . . . 0.0 110.617 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.54 -34.73 78.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -61.66 -27.22 68.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.997 1.319 . . . . 0.0 113.652 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.41 -33.15 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 0.0 111.321 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 65.73 -53.22 0.37 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 128.886 2.875 . . . . 0.0 115.32 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 57.3 m-85 -108.14 122.2 46.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -123.67 151.04 43.51 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.359 1.464 . . . . 0.0 112.606 -169.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -101.64 126.05 48.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.998 0.919 . . . . 0.0 110.903 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 10.4 mt -138.03 125.61 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.74 1.616 . . . . 0.0 108.811 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.27 37.01 13.97 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.395 1.078 . . . . 0.0 113.463 -173.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 61.96 7.1 1.93 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.044 2.138 . . . . 0.0 116.003 -171.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -95.34 163.01 13.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.87 1.668 . . . . 0.0 111.421 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -95.37 129.38 42.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.362 1.465 . . . . 0.0 111.061 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.1 165.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.589 1.556 . . . . 0.0 113.151 173.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -123.22 130.32 52.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.388 1.075 . . . . 0.0 111.762 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.72 144.44 25.51 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.982 0.913 . . . . 0.0 111.92 168.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -140.08 149.6 43.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.969 1.307 . . . . 0.0 108.591 170.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -64.56 131.18 46.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.983 1.265 . . . . 0.0 110.732 170.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.555 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.4 mttp . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 81.3 tttt -105.86 132.73 51.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.278 1.831 . . . . 0.0 111.583 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -120.3 150.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.918 1.287 . . . . 0.0 111.339 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -85.99 142.64 28.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.462 1.905 . . . . 0.0 109.441 165.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -126.6 100.55 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.519 1.528 . . . . 0.0 109.943 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.43 144.38 17.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.501 1.048 . . . . 0.0 113.952 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 19.72 54.09 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.41 1.005 . . . . 0.0 115.181 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.6 135.57 55.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.519 1.159 . . . . 0.0 111.379 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -66.81 144.0 56.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.024 0.53 . . . . 0.0 111.295 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 m -59.54 -16.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.98 -27.78 62.01 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.484 1.114 . . . . 0.0 113.303 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -77.11 131.24 38.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.637 1.575 . . . . 0.0 113.608 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.96 165.54 15.15 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.01 -34.98 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -71.46 -36.69 71.3 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 111.595 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -55.84 -51.67 66.69 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.411 0.551 . . . . 0.0 111.949 169.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.67 -42.58 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.9 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -57.59 -52.96 63.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.814 0.734 . . . . 0.0 111.123 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -62.48 -39.83 94.72 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.259 22.5 m-85 -63.67 -20.01 65.36 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 60.6 m-85 -97.3 -27.23 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 169.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.4 -23.51 38.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.223 1.409 . . . . 0.0 114.532 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -62.86 -29.78 71.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -85.75 -35.81 20.54 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.665 0.786 . . . . 0.0 111.628 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.69 163.04 24.97 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.179 2.799 . . . . 0.0 109.328 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -66.88 155.66 37.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -169.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.97 121.29 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.195 -1.82 . . . . 0.0 108.649 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -73.2 -39.6 65.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.746 1.218 . . . . 0.0 111.244 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.13 144.33 18.65 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.924 2.09 . . . . 0.0 115.206 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -132.16 148.17 52.46 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.621 1.168 . . . . 0.0 110.66 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -148.66 138.38 22.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.34 1.056 . . . . 0.0 111.564 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 46.1 mt -100.18 139.61 35.61 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.686 0.795 . . . . 0.0 110.444 170.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.7 mmm . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 122.892 0.477 . . . . 0.0 110.09 -179.48 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 121.578 0.704 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -79.16 11.8 2.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.594 2.358 . . . . 0.0 113.598 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.931 -1.106 . . . . 0.0 115.466 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.34 166.36 32.1 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.652 1.226 . . . . 0.0 112.329 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.25 -179.71 35.21 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.12 0.867 . . . . 0.0 113.529 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 95.7 m-85 -117.94 148.15 42.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.069 1.748 . . . . 0.0 115.248 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.8 t -137.03 126.83 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.918 1.287 . . . . 0.0 111.961 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -106.14 131.91 52.83 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.101 2.161 . . . . 0.0 114.479 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -102.54 159.49 15.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 120.33 3.455 . . . . 0.0 120.33 -167.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -58.32 -38.76 77.75 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.22 2.208 . . . . 0.0 113.501 170.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.9 t -155.26 153.42 30.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.408 1.483 . . . . 0.0 111.337 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -60.17 -32.3 70.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 111.25 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -61.96 -34.18 75.65 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.02 -42.93 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.179 -0.439 . . . . 0.0 110.195 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.95 -43.88 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.814 0.734 . . . . 0.0 110.511 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.31 -46.45 88.69 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.45 -45.5 88.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.59 1.156 . . . . 0.0 112.418 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.14 -48.91 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.002 1.721 . . . . 0.0 110.646 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.96 -30.58 71.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -64.55 -27.92 69.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 113.276 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.02 -33.27 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.208 1.003 . . . . 0.0 111.256 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 65.34 -58.84 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.543 2.737 . . . . 0.0 114.667 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 54.1 m-85 -104.3 116.97 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -112.15 152.69 28.04 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.91 1.684 . . . . 0.0 111.47 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.69 125.15 48.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.748 0.819 . . . . 0.0 110.495 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.04 122.46 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.545 1.538 . . . . 0.0 108.901 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 50.2 35.84 11.23 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.0 m120 63.03 2.12 0.98 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.427 2.291 . . . . 0.0 116.611 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -83.52 138.67 33.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.444 1.498 . . . . 0.0 109.112 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.8 mmm -86.43 129.82 34.72 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.833 -0.542 . . . . 0.0 110.78 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.13 152.2 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.526 1.53 . . . . 0.0 112.605 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -105.51 120.41 41.55 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.082 0.953 . . . . 0.0 111.654 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.33 141.86 28.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.151 0.58 . . . . 0.0 111.415 168.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -148.28 146.29 28.54 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 109.006 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.88 137.25 58.23 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.753 1.161 . . . . 0.0 110.155 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.577 0.703 . . . . 0.0 112.164 -174.972 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -142.08 138.92 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.789 -1.194 . . . . 0.0 113.041 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.69 151.91 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.932 1.293 . . . . 0.0 111.159 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.27 144.52 27.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.316 2.246 . . . . 0.0 106.546 165.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.08 108.9 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.806 1.642 . . . . 0.0 108.899 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.44 147.96 18.61 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.444 1.021 . . . . 0.0 114.531 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.56 19.96 36.25 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.896 1.236 . . . . 0.0 114.734 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.17 134.98 53.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.774 1.23 . . . . 0.0 111.466 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 t -63.24 152.39 37.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.928 0.891 . . . . 0.0 112.488 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 m -59.61 -20.08 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.625 1.17 . . . . 0.0 113.535 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -79.56 -25.91 41.51 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.572 1.149 . . . . 0.0 112.893 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 36.2 m -73.78 140.96 46.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.077 1.351 . . . . 0.0 113.713 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -122.87 164.13 19.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.736 1.614 . . . . 0.0 114.903 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.08 -35.84 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.17 -29.83 67.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.593 0.757 . . . . 0.0 112.775 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.41 -48.93 68.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.67 -43.01 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.821 0.848 . . . . 0.0 111.742 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.98 -46.54 90.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.156 0.582 . . . . 0.0 111.801 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -59.38 -45.26 91.95 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.986 0.914 . . . . 0.0 113.088 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -63.69 -35.33 80.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.346 62.3 m-85 -84.03 -25.82 29.58 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -59.37 -21.13 59.39 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.82 -31.81 73.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.119 1.367 . . . . 0.0 112.322 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -80.89 -26.54 36.78 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.0 165.0 15.18 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.993 2.235 . . . . 0.0 110.974 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.99 133.43 56.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.958 0.885 . . . . 0.0 112.638 -171.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.97 125.23 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.96 1.704 . . . . 0.0 108.093 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.99 -35.43 59.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -163.87 157.48 18.81 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.17 0.988 . . . . 0.0 110.435 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.9 150.49 43.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 111.218 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptm -153.88 133.73 13.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.633 1.173 . . . . 0.0 111.883 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.6 mt -103.9 147.66 27.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 170.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.9 mmm . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -171.506 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.0 p80 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 -72.76 9.85 1.02 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.42 22.16 77.83 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.122 -0.986 . . . . 0.0 113.853 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -150.34 166.27 30.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.518 1.151 . . . . 0.0 108.222 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.92 -170.33 23.35 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.79 1.186 . . . . 0.0 113.088 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.47 152.68 36.51 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.677 1.591 . . . . 0.0 114.486 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.79 127.41 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.13 1.372 . . . . 0.0 110.835 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.09 139.1 38.16 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.854 2.062 . . . . 0.0 113.759 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -112.09 155.34 24.02 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -66.87 -34.86 78.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.454 0.702 . . . . 0.0 112.087 172.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.5 t -141.64 143.51 33.67 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 112.206 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -67.01 -20.42 65.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.747 0.819 . . . . 0.0 111.976 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.62 -31.44 71.52 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.8 mm -72.84 -40.8 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.283 171.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.18 -44.85 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.941 0.791 . . . . 0.0 109.957 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -63.95 -45.0 91.11 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -56.91 -46.38 82.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.367 1.067 . . . . 0.0 111.868 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.88 -49.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.885 1.674 . . . . 0.0 110.651 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.15 -33.29 75.15 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.88 -27.38 68.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.462 1.105 . . . . 0.0 113.459 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.1 mt -72.56 -31.66 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.743 1.217 . . . . 0.0 111.754 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 66.04 -48.89 0.41 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 128.87 2.868 . . . . 0.0 115.607 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 51.8 m-85 -117.51 122.46 43.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -120.89 149.4 42.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 111.899 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -87.57 131.77 34.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.327 0.651 . . . . 0.0 111.846 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.8 mt -141.23 125.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.488 1.915 . . . . 0.0 108.74 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 51.27 41.36 27.88 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.726 1.211 . . . . 0.0 114.255 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 64.5 t30 60.27 21.13 10.57 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.13 1.772 . . . . 0.0 114.654 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -120.4 167.18 12.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.203 2.201 . . . . 0.0 110.318 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 95.9 mmm -105.52 141.19 37.43 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.928 0.891 . . . . 0.0 112.448 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.68 149.62 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.838 1.655 . . . . 0.0 112.29 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -94.78 127.76 41.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.023 0.929 . . . . 0.0 111.391 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.67 135.0 35.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.712 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -138.63 149.7 45.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.599 1.559 . . . . 0.0 109.585 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -61.15 136.29 58.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.959 1.254 . . . . 0.0 110.685 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 122.758 0.423 . . . . 0.0 110.838 -177.789 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -118.89 137.96 53.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.805 1.242 . . . . 0.0 112.761 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.3 pt -118.17 152.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.871 1.268 . . . . 0.0 111.065 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 182' ' ' LYS . 49.8 t80 -87.62 141.44 28.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.745 2.018 . . . . 0.0 108.098 165.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.81 114.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.227 1.411 . . . . 0.0 109.347 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.11 144.37 18.41 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.423 1.011 . . . . 0.0 114.334 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.59 20.56 50.9 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.523 1.058 . . . . 0.0 114.562 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.0 mt -61.91 141.42 58.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.6 1.2 . . . . 0.0 111.103 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.32 141.7 58.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.888 -0.508 . . . . 0.0 111.128 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.01 -17.34 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.44 -25.85 50.99 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.543 1.137 . . . . 0.0 112.876 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 140.06 55.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.112 1.365 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -113.67 161.1 17.88 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.004 1.322 . . . . 0.0 114.42 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -54.7 -34.51 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.48 -31.35 68.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -64.6 -42.19 95.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.897 0.772 . . . . 0.0 109.25 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.7 -48.83 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.585 1.154 . . . . 0.0 111.3 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -60.26 -48.29 82.37 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.629 0.65 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -58.53 -41.17 84.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.672 0.789 . . . . 0.0 112.796 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.7 -47.01 82.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 57.5 m-85 -70.2 -25.89 63.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -60.48 -43.66 96.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.622 1.169 . . . . 0.0 112.784 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.46 -35.63 70.94 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 113.04 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.62 166.12 26.17 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.123 2.297 . . . . 0.0 110.731 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.072 0.939 . . . . 0.0 112.978 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.6 t -106.79 129.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.556 1.943 . . . . 0.0 108.395 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.89 -56.59 5.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 112.163 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -155.46 161.46 40.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.048 0.939 . . . . 0.0 110.319 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.44 152.63 38.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.47 1.508 . . . . 0.0 111.044 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -154.17 132.0 11.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.975 0.91 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.5 mt -100.59 137.49 38.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.27 1.028 . . . . 0.0 111.087 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.3 mmt . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 122.885 0.474 . . . . 0.0 112.264 -174.803 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.2 p80 . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.277 0.561 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -77.78 19.22 0.4 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.218 1.407 . . . . 0.0 114.709 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.42 22.52 76.44 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.128 -0.982 . . . . 0.0 113.824 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -151.7 164.0 37.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.559 1.179 . . . . 0.0 109.224 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.34 -167.57 29.18 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.279 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.62 150.1 44.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.916 1.686 . . . . 0.0 114.337 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.95 128.66 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.191 1.397 . . . . 0.0 110.815 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -108.54 134.22 51.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.209 1.803 . . . . 0.0 114.079 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -105.82 160.04 15.55 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -69.12 -33.68 73.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.933 0.893 . . . . 0.0 112.753 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t -142.66 147.07 35.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.707 1.203 . . . . 0.0 112.316 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.21 -30.09 67.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.517 1.127 . . . . 0.0 111.765 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.75 -35.27 72.46 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.65 -40.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.562 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.95 -44.21 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.994 0.816 . . . . 0.0 110.138 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -62.15 -48.07 81.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.44 -46.46 76.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.023 1.329 . . . . 0.0 112.547 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.85 -45.14 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.358 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.9 t -67.62 -36.13 80.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.699 0.799 . . . . 0.0 112.846 -176.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.54 -22.64 67.02 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.8 -33.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.803 0.841 . . . . 0.0 111.051 172.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 67.11 -51.32 0.48 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.838 2.855 . . . . 0.0 115.42 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.332 59.2 m-85 -110.28 123.57 50.06 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -123.86 170.36 10.64 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.281 2.232 . . . . 0.0 110.578 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -142.47 122.54 13.71 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.816 -1.178 . . . . 0.0 112.939 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.88 128.84 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.77 1.628 . . . . 0.0 108.989 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.72 39.64 18.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.65 1.18 . . . . 0.0 113.294 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 62.22 9.02 2.97 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.118 2.167 . . . . 0.0 116.231 -174.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -98.68 134.06 42.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.16 1.384 . . . . 0.0 110.42 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 18.7 ttm -82.53 137.24 34.65 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.757 0.823 . . . . 0.0 110.784 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.17 157.52 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.171 1.788 . . . . 0.0 112.259 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -106.47 128.77 54.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.065 0.946 . . . . 0.0 111.913 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.1 p -90.7 138.62 31.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.093 0.557 . . . . 0.0 110.632 167.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 112' ' ' PHE . 46.6 mtmt -140.36 146.44 38.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.828 1.251 . . . . 0.0 109.518 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -62.79 128.1 34.36 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.218 0.917 . . . . 0.0 110.781 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 120.867 0.365 . . . . 0.0 111.945 -172.578 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.2 mttp . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.174 0.035 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -133.55 139.8 46.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -167.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 pt -121.07 153.07 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.192 1.397 . . . . 0.0 111.032 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.55 143.9 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.211 2.604 . . . . 0.0 105.009 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.58 103.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.949 1.7 . . . . 0.0 109.263 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -104.29 142.44 15.49 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.568 1.08 . . . . 0.0 114.264 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.13 54.69 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.747 1.165 . . . . 0.0 114.997 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 mt -62.54 145.16 55.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.757 1.223 . . . . 0.0 112.475 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 t -66.93 137.69 56.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 110.719 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.76 -9.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.28 -20.29 28.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.098 0.959 . . . . 0.0 113.071 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.8 m -72.22 129.92 39.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.725 1.21 . . . . 0.0 111.37 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -103.01 163.95 11.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.72 -38.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.56 -29.64 68.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.276 0.63 . . . . 0.0 112.616 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -65.75 -45.73 81.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.308 0.958 . . . . 0.0 110.172 173.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.52 -48.21 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.576 1.15 . . . . 0.0 110.812 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -56.64 -51.13 69.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.149 1.38 . . . . 0.0 112.377 173.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -62.42 -36.86 83.7 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.872 0.869 . . . . 0.0 112.934 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -65.97 -45.38 81.92 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 58.3 m-85 -71.14 -25.51 62.6 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 176.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -56.83 -22.38 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.532 1.533 . . . . 0.0 114.631 170.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.79 -43.53 97.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.57 -33.28 68.94 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.52 170.8 30.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.336 1.922 . . . . 0.0 112.049 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -60.62 132.08 52.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.22 1.008 . . . . 0.0 112.188 -171.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.62 134.95 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.161 1.784 . . . . 0.0 108.431 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.93 -45.6 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.437 1.095 . . . . 0.0 113.703 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.73 162.35 23.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.911 1.285 . . . . 0.0 109.73 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.43 153.09 42.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.287 1.435 . . . . 0.0 111.71 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -156.33 134.72 11.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.53 1.132 . . . . 0.0 112.276 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 18.4 mt -101.49 147.07 26.81 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.864 0.866 . . . . 0.0 110.839 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.492 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 33.4 mmt . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 112.91 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.6 p80 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 121.624 0.726 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 ttp85 -72.88 17.41 0.12 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.88 2.072 . . . . 0.0 114.489 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.29 15.35 69.34 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.198 1.38 . . . . 0.0 114.766 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.492 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 27.4 p90 -156.02 168.47 27.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.219 1.51 . . . . 0.0 111.237 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.87 -167.74 25.92 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.829 1.204 . . . . 0.0 113.573 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.71 150.83 50.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.268 1.827 . . . . 0.0 115.014 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.48 128.52 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.29 1.436 . . . . 0.0 111.498 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -100.72 146.51 27.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.735 2.014 . . . . 0.0 113.687 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.8 151.94 38.97 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.41 -27.76 63.53 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.926 0.891 . . . . 0.0 112.948 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.8 t -141.68 142.34 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.995 1.318 . . . . 0.0 112.148 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -64.23 -26.52 68.54 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.125 . . . . 0.0 111.754 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.76 -32.82 72.1 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.9 -42.34 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.336 172.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.56 -44.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.666 0.666 . . . . 0.0 110.514 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -64.23 -47.3 80.19 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.84 -46.58 74.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.403 1.081 . . . . 0.0 111.946 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.91 -49.62 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.827 1.651 . . . . 0.0 110.872 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.61 -33.31 75.63 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -65.67 -21.6 66.56 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.68 -31.77 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.021 0.928 . . . . 0.0 111.304 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 66.1 -52.75 0.4 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.828 2.851 . . . . 0.0 115.535 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.337 49.6 m-85 -111.41 121.5 45.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 173.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -118.42 165.65 13.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.117 2.167 . . . . 0.0 110.849 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -131.14 113.9 14.46 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.276 -0.89 . . . . 0.0 112.14 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.75 129.24 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.776 1.23 . . . . 0.0 109.314 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 48.1 45.12 19.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.648 1.179 . . . . 0.0 112.686 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.297 0.9 OUTLIER 52.81 31.79 11.18 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.448 2.299 . . . . 0.0 115.748 -174.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -130.84 142.2 50.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.78 1.632 . . . . 0.0 110.344 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.3 mmm -84.11 135.1 34.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.312 1.045 . . . . 0.0 111.79 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.71 153.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.834 1.254 . . . . 0.0 111.892 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.38 127.63 46.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.651 0.78 . . . . 0.0 111.933 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -89.79 136.38 33.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.846 0.458 . . . . 0.0 110.432 167.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -140.76 148.11 40.17 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.974 1.309 . . . . 0.0 108.744 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.45 135.5 55.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.897 1.226 . . . . 0.0 110.879 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 122.742 0.417 . . . . 0.0 111.29 -175.676 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.2 mttp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.55 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 80.2 tttt -136.63 138.33 41.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.346 1.458 . . . . 0.0 111.72 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.0 149.29 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.592 1.157 . . . . 0.0 111.333 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -83.97 145.22 28.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.251 1.82 . . . . 0.0 107.534 165.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.82 108.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.977 1.711 . . . . 0.0 109.984 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.74 147.63 18.66 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.594 1.092 . . . . 0.0 114.5 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.8 17.42 63.57 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.243 0.925 . . . . 0.0 114.61 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.1 mt -61.66 144.68 54.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.841 1.256 . . . . 0.0 111.494 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.5 t -69.36 137.0 52.49 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.061 -0.399 . . . . 0.0 110.133 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.4 m -64.52 -12.2 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -27.63 42.11 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.75 1.22 . . . . 0.0 113.145 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.2 m -67.4 132.39 47.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 111.974 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.49 161.46 20.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -35.02 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -71.6 -37.35 70.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.489 0.716 . . . . 0.0 111.685 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.51 -50.26 72.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.539 0.609 . . . . 0.0 111.787 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.81 -43.49 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.84 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.94 -52.57 64.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.053 0.842 . . . . 0.0 111.647 174.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -59.55 -39.79 85.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.27 24.4 m-85 -64.32 -16.24 61.82 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 118.309 2.707 . . . . 0.0 118.309 170.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 58.3 m-85 -101.5 -25.61 13.85 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.72 -21.87 56.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.159 1.384 . . . . 0.0 113.824 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.19 -29.92 71.17 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.31 -28.55 31.61 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.72 169.19 24.7 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.496 2.474 . . . . 0.0 110.079 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -63.27 130.23 43.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.843 0.83 . . . . 0.0 112.589 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.44 132.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.193 1.797 . . . . 0.0 108.938 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.94 -57.91 3.6 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.174 0.989 . . . . 0.0 112.743 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -157.47 166.99 31.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.271 1.029 . . . . 0.0 109.883 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.39 157.72 43.66 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.398 1.479 . . . . 0.0 111.315 174.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -152.16 125.02 8.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.421 1.088 . . . . 0.0 111.391 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.36 146.97 25.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.305 0.642 . . . . 0.0 110.568 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.44 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 36.8 mmt . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 112.114 -172.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.4 p80 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -70.7 -15.67 62.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.303 1.441 . . . . 0.0 114.081 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 114.9 22.27 5.04 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.509 1.052 . . . . 0.0 114.841 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.44 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 41.6 p90 -153.46 166.04 33.93 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.778 1.289 . . . . 0.0 111.237 171.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.3 -169.58 33.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.614 1.102 . . . . 0.0 114.289 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.55 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 92.8 m-85 -124.11 152.57 42.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.875 2.07 . . . . 0.0 115.979 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -137.86 133.65 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.412 1.485 . . . . 0.0 111.807 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.58 140.89 39.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.328 2.251 . . . . 0.0 114.934 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -117.2 155.61 29.12 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -168.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -72.24 -31.29 65.68 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.866 0.866 . . . . 0.0 113.095 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.7 t -144.37 145.99 32.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.65 1.18 . . . . 0.0 112.633 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.32 -25.07 66.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.88 0.872 . . . . 0.0 111.872 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.12 -32.52 72.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.7 mm -72.33 -42.56 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.312 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.51 -44.68 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.772 0.715 . . . . 0.0 110.23 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.75 -49.7 76.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -55.76 -47.39 77.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.513 1.125 . . . . 0.0 112.301 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.32 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.749 1.62 . . . . 0.0 110.725 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 61.6 m -65.7 -33.27 75.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.24 -23.03 66.95 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.8 mt -72.98 -33.03 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.914 0.885 . . . . 0.0 111.251 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 65.7 -48.94 0.39 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.032 2.933 . . . . 0.0 115.531 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.301 46.9 m-85 -115.7 124.14 50.1 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -123.56 139.32 54.12 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.665 1.586 . . . . 0.0 111.816 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -86.05 124.62 32.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.072 0.949 . . . . 0.0 111.222 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.1 mt -138.76 124.75 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.213 1.805 . . . . 0.0 108.729 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 48.29 44.72 20.04 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.313 0.8 OUTLIER 53.45 29.22 8.58 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.688 1.995 . . . . 0.0 115.947 -172.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -127.53 136.06 51.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.318 2.247 . . . . 0.0 109.819 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 88.0 mtp -86.25 132.72 33.93 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.776 -0.578 . . . . 0.0 111.207 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.2 m -127.37 153.27 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.625 1.57 . . . . 0.0 112.712 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -101.25 125.98 47.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.781 0.833 . . . . 0.0 111.982 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.11 139.31 30.75 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.392 0.677 . . . . 0.0 111.462 167.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -136.37 145.3 45.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.72 1.208 . . . . 0.0 109.237 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.72 130.28 45.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.367 0.985 . . . . 0.0 109.758 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -172.699 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.0 mttt . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 84.0 tttt -137.86 140.1 40.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.877 1.271 . . . . 0.0 111.178 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt -124.82 150.62 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.489 1.116 . . . . 0.0 111.922 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -85.12 144.14 28.39 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.09 117.09 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.613 1.565 . . . . 0.0 109.762 172.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.0 145.81 16.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.269 0.938 . . . . 0.0 114.267 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.02 11.9 58.26 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.855 1.217 . . . . 0.0 115.121 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -59.63 142.78 52.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 111.275 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t -67.83 144.71 55.21 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.63 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.25 1.4 p -65.07 -13.57 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -72.75 -26.85 61.71 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 112.545 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.2 m -72.22 135.37 46.06 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 112.832 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 t -106.15 160.05 15.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 171.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.89 -34.42 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.435 1.494 . . . . 0.0 114.564 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.29 -34.88 75.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.235 0.614 . . . . 0.0 112.598 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -61.2 -42.37 98.47 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.222 0.919 . . . . 0.0 109.85 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.85 -47.81 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.74 1.216 . . . . 0.0 111.244 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -60.85 -48.48 81.61 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.664 0.665 . . . . 0.0 112.156 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -59.83 -37.02 78.04 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.67 -48.37 72.32 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 54.4 m-85 -68.99 -25.0 64.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -59.79 -18.65 45.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -59.43 -45.0 92.8 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.633 1.173 . . . . 0.0 112.82 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -73.01 -36.85 67.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.963 1.305 . . . . 0.0 112.535 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.68 165.88 29.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.097 1.808 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -59.09 126.22 26.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.963 0.905 . . . . 0.0 112.432 -169.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.97 128.67 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.756 1.622 . . . . 0.0 108.593 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.37 -57.2 4.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.195 0.998 . . . . 0.0 113.093 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -156.19 165.56 36.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 110.039 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.8 155.81 41.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.571 1.549 . . . . 0.0 111.272 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -154.86 134.88 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.373 1.069 . . . . 0.0 112.347 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.2 mt -103.25 142.45 34.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 111.236 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.438 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 38.3 mmt . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 121.863 0.84 . . . . 0.0 111.611 -175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.7 p80 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.763 0.316 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.06 2.65 6.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.03 58.27 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.059 -1.025 . . . . 0.0 113.952 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 14.9 p90 -152.39 165.15 35.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.562 1.181 . . . . 0.0 109.234 172.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.65 -167.88 33.94 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.477 1.037 . . . . 0.0 113.668 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.517 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.5 m-85 -124.79 151.73 44.78 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.988 1.715 . . . . 0.0 114.974 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.15 132.91 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.288 1.435 . . . . 0.0 111.526 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.14 142.76 37.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.942 2.097 . . . . 0.0 114.647 -178.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.21 156.88 30.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -168.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.37 -32.92 73.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.796 0.838 . . . . 0.0 112.99 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.9 t -144.41 145.96 32.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.795 1.238 . . . . 0.0 112.377 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -60.18 -31.13 69.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.838 0.855 . . . . 0.0 111.638 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -59.69 -30.34 68.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.3 mm -72.36 -44.66 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 122.06 -0.4 . . . . 0.0 110.086 169.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.25 -41.33 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.639 0.654 . . . . 0.0 110.504 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -58.19 -51.37 70.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.291 0.636 . . . . 0.0 112.631 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.17 -46.38 88.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.639 1.176 . . . . 0.0 112.435 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.33 -46.87 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.806 1.642 . . . . 0.0 110.791 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.48 -38.52 91.46 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.622 0.769 . . . . 0.0 112.988 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -63.45 -19.46 64.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 73.4 mt -71.87 -33.71 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.28 -0.888 . . . . 0.0 111.464 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 65.08 -55.39 0.31 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.851 2.86 . . . . 0.0 115.179 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.359 46.3 m-85 -107.6 109.55 21.22 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -100.15 168.95 9.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.602 2.361 . . . . 0.0 111.353 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -132.45 118.41 19.28 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.362 -0.836 . . . . 0.0 111.889 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.91 127.95 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.787 1.235 . . . . 0.0 109.262 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.5 43.21 19.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.758 1.223 . . . . 0.0 112.939 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.301 0.7 OUTLIER 53.92 20.58 2.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.76 2.424 . . . . 0.0 116.352 -173.086 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -106.43 138.74 42.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.697 1.599 . . . . 0.0 110.24 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.1 mmm -80.7 133.56 35.71 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.896 0.878 . . . . 0.0 110.457 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.86 147.67 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.792 1.237 . . . . 0.0 112.84 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -97.35 124.63 41.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.225 1.01 . . . . 0.0 111.987 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.2 p -90.55 147.64 23.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.05 0.54 . . . . 0.0 111.426 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -143.34 151.02 39.98 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.927 1.291 . . . . 0.0 109.128 170.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.49 126.81 29.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.016 0.825 . . . . 0.0 109.149 168.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 121.435 0.636 . . . . 0.0 112.161 -175.99 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.8 mttt . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -124.0 138.49 54.45 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.543 1.065 . . . . 0.0 113.027 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.5 pt -118.66 153.04 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.894 1.278 . . . . 0.0 111.537 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -88.54 139.46 30.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.783 2.433 . . . . 0.0 108.12 165.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.4 t -130.73 111.13 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.31 1.444 . . . . 0.0 109.809 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.58 17.6 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.536 1.065 . . . . 0.0 113.807 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.52 12.76 37.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.917 1.246 . . . . 0.0 114.534 -177.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.02 139.23 58.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.429 1.092 . . . . 0.0 110.876 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -66.85 142.12 57.44 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.868 -0.52 . . . . 0.0 110.029 169.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.92 -14.61 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -74.18 -21.7 59.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.303 1.441 . . . . 0.0 113.744 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -71.24 145.48 49.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.404 1.481 . . . . 0.0 112.448 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -118.59 159.36 23.72 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.897 1.279 . . . . 0.0 114.113 169.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.54 -34.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.269 1.427 . . . . 0.0 114.847 -173.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.57 -28.82 65.19 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.56 0.744 . . . . 0.0 112.942 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -64.88 -51.59 61.14 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 t -58.83 -44.81 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.148 0.979 . . . . 0.0 111.489 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -59.21 -48.01 83.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.929 0.492 . . . . 0.0 111.952 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -62.71 -40.08 96.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -58.57 -30.38 67.12 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.262 59.7 m-85 -88.42 -24.1 23.13 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.13 -14.07 22.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -59.19 -42.58 91.19 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 112.523 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -80.51 -32.98 36.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.06 172.87 35.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.39 1.948 . . . . 0.0 111.058 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.16 125.5 24.08 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.134 0.967 . . . . 0.0 112.391 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 38.3 t -97.66 128.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.516 1.527 . . . . 0.0 110.107 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -75.05 -50.68 15.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.973 1.309 . . . . 0.0 112.906 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -160.9 164.25 31.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.18 0.992 . . . . 0.0 110.471 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.62 154.56 39.88 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.546 1.539 . . . . 0.0 111.383 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -151.71 136.71 17.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.697 1.199 . . . . 0.0 111.67 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.75 146.83 34.28 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 111.396 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 124.287 1.035 . . . . 0.0 112.363 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.8 p80 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -67.23 7.96 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.204 1.802 . . . . 0.0 115.751 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.84 65.73 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.581 1.086 . . . . 0.0 114.208 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -153.7 167.6 29.04 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.719 1.26 . . . . 0.0 111.21 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.78 -164.7 22.88 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.102 0.858 . . . . 0.0 113.41 170.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -120.89 150.58 40.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.104 1.762 . . . . 0.0 114.892 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.17 127.77 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.066 1.346 . . . . 0.0 111.159 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.66 136.34 48.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.432 1.893 . . . . 0.0 114.62 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -109.76 158.68 17.88 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.141 1.776 . . . . 0.0 115.643 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.32 -28.44 63.07 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.2 t -141.85 144.84 34.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.169 1.388 . . . . 0.0 112.459 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -60.58 -31.67 70.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 111.684 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.62 -31.46 70.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.75 -42.04 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 110.134 171.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.9 -43.19 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.834 0.743 . . . . 0.0 110.248 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -59.94 -47.15 86.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 173.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -58.67 -51.21 70.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.189 0.995 . . . . 0.0 112.466 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.0 t -64.19 -43.18 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.703 1.601 . . . . 0.0 110.809 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 46.7 t -70.23 -35.52 73.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -64.28 -26.58 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.923 -1.111 . . . . 0.0 113.781 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.5 mt -71.07 -39.43 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.844 0.858 . . . . 0.0 110.874 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 65.45 -43.15 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.973 2.909 . . . . 0.0 115.969 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.283 53.2 m-85 -111.69 123.36 50.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 174.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -129.52 159.84 35.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.502 1.521 . . . . 0.0 112.356 -169.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -106.41 127.08 53.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.129 0.972 . . . . 0.0 111.282 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.74 123.79 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.327 1.451 . . . . 0.0 108.998 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.58 37.48 16.28 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.279 1.032 . . . . 0.0 113.298 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.83 12.92 4.07 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 127.339 2.256 . . . . 0.0 115.7 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -97.86 145.57 26.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.082 1.753 . . . . 0.0 110.584 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.67 128.96 34.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.368 1.467 . . . . 0.0 110.205 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.39 147.31 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.702 1.201 . . . . 0.0 113.318 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -94.18 129.18 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.549 1.139 . . . . 0.0 110.187 171.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.85 126.58 54.14 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.754 1.222 . . . . 0.0 110.388 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -148.88 148.69 30.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.025 1.33 . . . . 0.0 111.296 -171.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.31 138.94 58.25 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.411 -0.806 . . . . 0.0 111.817 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.382 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.8 m -66.61 -23.54 66.2 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -148.84 153.44 38.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.755 1.622 . . . . 0.0 111.66 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 50.1 tpp -86.36 157.33 19.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.833 0.853 . . . . 0.0 110.41 168.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -75.76 46.48 0.37 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.522 1.529 . . . . 0.0 112.048 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -150.71 147.61 27.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.937 2.495 . . . . 0.0 109.797 -168.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -108.65 152.2 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.837 . . . . 0.0 111.307 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -85.41 144.54 27.95 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 164.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.71 110.34 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.44 1.496 . . . . 0.0 109.74 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.65 150.94 18.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.421 1.01 . . . . 0.0 113.908 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.62 15.52 54.68 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.316 0.96 . . . . 0.0 114.51 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.87 134.86 55.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.655 1.182 . . . . 0.0 111.66 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -62.47 148.69 44.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.299 0.639 . . . . 0.0 111.842 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t -58.73 -25.76 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.504 1.122 . . . . 0.0 113.885 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -74.26 -27.83 60.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.274 1.03 . . . . 0.0 112.476 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.4 m -72.75 127.38 32.38 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -94.42 165.76 12.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.48 -34.52 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -73.84 -37.43 64.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.403 0.681 . . . . 0.0 111.878 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -54.08 -46.08 71.93 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.851 0.75 . . . . 0.0 112.795 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.61 -48.53 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.624 1.17 . . . . 0.0 109.801 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -61.34 -42.98 99.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.027 0.931 . . . . 0.0 112.715 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -72.98 -28.8 62.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -69.11 -50.49 47.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.317 67.3 m-85 -65.83 -20.27 66.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -56.57 -18.03 10.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 170.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.63 -29.32 69.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.958 -1.089 . . . . 0.0 112.817 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -87.32 -34.55 18.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.005 0.922 . . . . 0.0 112.609 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.02 171.58 35.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.027 2.251 . . . . 0.0 110.576 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -66.67 133.47 50.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.709 0.766 . . . . 0.0 112.282 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.65 127.02 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.286 1.834 . . . . 0.0 109.296 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.84 -52.61 16.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -164.24 173.85 11.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.672 0.789 . . . . 0.0 110.011 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -138.59 157.33 46.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.197 1.399 . . . . 0.0 111.899 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptm -150.53 133.42 15.97 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.01 1.324 . . . . 0.0 111.049 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.36 150.61 25.07 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.563 -0.711 . . . . 0.0 110.622 169.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.1 mmm -80.39 72.72 7.28 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.166 0.508 . . . . 0.0 111.904 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.287 53.4 m-85 -61.85 137.99 58.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -118.81 112.04 19.2 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.967 1.707 . . . . 0.0 113.181 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -64.31 -18.08 64.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -25.38 64.94 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 170.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.3 p -130.56 -14.79 3.63 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 65.68 11.65 7.68 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.125 2.17 . . . . 0.0 114.444 -171.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.28 167.77 9.77 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.907 1.683 . . . . 0.0 111.716 169.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -91.97 156.65 17.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.969 0.908 . . . . 0.0 113.064 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 21.23 0.07 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.491 2.316 . . . . 0.0 113.428 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.66 6.23 71.04 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.045 -1.66 . . . . 0.0 115.25 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.76 167.35 24.08 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.887 1.344 . . . . 0.0 110.13 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.19 -165.33 22.32 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.223 1.392 . . . . 0.0 112.676 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.56 152.23 50.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.191 1.796 . . . . 0.0 114.92 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.54 119.08 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.075 1.35 . . . . 0.0 112.058 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -89.11 144.76 25.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.502 1.921 . . . . 0.0 113.763 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -116.6 162.33 17.8 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.53 -40.9 76.62 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.829 -0.544 . . . . 0.0 111.137 168.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t -139.51 144.39 37.89 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.262 1.425 . . . . 0.0 112.406 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -65.5 -18.12 65.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.44 -32.63 71.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.9 mm -75.87 -41.75 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.751 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.27 -44.56 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.085 0.857 . . . . 0.0 109.888 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -60.82 -49.91 75.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 113.165 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.32 -45.44 80.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 0.0 112.531 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.35 -46.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.611 1.565 . . . . 0.0 111.225 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.5 m -66.2 -31.15 71.8 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -63.93 -31.38 72.55 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.151 1.38 . . . . 0.0 112.834 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.7 mt -68.82 -33.79 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.286 1.034 . . . . 0.0 111.319 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 65.19 -58.51 0.27 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 128.547 2.739 . . . . 0.0 114.884 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 46.1 m-85 -102.25 116.37 32.52 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 170.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -109.57 173.61 6.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.148 2.179 . . . . 0.0 110.709 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -140.84 123.22 15.88 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.07 -1.019 . . . . 0.0 112.505 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -137.38 133.01 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.987 1.715 . . . . 0.0 108.983 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 50.6 41.51 25.73 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.894 1.278 . . . . 0.0 114.025 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.15 24.7 14.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.049 1.74 . . . . 0.0 114.163 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -129.35 153.18 48.12 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.467 1.507 . . . . 0.0 110.713 169.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.8 mtp -94.47 144.47 25.54 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.39 144.97 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.426 1.491 . . . . 0.0 111.677 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -95.36 121.57 37.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.205 1.002 . . . . 0.0 110.646 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 72.6 m -105.89 131.07 53.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.334 1.053 . . . . 0.0 111.809 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.356 1.862 . . . . 0.0 110.14 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.49 135.07 57.64 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.82 1.191 . . . . 0.0 111.094 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.51 118.08 12.86 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.274 0.559 . . . . 0.0 110.871 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -66.82 147.66 99.0 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.676 1.191 . . . . 0.0 111.479 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.78 36.13 0.47 Allowed 'Trans proline' 0 CA--C 1.547 1.16 1 C-N-CA 125.713 4.275 . . . . 0.0 117.948 -166.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 59.98 -15.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 129.409 3.084 . . . . 0.0 118.32 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.27 -31.02 71.55 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.016 -1.053 . . . . 0.0 111.617 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.4 m -67.99 -5.03 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.124 1.77 . . . . 0.0 115.173 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 81.3 mtp -70.25 -12.18 61.41 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.177 0.898 . . . . 0.0 112.825 169.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.2 t -56.9 148.92 46.61 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.925 1.29 . . . . 0.0 112.068 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -54.83 -20.97 24.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.474 2.783 . . . . 0.0 115.345 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.7 p -70.11 -15.95 63.05 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 171.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.47 -11.54 0.99 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.023 1.297 . . . . 0.0 116.157 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 89.1 p -62.06 -21.17 64.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.777 1.788 . . . . 0.0 114.53 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.62 54.66 1.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.283 1.433 . . . . 0.0 111.87 169.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 48.65 32.74 3.69 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.941 2.496 . . . . 0.0 114.681 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.04 171.71 48.81 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.493 1.521 . . . . 0.0 115.334 -171.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 149.81 49.79 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.916 2.086 . . . . 0.0 111.222 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.547 1.539 . . . . 0.0 113.748 -178.844 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.154 1 O4'-C1'-N19 112.946 4.746 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.434 1 O4'-C1'-N19 112.623 4.423 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.308 1 O4'-C1'-N19 112.606 4.406 . 0.089 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.205 1 O4'-C1'-N19 113.181 4.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.171 0 O4'-C1'-N19 111.702 3.502 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.076 -0.409 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.2 p -153.46 163.08 40.57 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.163 1.385 . . . . 0.0 112.362 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -153.07 175.05 13.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.693 1.597 . . . . 0.0 111.632 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.65 35.92 4.74 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.576 1.55 . . . . 0.0 111.324 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -75.0 -1.64 23.62 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -174.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -105.15 133.65 49.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.349 1.06 . . . . 0.0 112.772 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.8 pt -112.46 154.58 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.205 1.402 . . . . 0.0 111.359 169.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.66 142.31 28.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.281 2.232 . . . . 0.0 107.843 165.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 t -133.56 110.43 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.135 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.06 153.85 16.68 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.459 1.028 . . . . 0.0 113.921 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.47 9.4 56.68 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.225 1.393 . . . . 0.0 115.249 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.0 mt -63.39 141.16 58.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.998 1.319 . . . . 0.0 110.931 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 t -66.85 142.98 57.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.972 -0.455 . . . . 0.0 110.838 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.79 -11.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -86.37 -13.36 46.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.807 1.243 . . . . 0.0 114.151 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.5 m -73.88 132.82 42.9 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.59 1.156 . . . . 0.0 111.676 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.88 161.63 17.38 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 175.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -60.29 -33.65 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 169.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -74.22 -34.25 63.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.697 0.799 . . . . 0.0 112.068 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -56.25 -46.05 79.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.081 0.855 . . . . 0.0 112.135 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.64 -47.92 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.077 0.951 . . . . 0.0 110.649 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.11 -47.28 86.54 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.66 0.664 . . . . 0.0 111.735 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -62.87 -38.82 92.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.196 0.998 . . . . 0.0 112.992 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -64.68 -51.0 64.8 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 57.0 m-85 -64.44 -21.24 66.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -66.61 0.02 2.55 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 170.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.49 -29.47 63.66 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.389 -1.444 . . . . 0.0 111.862 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -88.95 -21.13 23.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.13 -158.3 25.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.681 2.086 . . . . 0.0 110.49 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -97.95 147.52 24.39 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.484 1.142 . . . . 0.0 110.791 170.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.32 129.92 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.412 1.485 . . . . 0.0 109.302 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -71.08 -47.09 60.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.774 1.63 . . . . 0.0 114.738 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -162.69 161.07 26.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.156 0.983 . . . . 0.0 110.241 -173.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.34 153.72 40.85 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.566 1.546 . . . . 0.0 111.271 170.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -152.75 132.35 13.06 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.425 1.09 . . . . 0.0 111.794 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.0 mt -103.98 146.97 27.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.71 0.804 . . . . 0.0 110.752 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.1 mmt -87.15 85.24 7.2 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 149' ' ' HIS . 40.9 m-85 -69.61 136.63 51.45 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 118.41 2.744 . . . . 0.0 118.41 174.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -94.17 129.39 40.78 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.218 1.407 . . . . 0.0 113.414 168.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.5 -38.01 89.51 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -171.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -76.99 -52.5 9.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.063 1.345 . . . . 0.0 109.028 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 p -69.32 -19.67 63.87 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.322 9.1 p30 51.2 26.66 3.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.109 2.163 . . . . 0.0 114.841 -172.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -131.64 160.91 34.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.3 2.24 . . . . 0.0 111.119 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 35.7 p80 -86.43 157.88 19.72 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 173.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -68.69 5.94 0.96 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.59 18.62 67.95 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.751 -1.218 . . . . 0.0 114.286 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.2 161.66 38.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.289 1.045 . . . . 0.0 112.48 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.85 27.08 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.632 0.634 . . . . 0.0 113.451 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.61 150.63 39.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.235 1.814 . . . . 0.0 114.343 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.72 127.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.421 1.488 . . . . 0.0 111.527 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -110.26 125.92 53.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.321 1.449 . . . . 0.0 114.394 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -91.48 162.09 14.7 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -170.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -60.7 -45.41 94.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.246 1.018 . . . . 0.0 111.605 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -136.73 142.66 43.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.572 1.549 . . . . 0.0 111.612 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.04 -24.67 67.79 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.509 1.124 . . . . 0.0 112.039 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.01 -28.9 70.42 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 172.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.7 -42.48 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 121.954 -0.467 . . . . 0.0 110.539 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.09 -41.29 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.236 0.614 . . . . 0.0 110.359 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.47 -47.23 82.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.985 0.514 . . . . 0.0 112.364 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -64.35 -45.97 85.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.307 1.043 . . . . 0.0 112.157 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.26 -41.33 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.144 1.377 . . . . 0.0 111.405 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.31 -33.92 70.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.983 0.913 . . . . 0.0 112.716 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -26.94 68.03 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.8 mt -67.32 -36.62 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.421 -0.799 . . . . 0.0 110.313 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 65.19 -60.27 0.25 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 128.826 2.85 . . . . 0.0 114.233 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 64.9 m-85 -100.03 123.51 44.36 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -124.17 176.01 6.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.741 2.416 . . . . 0.0 110.124 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -139.6 129.24 24.48 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.426 -1.421 . . . . 0.0 112.783 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 39.5 mt -138.15 131.99 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.296 1.438 . . . . 0.0 109.278 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.7 41.17 25.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.177 1.391 . . . . 0.0 114.543 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.3 t30 60.55 33.19 20.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.032 1.733 . . . . 0.0 113.794 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -133.97 143.62 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.05 1.74 . . . . 0.0 111.456 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 7.2 ttm -85.17 133.58 34.19 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.785 0.834 . . . . 0.0 110.723 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.32 156.72 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.571 1.548 . . . . 0.0 112.787 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -118.42 112.3 19.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.812 0.845 . . . . 0.0 112.097 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 t -78.72 131.21 36.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.785 0.834 . . . . 0.0 111.458 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -150.18 146.77 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.927 1.691 . . . . 0.0 110.709 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.79 135.15 55.47 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.448 -0.783 . . . . 0.0 112.493 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.0 122.5 18.81 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -129.67 155.63 80.05 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 126.407 1.883 . . . . 0.0 111.896 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.84 151.05 86.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.3 2.667 . . . . 0.0 114.237 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -66.05 -16.43 63.91 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -65.61 -41.66 92.46 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.858 1.263 . . . . 0.0 112.487 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.268 1.0 OUTLIER -77.12 -31.86 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 178.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 22.4 mmt -79.46 -17.05 55.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.712 1.205 . . . . 0.0 113.489 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.0 t 63.86 133.7 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.876 2.87 . . . . 0.0 114.316 -168.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.33 -21.35 54.39 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.873 2.382 . . . . 0.0 113.565 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.268 1.0 OUTLIER -81.99 158.46 23.85 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -177.43 167.99 39.4 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.419 1.009 . . . . 0.0 113.608 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 91.9 p -156.21 163.71 39.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.547 1.539 . . . . 0.0 111.915 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 54.83 31.75 16.29 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.73 1.612 . . . . 0.0 114.939 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -62.44 141.42 58.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.319 1.448 . . . . 0.0 111.505 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.67 -10.51 50.14 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 116.541 1.376 . . . . 0.0 116.541 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -113.89 9.26 17.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.499 1.92 . . . . 0.0 114.014 174.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.254 1.337 0 C-N-CA 125.407 1.483 . . . . 0.0 112.217 178.137 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.38 0 O4'-C1'-N19 110.497 2.297 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 0 O4'-C1'-N19 111.557 3.357 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.123 0 O4'-C4'-C3' 109.314 2.725 . 0.55 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.375 0 O4'-C1'-N19 111.464 3.264 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.498 2 O4'-C1'-N19 113.574 5.374 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.4 p -153.1 160.27 42.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.183 1.393 . . . . 0.0 112.691 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -76.7 177.75 7.3 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.078 1.351 . . . . 0.0 113.09 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 20.7 ptp -130.12 41.23 3.44 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.952 1.301 . . . . 0.0 112.811 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -71.08 30.19 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.15 137.91 43.2 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.475 -1.391 . . . . 0.0 112.667 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.8 pt -123.58 148.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.94 1.296 . . . . 0.0 112.456 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -85.96 139.49 31.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.919 2.088 . . . . 0.0 109.908 164.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.1 t -127.32 113.66 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.945 1.298 . . . . 0.0 109.521 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.09 154.12 16.6 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.8 1.191 . . . . 0.0 114.115 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.88 13.31 75.3 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.458 1.028 . . . . 0.0 114.506 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.06 144.17 46.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -65.61 139.74 58.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.23 -13.04 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.877 . . . . 0.0 112.528 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -22.09 27.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.63 1.172 . . . . 0.0 111.954 171.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 82.9 m -75.44 139.95 42.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.88 1.272 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -114.8 163.85 14.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.405 1.482 . . . . 0.0 114.745 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.7 p -54.47 -36.65 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.37 -30.49 69.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.557 0.743 . . . . 0.0 112.619 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.59 -47.29 67.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.89 -42.54 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.46 0.704 . . . . 0.0 111.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -60.76 -48.16 83.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.545 0.738 . . . . 0.0 112.051 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -60.54 -39.08 86.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.444 1.098 . . . . 0.0 113.679 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -68.07 -39.22 82.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 47.9 m-85 -81.21 -24.9 37.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.513 2.783 . . . . 0.0 118.513 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -57.72 -29.25 64.58 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.62 -26.03 68.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.367 1.467 . . . . 0.0 112.712 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -75.22 -20.78 59.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 116.436 2.014 . . . . 0.0 116.436 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.54 -93.6 0.09 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.033 1.302 . . . . 0.0 111.439 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -157.65 137.53 12.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.312 1.445 . . . . 0.0 111.809 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.1 136.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.409 1.484 . . . . 0.0 108.457 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -92.64 -30.71 15.45 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -162.23 153.84 18.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.283 1.033 . . . . 0.0 110.273 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.51 152.78 44.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.005 1.322 . . . . 0.0 111.757 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.8 ptm -154.21 134.89 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.013 1.325 . . . . 0.0 112.004 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.4 mt -109.46 145.12 36.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.178 0.991 . . . . 0.0 111.26 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 47.7 mmm -85.79 74.91 10.13 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.287 40.9 m-85 -58.49 137.43 57.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 171.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.09 119.17 33.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.567 1.547 . . . . 0.0 113.341 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -57.07 -26.31 60.15 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.316 1.446 . . . . 0.0 113.321 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.42 -24.91 67.79 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.499 2.036 . . . . 0.0 116.499 173.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 p -128.71 -16.98 4.13 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.6 t30 56.58 30.96 18.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.079 1.752 . . . . 0.0 113.116 -172.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -135.35 163.75 29.3 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.192 2.197 . . . . 0.0 110.11 172.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -79.36 154.47 29.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.642 0.734 . . . . 0.0 112.368 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -70.89 15.01 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.319 1.848 . . . . 0.0 115.246 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.9 12.6 82.49 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.431 1.015 . . . . 0.0 114.494 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -152.09 167.8 27.31 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.607 1.204 . . . . 0.0 110.457 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.84 27.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.383 1.468 . . . . 0.0 113.182 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.93 149.62 48.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.349 1.86 . . . . 0.0 115.256 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.7 t -135.77 130.61 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 111.404 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.8 m -107.83 138.17 44.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.548 1.939 . . . . 0.0 113.203 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.89 157.95 18.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -67.17 -32.09 72.95 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.437 0.695 . . . . 0.0 112.477 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.0 t -146.24 143.52 29.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.797 1.239 . . . . 0.0 112.428 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.82 -17.55 64.55 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.93 -24.94 67.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.7 mm -78.24 -45.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.4 -44.55 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.592 0.757 . . . . 0.0 110.935 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.0 -37.06 86.05 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.857 0.753 . . . . 0.0 112.564 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -67.84 -47.56 68.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.697 1.199 . . . . 0.0 111.73 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.97 -47.01 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.984 1.314 . . . . 0.0 110.525 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.4 t -69.19 -32.83 72.39 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.704 0.802 . . . . 0.0 112.116 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.74 -30.27 71.28 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.77 1.228 . . . . 0.0 113.296 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 69.0 mt -64.98 -33.52 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.647 0.779 . . . . 0.0 111.099 171.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 66.84 -56.22 0.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.69 2.796 . . . . 0.0 114.93 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.279 63.3 m-85 -106.57 125.25 50.77 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -125.21 161.53 26.7 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.903 1.681 . . . . 0.0 111.3 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -109.58 135.15 51.02 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.372 1.069 . . . . 0.0 111.49 172.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.5 mt -141.93 124.76 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.362 1.865 . . . . 0.0 108.509 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 51.06 34.66 11.27 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.316 1.046 . . . . 0.0 113.425 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.275 3.6 m120 63.62 3.88 1.65 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.683 2.393 . . . . 0.0 116.298 -172.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -86.71 142.3 28.28 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.416 1.486 . . . . 0.0 108.821 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 29.2 ttm -88.82 135.93 33.27 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.578 -0.701 . . . . 0.0 111.201 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.66 158.89 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.143 1.777 . . . . 0.0 112.329 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -110.54 133.04 53.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.43 1.092 . . . . 0.0 111.428 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -97.73 145.76 26.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.019 0.928 . . . . 0.0 112.204 168.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -143.37 152.1 41.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.044 1.738 . . . . 0.0 108.843 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.76 136.43 56.92 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.334 1.425 . . . . 0.0 110.818 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -77.99 104.68 8.71 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -90.61 149.8 41.36 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.471 1.508 . . . . 0.0 110.859 169.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.25 151.46 71.96 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.473 2.115 . . . . 0.0 111.619 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -61.56 -14.71 32.15 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -59.75 -29.54 68.23 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.579 1.551 . . . . 0.0 113.514 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.255 1.4 m -76.15 -4.9 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 24.3 mmt -122.97 115.27 21.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.954 1.702 . . . . 0.0 109.798 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.2 m -57.02 146.54 59.69 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.183 1.393 . . . . 0.0 113.439 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -64.23 -26.68 64.36 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.972 2.448 . . . . 0.0 115.658 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.251 1.5 t -71.27 144.97 49.84 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.34 179.07 21.72 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.99 1.281 . . . . 0.0 114.888 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 79.9 p -159.22 150.2 19.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.044 1.338 . . . . 0.0 112.218 177.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.15 149.72 40.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.172 0.589 . . . . 0.0 111.56 170.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 155.8 30.19 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.478 1.511 . . . . 0.0 111.737 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 170.8 -166.86 40.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.39 1.472 . . . . 0.0 112.128 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.6 133.92 16.29 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.082 1.353 . . . . 0.0 111.549 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 126.049 1.74 . . . . 0.0 113.741 179.152 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.572 0 O4'-C1'-N19 111.015 2.815 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.291 0 O4'-C1'-N19 111.868 3.668 . 0.062 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.596 0 O4'-C1'-N19 111.828 3.628 . 0.166 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 C4'-C3'-C2' 99.5 -3.2 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.098 1 O4'-C1'-N19 112.465 4.265 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.0 m -64.45 149.85 47.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.889 1.275 . . . . 0.0 113.91 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -80.42 169.33 17.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.869 0.868 . . . . 0.0 110.909 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 77.5 mtm -60.1 125.48 23.81 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.235 -0.915 . . . . 0.0 110.945 173.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -74.98 37.52 0.12 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.981 1.312 . . . . 0.0 114.46 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -130.59 137.55 49.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.626 1.17 . . . . 0.0 112.436 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 pt -113.24 152.68 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 111.024 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -86.04 144.04 27.78 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -127.04 106.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.556 1.542 . . . . 0.0 109.279 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -107.1 150.84 16.83 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.988 1.28 . . . . 0.0 114.225 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.79 65.57 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.376 0.988 . . . . 0.0 114.569 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.19 137.78 57.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.489 1.116 . . . . 0.0 111.391 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.8 t -69.35 142.42 54.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.751 0.82 . . . . 0.0 111.641 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 p -61.21 -17.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -73.02 -29.03 62.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.937 0.895 . . . . 0.0 112.331 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.4 m -73.12 137.15 45.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.587 1.555 . . . . 0.0 112.927 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t -112.11 161.99 15.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.05 1.34 . . . . 0.0 114.41 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.89 -34.92 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.4 -31.13 69.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.574 0.75 . . . . 0.0 112.837 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -66.41 -43.54 85.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.895 0.77 . . . . 0.0 109.425 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -45.73 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.614 1.165 . . . . 0.0 111.564 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.92 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.717 0.807 . . . . 0.0 111.776 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -57.52 -41.57 81.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.954 0.901 . . . . 0.0 112.942 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.87 -46.92 73.48 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -70.92 -23.72 62.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -59.68 -29.91 68.4 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 171.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -64.24 -26.9 68.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.934 0.894 . . . . 0.0 112.906 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -72.76 -26.67 61.64 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -175.89 -94.21 0.09 OUTLIER Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.04 1.305 . . . . 0.0 112.006 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -157.29 133.6 9.72 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.437 1.495 . . . . 0.0 111.667 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.51 134.91 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.351 1.46 . . . . 0.0 108.666 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.9 -44.74 17.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.992 1.317 . . . . 0.0 113.915 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -161.9 160.76 28.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.09 1.356 . . . . 0.0 109.915 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.05 148.88 39.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.184 1.394 . . . . 0.0 111.707 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -153.3 132.47 12.67 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 112.53 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.57 145.94 25.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.691 0.796 . . . . 0.0 110.042 169.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.9 mmt -83.33 127.34 33.58 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.118 -0.364 . . . . 0.0 110.049 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.288 64.2 m-85 -103.64 139.69 38.58 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -174.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -96.86 110.0 22.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.381 1.472 . . . . 0.0 113.567 171.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.12 -16.07 58.81 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -35.97 82.2 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 174.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.281 0.7 OUTLIER -136.55 -2.98 2.14 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 65.08 12.59 8.07 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.974 2.11 . . . . 0.0 114.638 -171.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -71.35 156.48 39.45 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.75 1.22 . . . . 0.0 110.937 168.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -87.08 156.14 19.85 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.283 0.563 . . . . 0.0 110.506 167.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -76.2 8.06 3.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.369 2.267 . . . . 0.0 114.695 -169.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.16 6.1 84.91 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.992 1.282 . . . . 0.0 114.46 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.33 168.56 26.68 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.413 1.106 . . . . 0.0 111.218 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.37 -167.73 23.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.808 1.194 . . . . 0.0 113.337 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.8 149.99 50.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.27 1.828 . . . . 0.0 114.77 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -136.76 123.05 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.918 1.287 . . . . 0.0 111.609 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.06 148.94 21.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.829 2.052 . . . . 0.0 114.168 175.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.9 155.63 35.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -66.1 -36.38 83.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.209 0.604 . . . . 0.0 112.201 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -141.25 144.25 34.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.053 1.341 . . . . 0.0 112.485 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -64.5 -20.7 66.36 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.39 0.676 . . . . 0.0 112.557 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -61.78 -33.72 74.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mm -72.5 -40.62 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.008 -0.433 . . . . 0.0 110.434 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.4 t -57.14 -43.8 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.073 0.851 . . . . 0.0 110.288 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -60.66 -48.43 81.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.328 0.651 . . . . 0.0 112.699 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.01 -47.55 80.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.321 1.448 . . . . 0.0 112.703 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.67 -43.5 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.916 1.686 . . . . 0.0 111.159 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.63 -35.75 79.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 112.482 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.15 -29.34 70.28 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.041 1.336 . . . . 0.0 113.161 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.83 -35.13 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.272 1.029 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 65.75 -55.04 0.36 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.739 2.816 . . . . 0.0 115.238 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.314 59.9 m-85 -105.93 124.55 49.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -126.61 171.18 11.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.205 2.202 . . . . 0.0 110.734 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -137.65 132.48 33.02 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.828 -1.17 . . . . 0.0 112.919 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mt -140.99 127.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.509 1.523 . . . . 0.0 108.762 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 50.9 38.81 21.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.65 1.18 . . . . 0.0 113.746 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.05 -0.66 1.01 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.465 2.306 . . . . 0.0 116.195 -173.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -85.31 131.1 34.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.843 1.257 . . . . 0.0 109.631 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.3 ttm -80.17 132.97 36.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.164 0.586 . . . . 0.0 110.196 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.64 159.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.78 1.632 . . . . 0.0 111.806 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -114.96 126.22 54.52 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.268 1.027 . . . . 0.0 111.639 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.1 p -87.17 147.8 25.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.389 0.614 . . . . 0.0 111.605 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -143.49 151.78 40.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.387 1.475 . . . . 0.0 108.169 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.24 132.74 48.37 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.913 1.233 . . . . 0.0 109.922 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.94 136.38 48.48 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.089 0.404 . . . . 0.0 110.603 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -137.18 158.19 72.99 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.435 1.094 . . . . 0.0 111.8 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.97 156.12 51.26 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.667 2.911 . . . . 0.0 114.354 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -61.78 -20.65 63.81 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 59.8 mp0 -63.73 -21.92 66.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.87 1.668 . . . . 0.0 113.189 170.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.256 1.0 OUTLIER -118.31 -9.36 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.265 1.826 . . . . 0.0 115.209 175.009 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 26.2 mmt -127.26 103.27 7.31 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.837 2.055 . . . . 0.0 110.862 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.7 t -144.09 135.25 12.52 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.917 1.287 . . . . 0.0 110.982 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.65 165.08 27.45 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.822 3.014 . . . . 0.0 113.239 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.267 0.6 OUTLIER -69.63 161.0 30.53 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 169.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -77.21 -0.95 72.81 Favored Glycine 0 CA--C 1.54 1.594 0 N-CA-C 115.335 0.894 . . . . 0.0 115.335 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.1 t -71.76 133.33 45.5 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 118.977 1.389 . . . . 0.0 112.693 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.97 158.87 26.47 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.737 1.215 . . . . 0.0 112.723 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 32.1 ttt-85 -65.44 141.57 58.47 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.937 0.895 . . . . 0.0 111.057 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.28 138.55 34.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.35 0.5 . . . . 0.0 112.692 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 53.2 tpt85 -84.22 -27.63 27.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.242 1.417 . . . . 0.0 113.652 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.6 1.96 . . . . 0.0 112.403 -173.352 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 0 O4'-C1'-N19 111.765 3.565 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 O4'-C1'-N19 112.01 3.81 . 0.071 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 111.07 2.87 . 0.041 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.49 1 O4'-C1'-N19 112.967 4.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.411 0 O4'-C1'-N19 111.662 3.462 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.1 p -76.35 166.98 22.66 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.231 1.012 . . . . 0.0 113.085 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -71.14 -6.29 38.22 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 86.5 mtp -76.89 39.21 0.22 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.103 1.761 . . . . 0.0 113.954 -174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -76.89 38.65 0.21 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.464 1.506 . . . . 0.0 113.019 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -149.69 147.15 27.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.214 2.206 . . . . 0.0 110.024 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.8 pt -123.54 152.35 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.45 1.1 . . . . 0.0 111.91 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -87.8 140.93 29.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.749 2.02 . . . . 0.0 105.849 164.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.9 110.11 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.195 1.398 . . . . 0.0 110.038 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.15 147.65 18.2 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.958 1.266 . . . . 0.0 114.475 -172.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.19 14.55 58.78 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.784 1.183 . . . . 0.0 114.671 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.79 135.01 57.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.734 1.267 . . . . 0.0 110.321 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 150.79 48.69 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.275 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.01 -20.89 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.16 -27.49 42.73 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.899 1.28 . . . . 0.0 113.664 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 83.2 m -68.93 138.84 54.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.454 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 2.1 t -118.13 165.29 13.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.63 -34.75 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.76 -30.04 66.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 112.625 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.11 -47.37 71.35 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.02 -45.57 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.817 0.847 . . . . 0.0 110.144 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.72 -48.79 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.627 0.771 . . . . 0.0 111.937 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -59.33 -50.34 74.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.978 0.911 . . . . 0.0 113.035 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.25 26.4 m-85 -59.81 -31.91 70.15 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.342 51.3 m-85 -85.25 -24.28 27.86 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -63.95 -20.2 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -62.81 -34.64 77.72 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.071 0.948 . . . . 0.0 111.948 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -74.94 -25.67 59.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.67 -94.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.709 1.147 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -154.87 136.16 14.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.072 1.349 . . . . 0.0 112.239 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -87.31 137.18 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.593 1.557 . . . . 0.0 108.847 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.87 -46.32 12.28 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.019 1.328 . . . . 0.0 113.056 169.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -160.57 155.17 23.75 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.983 1.313 . . . . 0.0 109.929 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.97 47.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.538 1.535 . . . . 0.0 111.461 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -154.12 127.83 8.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.168 0.987 . . . . 0.0 113.014 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.6 mt -88.24 143.96 26.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.749 0.82 . . . . 0.0 110.929 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 36.6 mmt -91.43 141.92 28.23 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.374 0.669 . . . . 0.0 112.207 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.305 40.2 m-85 -109.2 142.31 40.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 118.768 2.877 . . . . 0.0 118.768 -169.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.61 118.93 23.18 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.58 1.552 . . . . 0.0 114.272 169.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -67.07 -19.44 65.66 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -43.82 55.48 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 p -126.18 -0.31 7.09 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 60.76 22.42 12.39 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.522 1.929 . . . . 0.0 115.546 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -101.2 162.76 12.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.27 1.828 . . . . 0.0 111.063 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -74.36 150.52 40.04 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.614 -0.679 . . . . 0.0 111.69 174.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -77.2 10.92 2.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.356 1.862 . . . . 0.0 115.044 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.8 79.56 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 121.281 -0.887 . . . . 0.0 114.121 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -152.3 165.49 34.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.742 1.271 . . . . 0.0 110.317 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.64 176.7 37.26 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.022 0.82 . . . . 0.0 113.829 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.38 146.59 28.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.19 116.09 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.882 1.273 . . . . 0.0 111.779 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -89.25 144.34 26.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.777 1.631 . . . . 0.0 113.001 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.54 163.44 14.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -69.58 -40.37 76.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.274 0.63 . . . . 0.0 111.849 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.6 t -140.33 145.42 37.15 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.172 1.389 . . . . 0.0 112.861 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.69 -25.99 68.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.709 1.203 . . . . 0.0 111.897 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.71 -35.9 79.38 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.27 -42.41 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.22 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.4 t -54.55 -45.67 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.657 0.662 . . . . 0.0 110.301 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.34 -39.03 74.95 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.82 -48.3 75.67 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.624 1.102 . . . . 0.0 111.685 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.13 -49.45 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.104 1.762 . . . . 0.0 110.797 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 33.1 m -66.54 -30.52 70.85 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -67.99 -25.68 65.53 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.555 1.07 . . . . 0.0 113.587 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 70.2 mt -71.28 -32.9 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.77 0.828 . . . . 0.0 111.079 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 65.36 -59.65 0.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 128.5 2.72 . . . . 0.0 114.923 173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 47.3 m-85 -100.41 123.12 44.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 171.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -121.04 147.32 45.68 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.676 1.59 . . . . 0.0 112.232 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -95.25 124.5 39.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.897 0.879 . . . . 0.0 110.738 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.67 129.38 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.828 1.651 . . . . 0.0 108.715 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 50.54 35.51 11.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.194 0.998 . . . . 0.0 113.223 -173.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 28.3 m120 59.37 26.46 15.34 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.595 1.958 . . . . 0.0 115.758 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -125.81 148.06 49.24 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.151 1.78 . . . . 0.0 110.223 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.9 mmm -90.75 134.37 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.837 0.855 . . . . 0.0 112.408 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.16 153.68 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.439 1.496 . . . . 0.0 112.245 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -102.06 122.05 43.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.306 1.043 . . . . 0.0 112.107 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 74.0 m -98.31 135.6 39.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.402 1.081 . . . . 0.0 112.318 173.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -140.04 145.83 38.23 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.724 1.609 . . . . 0.0 110.769 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.46 137.77 57.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.889 1.222 . . . . 0.0 111.06 171.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.01 94.43 0.86 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.733 0.777 . . . . 0.0 113.091 -174.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -80.86 156.35 72.55 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.516 1.926 . . . . 0.0 111.334 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.96 -179.93 4.3 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.475 3.45 . . . . 0.0 114.411 -169.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -68.85 66.53 0.14 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.611 1.565 . . . . 0.0 111.764 168.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -146.16 -41.54 0.21 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.767 2.427 . . . . 0.0 110.32 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 15.4 m -76.9 34.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 127.005 2.122 . . . . 0.0 113.531 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 69.2 mtm -71.05 -4.74 26.61 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -167.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.2 m -59.83 127.67 85.65 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.9 0.88 . . . . 0.0 112.179 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.73 147.65 45.29 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.198 2.599 . . . . 0.0 112.261 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.1 p -77.97 158.94 29.11 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -67.43 129.39 28.28 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 121.501 -0.749 . . . . 0.0 113.675 -175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.4 p -138.57 -1.92 1.82 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.174 1.39 . . . . 0.0 114.66 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.63 -7.13 52.22 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -173.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.84 134.64 20.06 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.719 1.208 . . . . 0.0 111.596 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.63 -155.45 30.74 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.986 1.279 . . . . 0.0 113.353 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -23.16 67.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.604 1.161 . . . . 0.0 113.126 173.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 C--O 1.253 1.239 0 C-N-CA 127.011 2.124 . . . . 0.0 110.056 174.033 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.223 0 O4'-C1'-N19 111.032 2.832 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.232 0 O5'-C5'-C4' 113.715 2.511 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.4 0 C1'-O4'-C4' 106.43 -3.522 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.611 0 O4'-C1'-N19 111.083 2.883 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.014 1 O4'-C1'-N19 112.241 4.041 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.0 m -59.75 -22.55 62.25 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -61.2 -23.49 65.64 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.173 0.989 . . . . 0.0 113.168 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 53.2 tpp -63.08 -21.04 65.91 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.225 1.01 . . . . 0.0 112.778 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -77.61 -0.98 28.58 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.476 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 83.2 tttt -107.36 138.11 44.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.108 1.363 . . . . 0.0 112.082 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.0 pt -123.39 151.78 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.225 1.41 . . . . 0.0 111.826 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -87.18 143.66 27.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.594 1.958 . . . . 0.0 108.064 165.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.72 125.98 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.834 1.653 . . . . 0.0 109.995 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.56 156.79 23.77 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.057 0.844 . . . . 0.0 114.48 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.89 10.5 58.72 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.712 1.149 . . . . 0.0 114.373 -174.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.3 mt -66.2 140.2 58.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.351 1.46 . . . . 0.0 111.327 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.8 p -75.23 152.15 38.35 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.757 -0.589 . . . . 0.0 111.372 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -65.92 -16.72 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -73.65 -34.81 65.12 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.651 1.18 . . . . 0.0 112.168 169.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.0 m -67.09 136.36 55.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.165 0.986 . . . . 0.0 111.698 173.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.0 163.79 16.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 p -53.65 -36.2 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.45 -31.26 68.35 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.34 -43.63 90.33 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.884 0.765 . . . . 0.0 109.078 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.15 -47.77 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.485 1.114 . . . . 0.0 111.141 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -60.36 -50.07 75.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.45 0.7 . . . . 0.0 112.07 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -61.43 -38.37 86.88 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.56 0.744 . . . . 0.0 112.964 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.58 -46.99 80.38 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.297 47.2 m-85 -67.83 -27.09 66.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -58.71 -19.5 40.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -61.93 -45.16 94.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.873 1.269 . . . . 0.0 112.881 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.01 -38.13 82.24 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.619 1.168 . . . . 0.0 112.802 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.44 158.64 14.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.2 2.333 . . . . 0.0 110.226 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.16 138.11 57.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.636 1.208 . . . . 0.0 112.885 -168.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.5 t -97.63 136.64 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.882 2.073 . . . . 0.0 109.222 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -78.89 -49.72 12.4 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.697 1.599 . . . . 0.0 112.471 173.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -159.3 159.94 34.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.335 1.054 . . . . 0.0 110.498 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.95 151.19 36.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.556 1.542 . . . . 0.0 111.464 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -153.94 133.73 13.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.468 1.107 . . . . 0.0 112.231 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.1 mt -102.41 143.23 32.41 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.083 0.953 . . . . 0.0 111.201 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.4 mmt -87.6 103.96 16.06 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.334 32.8 m-85 -72.17 147.21 46.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 118.589 2.811 . . . . 0.0 118.589 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -117.73 111.74 19.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.349 1.46 . . . . 0.0 111.488 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.1 mttp -64.6 -21.53 66.73 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 m -70.85 -27.6 63.97 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 171.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.5 p -106.59 -19.06 13.78 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.8 t30 56.75 32.83 21.92 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.139 1.775 . . . . 0.0 112.985 -172.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -136.15 165.68 25.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.048 2.139 . . . . 0.0 110.447 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -74.65 152.64 39.17 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.409 0.623 . . . . 0.0 111.554 169.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -75.28 16.1 0.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.83 1.652 . . . . 0.0 114.825 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.47 13.11 83.89 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.462 1.029 . . . . 0.0 114.405 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -147.47 162.71 38.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.998 1.399 . . . . 0.0 111.594 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.85 -168.32 30.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.446 1.498 . . . . 0.0 113.538 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.0 m-85 -125.03 151.02 46.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.153 1.781 . . . . 0.0 115.124 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.8 t -137.0 134.17 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.497 1.519 . . . . 0.0 110.414 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -114.89 134.42 55.16 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.69 1.596 . . . . 0.0 114.087 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -103.51 159.79 15.28 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.961 1.704 . . . . 0.0 115.471 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -72.46 -29.02 63.29 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.0 t -139.76 145.3 38.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.473 1.109 . . . . 0.0 112.867 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -62.5 -28.65 69.98 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.181 0.993 . . . . 0.0 111.782 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.92 -31.73 72.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.5 -43.2 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 119.228 -0.415 . . . . 0.0 109.977 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.73 -42.39 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 118.636 0.653 . . . . 0.0 110.577 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.0 -48.5 81.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.755 0.707 . . . . 0.0 112.668 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -58.19 -44.85 88.28 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.526 1.13 . . . . 0.0 112.118 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.65 -48.1 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.024 1.729 . . . . 0.0 111.019 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.23 -34.17 77.49 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.51 -21.47 66.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.6 mt -74.81 -30.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.099 0.96 . . . . 0.0 111.703 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 64.61 -62.21 0.19 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.297 2.639 . . . . 0.0 114.609 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 47.6 m-85 -101.5 120.2 39.93 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -115.66 154.72 29.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 111.747 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -112.85 108.28 17.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.585 0.754 . . . . 0.0 111.996 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.31 123.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.554 1.141 . . . . 0.0 109.467 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 51.17 37.01 17.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.075 0.95 . . . . 0.0 113.031 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 61.99 4.25 1.12 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 127.291 2.236 . . . . 0.0 115.646 -170.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -83.82 140.91 31.73 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.64 128.49 34.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 110.547 171.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.81 150.77 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 112.497 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -104.98 123.83 48.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.869 1.267 . . . . 0.0 111.327 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -89.66 147.95 23.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.676 0.791 . . . . 0.0 111.896 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -147.08 151.09 36.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.733 1.613 . . . . 0.0 108.786 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -64.56 135.18 55.73 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.051 1.296 . . . . 0.0 110.739 168.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.51 137.14 42.29 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.2 152.78 80.14 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.428 1.491 . . . . 0.0 111.645 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.95 150.89 84.48 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.558 2.839 . . . . 0.0 114.247 -171.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -64.28 -20.6 66.17 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -69.0 -22.55 64.07 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.518 1.927 . . . . 0.0 113.041 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.3 m -107.98 -36.01 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.406 1.483 . . . . 0.0 113.832 170.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 86.9 mmm -91.53 71.91 5.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.086 1.754 . . . . 0.0 110.83 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.7 p -81.29 144.24 53.56 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.644 0.778 . . . . 0.0 111.334 169.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.59 149.72 74.24 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.181 2.588 . . . . 0.0 113.038 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.9 p -78.98 -2.97 42.7 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 82.53 -152.34 30.47 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.73 1.157 . . . . 0.0 112.702 -172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.8 p -66.04 130.83 44.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.775 0.83 . . . . 0.0 112.554 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.02 156.94 38.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.23 1.412 . . . . 0.0 112.186 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -76.78 -23.1 52.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.943 1.297 . . . . 0.0 114.086 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 118.39 -145.87 18.41 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.758 1.647 . . . . 0.0 112.023 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -68.01 149.36 49.8 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.817 0.809 . . . . 0.0 111.707 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.73 1.612 . . . . 0.0 113.678 -178.638 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.242 0 O4'-C1'-N19 111.692 3.492 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.166 1 O4'-C1'-N19 112.336 4.136 . 0.342 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.544 2.644 0 O4'-C1'-N19 110.996 2.796 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 C4'-C3'-C2' 99.932 -2.768 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.289 0 O4'-C1'-N19 112.083 3.883 . 0.06 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.4 m 52.98 29.61 8.15 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 m80 56.96 22.44 7.22 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.163 1.785 . . . . 0.0 115.54 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.1 mmt -64.0 -26.8 68.73 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -83.89 8.35 15.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -118.03 143.53 46.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.902 1.281 . . . . 0.0 112.066 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.04 149.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.662 1.185 . . . . 0.0 110.51 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -86.63 141.75 28.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.744 2.018 . . . . 0.0 106.945 166.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.95 118.26 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.695 1.598 . . . . 0.0 109.529 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.69 146.69 16.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.139 0.876 . . . . 0.0 113.764 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.18 19.44 33.3 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.592 1.092 . . . . 0.0 114.493 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 mt -70.4 134.7 48.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 112.122 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.5 t -64.04 141.99 58.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.894 -0.504 . . . . 0.0 111.637 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 p -62.83 -16.87 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.44 -32.66 66.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.821 0.848 . . . . 0.0 112.071 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 m -69.29 135.43 50.45 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.552 1.541 . . . . 0.0 113.132 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -111.73 164.46 13.02 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.169 1.388 . . . . 0.0 114.598 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.35 -36.83 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.7 -33.89 75.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 112.417 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.98 -48.6 75.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.79 -43.2 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.376 0.671 . . . . 0.0 111.485 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.19 -50.64 72.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.801 0.84 . . . . 0.0 112.036 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.46 -38.76 92.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.13 -48.14 79.77 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 52.4 m-85 -69.18 -24.35 64.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -61.79 -14.23 30.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.85 -27.94 69.21 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.576 1.08 . . . . 0.0 112.4 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -85.54 -30.31 23.49 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.397 1.079 . . . . 0.0 113.647 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.55 173.05 32.77 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.917 2.199 . . . . 0.0 111.026 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.13 131.71 45.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.266 1.031 . . . . 0.0 113.011 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -99.27 133.67 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.63 1.972 . . . . 0.0 108.211 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.64 -48.67 16.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.172 1.389 . . . . 0.0 113.507 174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.43 163.4 27.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.483 1.113 . . . . 0.0 110.153 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.86 151.84 40.4 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.447 1.499 . . . . 0.0 111.553 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -153.77 134.18 13.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.198 0.999 . . . . 0.0 112.317 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.88 0.872 . . . . 0.0 110.556 172.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.4 mmt -85.05 140.89 30.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.771 0.428 . . . . 0.0 111.358 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.334 42.9 m-85 -106.15 150.3 25.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 118.734 2.864 . . . . 0.0 118.734 -173.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.63 120.33 37.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.009 1.724 . . . . 0.0 113.325 168.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -74.25 -14.05 60.86 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -42.47 68.56 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.2 p -123.23 -4.63 8.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.062 1.745 . . . . 0.0 115.703 -175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 60.65 13.51 4.33 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.748 2.019 . . . . 0.0 115.297 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -85.45 159.43 19.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.299 1.84 . . . . 0.0 111.492 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -75.15 153.17 38.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.723 -0.61 . . . . 0.0 111.004 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -78.69 8.62 5.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.531 1.532 . . . . 0.0 114.872 -171.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.36 15.13 81.72 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.512 -0.742 . . . . 0.0 114.276 -174.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.76 163.68 38.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.444 1.116 . . . . 0.0 109.478 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.37 -162.81 24.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.988 1.28 . . . . 0.0 113.166 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.8 151.56 51.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.941 1.696 . . . . 0.0 115.241 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.66 123.74 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.243 1.417 . . . . 0.0 111.385 171.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -98.09 140.17 32.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.104 1.762 . . . . 0.0 114.066 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -111.84 151.77 28.69 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.047 1.339 . . . . 0.0 114.043 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -76.7 -40.57 48.35 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.0 t -110.73 135.21 51.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.327 1.051 . . . . 0.0 111.775 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.27 -23.67 66.44 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.196 0.998 . . . . 0.0 112.213 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.02 -31.48 71.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.4 mm -69.53 -38.21 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.843 -0.536 . . . . 0.0 110.574 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.05 -43.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 118.614 0.643 . . . . 0.0 110.883 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -64.01 -49.16 73.53 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.905 0.882 . . . . 0.0 112.232 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.75 -45.15 78.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.617 1.567 . . . . 0.0 112.587 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.48 -49.43 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.731 1.612 . . . . 0.0 110.918 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.84 -32.74 74.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.1 0.56 . . . . 0.0 112.462 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.47 -28.81 68.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.227 1.411 . . . . 0.0 113.453 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.05 -30.6 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.431 1.092 . . . . 0.0 111.78 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 66.65 -51.15 0.45 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.863 2.865 . . . . 0.0 115.77 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.31 39.2 m-85 -112.92 124.22 52.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -123.13 153.83 39.47 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.124 1.77 . . . . 0.0 111.271 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -105.71 128.81 53.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.184 0.994 . . . . 0.0 110.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.2 mt -139.4 123.76 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.733 1.613 . . . . 0.0 108.758 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 50.46 35.07 10.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.015 0.926 . . . . 0.0 113.358 -174.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.6 m120 63.17 1.58 0.93 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.596 2.358 . . . . 0.0 116.957 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -83.47 142.52 30.88 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.166 1.387 . . . . 0.0 109.416 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 94.2 mmm -86.52 137.27 32.66 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.753 -0.592 . . . . 0.0 111.094 172.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.06 150.55 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.25 1.42 . . . . 0.0 111.771 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.99 130.8 45.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.622 0.769 . . . . 0.0 111.282 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.39 139.19 31.42 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.361 0.664 . . . . 0.0 110.797 167.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -136.92 154.22 50.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.266 1.426 . . . . 0.0 108.653 170.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.7 137.05 57.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.723 1.147 . . . . 0.0 110.276 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.81 114.18 12.96 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 0.0 111.673 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -66.25 148.97 98.27 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 166.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -60.36 151.3 75.3 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.843 2.362 . . . . 0.0 112.849 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -60.12 -17.38 39.82 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -78.57 -17.0 56.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.505 1.522 . . . . 0.0 114.052 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.0 p -65.61 -45.91 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -171.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.2 mmt 50.64 48.87 21.95 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.351 2.261 . . . . 0.0 112.868 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.7 m -60.83 151.14 74.34 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.443 1.097 . . . . 0.0 112.515 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -57.4 139.82 91.27 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.12 2.547 . . . . 0.0 113.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.8 p -71.98 157.44 37.81 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -174.5 126.29 1.18 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.301 0.953 . . . . 0.0 112.629 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 52.5 p -70.9 149.39 46.79 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -160.56 138.23 9.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.799 1.64 . . . . 0.0 111.209 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -81.34 -30.53 33.77 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.194 -0.941 . . . . 0.0 113.349 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.94 -169.79 40.8 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.974 1.273 . . . . 0.0 113.414 -169.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.5 mmm-85 -70.11 -18.99 63.26 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.1 p . . . . . 0 C--O 1.254 1.304 0 C-N-CA 126.46 1.904 . . . . 0.0 112.998 174.227 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.118 0 O4'-C1'-N19 112.058 3.858 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.132 0 O4'-C1'-N19 112.192 3.992 . 0.24 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.921 0 O4'-C1'-N19 110.113 1.913 . 0.352 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.455 1 O4'-C1'-N19 113.284 5.084 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.245 1 O4'-C1'-N19 112.225 4.025 . 0.184 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.2 t -155.79 -48.28 0.08 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.454 1.102 . . . . 0.0 112.781 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -71.15 94.01 1.11 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.694 1.198 . . . . 0.0 112.622 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 50.0 ttm -78.41 53.51 1.29 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.265 1.426 . . . . 0.0 111.48 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -75.92 30.57 0.11 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.541 1.536 . . . . 0.0 114.474 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -137.78 139.04 39.83 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.89 -1.131 . . . . 0.0 112.159 -173.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 pt -117.24 151.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.81 1.244 . . . . 0.0 111.593 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -89.75 136.83 32.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.35 2.66 . . . . 0.0 108.119 165.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.54 110.3 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.415 . . . . 0.0 110.136 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.8 142.78 17.07 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.255 0.931 . . . . 0.0 114.366 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.3 13.5 28.46 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.487 1.518 . . . . 0.0 115.027 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.72 151.43 42.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.264 1.426 . . . . 0.0 112.478 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.4 t -68.81 139.83 55.26 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.052 -0.405 . . . . 0.0 110.453 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.4 -14.44 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.538 0.735 . . . . 0.0 112.331 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.64 -19.55 35.22 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.914 1.285 . . . . 0.0 113.11 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.9 m -69.37 134.37 48.96 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.806 1.242 . . . . 0.0 111.759 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.5 t -102.28 157.97 16.52 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.39 -33.67 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.223 1.409 . . . . 0.0 114.608 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -71.35 -29.58 65.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.69 -43.89 95.3 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.162 0.892 . . . . 0.0 109.466 172.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.54 -47.62 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.109 1.364 . . . . 0.0 110.96 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -60.99 -45.25 95.59 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.845 -0.534 . . . . 0.0 112.057 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -60.34 -43.71 96.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 112.273 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.01 -43.88 97.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 61.5 m-85 -72.54 -27.49 62.26 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -62.01 -14.75 38.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.74 -44.64 96.52 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.689 1.196 . . . . 0.0 112.711 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.675 1.19 . . . . 0.0 113.769 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.87 164.82 24.22 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.004 2.24 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.83 134.13 56.78 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.224 1.012 . . . . 0.0 113.258 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.97 127.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.599 1.96 . . . . 0.0 109.228 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -72.5 -50.0 29.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.916 1.287 . . . . 0.0 112.875 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -160.09 160.45 33.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.487 1.115 . . . . 0.0 109.91 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.6 153.67 42.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.473 1.509 . . . . 0.0 111.115 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -153.16 133.89 13.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.408 1.083 . . . . 0.0 111.991 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 19.2 mt -102.25 142.76 32.97 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.135 0.974 . . . . 0.0 110.448 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.487 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 30.2 mmt -80.67 86.53 5.89 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.956 -0.465 . . . . 0.0 111.554 -169.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.349 53.5 m-85 -61.76 123.84 19.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -76.01 -43.11 45.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.971 0.891 . . . . 0.0 110.938 168.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -152.59 123.02 7.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.053 2.141 . . . . 0.0 108.255 168.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.3 p -63.25 -30.11 71.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.466 1.506 . . . . 0.0 111.876 -169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 p -75.68 -8.21 56.25 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -127.37 -71.56 0.67 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.08 1.352 . . . . 0.0 114.399 -169.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -163.29 159.9 23.19 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -169.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -103.86 167.33 9.85 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.842 1.657 . . . . 0.0 112.01 169.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -70.24 7.8 0.92 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.953 1.701 . . . . 0.0 115.245 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.66 15.96 76.62 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.551 1.072 . . . . 0.0 114.41 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.487 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 35.4 p90 -152.18 164.58 37.04 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.795 1.298 . . . . 0.0 110.977 176.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.42 32.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.365 0.983 . . . . 0.0 113.871 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -120.13 147.7 44.55 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.132 1.773 . . . . 0.0 114.675 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.66 124.09 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.016 1.326 . . . . 0.0 111.366 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -105.34 137.62 42.84 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.531 1.933 . . . . 0.0 114.459 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.62 155.87 23.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -67.15 -34.58 77.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.839 0.855 . . . . 0.0 112.197 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.3 t -141.39 143.15 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.827 1.251 . . . . 0.0 112.517 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -66.37 -20.16 66.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.44 0.696 . . . . 0.0 112.597 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.34 -31.32 71.93 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mm -73.89 -42.55 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.116 170.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.34 -44.02 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.801 0.728 . . . . 0.0 109.858 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -59.82 -48.18 82.73 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -57.0 -49.48 75.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.145 0.978 . . . . 0.0 112.285 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.4 -43.26 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.826 1.65 . . . . 0.0 110.987 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.2 m -69.23 -32.47 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -67.21 -27.79 67.54 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.239 0.927 . . . . 0.0 113.322 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.91 -36.36 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.569 0.748 . . . . 0.0 110.688 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 66.42 -53.36 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.796 2.838 . . . . 0.0 115.07 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.317 59.0 m-85 -106.19 125.89 51.54 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -127.92 169.36 14.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.716 2.007 . . . . 0.0 111.074 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -131.03 130.58 43.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.244 -0.91 . . . . 0.0 112.51 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 56.8 mt -139.77 127.45 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.396 1.478 . . . . 0.0 108.969 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 49.53 43.04 23.7 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.001 1.321 . . . . 0.0 113.784 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 66.29 0.03 1.6 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.544 2.338 . . . . 0.0 116.459 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.61 143.68 26.08 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.664 1.12 . . . . 0.0 111.551 168.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 17.5 ttm -89.05 136.36 33.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.674 0.79 . . . . 0.0 111.029 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.42 149.04 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.502 1.521 . . . . 0.0 112.559 -176.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -95.24 128.25 41.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.864 0.866 . . . . 0.0 110.39 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.02 129.6 55.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.639 1.176 . . . . 0.0 111.012 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -152.21 153.12 33.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 0.0 111.715 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.78 133.66 56.31 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.119 0.872 . . . . 0.0 112.58 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.72 127.48 32.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.186 0.595 . . . . 0.0 111.438 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -130.01 156.74 78.68 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.343 1.457 . . . . 0.0 112.339 -175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.16 141.03 81.17 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.022 2.481 . . . . 0.0 112.345 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -62.97 -21.29 66.01 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -63.54 -29.76 70.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.231 1.413 . . . . 0.0 113.439 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.259 0.9 OUTLIER -77.2 -27.24 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 173.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 25.5 mmt -86.67 -29.72 22.27 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.059 1.344 . . . . 0.0 113.077 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.7 t 51.43 57.08 16.84 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 126.369 1.868 . . . . 0.0 113.621 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.43 -13.91 20.39 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.149 3.232 . . . . 0.0 114.497 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.52 130.27 42.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 -170.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -77.39 168.28 54.43 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.507 1.051 . . . . 0.0 114.449 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.2 p -67.78 153.95 42.6 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.945 1.298 . . . . 0.0 113.405 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.37 134.2 56.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.181 0.992 . . . . 0.0 112.186 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -152.39 29.27 0.55 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.107 1.363 . . . . 0.0 114.028 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -170.19 -175.08 38.81 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.049 1.309 . . . . 0.0 113.429 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -148.68 164.39 34.47 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.688 1.595 . . . . 0.0 112.789 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.808 1.643 . . . . 0.0 112.784 171.938 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 1 O4'-C1'-N19 113.432 5.232 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.082 1 O4'-C1'-N19 112.396 4.196 . 0.084 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 0 O4'-C1'-N19 111.103 2.903 . 0.189 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . 0.417 " H1'" ' SD ' ' A' ' 141' ' ' MET . . . . . . . . 0 O4'--C4' 1.416 -3.089 0 O4'-C1'-N19 111.61 3.41 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.389 0 O4'-C1'-N19 111.356 3.156 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 112.109 -0.396 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.0 p -76.54 -28.99 56.52 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.434 1.094 . . . . 0.0 112.932 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -73.55 161.53 30.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.176 1.791 . . . . 0.0 112.542 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 57.4 21.59 7.03 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -70.69 33.2 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.151 1.38 . . . . 0.0 114.342 170.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -145.75 133.75 21.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 111.305 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.19 151.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.381 1.086 . . . . 0.0 111.168 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.73 136.17 34.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.238 2.615 . . . . 0.0 106.939 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 t -126.13 116.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.863 1.265 . . . . 0.0 110.478 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.29 148.29 18.89 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.666 1.127 . . . . 0.0 114.1 -173.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.91 58.94 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.256 1.408 . . . . 0.0 114.49 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.1 mt -65.47 135.69 55.5 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.699 1.2 . . . . 0.0 111.66 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -64.58 142.72 58.33 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.84 -0.538 . . . . 0.0 112.03 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.78 -14.67 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.42 -31.56 63.92 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.71 0.804 . . . . 0.0 112.169 169.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -71.91 125.47 27.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.476 . . . . 0.0 113.625 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.15 166.13 16.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.8 -32.6 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -73.08 -35.5 66.66 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.017 0.927 . . . . 0.0 111.545 174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.91 -49.19 78.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.498 0.59 . . . . 0.0 112.016 169.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -48.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 109.929 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.64 -49.16 77.36 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.665 0.666 . . . . 0.0 111.967 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -60.66 -46.67 89.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 113.037 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.26 19.0 m-85 -64.72 -21.97 66.87 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.321 61.0 m-85 -92.94 -23.58 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -62.6 -18.43 62.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -63.52 -28.95 70.3 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.359 -0.838 . . . . 0.0 113.058 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -83.75 -27.0 29.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.37 175.37 31.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.072 2.272 . . . . 0.0 110.973 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.89 132.64 49.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.453 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.11 133.72 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.633 1.973 . . . . 0.0 107.73 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.63 -46.58 14.18 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.786 1.234 . . . . 0.0 113.773 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -162.71 162.7 26.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 109.836 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.42 153.51 46.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.726 1.61 . . . . 0.0 111.482 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.6 ptm -155.52 151.0 27.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.505 1.122 . . . . 0.0 112.425 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.4 mt -119.29 144.52 46.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.539 1.536 . . . . 0.0 110.381 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 28.9 mmm -95.98 127.61 42.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.786 0.435 . . . . 0.0 110.751 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.426 62.1 m-85 -83.0 143.76 30.42 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 119.503 3.149 . . . . 0.0 119.503 -169.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -97.32 -52.43 3.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.78 0.832 . . . . 0.0 109.871 168.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -135.12 108.37 7.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.928 2.091 . . . . 0.0 108.071 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -28.5 65.09 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 -169.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.4 p -81.63 -6.61 59.17 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -135.61 -54.66 0.78 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -157.93 151.04 23.07 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.194 1.361 . . . . 0.0 113.742 -172.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 25.4 p80 -84.45 161.45 20.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.084 0.954 . . . . 0.0 112.063 170.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 8.56 8.6 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.366 2.266 . . . . 0.0 114.108 -172.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.81 13.16 59.71 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.022 -1.049 . . . . 0.0 115.034 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -152.25 163.26 39.78 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.139 1.47 . . . . 0.0 110.004 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.04 -170.84 28.5 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.834 1.207 . . . . 0.0 112.954 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.45 153.71 47.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.68 127.6 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.088 1.355 . . . . 0.0 111.948 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -99.92 145.8 27.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.297 1.839 . . . . 0.0 113.558 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.38 154.5 37.62 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -67.91 -34.97 77.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.367 0.667 . . . . 0.0 112.299 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.7 t -140.24 143.37 35.94 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.017 1.327 . . . . 0.0 111.984 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.44 -19.19 64.56 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.093 -0.379 . . . . 0.0 111.364 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.07 -31.12 70.79 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.81 -42.85 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.938 -0.476 . . . . 0.0 110.195 170.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.28 -43.61 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.74 0.7 . . . . 0.0 110.025 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.849 0.859 . . . . 0.0 112.763 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.91 -48.5 79.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.443 1.097 . . . . 0.0 112.353 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.16 -45.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.778 1.631 . . . . 0.0 110.825 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 48.4 t -70.1 -31.27 68.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.192 -0.942 . . . . 0.0 112.925 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.8 -32.55 74.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.803 1.241 . . . . 0.0 112.818 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.22 -34.18 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.9 0.88 . . . . 0.0 111.064 171.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 66.22 -58.91 0.34 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.628 2.771 . . . . 0.0 115.026 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 56.0 m-85 -100.97 121.74 42.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -118.86 168.74 10.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.136 1.774 . . . . 0.0 111.118 -175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -126.68 135.65 51.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.229 1.012 . . . . 0.0 111.699 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.7 mt -140.78 129.08 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.877 1.671 . . . . 0.0 108.746 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 51.24 37.93 19.89 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.417 1.087 . . . . 0.0 113.799 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 64.74 1.15 1.31 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.519 2.328 . . . . 0.0 116.292 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -88.91 133.6 34.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.52 1.128 . . . . 0.0 110.473 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 27.1 ttm -84.1 137.53 33.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.686 0.794 . . . . 0.0 110.71 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 154.66 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.039 1.736 . . . . 0.0 111.589 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -102.93 131.73 49.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.408 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 78.5 m -111.87 134.8 53.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.014 1.326 . . . . 0.0 111.57 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.89 157.73 43.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.02 1.728 . . . . 0.0 110.228 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.92 138.7 58.62 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.168 1.349 . . . . 0.0 112.038 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.99 133.24 41.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.347 0.659 . . . . 0.0 111.959 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -64.61 146.53 98.25 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 122.992 0.517 . . . . 0.0 109.988 168.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.73 -36.85 10.11 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.688 2.259 . . . . 0.0 116.853 -165.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -156.05 44.94 0.44 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -169.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 55.32 48.8 18.42 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.823 1.297 . . . . 0.0 110.752 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.16 -1.78 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -168.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 20.4 mmt -62.02 -33.8 75.03 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.03 1.332 . . . . 0.0 112.428 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.4 t -162.76 139.7 5.98 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 111.458 169.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.62 -14.3 43.41 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.074 2.516 . . . . 0.0 113.164 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.341 0.2 OUTLIER -116.97 19.44 14.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.944 2.098 . . . . 0.0 115.999 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 78.78 -20.33 4.52 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.835 1.683 . . . . 0.0 115.899 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 91.2 p -155.03 157.69 37.99 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.938 1.695 . . . . 0.0 111.04 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.67 132.12 48.8 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.546 -0.721 . . . . 0.0 111.756 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 156.17 39.71 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.519 1.128 . . . . 0.0 112.322 174.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -172.9 175.22 45.92 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.487 1.041 . . . . 0.0 113.732 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 95.0 mtm-85 -69.96 154.69 41.63 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.901 1.28 . . . . 0.0 113.045 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.7 p . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.762 1.625 . . . . 0.0 114.433 174.574 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.332 1 O4'-C1'-N19 114.637 6.437 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.138 0 O4'-C1'-N19 111.53 3.33 . 0.666 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.018 0 N19-C1'-C2' 116.561 1.976 . 0.221 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.511 1 O4'-C1'-N19 114.463 6.263 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.12 0 O4'-C1'-N19 111.123 2.923 . 0.143 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.1 m -139.45 147.89 41.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.699 1.6 . . . . 0.0 111.806 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -149.9 -51.57 0.14 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.11 0.964 . . . . 0.0 113.166 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 98.4 mmm -69.41 -11.56 60.92 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -76.33 46.08 0.4 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.464 1.906 . . . . 0.0 112.285 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -129.28 139.12 51.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.612 1.165 . . . . 0.0 113.846 -167.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -121.02 149.59 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.911 1.284 . . . . 0.0 112.081 173.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -87.11 139.43 30.58 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.054 2.542 . . . . 0.0 108.725 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.24 115.0 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.249 1.42 . . . . 0.0 109.452 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.07 147.63 16.62 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.278 0.942 . . . . 0.0 114.324 -173.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.81 18.34 48.06 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.054 1.312 . . . . 0.0 114.574 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.5 mt -58.44 144.44 42.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.948 1.299 . . . . 0.0 112.218 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 t -64.77 142.55 58.39 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.087 -0.383 . . . . 0.0 110.512 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.98 -14.83 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.64 -29.91 63.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.215 1.006 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.5 m -70.51 136.91 49.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.348 1.459 . . . . 0.0 114.753 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -116.84 164.08 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.516 1.527 . . . . 0.0 114.251 169.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -54.25 -35.5 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.23 -30.79 67.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.35 -44.67 86.94 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.824 0.738 . . . . 0.0 109.257 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.3 -47.03 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.963 1.305 . . . . 0.0 110.612 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.42 -51.02 71.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.694 0.798 . . . . 0.0 111.881 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -58.79 -43.95 90.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.843 0.857 . . . . 0.0 112.662 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.97 -42.7 94.33 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.349 63.6 m-85 -71.32 -28.25 63.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -59.88 -21.79 61.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.04 -33.92 74.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 112.199 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -72.0 -38.56 69.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 170.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.32 165.12 25.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 126.722 2.106 . . . . 0.0 111.497 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.13 134.28 52.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.277 1.037 . . . . 0.0 113.693 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.13 134.02 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.824 2.049 . . . . 0.0 108.237 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.17 -45.56 19.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.294 1.438 . . . . 0.0 113.419 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -161.81 158.82 26.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.426 1.091 . . . . 0.0 110.456 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.15 149.01 40.95 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.871 1.668 . . . . 0.0 111.346 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -154.95 130.76 10.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 0.0 112.513 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.5 mt -101.81 141.17 35.08 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.975 0.91 . . . . 0.0 110.488 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 34.8 mmt -84.18 86.54 7.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.248 0.547 . . . . 0.0 112.137 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.26 37.4 m-85 -66.9 136.23 55.05 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 118.275 2.694 . . . . 0.0 118.275 174.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -97.03 121.55 39.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.6 1.16 . . . . 0.0 113.193 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -63.04 -33.62 75.82 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.25 -50.94 16.89 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -23.86 65.91 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.254 30.7 m-80 58.54 33.02 22.77 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.7 1.6 . . . . 0.0 114.219 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -150.25 164.11 36.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.29 2.236 . . . . 0.0 110.74 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 34.3 p80 -77.35 153.47 33.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.532 0.682 . . . . 0.0 112.099 169.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -70.93 13.12 0.21 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.75 12.36 80.09 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.153 0.882 . . . . 0.0 114.058 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -150.26 164.38 35.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.841 1.32 . . . . 0.0 110.837 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.55 -168.19 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.041 1.305 . . . . 0.0 113.417 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.89 149.3 50.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.271 1.828 . . . . 0.0 115.158 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.14 130.14 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.162 1.385 . . . . 0.0 111.563 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -108.09 140.99 40.46 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.058 1.743 . . . . 0.0 113.49 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.53 153.72 28.28 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -169.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.49 -34.83 70.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.526 0.73 . . . . 0.0 112.314 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.6 t -132.91 140.95 48.11 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.981 1.312 . . . . 0.0 112.15 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -65.11 -25.62 67.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.247 1.019 . . . . 0.0 111.781 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.5 mm -70.26 -40.78 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.002 -0.436 . . . . 0.0 110.325 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.69 -42.91 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.787 0.721 . . . . 0.0 110.842 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -63.23 -46.98 84.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.599 0.636 . . . . 0.0 112.586 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -56.64 -46.12 81.19 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.393 1.477 . . . . 0.0 112.602 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.84 -47.41 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.059 1.744 . . . . 0.0 110.876 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 67.4 m -66.12 -30.75 71.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.25 -31.0 72.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.897 1.279 . . . . 0.0 112.832 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.54 -33.37 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.363 1.065 . . . . 0.0 111.337 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 64.27 -59.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.611 2.764 . . . . 0.0 115.225 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.334 39.2 m-85 -99.05 119.85 38.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -114.83 170.32 8.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.729 2.012 . . . . 0.0 111.312 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.85 122.98 20.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.55 0.74 . . . . 0.0 112.331 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 34.1 mt -138.26 130.08 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.0 1.72 . . . . 0.0 108.954 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 50.73 47.19 24.89 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.886 1.274 . . . . 0.0 113.914 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.8 t30 59.09 30.63 20.47 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.927 1.691 . . . . 0.0 114.101 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -145.61 156.34 43.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.06 1.744 . . . . 0.0 110.38 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 50.3 mtp -105.48 148.82 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.3 147.15 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.566 1.547 . . . . 0.0 111.737 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -88.85 129.78 35.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.598 0.759 . . . . 0.0 110.305 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.65 132.05 55.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.354 1.062 . . . . 0.0 111.391 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -153.43 151.46 29.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.102 1.361 . . . . 0.0 112.073 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 130.35 45.15 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.608 0.763 . . . . 0.0 111.647 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.04 130.94 42.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -170.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -129.75 151.55 78.32 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 126.774 2.03 . . . . 0.0 111.303 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.11 142.53 38.32 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.852 2.368 . . . . 0.0 112.971 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -60.25 -22.85 63.56 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.7 -27.41 68.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.565 1.546 . . . . 0.0 113.1 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.7 m -98.1 -24.9 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 25.9 mmt -73.57 -27.78 61.5 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.9 t 52.0 56.19 15.62 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.32 1.848 . . . . 0.0 113.848 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.77 0.87 8.25 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.216 3.277 . . . . 0.0 114.356 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.5 p -65.36 -16.77 63.95 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.117 2.266 . . . . 0.0 117.117 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -77.93 -174.77 43.17 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.7 1.143 . . . . 0.0 114.518 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 53.3 m -69.75 -3.72 16.68 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.25 -4.87 32.08 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -57.89 149.45 22.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.992 1.317 . . . . 0.0 114.225 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -85.23 -99.58 0.69 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.173 1.368 . . . . 0.0 112.097 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 56.71 39.33 29.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.288 2.235 . . . . 0.0 113.858 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.794 0.838 . . . . 0.0 111.784 168.571 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.43 0 O5'-C5'-C4' 113.621 2.444 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.043 0 O4'-C1'-N19 111.612 3.412 . 0.568 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.648 0 O4'-C1'-N19 110.501 2.301 . 0.081 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 1 O4'-C1'-N19 112.831 4.631 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 0 O4'-C1'-N19 111.381 3.181 . 0.149 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.2 m -76.83 -18.12 58.58 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -83.44 168.63 16.35 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.658 1.183 . . . . 0.0 112.548 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.66 154.25 34.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.142 1.377 . . . . 0.0 109.406 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -105.59 6.27 32.01 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 170.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.34 140.91 43.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.279 1.431 . . . . 0.0 111.125 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.8 pt -117.9 150.66 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.64 1.176 . . . . 0.0 110.925 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -86.23 142.83 28.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.055 2.142 . . . . 0.0 107.23 165.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.64 106.53 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.505 1.522 . . . . 0.0 109.722 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.1 141.58 15.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.521 1.058 . . . . 0.0 114.763 -170.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.33 17.54 58.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.783 1.183 . . . . 0.0 114.924 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.82 122.64 15.33 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.694 1.197 . . . . 0.0 110.394 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.3 t -62.84 140.89 58.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.785 0.434 . . . . 0.0 110.795 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.299 0.3 OUTLIER -66.35 -10.27 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -168.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -77.8 -19.19 55.44 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.659 1.184 . . . . 0.0 112.862 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.8 m -71.32 138.87 49.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.291 1.436 . . . . 0.0 112.24 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 t -113.81 162.93 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 173.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.61 -34.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.414 1.485 . . . . 0.0 114.252 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.56 -34.51 75.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.305 0.642 . . . . 0.0 112.279 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.86 -44.09 97.54 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.017 0.826 . . . . 0.0 109.503 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.15 -46.69 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 111.336 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.31 -50.6 73.35 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.059 0.944 . . . . 0.0 112.054 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -64.71 -34.85 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -63.85 -53.34 52.22 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 51.9 m-85 -65.02 -22.2 66.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -63.16 -12.99 31.78 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.31 -29.22 69.95 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.525 1.057 . . . . 0.0 112.546 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -86.18 -31.61 21.67 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.346 1.058 . . . . 0.0 112.82 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.31 168.49 28.57 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 127.729 2.585 . . . . 0.0 110.33 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.61 134.7 54.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.166 0.984 . . . . 0.0 112.082 -169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.0 t -97.63 134.08 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.034 1.733 . . . . 0.0 108.169 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.4 -45.73 15.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.792 1.237 . . . . 0.0 113.764 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -162.89 164.06 26.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.731 1.212 . . . . 0.0 109.866 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.76 153.27 43.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.276 1.43 . . . . 0.0 111.579 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptm -152.03 136.45 16.81 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.706 1.202 . . . . 0.0 111.618 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.1 mt -107.85 153.52 22.9 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.83 0.852 . . . . 0.0 110.303 168.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.8 mmm -82.47 71.67 9.54 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.924 0.869 . . . . 0.0 111.317 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -70.6 155.48 40.67 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -172.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -119.66 105.07 10.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.417 2.287 . . . . 0.0 110.976 167.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.06 -9.38 21.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -33.7 76.02 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 169.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -139.4 -3.53 1.52 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.277 76.4 m-20 62.16 12.61 5.19 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.097 2.159 . . . . 0.0 115.497 -170.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.27 169.39 16.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.793 1.237 . . . . 0.0 110.182 167.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -142.76 168.54 19.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.192 0.997 . . . . 0.0 112.446 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -67.33 2.42 1.69 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.13 68.37 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.432 1.015 . . . . 0.0 114.888 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -153.09 168.74 24.91 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.345 1.072 . . . . 0.0 110.139 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.94 -167.77 27.08 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.455 1.026 . . . . 0.0 113.085 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -126.7 150.12 49.19 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.085 1.754 . . . . 0.0 114.976 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.58 122.08 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.017 1.327 . . . . 0.0 111.153 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m -93.54 143.08 26.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.492 1.917 . . . . 0.0 113.78 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -115.41 155.69 26.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -66.95 -36.06 81.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.327 0.651 . . . . 0.0 111.608 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -142.95 141.83 31.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 0.0 112.837 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -61.5 -20.59 63.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.007 1.323 . . . . 0.0 113.004 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.9 -25.73 67.29 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.9 -40.86 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.749 -0.594 . . . . 0.0 110.193 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -58.01 -45.39 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 110.191 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -66.11 -35.78 81.41 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.832 0.742 . . . . 0.0 112.784 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.0 -46.29 85.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.586 1.555 . . . . 0.0 111.977 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.74 -47.61 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.608 1.563 . . . . 0.0 110.699 175.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.1 m -65.08 -30.71 71.68 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -64.9 -26.64 68.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.695 1.198 . . . . 0.0 113.402 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.47 -32.25 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.112 0.965 . . . . 0.0 111.119 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 67.69 -49.82 0.51 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.867 2.867 . . . . 0.0 115.488 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.33 49.2 m-85 -114.5 123.83 50.39 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -121.27 157.07 31.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.783 2.033 . . . . 0.0 110.885 -171.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -117.18 114.81 24.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.981 -174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 38.5 mt -131.33 125.39 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.51 1.124 . . . . 0.0 109.634 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 49.7 37.09 12.12 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.448 1.099 . . . . 0.0 112.971 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.251 33.7 m120 61.41 4.66 1.0 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.806 2.442 . . . . 0.0 116.864 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -86.61 138.81 31.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.473 1.109 . . . . 0.0 110.105 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.2 mmm -82.6 131.62 35.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.518 0.727 . . . . 0.0 110.537 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.04 148.22 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.099 1.359 . . . . 0.0 111.748 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -96.11 125.39 40.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.721 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -89.87 135.44 33.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.179 0.592 . . . . 0.0 110.801 168.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -142.09 149.79 40.35 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.01 1.324 . . . . 0.0 109.666 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -61.61 135.35 57.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.515 1.052 . . . . 0.0 110.522 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.95 137.51 49.24 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -134.82 148.91 69.06 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.968 1.307 . . . . 0.0 111.604 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.33 149.48 88.27 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.327 2.685 . . . . 0.0 113.862 -172.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -67.14 -16.64 64.44 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 173.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -72.6 -22.78 60.92 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.987 1.315 . . . . 0.0 112.894 169.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.63 -49.2 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.381 1.473 . . . . 0.0 110.602 169.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 70.7 mtp -82.37 60.22 4.95 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.034 1.734 . . . . 0.0 112.02 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.1 m -59.78 -37.06 45.73 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.58 137.17 53.45 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.224 2.616 . . . . 0.0 113.134 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.23 -14.43 62.96 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 75.03 -34.1 1.07 Allowed Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.789 1.662 . . . . 0.0 115.591 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.6 t -64.65 153.52 39.23 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.547 1.539 . . . . 0.0 113.091 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.37 151.42 37.44 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.702 1.601 . . . . 0.0 112.091 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -81.16 -8.25 59.72 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.99 154.2 52.82 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 124.38 0.991 . . . . 0.0 114.349 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -149.87 135.71 18.59 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.901 1.68 . . . . 0.0 110.942 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.201 1.4 . . . . 0.0 111.369 174.902 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.724 0 O5'-C5'-C4' 114.314 2.938 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.339 0 O4'-C1'-N19 112.095 3.895 . 0.024 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.503 0 O4'-C1'-N19 111.803 3.603 . 0.241 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.429 0 C4'-C3'-C2' 99.517 -3.183 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.431 -1.851 1 O4'-C1'-N19 113.857 5.657 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.6 p -72.37 160.66 31.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.74 1.216 . . . . 0.0 113.908 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -66.2 163.37 17.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.881 1.673 . . . . 0.0 112.817 171.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 77.7 mtm -59.24 142.1 52.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.57 0.748 . . . . 0.0 112.081 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -75.93 39.87 0.19 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.476 1.11 . . . . 0.0 112.848 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -132.64 138.13 47.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.843 1.257 . . . . 0.0 112.569 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.7 pt -117.26 149.82 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.783 1.233 . . . . 0.0 111.604 172.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -85.87 138.93 31.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.911 2.084 . . . . 0.0 108.257 163.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.86 108.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 109.609 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.07 147.43 17.78 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.4 9.98 58.58 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.647 1.117 . . . . 0.0 114.206 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.24 134.95 57.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.121 1.461 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.0 t -61.57 143.27 56.3 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.206 -0.309 . . . . 0.0 111.367 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -60.78 -18.43 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -75.42 -25.78 57.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.827 1.251 . . . . 0.0 113.295 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.8 m -70.94 134.16 46.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.221 1.408 . . . . 0.0 113.271 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -106.49 158.4 16.94 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.191 1.396 . . . . 0.0 113.613 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -56.54 -32.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.87 -30.02 67.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -65.17 -47.11 78.12 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.641 0.777 . . . . 0.0 111.459 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -60.77 -45.82 92.85 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.835 -0.541 . . . . 0.0 112.287 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -59.85 -44.27 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.116 0.871 . . . . 0.0 113.307 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -58.98 -33.94 71.26 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 55.9 m-85 -85.65 -24.97 26.85 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 174.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -60.82 -16.25 38.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -42.11 87.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 112.375 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -79.07 -29.66 43.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.91 -173.96 38.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.975 1.75 . . . . 0.0 111.949 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.11 107.34 3.62 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.638 -0.919 . . . . 0.0 112.645 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.07 130.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.308 1.443 . . . . 0.0 109.609 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.38 -57.38 3.9 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.12 0.968 . . . . 0.0 112.727 173.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -157.48 164.74 37.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.953 0.901 . . . . 0.0 110.467 -170.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.03 41.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.481 1.512 . . . . 0.0 111.404 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -154.44 129.71 9.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.182 0.993 . . . . 0.0 113.136 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.78 144.62 26.51 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.476 1.11 . . . . 0.0 111.209 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 32.6 mmt -93.96 82.63 4.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.065 0.936 . . . . 0.0 111.551 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.294 50.9 m-85 -60.2 137.45 58.11 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 178.026 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -81.08 -54.32 5.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.712 0.805 . . . . 0.0 110.839 168.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.2 114.72 11.09 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.624 1.97 . . . . 0.0 107.608 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -27.71 66.62 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.287 2.329 . . . . 0.0 117.287 -169.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 t -76.56 -9.99 59.06 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -129.25 -64.01 0.92 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -169.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -157.41 156.27 31.92 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -168.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 32.6 p80 -113.54 161.64 17.15 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.231 1.413 . . . . 0.0 112.848 171.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -73.75 11.09 0.91 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.6 13.89 83.02 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.112 -0.826 . . . . 0.0 114.367 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -145.2 161.78 38.7 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.215 1.507 . . . . 0.0 112.052 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.9 -179.19 34.53 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.868 1.223 . . . . 0.0 112.471 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -116.79 149.14 40.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.563 1.545 . . . . 0.0 114.922 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.0 124.17 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.87 1.268 . . . . 0.0 111.523 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.52 142.67 33.88 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.691 1.997 . . . . 0.0 114.068 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.13 149.79 40.45 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.0 113.998 -172.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.55 -40.93 48.34 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.03 -0.419 . . . . 0.0 111.721 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 12.9 m -110.71 132.05 54.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 112.144 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -63.18 -34.09 76.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.476 1.111 . . . . 0.0 112.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -58.76 -28.33 65.81 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.3 mm -70.9 -39.76 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.753 -0.592 . . . . 0.0 110.465 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.94 -42.18 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.569 0.622 . . . . 0.0 110.25 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.4 -47.71 80.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.629 0.772 . . . . 0.0 111.84 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -57.32 -50.59 72.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.664 1.186 . . . . 0.0 112.234 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.7 -45.0 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 111.062 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 35.2 t -71.21 -32.37 68.74 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.415 -0.803 . . . . 0.0 112.643 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.25 -32.71 74.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.61 1.164 . . . . 0.0 112.723 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.4 -35.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.982 0.913 . . . . 0.0 111.18 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 66.7 -51.84 0.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.525 2.73 . . . . 0.0 115.06 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.261 74.5 m-85 -108.71 125.84 52.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 176.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -132.24 155.87 47.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.407 1.483 . . . . 0.0 112.376 -169.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -107.96 127.6 53.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.228 1.011 . . . . 0.0 111.408 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 44.6 mt -137.05 124.36 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.737 1.615 . . . . 0.0 109.035 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.46 36.11 12.65 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.225 1.01 . . . . 0.0 113.223 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.82 6.19 1.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.609 2.363 . . . . 0.0 116.765 -171.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.02 143.96 26.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.001 1.721 . . . . 0.0 109.992 169.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 41.5 tpp -85.15 133.89 34.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.374 1.07 . . . . 0.0 110.876 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.83 152.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.871 1.669 . . . . 0.0 113.703 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -104.27 123.78 47.97 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.831 1.252 . . . . 0.0 110.591 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 83.7 m -104.88 130.94 52.93 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.063 1.345 . . . . 0.0 111.072 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -153.28 145.35 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.026 1.33 . . . . 0.0 111.582 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.42 137.31 57.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.15 0.886 . . . . 0.0 112.265 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.01 131.38 45.73 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 122.963 0.505 . . . . 0.0 112.258 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -129.68 155.49 80.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.911 1.685 . . . . 0.0 111.834 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -62.6 145.0 95.22 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.311 2.674 . . . . 0.0 115.318 -170.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -61.74 -28.28 69.32 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -78.9 -27.92 43.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.531 1.532 . . . . 0.0 113.315 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.71 -28.5 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 58.3 mtp -99.93 17.14 21.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.772 1.629 . . . . 0.0 114.539 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.4 p -60.55 145.87 86.43 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 121.108 -0.995 . . . . 0.0 113.138 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.96 143.78 61.73 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.287 2.658 . . . . 0.0 112.775 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 p -79.72 -17.42 53.59 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 168.8 -162.06 35.8 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.106 1.336 . . . . 0.0 113.177 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.2 t -65.9 155.36 36.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.259 1.024 . . . . 0.0 112.668 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.69 -15.17 63.51 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.819 1.248 . . . . 0.0 114.178 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -148.99 156.24 41.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.781 1.632 . . . . 0.0 112.417 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 169.33 174.05 37.45 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.712 1.149 . . . . 0.0 113.555 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -70.04 124.09 23.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.064 1.346 . . . . 0.0 111.403 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.917 1.687 . . . . 0.0 113.179 178.625 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.27 0 C5'-C4'-C3' 110.101 -3.599 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.665 1 C5'-C4'-C3' 108.207 -4.862 . 0.432 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.325 0 O4'-C1'-N19 112.191 3.991 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . 0.413 ' N3 ' " H5'" ' B' ' 204' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.427 -2.162 1 O4'-C1'-N19 113.277 5.077 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.525 1 O4'-C1'-N19 113.297 5.097 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.36 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.2 t -67.24 120.62 14.08 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.683 1.193 . . . . 0.0 112.673 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -75.32 -28.99 59.87 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.875 0.87 . . . . 0.0 111.783 169.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 96.4 mtp -66.94 -36.08 81.42 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.463 1.105 . . . . 0.0 113.301 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt 50.61 39.59 21.78 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.36 1.464 . . . . 0.0 113.732 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HE2' ' CD1' ' A' ' 154' ' ' PHE . 85.1 tttt -115.72 139.66 49.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.219 1.407 . . . . 0.0 112.099 -169.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.2 pt -121.94 150.15 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.12 1.368 . . . . 0.0 111.202 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -84.3 145.84 28.06 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.924 2.09 . . . . 0.0 107.379 166.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.12 117.28 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.736 1.614 . . . . 0.0 110.153 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.0 149.73 17.34 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.356 0.979 . . . . 0.0 114.037 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.0 55.48 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 124.951 1.262 . . . . 0.0 114.913 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.6 mt -68.38 135.39 51.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.881 1.273 . . . . 0.0 111.508 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.9 p -69.48 151.1 46.46 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.341 -0.849 . . . . 0.0 111.849 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -65.17 -16.23 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -79.77 -28.55 40.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.609 1.164 . . . . 0.0 112.941 171.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.8 m -71.22 136.99 48.31 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.486 1.115 . . . . 0.0 110.763 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.02 163.35 17.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.86 -36.58 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -173.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.06 -35.81 80.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.518 0.727 . . . . 0.0 112.468 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.14 -47.76 75.96 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.38 -42.25 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.049 0.539 . . . . 0.0 111.844 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -59.35 -53.05 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.603 0.638 . . . . 0.0 111.803 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -60.11 -38.74 83.87 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.282 33.3 m-85 -66.22 -16.48 64.03 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 52.5 m-85 -99.37 -26.76 14.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.55 -22.3 43.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.575 1.55 . . . . 0.0 114.234 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -62.77 -29.46 70.71 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -83.45 -27.44 29.5 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.82 169.19 21.92 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.355 2.407 . . . . 0.0 110.491 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -61.61 132.17 52.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.077 0.942 . . . . 0.0 113.279 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.45 124.46 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.667 1.987 . . . . 0.0 109.342 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.04 -56.25 7.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -146.54 160.01 42.69 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.24 40.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.777 1.231 . . . . 0.0 110.466 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptm -153.49 124.63 7.44 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.748 1.219 . . . . 0.0 111.159 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.8 mt -103.62 153.37 20.69 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.595 0.758 . . . . 0.0 111.413 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.438 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 37.6 mmt -76.71 62.47 2.0 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.072 1.349 . . . . 0.0 113.502 -173.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -65.78 136.53 56.34 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -99.25 113.19 25.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.178 1.391 . . . . 0.0 112.423 169.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -59.16 -18.67 38.21 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -25.13 63.57 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 172.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -134.84 -16.45 1.98 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 -173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 61.3 12.8 4.45 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.718 2.007 . . . . 0.0 115.318 -170.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -94.65 163.48 13.36 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.276 1.43 . . . . 0.0 109.994 168.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -114.6 163.84 14.85 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.857 0.863 . . . . 0.0 113.13 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -68.62 3.38 1.88 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.59 14.55 75.66 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.217 -0.927 . . . . 0.0 114.712 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 32.1 p90 -148.6 168.09 23.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.051 0.926 . . . . 0.0 110.441 174.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -172.57 -166.62 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.984 1.278 . . . . 0.0 113.189 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.452 ' CD1' ' HE2' ' A' ' 110' ' ' LYS . 94.6 m-85 -128.6 154.05 46.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 115.186 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.95 140.31 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.756 1.622 . . . . 0.0 110.854 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -123.05 136.89 55.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.848 2.059 . . . . 0.0 114.358 -174.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -110.87 156.65 20.85 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -168.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -63.97 -41.72 97.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.271 1.028 . . . . 0.0 112.302 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.4 t -137.78 143.04 40.89 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.624 1.17 . . . . 0.0 112.414 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -62.62 -26.29 68.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.299 1.04 . . . . 0.0 111.903 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.08 -32.92 71.4 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.51 -42.02 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.389 171.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.16 -43.52 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.843 0.747 . . . . 0.0 110.697 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.95 -47.99 80.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.395 0.678 . . . . 0.0 112.828 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.83 -47.07 81.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.734 1.213 . . . . 0.0 112.345 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.46 -48.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.705 1.602 . . . . 0.0 110.617 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.54 -34.73 78.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -61.66 -27.22 68.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.997 1.319 . . . . 0.0 113.652 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.41 -33.15 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 0.0 111.321 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 65.73 -53.22 0.37 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 128.886 2.875 . . . . 0.0 115.32 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 57.3 m-85 -108.14 122.2 46.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -123.67 151.04 43.51 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.359 1.464 . . . . 0.0 112.606 -169.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -101.64 126.05 48.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.998 0.919 . . . . 0.0 110.903 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 10.4 mt -138.03 125.61 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.74 1.616 . . . . 0.0 108.811 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.27 37.01 13.97 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.395 1.078 . . . . 0.0 113.463 -173.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 61.96 7.1 1.93 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.044 2.138 . . . . 0.0 116.003 -171.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -95.34 163.01 13.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.87 1.668 . . . . 0.0 111.421 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -95.37 129.38 42.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.362 1.465 . . . . 0.0 111.061 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.1 165.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.589 1.556 . . . . 0.0 113.151 173.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -123.22 130.32 52.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.388 1.075 . . . . 0.0 111.762 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.72 144.44 25.51 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.982 0.913 . . . . 0.0 111.92 168.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -140.08 149.6 43.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.969 1.307 . . . . 0.0 108.591 170.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -64.56 131.18 46.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.983 1.265 . . . . 0.0 110.732 170.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.83 150.62 37.64 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -144.78 150.66 47.32 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.504 1.521 . . . . 0.0 110.313 170.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.83 159.18 38.85 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.169 2.579 . . . . 0.0 115.832 -169.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -54.69 -28.82 50.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.408 2.283 . . . . 0.0 114.898 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -78.2 -25.63 47.16 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.707 1.603 . . . . 0.0 113.743 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.84 -34.02 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -169.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -158.18 163.03 37.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.706 1.602 . . . . 0.0 110.847 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 90.3 p -144.71 159.67 50.0 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 128.463 2.705 . . . . 0.0 111.003 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.73 147.93 45.8 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.67 2.247 . . . . 0.0 112.225 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.5 t -151.24 157.49 42.65 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 162.69 -173.39 38.92 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.41 1.481 . . . . 0.0 113.168 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.0 p -65.46 148.91 50.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.311 1.044 . . . . 0.0 112.995 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.69 -19.04 62.12 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -60.77 151.23 30.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.106 1.762 . . . . 0.0 113.008 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.63 161.43 54.1 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.094 0.854 . . . . 0.0 113.609 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 -72.14 139.81 48.5 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.605 1.162 . . . . 0.0 111.633 174.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.539 1.936 . . . . 0.0 112.493 -178.794 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.103 1 O4'-C1'-N19 112.419 4.219 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.204 0 O4'-C1'-N19 111.224 3.024 . 0.605 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 111.591 3.391 . 0.282 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.733 0 C5'-C4'-C3' 110.109 -3.594 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.219 0 O4'-C1'-N19 111.376 3.176 . 0.497 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 m -76.18 68.73 2.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.949 1.3 . . . . 0.0 113.089 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.79 -32.26 73.43 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.865 1.266 . . . . 0.0 113.295 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.39 144.37 57.12 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.776 1.231 . . . . 0.0 111.617 175.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -116.88 17.46 15.04 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -170.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 81.3 tttt -105.86 132.73 51.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.278 1.831 . . . . 0.0 111.583 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -120.3 150.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.918 1.287 . . . . 0.0 111.339 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -85.99 142.64 28.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.462 1.905 . . . . 0.0 109.441 165.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -126.6 100.55 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.519 1.528 . . . . 0.0 109.943 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.43 144.38 17.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.501 1.048 . . . . 0.0 113.952 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 19.72 54.09 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.41 1.005 . . . . 0.0 115.181 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.6 135.57 55.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.519 1.159 . . . . 0.0 111.379 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -66.81 144.0 56.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.024 0.53 . . . . 0.0 111.295 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 m -59.54 -16.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.98 -27.78 62.01 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.484 1.114 . . . . 0.0 113.303 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -77.11 131.24 38.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.637 1.575 . . . . 0.0 113.608 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.96 165.54 15.15 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.01 -34.98 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -71.46 -36.69 71.3 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 111.595 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -55.84 -51.67 66.69 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.411 0.551 . . . . 0.0 111.949 169.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.67 -42.58 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.9 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -57.59 -52.96 63.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.814 0.734 . . . . 0.0 111.123 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -62.48 -39.83 94.72 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.259 22.5 m-85 -63.67 -20.01 65.36 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 60.6 m-85 -97.3 -27.23 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 169.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.4 -23.51 38.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.223 1.409 . . . . 0.0 114.532 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -62.86 -29.78 71.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -85.75 -35.81 20.54 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.665 0.786 . . . . 0.0 111.628 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.69 163.04 24.97 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.179 2.799 . . . . 0.0 109.328 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -66.88 155.66 37.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -169.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.97 121.29 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.195 -1.82 . . . . 0.0 108.649 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -73.2 -39.6 65.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.746 1.218 . . . . 0.0 111.244 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.13 144.33 18.65 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.924 2.09 . . . . 0.0 115.206 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -132.16 148.17 52.46 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.621 1.168 . . . . 0.0 110.66 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -148.66 138.38 22.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.34 1.056 . . . . 0.0 111.564 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 46.1 mt -100.18 139.61 35.61 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.686 0.795 . . . . 0.0 110.444 170.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.7 mmm -89.49 138.9 31.05 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 122.892 0.477 . . . . 0.0 110.09 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.321 22.4 m-85 -102.46 145.35 29.68 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -175.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -69.83 126.82 30.86 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 168.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -70.1 3.22 2.9 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -169.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.7 p -70.76 -20.59 62.6 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.963 1.705 . . . . 0.0 109.057 164.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.522 0.3 OUTLIER 71.3 22.54 4.28 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.97 2.508 . . . . 0.0 116.277 -168.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.58 -59.43 2.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -149.02 168.98 21.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.723 2.009 . . . . 0.0 111.437 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -68.34 147.74 51.7 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.578 0.704 . . . . 0.0 110.987 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -79.16 11.8 2.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.594 2.358 . . . . 0.0 113.598 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.931 -1.106 . . . . 0.0 115.466 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.34 166.36 32.1 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.652 1.226 . . . . 0.0 112.329 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.25 -179.71 35.21 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.12 0.867 . . . . 0.0 113.529 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 95.7 m-85 -117.94 148.15 42.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.069 1.748 . . . . 0.0 115.248 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.8 t -137.03 126.83 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.918 1.287 . . . . 0.0 111.961 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -106.14 131.91 52.83 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.101 2.161 . . . . 0.0 114.479 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -102.54 159.49 15.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 120.33 3.455 . . . . 0.0 120.33 -167.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -58.32 -38.76 77.75 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.22 2.208 . . . . 0.0 113.501 170.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.9 t -155.26 153.42 30.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.408 1.483 . . . . 0.0 111.337 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -60.17 -32.3 70.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 111.25 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -61.96 -34.18 75.65 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.02 -42.93 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.179 -0.439 . . . . 0.0 110.195 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.95 -43.88 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.814 0.734 . . . . 0.0 110.511 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.31 -46.45 88.69 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.45 -45.5 88.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.59 1.156 . . . . 0.0 112.418 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.14 -48.91 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.002 1.721 . . . . 0.0 110.646 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.96 -30.58 71.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -64.55 -27.92 69.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 113.276 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.02 -33.27 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.208 1.003 . . . . 0.0 111.256 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 65.34 -58.84 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.543 2.737 . . . . 0.0 114.667 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 54.1 m-85 -104.3 116.97 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -112.15 152.69 28.04 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.91 1.684 . . . . 0.0 111.47 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.69 125.15 48.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.748 0.819 . . . . 0.0 110.495 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.04 122.46 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.545 1.538 . . . . 0.0 108.901 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 50.2 35.84 11.23 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.0 m120 63.03 2.12 0.98 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.427 2.291 . . . . 0.0 116.611 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -83.52 138.67 33.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.444 1.498 . . . . 0.0 109.112 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.8 mmm -86.43 129.82 34.72 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.833 -0.542 . . . . 0.0 110.78 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.13 152.2 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.526 1.53 . . . . 0.0 112.605 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -105.51 120.41 41.55 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.082 0.953 . . . . 0.0 111.654 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.33 141.86 28.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.151 0.58 . . . . 0.0 111.415 168.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -148.28 146.29 28.54 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 109.006 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.88 137.25 58.23 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.753 1.161 . . . . 0.0 110.155 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.12 133.81 49.53 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.577 0.703 . . . . 0.0 112.164 -174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -142.49 156.63 63.51 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.312 2.245 . . . . 0.0 111.855 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.0 167.87 26.15 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.276 2.651 . . . . 0.0 112.522 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -57.59 -12.15 2.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.321 1.848 . . . . 0.0 115.086 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -62.88 -26.46 68.79 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.155 1.382 . . . . 0.0 113.374 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.334 2.2 m -81.88 15.98 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -177.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 91.6 mtp -75.19 46.53 0.32 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.691 1.596 . . . . 0.0 113.568 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.6 p -68.79 152.86 96.52 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.441 1.096 . . . . 0.0 112.094 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.68 138.69 38.69 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.069 2.513 . . . . 0.0 112.703 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.306 1.3 p -130.67 15.62 5.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.33 1.852 . . . . 0.0 115.905 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 83.89 172.89 49.37 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.752 1.168 . . . . 0.0 113.372 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 39.7 t -68.97 -40.78 78.66 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.71 168.04 27.91 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.652 1.581 . . . . 0.0 111.791 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -67.01 -16.45 64.37 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 79.98 173.82 46.16 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.308 1.432 . . . . 0.0 114.389 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -78.86 91.66 4.79 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.169 1.387 . . . . 0.0 111.786 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.785 1.634 . . . . 0.0 112.37 169.589 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.124 0 O4'-C1'-N19 111.524 3.324 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.419 0 O5'-C5'-C4' 113.624 2.445 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.369 1 C1'-O4'-C4' 105.286 -4.793 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.626 0 C5'-C4'-C3' 109.855 -3.763 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.28 0 O4'-C1'-N19 110.967 2.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 54.5 p -69.21 159.05 33.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.916 1.286 . . . . 0.0 113.694 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -136.36 -73.04 0.44 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.548 1.539 . . . . 0.0 112.002 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 52.8 tpp -164.49 145.47 8.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.878 1.271 . . . . 0.0 111.687 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -74.79 36.28 0.11 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.367 1.467 . . . . 0.0 114.714 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -142.08 138.92 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.789 -1.194 . . . . 0.0 113.041 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.69 151.91 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.932 1.293 . . . . 0.0 111.159 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.27 144.52 27.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.316 2.246 . . . . 0.0 106.546 165.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.08 108.9 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.806 1.642 . . . . 0.0 108.899 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.44 147.96 18.61 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.444 1.021 . . . . 0.0 114.531 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.56 19.96 36.25 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.896 1.236 . . . . 0.0 114.734 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.17 134.98 53.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.774 1.23 . . . . 0.0 111.466 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 t -63.24 152.39 37.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.928 0.891 . . . . 0.0 112.488 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 m -59.61 -20.08 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.625 1.17 . . . . 0.0 113.535 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -79.56 -25.91 41.51 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.572 1.149 . . . . 0.0 112.893 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 36.2 m -73.78 140.96 46.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.077 1.351 . . . . 0.0 113.713 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -122.87 164.13 19.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.736 1.614 . . . . 0.0 114.903 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.08 -35.84 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.17 -29.83 67.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.593 0.757 . . . . 0.0 112.775 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.41 -48.93 68.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.67 -43.01 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.821 0.848 . . . . 0.0 111.742 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.98 -46.54 90.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.156 0.582 . . . . 0.0 111.801 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -59.38 -45.26 91.95 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.986 0.914 . . . . 0.0 113.088 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -63.69 -35.33 80.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.346 62.3 m-85 -84.03 -25.82 29.58 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -59.37 -21.13 59.39 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.82 -31.81 73.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.119 1.367 . . . . 0.0 112.322 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -80.89 -26.54 36.78 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.0 165.0 15.18 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.993 2.235 . . . . 0.0 110.974 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.99 133.43 56.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.958 0.885 . . . . 0.0 112.638 -171.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.97 125.23 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.96 1.704 . . . . 0.0 108.093 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.99 -35.43 59.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -163.87 157.48 18.81 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.17 0.988 . . . . 0.0 110.435 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.9 150.49 43.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 111.218 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptm -153.88 133.73 13.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.633 1.173 . . . . 0.0 111.883 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.6 mt -103.9 147.66 27.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 170.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.9 mmm -97.94 108.17 20.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -171.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.287 53.9 m-85 -80.84 149.4 29.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -90.7 169.05 11.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.042 1.737 . . . . 0.0 114.048 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -69.22 5.29 1.29 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 18.4 p -66.36 -21.88 66.25 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.395 1.078 . . . . 0.0 108.702 164.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.434 0.8 OUTLIER 62.91 14.23 7.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.322 2.249 . . . . 0.0 114.765 -169.54 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -140.8 -18.28 0.84 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -167.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -127.87 144.44 51.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.958 1.303 . . . . 0.0 112.148 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -101.26 159.57 15.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.612 1.165 . . . . 0.0 112.633 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 -72.76 9.85 1.02 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.42 22.16 77.83 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.122 -0.986 . . . . 0.0 113.853 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -150.34 166.27 30.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.518 1.151 . . . . 0.0 108.222 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.92 -170.33 23.35 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.79 1.186 . . . . 0.0 113.088 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.47 152.68 36.51 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.677 1.591 . . . . 0.0 114.486 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.79 127.41 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.13 1.372 . . . . 0.0 110.835 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.09 139.1 38.16 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.854 2.062 . . . . 0.0 113.759 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -112.09 155.34 24.02 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -66.87 -34.86 78.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.454 0.702 . . . . 0.0 112.087 172.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.5 t -141.64 143.51 33.67 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 112.206 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -67.01 -20.42 65.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.747 0.819 . . . . 0.0 111.976 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.62 -31.44 71.52 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.8 mm -72.84 -40.8 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.283 171.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.18 -44.85 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.941 0.791 . . . . 0.0 109.957 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -63.95 -45.0 91.11 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -56.91 -46.38 82.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.367 1.067 . . . . 0.0 111.868 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.88 -49.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.885 1.674 . . . . 0.0 110.651 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.15 -33.29 75.15 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.88 -27.38 68.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.462 1.105 . . . . 0.0 113.459 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.1 mt -72.56 -31.66 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.743 1.217 . . . . 0.0 111.754 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 66.04 -48.89 0.41 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 128.87 2.868 . . . . 0.0 115.607 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 51.8 m-85 -117.51 122.46 43.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -120.89 149.4 42.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 111.899 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -87.57 131.77 34.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.327 0.651 . . . . 0.0 111.846 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.8 mt -141.23 125.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.488 1.915 . . . . 0.0 108.74 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 51.27 41.36 27.88 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.726 1.211 . . . . 0.0 114.255 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 64.5 t30 60.27 21.13 10.57 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.13 1.772 . . . . 0.0 114.654 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -120.4 167.18 12.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.203 2.201 . . . . 0.0 110.318 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 95.9 mmm -105.52 141.19 37.43 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.928 0.891 . . . . 0.0 112.448 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.68 149.62 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.838 1.655 . . . . 0.0 112.29 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -94.78 127.76 41.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.023 0.929 . . . . 0.0 111.391 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.67 135.0 35.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.712 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -138.63 149.7 45.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.599 1.559 . . . . 0.0 109.585 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -61.15 136.29 58.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.959 1.254 . . . . 0.0 110.685 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -72.89 115.65 12.44 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.758 0.423 . . . . 0.0 110.838 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -102.68 153.48 38.17 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.546 1.138 . . . . 0.0 111.517 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.21 147.79 93.66 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.164 2.576 . . . . 0.0 112.903 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -66.28 -20.36 66.08 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.213 -0.93 . . . . 0.0 113.466 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -67.98 -28.57 67.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.92 1.688 . . . . 0.0 112.779 169.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.14 -46.32 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.249 1.42 . . . . 0.0 111.09 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 93.1 mmm -74.66 -19.64 60.19 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.8 t 65.52 126.51 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 128.431 2.692 . . . . 0.0 113.022 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.0 132.85 38.53 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.666 2.244 . . . . 0.0 111.414 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.7 t -161.71 176.0 11.41 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -169.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -169.79 156.0 26.45 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.592 1.091 . . . . 0.0 112.665 172.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -58.08 133.67 55.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.359 0.664 . . . . 0.0 112.325 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.32 -29.85 64.22 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -155.99 142.67 18.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.509 1.524 . . . . 0.0 111.427 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -168.38 168.0 40.63 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.13 1.347 . . . . 0.0 112.451 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.04 -55.81 0.17 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 128.434 2.693 . . . . 0.0 115.277 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 C--O 1.252 1.205 0 C-N-CA 126.585 1.954 . . . . 0.0 113.135 176.178 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.562 0 O5'-C5'-C4' 114.012 2.723 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.179 0 O4'-C1'-N19 111.639 3.439 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.142 0 O4'-C1'-N19 111.727 3.527 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.276 0 O4'-C1'-N19 111.689 3.489 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.067 1 O4'-C1'-N19 112.437 4.237 . 0.019 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.7 t -153.95 146.14 23.77 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.968 1.307 . . . . 0.0 111.583 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 64.67 -31.15 0.12 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.082 2.953 . . . . 0.0 116.606 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 35.3 mmt -73.72 53.99 0.46 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.807 2.043 . . . . 0.0 112.984 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.07 32.19 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.192 2.197 . . . . 0.0 114.736 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -118.89 137.96 53.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.805 1.242 . . . . 0.0 112.761 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.3 pt -118.17 152.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.871 1.268 . . . . 0.0 111.065 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 182' ' ' LYS . 49.8 t80 -87.62 141.44 28.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.745 2.018 . . . . 0.0 108.098 165.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.81 114.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.227 1.411 . . . . 0.0 109.347 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.11 144.37 18.41 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.423 1.011 . . . . 0.0 114.334 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.59 20.56 50.9 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.523 1.058 . . . . 0.0 114.562 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.0 mt -61.91 141.42 58.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.6 1.2 . . . . 0.0 111.103 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.32 141.7 58.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.888 -0.508 . . . . 0.0 111.128 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.01 -17.34 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.44 -25.85 50.99 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.543 1.137 . . . . 0.0 112.876 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 140.06 55.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.112 1.365 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -113.67 161.1 17.88 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.004 1.322 . . . . 0.0 114.42 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -54.7 -34.51 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.48 -31.35 68.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -64.6 -42.19 95.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.897 0.772 . . . . 0.0 109.25 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.7 -48.83 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.585 1.154 . . . . 0.0 111.3 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -60.26 -48.29 82.37 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.629 0.65 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -58.53 -41.17 84.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.672 0.789 . . . . 0.0 112.796 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.7 -47.01 82.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 57.5 m-85 -70.2 -25.89 63.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -60.48 -43.66 96.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.622 1.169 . . . . 0.0 112.784 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.46 -35.63 70.94 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 113.04 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.62 166.12 26.17 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.123 2.297 . . . . 0.0 110.731 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.072 0.939 . . . . 0.0 112.978 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.6 t -106.79 129.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.556 1.943 . . . . 0.0 108.395 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.89 -56.59 5.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 112.163 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -155.46 161.46 40.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.048 0.939 . . . . 0.0 110.319 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.44 152.63 38.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.47 1.508 . . . . 0.0 111.044 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -154.17 132.0 11.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.975 0.91 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.5 mt -100.59 137.49 38.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.27 1.028 . . . . 0.0 111.087 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.3 mmt -87.42 121.8 30.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.885 0.474 . . . . 0.0 112.264 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.378 25.2 m-85 -83.87 145.28 28.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -68.28 136.83 54.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.492 1.517 . . . . 0.0 109.067 169.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -64.38 -18.2 64.46 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -168.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -3.48 9.56 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 167.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.475 0.7 OUTLIER 63.67 19.19 11.59 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.723 2.009 . . . . 0.0 115.28 -169.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -77.94 -51.8 9.84 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -168.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.3 167.45 25.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.467 1.907 . . . . 0.0 111.405 -172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -79.58 150.7 30.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.56 0.618 . . . . 0.0 110.779 168.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -77.78 19.22 0.4 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.218 1.407 . . . . 0.0 114.709 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.42 22.52 76.44 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.128 -0.982 . . . . 0.0 113.824 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -151.7 164.0 37.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.559 1.179 . . . . 0.0 109.224 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.34 -167.57 29.18 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.279 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.62 150.1 44.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.916 1.686 . . . . 0.0 114.337 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.95 128.66 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.191 1.397 . . . . 0.0 110.815 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -108.54 134.22 51.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.209 1.803 . . . . 0.0 114.079 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -105.82 160.04 15.55 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -69.12 -33.68 73.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.933 0.893 . . . . 0.0 112.753 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t -142.66 147.07 35.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.707 1.203 . . . . 0.0 112.316 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.21 -30.09 67.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.517 1.127 . . . . 0.0 111.765 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.75 -35.27 72.46 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.65 -40.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.562 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.95 -44.21 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.994 0.816 . . . . 0.0 110.138 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -62.15 -48.07 81.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.44 -46.46 76.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.023 1.329 . . . . 0.0 112.547 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.85 -45.14 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.358 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.9 t -67.62 -36.13 80.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.699 0.799 . . . . 0.0 112.846 -176.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.54 -22.64 67.02 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.8 -33.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.803 0.841 . . . . 0.0 111.051 172.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 67.11 -51.32 0.48 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.838 2.855 . . . . 0.0 115.42 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.332 59.2 m-85 -110.28 123.57 50.06 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -123.86 170.36 10.64 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.281 2.232 . . . . 0.0 110.578 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -142.47 122.54 13.71 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.816 -1.178 . . . . 0.0 112.939 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.88 128.84 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.77 1.628 . . . . 0.0 108.989 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.72 39.64 18.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.65 1.18 . . . . 0.0 113.294 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 62.22 9.02 2.97 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.118 2.167 . . . . 0.0 116.231 -174.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -98.68 134.06 42.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.16 1.384 . . . . 0.0 110.42 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 18.7 ttm -82.53 137.24 34.65 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.757 0.823 . . . . 0.0 110.784 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.17 157.52 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.171 1.788 . . . . 0.0 112.259 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -106.47 128.77 54.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.065 0.946 . . . . 0.0 111.913 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.1 p -90.7 138.62 31.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.093 0.557 . . . . 0.0 110.632 167.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 112' ' ' PHE . 46.6 mtmt -140.36 146.44 38.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.828 1.251 . . . . 0.0 109.518 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -62.79 128.1 34.36 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.218 0.917 . . . . 0.0 110.781 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.71 125.24 26.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.867 0.365 . . . . 0.0 111.945 -172.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -126.11 134.85 26.35 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.496 1.519 . . . . 0.0 110.922 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.47 138.66 81.88 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.001 2.468 . . . . 0.0 112.807 174.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -60.66 -21.93 63.32 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -67.76 -21.24 65.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.457 1.903 . . . . 0.0 113.797 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.77 -30.5 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.439 ' HG3' ' H ' ' A' ' 191' ' ' SER . 6.3 ptm -84.8 -70.69 0.56 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.051 0.841 . . . . 0.0 112.923 173.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.439 ' H ' ' HG3' ' A' ' 190' ' ' MET . 32.5 t -166.23 136.53 2.71 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.507 1.523 . . . . 0.0 110.773 176.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.77 149.91 78.72 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.118 2.545 . . . . 0.0 112.299 175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.9 t -68.34 156.74 37.15 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -145.39 16.89 1.87 Allowed Glycine 0 CA--C 1.538 1.475 0 C-N-CA 126.041 1.782 . . . . 0.0 113.658 172.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.0 t -66.46 131.97 47.24 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.307 1.054 . . . . 0.0 112.366 -175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.02 154.19 38.12 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.519 1.127 . . . . 0.0 113.519 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -74.38 -21.79 59.49 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.55 1.14 . . . . 0.0 113.583 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.45 -98.63 0.07 OUTLIER Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.911 1.719 . . . . 0.0 112.936 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 50.31 56.33 8.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.407 1.483 . . . . 0.0 111.477 177.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.924 2.09 . . . . 0.0 113.129 -169.668 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.282 1 O4'-C1'-N19 112.233 4.033 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.057 0 O4'-C1'-N19 111.757 3.557 . 0.264 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 111.619 3.419 . 0.093 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 C5'-C4'-C3' 111.858 -2.428 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.746 0 O5'-C5'-C4' 106.933 -2.333 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.1 t -68.31 144.93 54.63 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.123 0.969 . . . . 0.0 113.029 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -80.9 14.17 2.33 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.808 1.643 . . . . 0.0 113.855 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -58.89 152.19 19.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.438 1.495 . . . . 0.0 113.59 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.15 60.55 1.7 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.937 1.695 . . . . 0.0 111.026 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -133.55 139.8 46.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -167.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 pt -121.07 153.07 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.192 1.397 . . . . 0.0 111.032 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.55 143.9 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.211 2.604 . . . . 0.0 105.009 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.58 103.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.949 1.7 . . . . 0.0 109.263 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -104.29 142.44 15.49 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.568 1.08 . . . . 0.0 114.264 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.13 54.69 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.747 1.165 . . . . 0.0 114.997 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 mt -62.54 145.16 55.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.757 1.223 . . . . 0.0 112.475 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 t -66.93 137.69 56.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 110.719 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.76 -9.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.28 -20.29 28.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.098 0.959 . . . . 0.0 113.071 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.8 m -72.22 129.92 39.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.725 1.21 . . . . 0.0 111.37 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -103.01 163.95 11.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.72 -38.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.56 -29.64 68.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.276 0.63 . . . . 0.0 112.616 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -65.75 -45.73 81.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.308 0.958 . . . . 0.0 110.172 173.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.52 -48.21 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.576 1.15 . . . . 0.0 110.812 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -56.64 -51.13 69.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.149 1.38 . . . . 0.0 112.377 173.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -62.42 -36.86 83.7 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.872 0.869 . . . . 0.0 112.934 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -65.97 -45.38 81.92 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 58.3 m-85 -71.14 -25.51 62.6 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 176.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -56.83 -22.38 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.532 1.533 . . . . 0.0 114.631 170.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.79 -43.53 97.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.57 -33.28 68.94 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.52 170.8 30.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.336 1.922 . . . . 0.0 112.049 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -60.62 132.08 52.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.22 1.008 . . . . 0.0 112.188 -171.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.62 134.95 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.161 1.784 . . . . 0.0 108.431 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.93 -45.6 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.437 1.095 . . . . 0.0 113.703 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.73 162.35 23.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.911 1.285 . . . . 0.0 109.73 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.43 153.09 42.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.287 1.435 . . . . 0.0 111.71 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -156.33 134.72 11.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.53 1.132 . . . . 0.0 112.276 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 18.4 mt -101.49 147.07 26.81 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.864 0.866 . . . . 0.0 110.839 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.492 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 33.4 mmt -81.45 75.89 8.4 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 112.91 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.271 53.4 m-85 -62.94 141.68 58.62 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 178.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -103.02 123.49 46.71 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.873 1.669 . . . . 0.0 113.349 168.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -62.06 -25.95 67.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.479 1.112 . . . . 0.0 113.362 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -67.86 0.5 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 175.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -19.9 62.31 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 177.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.269 37.9 m-80 57.66 32.89 22.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.506 1.522 . . . . 0.0 113.684 -174.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -132.09 159.11 39.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.49 2.716 . . . . 0.0 109.633 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 32.6 p80 -84.18 156.29 22.13 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.624 0.726 . . . . 0.0 112.427 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 ttp85 -72.88 17.41 0.12 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.88 2.072 . . . . 0.0 114.489 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.29 15.35 69.34 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.198 1.38 . . . . 0.0 114.766 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.492 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 27.4 p90 -156.02 168.47 27.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.219 1.51 . . . . 0.0 111.237 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.87 -167.74 25.92 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.829 1.204 . . . . 0.0 113.573 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.71 150.83 50.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.268 1.827 . . . . 0.0 115.014 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.48 128.52 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.29 1.436 . . . . 0.0 111.498 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -100.72 146.51 27.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.735 2.014 . . . . 0.0 113.687 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.8 151.94 38.97 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.41 -27.76 63.53 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.926 0.891 . . . . 0.0 112.948 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.8 t -141.68 142.34 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.995 1.318 . . . . 0.0 112.148 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -64.23 -26.52 68.54 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.125 . . . . 0.0 111.754 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.76 -32.82 72.1 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.9 -42.34 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.336 172.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.56 -44.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.666 0.666 . . . . 0.0 110.514 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -64.23 -47.3 80.19 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.84 -46.58 74.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.403 1.081 . . . . 0.0 111.946 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.91 -49.62 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.827 1.651 . . . . 0.0 110.872 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.61 -33.31 75.63 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -65.67 -21.6 66.56 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.68 -31.77 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.021 0.928 . . . . 0.0 111.304 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 66.1 -52.75 0.4 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.828 2.851 . . . . 0.0 115.535 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.337 49.6 m-85 -111.41 121.5 45.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 173.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -118.42 165.65 13.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.117 2.167 . . . . 0.0 110.849 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -131.14 113.9 14.46 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.276 -0.89 . . . . 0.0 112.14 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.75 129.24 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.776 1.23 . . . . 0.0 109.314 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 48.1 45.12 19.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.648 1.179 . . . . 0.0 112.686 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.297 0.9 OUTLIER 52.81 31.79 11.18 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.448 2.299 . . . . 0.0 115.748 -174.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -130.84 142.2 50.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.78 1.632 . . . . 0.0 110.344 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.3 mmm -84.11 135.1 34.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.312 1.045 . . . . 0.0 111.79 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.71 153.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.834 1.254 . . . . 0.0 111.892 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.38 127.63 46.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.651 0.78 . . . . 0.0 111.933 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -89.79 136.38 33.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.846 0.458 . . . . 0.0 110.432 167.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -140.76 148.11 40.17 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.974 1.309 . . . . 0.0 108.744 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.45 135.5 55.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.897 1.226 . . . . 0.0 110.879 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.52 117.36 15.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.742 0.417 . . . . 0.0 111.29 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -73.51 149.53 88.67 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.323 0.649 . . . . 0.0 111.56 170.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.59 148.65 92.52 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.929 2.419 . . . . 0.0 112.915 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -60.73 -22.87 64.45 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.366 -0.834 . . . . 0.0 113.21 169.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -66.03 -26.57 67.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.732 1.613 . . . . 0.0 113.509 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.269 1.2 m -87.37 -7.64 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 7.1 ptm -156.39 76.0 0.88 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.335 1.454 . . . . 0.0 112.353 -171.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.8 p -147.52 150.94 38.51 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.154 1.381 . . . . 0.0 112.328 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.93 161.14 45.8 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.645 2.897 . . . . 0.0 113.459 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.75 138.63 44.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.741 1.616 . . . . 0.0 115.351 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 76.43 174.57 38.73 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.624 1.106 . . . . 0.0 114.805 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.6 t -76.82 160.18 29.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.547 1.139 . . . . 0.0 112.384 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.17 154.19 40.39 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.662 1.185 . . . . 0.0 112.963 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -149.75 147.75 28.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.639 1.576 . . . . 0.0 111.342 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.07 53.19 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.256 0.932 . . . . 0.0 113.985 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -133.45 155.62 49.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.154 1.782 . . . . 0.0 112.385 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.933 1.693 . . . . 0.0 113.581 179.159 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.173 1 O4'-C1'-N19 112.891 4.691 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.343 0 O4'-C1'-N19 111.66 3.46 . 0.266 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 C4'-C3'-C2' 100.679 -2.021 . 0.282 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.303 1 O4'-C1'-N19 114.004 5.804 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.225 0 O4'-C1'-N19 111.553 3.353 . 0.035 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -65.92 157.17 31.38 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.756 1.222 . . . . 0.0 113.28 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -144.5 170.43 16.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.916 1.286 . . . . 0.0 112.391 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 73.3 mtm -55.41 137.29 48.44 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.697 0.799 . . . . 0.0 111.522 171.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -77.01 43.22 0.35 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.33 1.452 . . . . 0.0 112.86 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.55 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 80.2 tttt -136.63 138.33 41.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.346 1.458 . . . . 0.0 111.72 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.0 149.29 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.592 1.157 . . . . 0.0 111.333 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -83.97 145.22 28.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.251 1.82 . . . . 0.0 107.534 165.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.82 108.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.977 1.711 . . . . 0.0 109.984 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.74 147.63 18.66 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.594 1.092 . . . . 0.0 114.5 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.8 17.42 63.57 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.243 0.925 . . . . 0.0 114.61 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.1 mt -61.66 144.68 54.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.841 1.256 . . . . 0.0 111.494 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.5 t -69.36 137.0 52.49 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.061 -0.399 . . . . 0.0 110.133 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.4 m -64.52 -12.2 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -27.63 42.11 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.75 1.22 . . . . 0.0 113.145 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.2 m -67.4 132.39 47.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 111.974 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.49 161.46 20.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -35.02 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -71.6 -37.35 70.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.489 0.716 . . . . 0.0 111.685 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.51 -50.26 72.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.539 0.609 . . . . 0.0 111.787 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.81 -43.49 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.84 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.94 -52.57 64.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.053 0.842 . . . . 0.0 111.647 174.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -59.55 -39.79 85.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.27 24.4 m-85 -64.32 -16.24 61.82 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 118.309 2.707 . . . . 0.0 118.309 170.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 58.3 m-85 -101.5 -25.61 13.85 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.72 -21.87 56.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.159 1.384 . . . . 0.0 113.824 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.19 -29.92 71.17 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.31 -28.55 31.61 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.72 169.19 24.7 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.496 2.474 . . . . 0.0 110.079 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -63.27 130.23 43.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.843 0.83 . . . . 0.0 112.589 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.44 132.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.193 1.797 . . . . 0.0 108.938 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.94 -57.91 3.6 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.174 0.989 . . . . 0.0 112.743 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -157.47 166.99 31.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.271 1.029 . . . . 0.0 109.883 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.39 157.72 43.66 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.398 1.479 . . . . 0.0 111.315 174.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -152.16 125.02 8.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.421 1.088 . . . . 0.0 111.391 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.36 146.97 25.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.305 0.642 . . . . 0.0 110.568 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.44 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 36.8 mmt -82.29 82.33 7.83 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 112.114 -172.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.363 10.8 m-85 -54.68 138.71 41.0 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 118.221 2.675 . . . . 0.0 118.221 174.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -75.61 148.75 38.54 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.436 ' H ' ' HD3' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -70.4 -1.77 11.69 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 116.183 1.919 . . . . 0.0 116.183 -169.011 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.2 p -69.23 -17.87 63.82 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.394 1.477 . . . . 0.0 109.305 166.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.501 0.5 OUTLIER 67.18 17.81 10.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.339 2.256 . . . . 0.0 114.967 -168.677 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -84.88 -58.44 2.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.025 0.93 . . . . 0.0 113.066 -170.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -148.64 166.76 27.35 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 128.038 2.535 . . . . 0.0 111.507 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 28.4 p80 -87.23 161.59 17.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.281 1.032 . . . . 0.0 112.954 169.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -70.7 -15.67 62.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.303 1.441 . . . . 0.0 114.081 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 114.9 22.27 5.04 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.509 1.052 . . . . 0.0 114.841 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.44 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 41.6 p90 -153.46 166.04 33.93 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.778 1.289 . . . . 0.0 111.237 171.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.3 -169.58 33.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.614 1.102 . . . . 0.0 114.289 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.55 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 92.8 m-85 -124.11 152.57 42.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.875 2.07 . . . . 0.0 115.979 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -137.86 133.65 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.412 1.485 . . . . 0.0 111.807 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.58 140.89 39.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.328 2.251 . . . . 0.0 114.934 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -117.2 155.61 29.12 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -168.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -72.24 -31.29 65.68 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.866 0.866 . . . . 0.0 113.095 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.7 t -144.37 145.99 32.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.65 1.18 . . . . 0.0 112.633 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.32 -25.07 66.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.88 0.872 . . . . 0.0 111.872 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.12 -32.52 72.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.7 mm -72.33 -42.56 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.312 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.51 -44.68 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.772 0.715 . . . . 0.0 110.23 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.75 -49.7 76.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -55.76 -47.39 77.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.513 1.125 . . . . 0.0 112.301 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.32 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.749 1.62 . . . . 0.0 110.725 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 61.6 m -65.7 -33.27 75.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.24 -23.03 66.95 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.8 mt -72.98 -33.03 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.914 0.885 . . . . 0.0 111.251 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 65.7 -48.94 0.39 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.032 2.933 . . . . 0.0 115.531 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.301 46.9 m-85 -115.7 124.14 50.1 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -123.56 139.32 54.12 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.665 1.586 . . . . 0.0 111.816 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -86.05 124.62 32.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.072 0.949 . . . . 0.0 111.222 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.1 mt -138.76 124.75 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.213 1.805 . . . . 0.0 108.729 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 48.29 44.72 20.04 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.313 0.8 OUTLIER 53.45 29.22 8.58 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.688 1.995 . . . . 0.0 115.947 -172.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -127.53 136.06 51.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.318 2.247 . . . . 0.0 109.819 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 88.0 mtp -86.25 132.72 33.93 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.776 -0.578 . . . . 0.0 111.207 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.2 m -127.37 153.27 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.625 1.57 . . . . 0.0 112.712 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -101.25 125.98 47.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.781 0.833 . . . . 0.0 111.982 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.11 139.31 30.75 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.392 0.677 . . . . 0.0 111.462 167.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -136.37 145.3 45.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.72 1.208 . . . . 0.0 109.237 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.72 130.28 45.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.367 0.985 . . . . 0.0 109.758 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.87 140.9 53.25 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -139.31 154.33 71.8 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.533 1.933 . . . . 0.0 110.941 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.85 153.88 73.06 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.063 2.509 . . . . 0.0 114.622 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -62.04 -19.65 63.11 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -71.61 -33.63 69.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.398 1.479 . . . . 0.0 112.415 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.14 -36.59 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.762 1.225 . . . . 0.0 111.221 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 19.7 mmt -80.55 83.2 6.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.747 1.219 . . . . 0.0 111.79 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.1 m -54.68 144.25 45.91 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.066 1.346 . . . . 0.0 114.211 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.91 -8.43 17.84 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.964 3.109 . . . . 0.0 114.902 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.273 1.2 p -65.14 153.8 39.82 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 75.01 -177.72 47.7 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.502 1.048 . . . . 0.0 114.116 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.3 t -157.4 156.17 31.78 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.896 1.278 . . . . 0.0 111.58 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.23 157.3 37.92 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.636 1.174 . . . . 0.0 113.066 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -150.21 162.94 39.5 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.704 1.601 . . . . 0.0 112.194 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -176.34 -171.79 40.43 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.929 1.252 . . . . 0.0 113.406 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -63.5 139.26 58.75 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.841 1.256 . . . . 0.0 112.055 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.973 1.709 . . . . 0.0 114.281 178.533 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.308 0 C4'-C3'-C2' 99.432 -3.268 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.247 0 O4'-C1'-N19 111.682 3.482 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.015 0 C3'-C2'-C1' 98.221 -3.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.991 1 O4'-C1'-N19 114.009 5.809 . 0.011 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.331 0 O4'-C1'-N19 111.515 3.315 . 0.181 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -86.06 -9.52 56.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.8 m80 60.14 34.8 21.17 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.194 1.798 . . . . 0.0 115.273 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.26 88.54 0.45 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.196 -0.94 . . . . 0.0 112.251 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -96.36 22.03 8.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.861 1.664 . . . . 0.0 113.405 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 84.0 tttt -137.86 140.1 40.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.877 1.271 . . . . 0.0 111.178 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt -124.82 150.62 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.489 1.116 . . . . 0.0 111.922 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -85.12 144.14 28.39 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.09 117.09 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.613 1.565 . . . . 0.0 109.762 172.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.0 145.81 16.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.269 0.938 . . . . 0.0 114.267 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.02 11.9 58.26 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.855 1.217 . . . . 0.0 115.121 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -59.63 142.78 52.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 111.275 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t -67.83 144.71 55.21 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.63 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.25 1.4 p -65.07 -13.57 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -72.75 -26.85 61.71 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 112.545 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.2 m -72.22 135.37 46.06 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 112.832 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 t -106.15 160.05 15.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 171.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.89 -34.42 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.435 1.494 . . . . 0.0 114.564 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.29 -34.88 75.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.235 0.614 . . . . 0.0 112.598 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -61.2 -42.37 98.47 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.222 0.919 . . . . 0.0 109.85 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.85 -47.81 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.74 1.216 . . . . 0.0 111.244 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -60.85 -48.48 81.61 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.664 0.665 . . . . 0.0 112.156 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -59.83 -37.02 78.04 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.67 -48.37 72.32 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 54.4 m-85 -68.99 -25.0 64.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -59.79 -18.65 45.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -59.43 -45.0 92.8 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.633 1.173 . . . . 0.0 112.82 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -73.01 -36.85 67.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.963 1.305 . . . . 0.0 112.535 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.68 165.88 29.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.097 1.808 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -59.09 126.22 26.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.963 0.905 . . . . 0.0 112.432 -169.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.97 128.67 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.756 1.622 . . . . 0.0 108.593 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.37 -57.2 4.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.195 0.998 . . . . 0.0 113.093 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -156.19 165.56 36.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 110.039 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.8 155.81 41.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.571 1.549 . . . . 0.0 111.272 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -154.86 134.88 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.373 1.069 . . . . 0.0 112.347 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.2 mt -103.25 142.45 34.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 111.236 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.438 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 38.3 mmt -83.7 90.08 7.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.863 0.84 . . . . 0.0 111.611 -175.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.308 57.9 m-85 -61.23 138.32 58.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 175.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -88.06 -47.21 8.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.735 1.214 . . . . 0.0 110.538 168.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.97 112.17 8.04 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.924 2.089 . . . . 0.0 108.355 168.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.54 -27.05 64.18 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 -169.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.3 p -80.6 -10.04 59.75 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.786 1.634 . . . . 0.0 114.71 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -138.03 -58.99 0.65 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -168.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -144.8 149.59 35.73 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -168.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -123.1 159.97 27.39 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.045 1.738 . . . . 0.0 111.832 169.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.06 2.65 6.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.03 58.27 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.059 -1.025 . . . . 0.0 113.952 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 14.9 p90 -152.39 165.15 35.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.562 1.181 . . . . 0.0 109.234 172.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.65 -167.88 33.94 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.477 1.037 . . . . 0.0 113.668 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.517 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.5 m-85 -124.79 151.73 44.78 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.988 1.715 . . . . 0.0 114.974 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.15 132.91 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.288 1.435 . . . . 0.0 111.526 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.14 142.76 37.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.942 2.097 . . . . 0.0 114.647 -178.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.21 156.88 30.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -168.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.37 -32.92 73.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.796 0.838 . . . . 0.0 112.99 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.9 t -144.41 145.96 32.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.795 1.238 . . . . 0.0 112.377 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -60.18 -31.13 69.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.838 0.855 . . . . 0.0 111.638 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -59.69 -30.34 68.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.3 mm -72.36 -44.66 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 122.06 -0.4 . . . . 0.0 110.086 169.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.25 -41.33 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.639 0.654 . . . . 0.0 110.504 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -58.19 -51.37 70.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.291 0.636 . . . . 0.0 112.631 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.17 -46.38 88.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.639 1.176 . . . . 0.0 112.435 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.33 -46.87 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.806 1.642 . . . . 0.0 110.791 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.48 -38.52 91.46 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.622 0.769 . . . . 0.0 112.988 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -63.45 -19.46 64.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 73.4 mt -71.87 -33.71 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.28 -0.888 . . . . 0.0 111.464 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 65.08 -55.39 0.31 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.851 2.86 . . . . 0.0 115.179 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.359 46.3 m-85 -107.6 109.55 21.22 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -100.15 168.95 9.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.602 2.361 . . . . 0.0 111.353 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -132.45 118.41 19.28 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.362 -0.836 . . . . 0.0 111.889 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.91 127.95 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.787 1.235 . . . . 0.0 109.262 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.5 43.21 19.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.758 1.223 . . . . 0.0 112.939 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.301 0.7 OUTLIER 53.92 20.58 2.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.76 2.424 . . . . 0.0 116.352 -173.086 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -106.43 138.74 42.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.697 1.599 . . . . 0.0 110.24 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.1 mmm -80.7 133.56 35.71 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.896 0.878 . . . . 0.0 110.457 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.86 147.67 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.792 1.237 . . . . 0.0 112.84 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -97.35 124.63 41.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.225 1.01 . . . . 0.0 111.987 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.2 p -90.55 147.64 23.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.05 0.54 . . . . 0.0 111.426 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -143.34 151.02 39.98 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.927 1.291 . . . . 0.0 109.128 170.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.49 126.81 29.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.016 0.825 . . . . 0.0 109.149 168.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.66 141.67 36.25 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.435 0.636 . . . . 0.0 112.161 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -63.22 157.66 61.63 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.787 0.835 . . . . 0.0 111.085 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.27 -23.36 17.9 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.019 1.813 . . . . 0.0 113.214 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -162.6 -155.02 0.33 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.045 2.538 . . . . 0.0 107.783 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -74.82 28.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.944 2.098 . . . . 0.0 114.606 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.5 m -60.77 -12.47 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 95.4 mmm -66.24 -25.53 66.94 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.468 1.507 . . . . 0.0 112.327 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 t -153.77 85.8 3.96 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.701 1.2 . . . . 0.0 111.138 173.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.4 157.61 53.71 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.573 2.849 . . . . 0.0 113.36 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.0 t -149.5 162.02 40.96 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 168.24 -145.79 9.92 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.309 1.433 . . . . 0.0 112.446 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.0 m -68.33 -8.04 36.42 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -143.61 174.87 10.4 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.976 2.111 . . . . 0.0 111.045 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -60.46 163.35 5.34 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.752 1.221 . . . . 0.0 113.135 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.4 130.09 48.21 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 123.911 0.767 . . . . 0.0 113.287 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -157.49 161.79 38.87 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.004 1.722 . . . . 0.0 111.455 -176.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.247 1.819 . . . . 0.0 112.556 -177.222 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.127 2.927 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 0 O4'-C4'-C3' 108.893 2.424 . 0.113 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.939 0 O4'-C1'-N19 110.061 1.861 . 0.364 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.615 2.153 1 O4'-C1'-N19 115.453 7.253 . 0.062 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.329 0 O4'-C1'-N19 111.76 3.56 . 0.173 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.9 m 61.13 164.61 0.08 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.507 1.923 . . . . 0.0 115.282 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -76.67 37.51 0.18 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.117 1.767 . . . . 0.0 114.371 -174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 47.5 tpp -70.9 115.21 9.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.864 -1.148 . . . . 0.0 111.777 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -114.0 12.01 17.9 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -124.0 138.49 54.45 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.543 1.065 . . . . 0.0 113.027 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.5 pt -118.66 153.04 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.894 1.278 . . . . 0.0 111.537 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -88.54 139.46 30.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.783 2.433 . . . . 0.0 108.12 165.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.4 t -130.73 111.13 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.31 1.444 . . . . 0.0 109.809 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.58 17.6 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.536 1.065 . . . . 0.0 113.807 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.52 12.76 37.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.917 1.246 . . . . 0.0 114.534 -177.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.02 139.23 58.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.429 1.092 . . . . 0.0 110.876 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -66.85 142.12 57.44 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.868 -0.52 . . . . 0.0 110.029 169.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.92 -14.61 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -74.18 -21.7 59.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.303 1.441 . . . . 0.0 113.744 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -71.24 145.48 49.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.404 1.481 . . . . 0.0 112.448 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -118.59 159.36 23.72 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.897 1.279 . . . . 0.0 114.113 169.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.54 -34.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.269 1.427 . . . . 0.0 114.847 -173.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.57 -28.82 65.19 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.56 0.744 . . . . 0.0 112.942 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -64.88 -51.59 61.14 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 t -58.83 -44.81 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.148 0.979 . . . . 0.0 111.489 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -59.21 -48.01 83.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.929 0.492 . . . . 0.0 111.952 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -62.71 -40.08 96.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -58.57 -30.38 67.12 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.262 59.7 m-85 -88.42 -24.1 23.13 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.13 -14.07 22.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -59.19 -42.58 91.19 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 112.523 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -80.51 -32.98 36.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.06 172.87 35.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.39 1.948 . . . . 0.0 111.058 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.16 125.5 24.08 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.134 0.967 . . . . 0.0 112.391 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 38.3 t -97.66 128.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.516 1.527 . . . . 0.0 110.107 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -75.05 -50.68 15.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.973 1.309 . . . . 0.0 112.906 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -160.9 164.25 31.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.18 0.992 . . . . 0.0 110.471 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.62 154.56 39.88 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.546 1.539 . . . . 0.0 111.383 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -151.71 136.71 17.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.697 1.199 . . . . 0.0 111.67 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.75 146.83 34.28 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 111.396 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.25 78.48 8.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.287 1.035 . . . . 0.0 112.363 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.285 53.6 m-85 -64.26 134.5 54.85 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 176.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.32 121.19 14.26 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.592 1.157 . . . . 0.0 112.57 169.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.46 -16.05 53.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.097 1.359 . . . . 0.0 114.304 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -1.87 7.89 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 167.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.497 0.2 OUTLIER 70.33 31.81 2.97 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -177.264 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.83 -78.87 0.26 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.017 0.927 . . . . 0.0 113.364 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.69 166.46 20.0 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.097 2.559 . . . . 0.0 110.266 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 34.8 p80 -74.99 158.36 33.38 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -67.23 7.96 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.204 1.802 . . . . 0.0 115.751 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.84 65.73 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.581 1.086 . . . . 0.0 114.208 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -153.7 167.6 29.04 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.719 1.26 . . . . 0.0 111.21 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.78 -164.7 22.88 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.102 0.858 . . . . 0.0 113.41 170.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -120.89 150.58 40.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.104 1.762 . . . . 0.0 114.892 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.17 127.77 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.066 1.346 . . . . 0.0 111.159 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.66 136.34 48.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.432 1.893 . . . . 0.0 114.62 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -109.76 158.68 17.88 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.141 1.776 . . . . 0.0 115.643 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.32 -28.44 63.07 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.2 t -141.85 144.84 34.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.169 1.388 . . . . 0.0 112.459 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -60.58 -31.67 70.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 111.684 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.62 -31.46 70.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.75 -42.04 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 110.134 171.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.9 -43.19 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.834 0.743 . . . . 0.0 110.248 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -59.94 -47.15 86.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 173.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -58.67 -51.21 70.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.189 0.995 . . . . 0.0 112.466 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.0 t -64.19 -43.18 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.703 1.601 . . . . 0.0 110.809 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 46.7 t -70.23 -35.52 73.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -64.28 -26.58 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.923 -1.111 . . . . 0.0 113.781 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.5 mt -71.07 -39.43 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.844 0.858 . . . . 0.0 110.874 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 65.45 -43.15 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.973 2.909 . . . . 0.0 115.969 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.283 53.2 m-85 -111.69 123.36 50.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 174.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -129.52 159.84 35.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.502 1.521 . . . . 0.0 112.356 -169.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -106.41 127.08 53.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.129 0.972 . . . . 0.0 111.282 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.74 123.79 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.327 1.451 . . . . 0.0 108.998 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.58 37.48 16.28 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.279 1.032 . . . . 0.0 113.298 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.83 12.92 4.07 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 127.339 2.256 . . . . 0.0 115.7 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -97.86 145.57 26.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.082 1.753 . . . . 0.0 110.584 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.67 128.96 34.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.368 1.467 . . . . 0.0 110.205 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.39 147.31 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.702 1.201 . . . . 0.0 113.318 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -94.18 129.18 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.549 1.139 . . . . 0.0 110.187 171.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.85 126.58 54.14 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.754 1.222 . . . . 0.0 110.388 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -148.88 148.69 30.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.025 1.33 . . . . 0.0 111.296 -171.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.31 138.94 58.25 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.411 -0.806 . . . . 0.0 111.817 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.05 134.98 51.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -123.55 150.39 61.1 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.429 1.492 . . . . 0.0 111.365 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -57.08 149.04 65.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.391 2.727 . . . . 0.0 115.751 -171.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -58.55 -28.12 65.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.101 1.76 . . . . 0.0 113.778 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -70.56 -26.84 63.72 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.204 1.802 . . . . 0.0 113.565 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.3 m -114.0 4.54 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -172.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 27.2 mmt -122.55 113.13 18.88 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.448 1.899 . . . . 0.0 110.674 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.6 t -129.2 137.83 31.85 Favored Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 126.124 1.77 . . . . 0.0 111.282 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.46 -13.78 18.34 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.129 2.552 . . . . 0.0 113.209 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.422 0.2 OUTLIER 61.47 -21.11 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 119.132 3.012 . . . . 0.0 119.132 -176.298 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -165.01 141.52 7.11 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.055 1.788 . . . . 0.0 111.935 171.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.4 m -85.97 129.21 34.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.18 -27.57 48.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.183 0.993 . . . . 0.0 112.828 169.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.0 mtm105 -64.82 170.96 3.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.21 2.204 . . . . 0.0 112.864 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 89.37 27.44 22.73 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.014 0.816 . . . . 0.0 114.666 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.03 161.73 36.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.466 1.906 . . . . 0.0 112.32 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.08 1.752 . . . . 0.0 113.53 -175.862 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.671 0 O4'-C4'-C3' 108.587 2.205 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 0 O5'-C5'-C4' 113.915 2.654 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.819 0 C4'-C3'-C2' 99.563 -3.137 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.274 2 O4'-C1'-N19 112.564 4.364 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.054 2 O4'-C1'-N19 113.851 5.651 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 122.413 1.101 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -150.71 147.61 27.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.937 2.495 . . . . 0.0 109.797 -168.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -108.65 152.2 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.837 . . . . 0.0 111.307 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -85.41 144.54 27.95 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 164.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.71 110.34 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.44 1.496 . . . . 0.0 109.74 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.65 150.94 18.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.421 1.01 . . . . 0.0 113.908 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.62 15.52 54.68 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.316 0.96 . . . . 0.0 114.51 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.87 134.86 55.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.655 1.182 . . . . 0.0 111.66 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -62.47 148.69 44.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.299 0.639 . . . . 0.0 111.842 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t -58.73 -25.76 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.504 1.122 . . . . 0.0 113.885 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -74.26 -27.83 60.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.274 1.03 . . . . 0.0 112.476 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.4 m -72.75 127.38 32.38 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -94.42 165.76 12.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.48 -34.52 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -73.84 -37.43 64.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.403 0.681 . . . . 0.0 111.878 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -54.08 -46.08 71.93 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.851 0.75 . . . . 0.0 112.795 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.61 -48.53 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.624 1.17 . . . . 0.0 109.801 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -61.34 -42.98 99.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.027 0.931 . . . . 0.0 112.715 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -72.98 -28.8 62.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -69.11 -50.49 47.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.317 67.3 m-85 -65.83 -20.27 66.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -56.57 -18.03 10.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 170.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.63 -29.32 69.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.958 -1.089 . . . . 0.0 112.817 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -87.32 -34.55 18.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.005 0.922 . . . . 0.0 112.609 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.02 171.58 35.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.027 2.251 . . . . 0.0 110.576 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -66.67 133.47 50.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.709 0.766 . . . . 0.0 112.282 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.65 127.02 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.286 1.834 . . . . 0.0 109.296 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.84 -52.61 16.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -164.24 173.85 11.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.672 0.789 . . . . 0.0 110.011 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -138.59 157.33 46.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.197 1.399 . . . . 0.0 111.899 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptm -150.53 133.42 15.97 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.01 1.324 . . . . 0.0 111.049 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.36 150.61 25.07 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.563 -0.711 . . . . 0.0 110.622 169.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.1 mmm . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 121.166 0.508 . . . . 0.0 111.904 -173.171 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.3 p80 . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 21.23 0.07 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.491 2.316 . . . . 0.0 113.428 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.66 6.23 71.04 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.045 -1.66 . . . . 0.0 115.25 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.76 167.35 24.08 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.887 1.344 . . . . 0.0 110.13 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.19 -165.33 22.32 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.223 1.392 . . . . 0.0 112.676 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.56 152.23 50.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.191 1.796 . . . . 0.0 114.92 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.54 119.08 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.075 1.35 . . . . 0.0 112.058 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -89.11 144.76 25.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.502 1.921 . . . . 0.0 113.763 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -116.6 162.33 17.8 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.53 -40.9 76.62 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.829 -0.544 . . . . 0.0 111.137 168.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t -139.51 144.39 37.89 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.262 1.425 . . . . 0.0 112.406 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -65.5 -18.12 65.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.44 -32.63 71.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.9 mm -75.87 -41.75 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.751 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.27 -44.56 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.085 0.857 . . . . 0.0 109.888 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -60.82 -49.91 75.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 113.165 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.32 -45.44 80.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 0.0 112.531 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.35 -46.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.611 1.565 . . . . 0.0 111.225 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.5 m -66.2 -31.15 71.8 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -63.93 -31.38 72.55 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.151 1.38 . . . . 0.0 112.834 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.7 mt -68.82 -33.79 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.286 1.034 . . . . 0.0 111.319 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 65.19 -58.51 0.27 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 128.547 2.739 . . . . 0.0 114.884 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 46.1 m-85 -102.25 116.37 32.52 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 170.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -109.57 173.61 6.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.148 2.179 . . . . 0.0 110.709 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -140.84 123.22 15.88 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.07 -1.019 . . . . 0.0 112.505 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -137.38 133.01 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.987 1.715 . . . . 0.0 108.983 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 50.6 41.51 25.73 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.894 1.278 . . . . 0.0 114.025 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.15 24.7 14.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.049 1.74 . . . . 0.0 114.163 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -129.35 153.18 48.12 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.467 1.507 . . . . 0.0 110.713 169.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.8 mtp -94.47 144.47 25.54 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.39 144.97 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.426 1.491 . . . . 0.0 111.677 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -95.36 121.57 37.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.205 1.002 . . . . 0.0 110.646 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 72.6 m -105.89 131.07 53.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.334 1.053 . . . . 0.0 111.809 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.356 1.862 . . . . 0.0 110.14 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.49 135.07 57.64 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.82 1.191 . . . . 0.0 111.094 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 121.274 0.559 . . . . 0.0 110.871 175.944 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -105.15 133.65 49.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.349 1.06 . . . . 0.0 112.772 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.8 pt -112.46 154.58 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.205 1.402 . . . . 0.0 111.359 169.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.66 142.31 28.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.281 2.232 . . . . 0.0 107.843 165.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 t -133.56 110.43 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.135 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.06 153.85 16.68 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.459 1.028 . . . . 0.0 113.921 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.47 9.4 56.68 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.225 1.393 . . . . 0.0 115.249 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.0 mt -63.39 141.16 58.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.998 1.319 . . . . 0.0 110.931 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 t -66.85 142.98 57.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.972 -0.455 . . . . 0.0 110.838 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.79 -11.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -86.37 -13.36 46.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.807 1.243 . . . . 0.0 114.151 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.5 m -73.88 132.82 42.9 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.59 1.156 . . . . 0.0 111.676 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.88 161.63 17.38 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 175.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -60.29 -33.65 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 169.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -74.22 -34.25 63.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.697 0.799 . . . . 0.0 112.068 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -56.25 -46.05 79.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.081 0.855 . . . . 0.0 112.135 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.64 -47.92 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.077 0.951 . . . . 0.0 110.649 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.11 -47.28 86.54 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.66 0.664 . . . . 0.0 111.735 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -62.87 -38.82 92.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.196 0.998 . . . . 0.0 112.992 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -64.68 -51.0 64.8 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 57.0 m-85 -64.44 -21.24 66.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -66.61 0.02 2.55 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 170.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.49 -29.47 63.66 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.389 -1.444 . . . . 0.0 111.862 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -88.95 -21.13 23.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.13 -158.3 25.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.681 2.086 . . . . 0.0 110.49 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -97.95 147.52 24.39 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.484 1.142 . . . . 0.0 110.791 170.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.32 129.92 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.412 1.485 . . . . 0.0 109.302 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -71.08 -47.09 60.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.774 1.63 . . . . 0.0 114.738 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -162.69 161.07 26.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.156 0.983 . . . . 0.0 110.241 -173.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.34 153.72 40.85 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.566 1.546 . . . . 0.0 111.271 170.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -152.75 132.35 13.06 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.425 1.09 . . . . 0.0 111.794 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.0 mt -103.98 146.97 27.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.71 0.804 . . . . 0.0 110.752 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.87 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.7 p80 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -68.69 5.94 0.96 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.59 18.62 67.95 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.751 -1.218 . . . . 0.0 114.286 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.2 161.66 38.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.289 1.045 . . . . 0.0 112.48 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.85 27.08 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.632 0.634 . . . . 0.0 113.451 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.61 150.63 39.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.235 1.814 . . . . 0.0 114.343 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.72 127.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.421 1.488 . . . . 0.0 111.527 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -110.26 125.92 53.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.321 1.449 . . . . 0.0 114.394 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -91.48 162.09 14.7 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -170.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -60.7 -45.41 94.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.246 1.018 . . . . 0.0 111.605 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -136.73 142.66 43.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.572 1.549 . . . . 0.0 111.612 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.04 -24.67 67.79 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.509 1.124 . . . . 0.0 112.039 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.01 -28.9 70.42 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 172.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.7 -42.48 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 121.954 -0.467 . . . . 0.0 110.539 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.09 -41.29 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.236 0.614 . . . . 0.0 110.359 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.47 -47.23 82.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.985 0.514 . . . . 0.0 112.364 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -64.35 -45.97 85.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.307 1.043 . . . . 0.0 112.157 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.26 -41.33 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.144 1.377 . . . . 0.0 111.405 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.31 -33.92 70.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.983 0.913 . . . . 0.0 112.716 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -26.94 68.03 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.8 mt -67.32 -36.62 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.421 -0.799 . . . . 0.0 110.313 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 65.19 -60.27 0.25 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 128.826 2.85 . . . . 0.0 114.233 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 64.9 m-85 -100.03 123.51 44.36 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -124.17 176.01 6.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.741 2.416 . . . . 0.0 110.124 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -139.6 129.24 24.48 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.426 -1.421 . . . . 0.0 112.783 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 39.5 mt -138.15 131.99 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.296 1.438 . . . . 0.0 109.278 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.7 41.17 25.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.177 1.391 . . . . 0.0 114.543 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.3 t30 60.55 33.19 20.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.032 1.733 . . . . 0.0 113.794 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -133.97 143.62 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.05 1.74 . . . . 0.0 111.456 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 7.2 ttm -85.17 133.58 34.19 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.785 0.834 . . . . 0.0 110.723 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.32 156.72 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.571 1.548 . . . . 0.0 112.787 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -118.42 112.3 19.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.812 0.845 . . . . 0.0 112.097 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 t -78.72 131.21 36.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.785 0.834 . . . . 0.0 111.458 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -150.18 146.77 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.927 1.691 . . . . 0.0 110.709 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.79 135.15 55.47 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.448 -0.783 . . . . 0.0 112.493 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.076 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.15 137.91 43.2 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.475 -1.391 . . . . 0.0 112.667 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.8 pt -123.58 148.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.94 1.296 . . . . 0.0 112.456 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -85.96 139.49 31.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.919 2.088 . . . . 0.0 109.908 164.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.1 t -127.32 113.66 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.945 1.298 . . . . 0.0 109.521 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.09 154.12 16.6 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.8 1.191 . . . . 0.0 114.115 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.88 13.31 75.3 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.458 1.028 . . . . 0.0 114.506 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.06 144.17 46.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -65.61 139.74 58.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.23 -13.04 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.877 . . . . 0.0 112.528 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -22.09 27.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.63 1.172 . . . . 0.0 111.954 171.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 82.9 m -75.44 139.95 42.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.88 1.272 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -114.8 163.85 14.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.405 1.482 . . . . 0.0 114.745 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.7 p -54.47 -36.65 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.37 -30.49 69.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.557 0.743 . . . . 0.0 112.619 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.59 -47.29 67.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.89 -42.54 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.46 0.704 . . . . 0.0 111.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -60.76 -48.16 83.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.545 0.738 . . . . 0.0 112.051 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -60.54 -39.08 86.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.444 1.098 . . . . 0.0 113.679 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -68.07 -39.22 82.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 47.9 m-85 -81.21 -24.9 37.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.513 2.783 . . . . 0.0 118.513 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -57.72 -29.25 64.58 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.62 -26.03 68.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.367 1.467 . . . . 0.0 112.712 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -75.22 -20.78 59.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 116.436 2.014 . . . . 0.0 116.436 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.54 -93.6 0.09 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.033 1.302 . . . . 0.0 111.439 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -157.65 137.53 12.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.312 1.445 . . . . 0.0 111.809 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.1 136.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.409 1.484 . . . . 0.0 108.457 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -92.64 -30.71 15.45 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -162.23 153.84 18.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.283 1.033 . . . . 0.0 110.273 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.51 152.78 44.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.005 1.322 . . . . 0.0 111.757 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.8 ptm -154.21 134.89 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.013 1.325 . . . . 0.0 112.004 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.4 mt -109.46 145.12 36.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.178 0.991 . . . . 0.0 111.26 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 47.7 mmm . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.018 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.0 p80 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.642 0.734 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -70.89 15.01 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.319 1.848 . . . . 0.0 115.246 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.9 12.6 82.49 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.431 1.015 . . . . 0.0 114.494 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -152.09 167.8 27.31 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.607 1.204 . . . . 0.0 110.457 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.84 27.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.383 1.468 . . . . 0.0 113.182 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.93 149.62 48.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.349 1.86 . . . . 0.0 115.256 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.7 t -135.77 130.61 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 111.404 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.8 m -107.83 138.17 44.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.548 1.939 . . . . 0.0 113.203 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.89 157.95 18.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -67.17 -32.09 72.95 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.437 0.695 . . . . 0.0 112.477 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.0 t -146.24 143.52 29.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.797 1.239 . . . . 0.0 112.428 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.82 -17.55 64.55 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.93 -24.94 67.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.7 mm -78.24 -45.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.4 -44.55 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.592 0.757 . . . . 0.0 110.935 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.0 -37.06 86.05 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.857 0.753 . . . . 0.0 112.564 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -67.84 -47.56 68.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.697 1.199 . . . . 0.0 111.73 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.97 -47.01 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.984 1.314 . . . . 0.0 110.525 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.4 t -69.19 -32.83 72.39 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.704 0.802 . . . . 0.0 112.116 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.74 -30.27 71.28 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.77 1.228 . . . . 0.0 113.296 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 69.0 mt -64.98 -33.52 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.647 0.779 . . . . 0.0 111.099 171.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 66.84 -56.22 0.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.69 2.796 . . . . 0.0 114.93 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.279 63.3 m-85 -106.57 125.25 50.77 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -125.21 161.53 26.7 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.903 1.681 . . . . 0.0 111.3 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -109.58 135.15 51.02 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.372 1.069 . . . . 0.0 111.49 172.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.5 mt -141.93 124.76 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.362 1.865 . . . . 0.0 108.509 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 51.06 34.66 11.27 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.316 1.046 . . . . 0.0 113.425 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.275 3.6 m120 63.62 3.88 1.65 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.683 2.393 . . . . 0.0 116.298 -172.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -86.71 142.3 28.28 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.416 1.486 . . . . 0.0 108.821 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 29.2 ttm -88.82 135.93 33.27 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.578 -0.701 . . . . 0.0 111.201 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.66 158.89 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.143 1.777 . . . . 0.0 112.329 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -110.54 133.04 53.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.43 1.092 . . . . 0.0 111.428 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -97.73 145.76 26.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.019 0.928 . . . . 0.0 112.204 168.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -143.37 152.1 41.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.044 1.738 . . . . 0.0 108.843 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.76 136.43 56.92 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.334 1.425 . . . . 0.0 110.818 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -171.515 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -130.59 137.55 49.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.626 1.17 . . . . 0.0 112.436 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 pt -113.24 152.68 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 111.024 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -86.04 144.04 27.78 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -127.04 106.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.556 1.542 . . . . 0.0 109.279 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -107.1 150.84 16.83 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.988 1.28 . . . . 0.0 114.225 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.79 65.57 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.376 0.988 . . . . 0.0 114.569 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.19 137.78 57.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.489 1.116 . . . . 0.0 111.391 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.8 t -69.35 142.42 54.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.751 0.82 . . . . 0.0 111.641 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 p -61.21 -17.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -73.02 -29.03 62.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.937 0.895 . . . . 0.0 112.331 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.4 m -73.12 137.15 45.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.587 1.555 . . . . 0.0 112.927 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t -112.11 161.99 15.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.05 1.34 . . . . 0.0 114.41 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.89 -34.92 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.4 -31.13 69.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.574 0.75 . . . . 0.0 112.837 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -66.41 -43.54 85.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.895 0.77 . . . . 0.0 109.425 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -45.73 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.614 1.165 . . . . 0.0 111.564 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.92 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.717 0.807 . . . . 0.0 111.776 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -57.52 -41.57 81.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.954 0.901 . . . . 0.0 112.942 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.87 -46.92 73.48 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -70.92 -23.72 62.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -59.68 -29.91 68.4 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 171.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -64.24 -26.9 68.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.934 0.894 . . . . 0.0 112.906 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -72.76 -26.67 61.64 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -175.89 -94.21 0.09 OUTLIER Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.04 1.305 . . . . 0.0 112.006 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -157.29 133.6 9.72 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.437 1.495 . . . . 0.0 111.667 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.51 134.91 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.351 1.46 . . . . 0.0 108.666 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.9 -44.74 17.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.992 1.317 . . . . 0.0 113.915 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -161.9 160.76 28.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.09 1.356 . . . . 0.0 109.915 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.05 148.88 39.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.184 1.394 . . . . 0.0 111.707 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -153.3 132.47 12.67 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 112.53 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.57 145.94 25.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.691 0.796 . . . . 0.0 110.042 169.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.47 0.559 0 O-C-N 122.118 -0.364 . . . . 0.0 110.049 -178.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 p80 . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 121.283 0.563 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -76.2 8.06 3.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.369 2.267 . . . . 0.0 114.695 -169.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.16 6.1 84.91 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.992 1.282 . . . . 0.0 114.46 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.33 168.56 26.68 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.413 1.106 . . . . 0.0 111.218 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.37 -167.73 23.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.808 1.194 . . . . 0.0 113.337 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.8 149.99 50.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.27 1.828 . . . . 0.0 114.77 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -136.76 123.05 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.918 1.287 . . . . 0.0 111.609 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.06 148.94 21.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.829 2.052 . . . . 0.0 114.168 175.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.9 155.63 35.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -66.1 -36.38 83.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.209 0.604 . . . . 0.0 112.201 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -141.25 144.25 34.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.053 1.341 . . . . 0.0 112.485 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -64.5 -20.7 66.36 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.39 0.676 . . . . 0.0 112.557 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -61.78 -33.72 74.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mm -72.5 -40.62 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.008 -0.433 . . . . 0.0 110.434 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.4 t -57.14 -43.8 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.073 0.851 . . . . 0.0 110.288 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -60.66 -48.43 81.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.328 0.651 . . . . 0.0 112.699 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.01 -47.55 80.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.321 1.448 . . . . 0.0 112.703 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.67 -43.5 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.916 1.686 . . . . 0.0 111.159 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.63 -35.75 79.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 112.482 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.15 -29.34 70.28 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.041 1.336 . . . . 0.0 113.161 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.83 -35.13 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.272 1.029 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 65.75 -55.04 0.36 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.739 2.816 . . . . 0.0 115.238 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.314 59.9 m-85 -105.93 124.55 49.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -126.61 171.18 11.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.205 2.202 . . . . 0.0 110.734 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -137.65 132.48 33.02 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.828 -1.17 . . . . 0.0 112.919 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mt -140.99 127.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.509 1.523 . . . . 0.0 108.762 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 50.9 38.81 21.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.65 1.18 . . . . 0.0 113.746 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.05 -0.66 1.01 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.465 2.306 . . . . 0.0 116.195 -173.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -85.31 131.1 34.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.843 1.257 . . . . 0.0 109.631 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.3 ttm -80.17 132.97 36.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.164 0.586 . . . . 0.0 110.196 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.64 159.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.78 1.632 . . . . 0.0 111.806 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -114.96 126.22 54.52 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.268 1.027 . . . . 0.0 111.639 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.1 p -87.17 147.8 25.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.389 0.614 . . . . 0.0 111.605 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -143.49 151.78 40.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.387 1.475 . . . . 0.0 108.169 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.24 132.74 48.37 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.913 1.233 . . . . 0.0 109.922 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-N 118.089 0.404 . . . . 0.0 110.603 177.779 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt . . . . . 0 CA--C 1.553 1.067 0 CA-C-O 121.707 0.765 . . . . 0.0 113.019 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -149.69 147.15 27.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.214 2.206 . . . . 0.0 110.024 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.8 pt -123.54 152.35 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.45 1.1 . . . . 0.0 111.91 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -87.8 140.93 29.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.749 2.02 . . . . 0.0 105.849 164.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.9 110.11 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.195 1.398 . . . . 0.0 110.038 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.15 147.65 18.2 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.958 1.266 . . . . 0.0 114.475 -172.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.19 14.55 58.78 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.784 1.183 . . . . 0.0 114.671 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.79 135.01 57.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.734 1.267 . . . . 0.0 110.321 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 150.79 48.69 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.275 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.01 -20.89 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.16 -27.49 42.73 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.899 1.28 . . . . 0.0 113.664 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 83.2 m -68.93 138.84 54.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.454 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 2.1 t -118.13 165.29 13.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.63 -34.75 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.76 -30.04 66.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 112.625 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.11 -47.37 71.35 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.02 -45.57 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.817 0.847 . . . . 0.0 110.144 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.72 -48.79 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.627 0.771 . . . . 0.0 111.937 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -59.33 -50.34 74.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.978 0.911 . . . . 0.0 113.035 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.25 26.4 m-85 -59.81 -31.91 70.15 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.342 51.3 m-85 -85.25 -24.28 27.86 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -63.95 -20.2 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -62.81 -34.64 77.72 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.071 0.948 . . . . 0.0 111.948 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -74.94 -25.67 59.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.67 -94.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.709 1.147 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -154.87 136.16 14.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.072 1.349 . . . . 0.0 112.239 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -87.31 137.18 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.593 1.557 . . . . 0.0 108.847 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.87 -46.32 12.28 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.019 1.328 . . . . 0.0 113.056 169.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -160.57 155.17 23.75 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.983 1.313 . . . . 0.0 109.929 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.97 47.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.538 1.535 . . . . 0.0 111.461 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -154.12 127.83 8.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.168 0.987 . . . . 0.0 113.014 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.6 mt -88.24 143.96 26.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.749 0.82 . . . . 0.0 110.929 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 36.6 mmt . . . . . 0 N--CA 1.473 0.716 0 C-N-CA 123.374 0.669 . . . . 0.0 112.207 -179.813 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.8 p80 . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.317 0.58 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -77.2 10.92 2.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.356 1.862 . . . . 0.0 115.044 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.8 79.56 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 121.281 -0.887 . . . . 0.0 114.121 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -152.3 165.49 34.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.742 1.271 . . . . 0.0 110.317 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.64 176.7 37.26 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.022 0.82 . . . . 0.0 113.829 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.38 146.59 28.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.19 116.09 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.882 1.273 . . . . 0.0 111.779 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -89.25 144.34 26.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.777 1.631 . . . . 0.0 113.001 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.54 163.44 14.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -69.58 -40.37 76.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.274 0.63 . . . . 0.0 111.849 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.6 t -140.33 145.42 37.15 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.172 1.389 . . . . 0.0 112.861 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.69 -25.99 68.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.709 1.203 . . . . 0.0 111.897 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.71 -35.9 79.38 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.27 -42.41 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.22 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.4 t -54.55 -45.67 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.657 0.662 . . . . 0.0 110.301 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.34 -39.03 74.95 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.82 -48.3 75.67 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.624 1.102 . . . . 0.0 111.685 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.13 -49.45 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.104 1.762 . . . . 0.0 110.797 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 33.1 m -66.54 -30.52 70.85 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -67.99 -25.68 65.53 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.555 1.07 . . . . 0.0 113.587 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 70.2 mt -71.28 -32.9 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.77 0.828 . . . . 0.0 111.079 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 65.36 -59.65 0.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 128.5 2.72 . . . . 0.0 114.923 173.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 47.3 m-85 -100.41 123.12 44.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 171.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -121.04 147.32 45.68 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.676 1.59 . . . . 0.0 112.232 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -95.25 124.5 39.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.897 0.879 . . . . 0.0 110.738 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.67 129.38 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.828 1.651 . . . . 0.0 108.715 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 50.54 35.51 11.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.194 0.998 . . . . 0.0 113.223 -173.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 28.3 m120 59.37 26.46 15.34 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.595 1.958 . . . . 0.0 115.758 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -125.81 148.06 49.24 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.151 1.78 . . . . 0.0 110.223 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.9 mmm -90.75 134.37 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.837 0.855 . . . . 0.0 112.408 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.16 153.68 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.439 1.496 . . . . 0.0 112.245 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -102.06 122.05 43.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.306 1.043 . . . . 0.0 112.107 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 74.0 m -98.31 135.6 39.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.402 1.081 . . . . 0.0 112.318 173.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -140.04 145.83 38.23 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.724 1.609 . . . . 0.0 110.769 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.46 137.77 57.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.889 1.222 . . . . 0.0 111.06 171.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.796 0 CA-C-O 121.733 0.777 . . . . 0.0 113.091 -174.558 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.476 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 83.2 tttt -107.36 138.11 44.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.108 1.363 . . . . 0.0 112.082 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.0 pt -123.39 151.78 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.225 1.41 . . . . 0.0 111.826 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -87.18 143.66 27.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.594 1.958 . . . . 0.0 108.064 165.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.72 125.98 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.834 1.653 . . . . 0.0 109.995 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.56 156.79 23.77 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.057 0.844 . . . . 0.0 114.48 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.89 10.5 58.72 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.712 1.149 . . . . 0.0 114.373 -174.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.3 mt -66.2 140.2 58.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.351 1.46 . . . . 0.0 111.327 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.8 p -75.23 152.15 38.35 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.757 -0.589 . . . . 0.0 111.372 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -65.92 -16.72 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -73.65 -34.81 65.12 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.651 1.18 . . . . 0.0 112.168 169.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.0 m -67.09 136.36 55.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.165 0.986 . . . . 0.0 111.698 173.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.0 163.79 16.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 p -53.65 -36.2 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.45 -31.26 68.35 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.34 -43.63 90.33 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.884 0.765 . . . . 0.0 109.078 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.15 -47.77 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.485 1.114 . . . . 0.0 111.141 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -60.36 -50.07 75.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.45 0.7 . . . . 0.0 112.07 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -61.43 -38.37 86.88 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.56 0.744 . . . . 0.0 112.964 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.58 -46.99 80.38 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.297 47.2 m-85 -67.83 -27.09 66.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -58.71 -19.5 40.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -61.93 -45.16 94.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.873 1.269 . . . . 0.0 112.881 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.01 -38.13 82.24 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.619 1.168 . . . . 0.0 112.802 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.44 158.64 14.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.2 2.333 . . . . 0.0 110.226 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.16 138.11 57.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.636 1.208 . . . . 0.0 112.885 -168.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.5 t -97.63 136.64 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.882 2.073 . . . . 0.0 109.222 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -78.89 -49.72 12.4 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.697 1.599 . . . . 0.0 112.471 173.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -159.3 159.94 34.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.335 1.054 . . . . 0.0 110.498 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.95 151.19 36.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.556 1.542 . . . . 0.0 111.464 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -153.94 133.73 13.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.468 1.107 . . . . 0.0 112.231 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.1 mt -102.41 143.23 32.41 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.083 0.953 . . . . 0.0 111.201 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.4 mmt . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.185 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.7 p80 . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 121.409 0.623 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -75.28 16.1 0.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.83 1.652 . . . . 0.0 114.825 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.47 13.11 83.89 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.462 1.029 . . . . 0.0 114.405 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -147.47 162.71 38.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.998 1.399 . . . . 0.0 111.594 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.85 -168.32 30.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.446 1.498 . . . . 0.0 113.538 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.0 m-85 -125.03 151.02 46.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.153 1.781 . . . . 0.0 115.124 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.8 t -137.0 134.17 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.497 1.519 . . . . 0.0 110.414 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -114.89 134.42 55.16 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.69 1.596 . . . . 0.0 114.087 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -103.51 159.79 15.28 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.961 1.704 . . . . 0.0 115.471 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -72.46 -29.02 63.29 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.0 t -139.76 145.3 38.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.473 1.109 . . . . 0.0 112.867 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -62.5 -28.65 69.98 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.181 0.993 . . . . 0.0 111.782 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.92 -31.73 72.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.5 -43.2 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 119.228 -0.415 . . . . 0.0 109.977 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.73 -42.39 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 118.636 0.653 . . . . 0.0 110.577 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.0 -48.5 81.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.755 0.707 . . . . 0.0 112.668 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -58.19 -44.85 88.28 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.526 1.13 . . . . 0.0 112.118 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.65 -48.1 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.024 1.729 . . . . 0.0 111.019 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.23 -34.17 77.49 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.51 -21.47 66.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.6 mt -74.81 -30.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.099 0.96 . . . . 0.0 111.703 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 64.61 -62.21 0.19 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.297 2.639 . . . . 0.0 114.609 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 47.6 m-85 -101.5 120.2 39.93 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -115.66 154.72 29.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 111.747 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -112.85 108.28 17.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.585 0.754 . . . . 0.0 111.996 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.31 123.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.554 1.141 . . . . 0.0 109.467 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 51.17 37.01 17.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.075 0.95 . . . . 0.0 113.031 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 61.99 4.25 1.12 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 127.291 2.236 . . . . 0.0 115.646 -170.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -83.82 140.91 31.73 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.64 128.49 34.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 110.547 171.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.81 150.77 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 112.497 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -104.98 123.83 48.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.869 1.267 . . . . 0.0 111.327 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -89.66 147.95 23.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.676 0.791 . . . . 0.0 111.896 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -147.08 151.09 36.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.733 1.613 . . . . 0.0 108.786 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -64.56 135.18 55.73 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.051 1.296 . . . . 0.0 110.739 168.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.436 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -118.03 143.53 46.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.902 1.281 . . . . 0.0 112.066 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.04 149.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.662 1.185 . . . . 0.0 110.51 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -86.63 141.75 28.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.744 2.018 . . . . 0.0 106.945 166.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.95 118.26 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.695 1.598 . . . . 0.0 109.529 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.69 146.69 16.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.139 0.876 . . . . 0.0 113.764 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.18 19.44 33.3 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.592 1.092 . . . . 0.0 114.493 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 mt -70.4 134.7 48.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 112.122 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.5 t -64.04 141.99 58.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.894 -0.504 . . . . 0.0 111.637 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 p -62.83 -16.87 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.44 -32.66 66.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.821 0.848 . . . . 0.0 112.071 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 m -69.29 135.43 50.45 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.552 1.541 . . . . 0.0 113.132 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -111.73 164.46 13.02 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.169 1.388 . . . . 0.0 114.598 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.35 -36.83 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.7 -33.89 75.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 112.417 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.98 -48.6 75.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.79 -43.2 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.376 0.671 . . . . 0.0 111.485 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.19 -50.64 72.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.801 0.84 . . . . 0.0 112.036 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.46 -38.76 92.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.13 -48.14 79.77 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 52.4 m-85 -69.18 -24.35 64.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -61.79 -14.23 30.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.85 -27.94 69.21 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.576 1.08 . . . . 0.0 112.4 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -85.54 -30.31 23.49 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.397 1.079 . . . . 0.0 113.647 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.55 173.05 32.77 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.917 2.199 . . . . 0.0 111.026 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.13 131.71 45.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.266 1.031 . . . . 0.0 113.011 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -99.27 133.67 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.63 1.972 . . . . 0.0 108.211 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.64 -48.67 16.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.172 1.389 . . . . 0.0 113.507 174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.43 163.4 27.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.483 1.113 . . . . 0.0 110.153 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.86 151.84 40.4 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.447 1.499 . . . . 0.0 111.553 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -153.77 134.18 13.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.198 0.999 . . . . 0.0 112.317 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.88 0.872 . . . . 0.0 110.556 172.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.4 mmt . . . . . 0 N--CA 1.47 0.572 0 C-N-CA 122.771 0.428 . . . . 0.0 111.358 179.762 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.4 p80 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.194 0.521 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -78.69 8.62 5.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.531 1.532 . . . . 0.0 114.872 -171.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.36 15.13 81.72 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.512 -0.742 . . . . 0.0 114.276 -174.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.76 163.68 38.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.444 1.116 . . . . 0.0 109.478 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.37 -162.81 24.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.988 1.28 . . . . 0.0 113.166 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.8 151.56 51.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.941 1.696 . . . . 0.0 115.241 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.66 123.74 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.243 1.417 . . . . 0.0 111.385 171.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -98.09 140.17 32.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.104 1.762 . . . . 0.0 114.066 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -111.84 151.77 28.69 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.047 1.339 . . . . 0.0 114.043 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -76.7 -40.57 48.35 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.0 t -110.73 135.21 51.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.327 1.051 . . . . 0.0 111.775 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.27 -23.67 66.44 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.196 0.998 . . . . 0.0 112.213 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.02 -31.48 71.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.4 mm -69.53 -38.21 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.843 -0.536 . . . . 0.0 110.574 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.05 -43.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 118.614 0.643 . . . . 0.0 110.883 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -64.01 -49.16 73.53 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.905 0.882 . . . . 0.0 112.232 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.75 -45.15 78.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.617 1.567 . . . . 0.0 112.587 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.48 -49.43 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.731 1.612 . . . . 0.0 110.918 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.84 -32.74 74.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.1 0.56 . . . . 0.0 112.462 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.47 -28.81 68.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.227 1.411 . . . . 0.0 113.453 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.05 -30.6 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.431 1.092 . . . . 0.0 111.78 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 66.65 -51.15 0.45 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.863 2.865 . . . . 0.0 115.77 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.31 39.2 m-85 -112.92 124.22 52.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -123.13 153.83 39.47 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.124 1.77 . . . . 0.0 111.271 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -105.71 128.81 53.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.184 0.994 . . . . 0.0 110.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.2 mt -139.4 123.76 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.733 1.613 . . . . 0.0 108.758 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 50.46 35.07 10.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.015 0.926 . . . . 0.0 113.358 -174.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.6 m120 63.17 1.58 0.93 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.596 2.358 . . . . 0.0 116.957 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -83.47 142.52 30.88 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.166 1.387 . . . . 0.0 109.416 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 94.2 mmm -86.52 137.27 32.66 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.753 -0.592 . . . . 0.0 111.094 172.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.06 150.55 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.25 1.42 . . . . 0.0 111.771 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.99 130.8 45.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.622 0.769 . . . . 0.0 111.282 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.39 139.19 31.42 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.361 0.664 . . . . 0.0 110.797 167.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -136.92 154.22 50.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.266 1.426 . . . . 0.0 108.653 170.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.7 137.05 57.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.723 1.147 . . . . 0.0 110.276 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 0.0 111.673 -175.285 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 91.1 mttt . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -137.78 139.04 39.83 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.89 -1.131 . . . . 0.0 112.159 -173.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 pt -117.24 151.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.81 1.244 . . . . 0.0 111.593 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -89.75 136.83 32.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.35 2.66 . . . . 0.0 108.119 165.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.54 110.3 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.415 . . . . 0.0 110.136 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.8 142.78 17.07 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.255 0.931 . . . . 0.0 114.366 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.3 13.5 28.46 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.487 1.518 . . . . 0.0 115.027 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.72 151.43 42.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.264 1.426 . . . . 0.0 112.478 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.4 t -68.81 139.83 55.26 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.052 -0.405 . . . . 0.0 110.453 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.4 -14.44 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.538 0.735 . . . . 0.0 112.331 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.64 -19.55 35.22 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.914 1.285 . . . . 0.0 113.11 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.9 m -69.37 134.37 48.96 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.806 1.242 . . . . 0.0 111.759 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.5 t -102.28 157.97 16.52 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.39 -33.67 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.223 1.409 . . . . 0.0 114.608 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -71.35 -29.58 65.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.69 -43.89 95.3 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.162 0.892 . . . . 0.0 109.466 172.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.54 -47.62 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.109 1.364 . . . . 0.0 110.96 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -60.99 -45.25 95.59 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.845 -0.534 . . . . 0.0 112.057 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -60.34 -43.71 96.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 112.273 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.01 -43.88 97.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 61.5 m-85 -72.54 -27.49 62.26 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -62.01 -14.75 38.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.74 -44.64 96.52 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.689 1.196 . . . . 0.0 112.711 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.675 1.19 . . . . 0.0 113.769 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.87 164.82 24.22 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.004 2.24 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.83 134.13 56.78 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.224 1.012 . . . . 0.0 113.258 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.97 127.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.599 1.96 . . . . 0.0 109.228 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -72.5 -50.0 29.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.916 1.287 . . . . 0.0 112.875 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -160.09 160.45 33.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.487 1.115 . . . . 0.0 109.91 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.6 153.67 42.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.473 1.509 . . . . 0.0 111.115 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -153.16 133.89 13.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.408 1.083 . . . . 0.0 111.991 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 19.2 mt -102.25 142.76 32.97 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.135 0.974 . . . . 0.0 110.448 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.487 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 30.2 mmt . . . . . 0 N--CA 1.47 0.541 0 O-C-N 121.956 -0.465 . . . . 0.0 111.554 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.0 p80 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.284 0.564 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -70.24 7.8 0.92 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.953 1.701 . . . . 0.0 115.245 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.66 15.96 76.62 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.551 1.072 . . . . 0.0 114.41 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.487 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 35.4 p90 -152.18 164.58 37.04 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.795 1.298 . . . . 0.0 110.977 176.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.42 32.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.365 0.983 . . . . 0.0 113.871 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -120.13 147.7 44.55 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.132 1.773 . . . . 0.0 114.675 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.66 124.09 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.016 1.326 . . . . 0.0 111.366 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -105.34 137.62 42.84 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.531 1.933 . . . . 0.0 114.459 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.62 155.87 23.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -67.15 -34.58 77.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.839 0.855 . . . . 0.0 112.197 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.3 t -141.39 143.15 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.827 1.251 . . . . 0.0 112.517 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -66.37 -20.16 66.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.44 0.696 . . . . 0.0 112.597 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.34 -31.32 71.93 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mm -73.89 -42.55 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.116 170.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.34 -44.02 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.801 0.728 . . . . 0.0 109.858 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -59.82 -48.18 82.73 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -57.0 -49.48 75.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.145 0.978 . . . . 0.0 112.285 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.4 -43.26 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.826 1.65 . . . . 0.0 110.987 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.2 m -69.23 -32.47 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -67.21 -27.79 67.54 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.239 0.927 . . . . 0.0 113.322 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.91 -36.36 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.569 0.748 . . . . 0.0 110.688 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 66.42 -53.36 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.796 2.838 . . . . 0.0 115.07 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.317 59.0 m-85 -106.19 125.89 51.54 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -127.92 169.36 14.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.716 2.007 . . . . 0.0 111.074 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -131.03 130.58 43.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.244 -0.91 . . . . 0.0 112.51 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 56.8 mt -139.77 127.45 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.396 1.478 . . . . 0.0 108.969 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 49.53 43.04 23.7 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.001 1.321 . . . . 0.0 113.784 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 66.29 0.03 1.6 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.544 2.338 . . . . 0.0 116.459 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.61 143.68 26.08 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.664 1.12 . . . . 0.0 111.551 168.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 17.5 ttm -89.05 136.36 33.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.674 0.79 . . . . 0.0 111.029 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.42 149.04 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.502 1.521 . . . . 0.0 112.559 -176.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -95.24 128.25 41.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.864 0.866 . . . . 0.0 110.39 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.02 129.6 55.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.639 1.176 . . . . 0.0 111.012 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -152.21 153.12 33.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 0.0 111.715 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.78 133.66 56.31 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.119 0.872 . . . . 0.0 112.58 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.592 0 C-N-CA 123.186 0.595 . . . . 0.0 111.438 -179.319 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.4 mttt . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -145.75 133.75 21.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 111.305 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.19 151.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.381 1.086 . . . . 0.0 111.168 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.73 136.17 34.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.238 2.615 . . . . 0.0 106.939 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 t -126.13 116.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.863 1.265 . . . . 0.0 110.478 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.29 148.29 18.89 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.666 1.127 . . . . 0.0 114.1 -173.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.91 58.94 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.256 1.408 . . . . 0.0 114.49 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.1 mt -65.47 135.69 55.5 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.699 1.2 . . . . 0.0 111.66 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -64.58 142.72 58.33 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.84 -0.538 . . . . 0.0 112.03 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.78 -14.67 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.42 -31.56 63.92 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.71 0.804 . . . . 0.0 112.169 169.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -71.91 125.47 27.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.476 . . . . 0.0 113.625 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.15 166.13 16.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.8 -32.6 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -73.08 -35.5 66.66 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.017 0.927 . . . . 0.0 111.545 174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.91 -49.19 78.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.498 0.59 . . . . 0.0 112.016 169.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -48.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 109.929 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.64 -49.16 77.36 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.665 0.666 . . . . 0.0 111.967 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -60.66 -46.67 89.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 113.037 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.26 19.0 m-85 -64.72 -21.97 66.87 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.321 61.0 m-85 -92.94 -23.58 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -62.6 -18.43 62.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -63.52 -28.95 70.3 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.359 -0.838 . . . . 0.0 113.058 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -83.75 -27.0 29.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.37 175.37 31.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.072 2.272 . . . . 0.0 110.973 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.89 132.64 49.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.453 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.11 133.72 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.633 1.973 . . . . 0.0 107.73 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.63 -46.58 14.18 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.786 1.234 . . . . 0.0 113.773 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -162.71 162.7 26.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 109.836 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.42 153.51 46.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.726 1.61 . . . . 0.0 111.482 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.6 ptm -155.52 151.0 27.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.505 1.122 . . . . 0.0 112.425 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.4 mt -119.29 144.52 46.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.539 1.536 . . . . 0.0 110.381 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 28.9 mmm . . . . . 0 N--CA 1.47 0.531 0 C-N-CA 122.786 0.435 . . . . 0.0 110.751 -179.729 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.4 p80 . . . . . 0 CA--C 1.544 0.73 0 CA-C-O 121.086 0.469 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 8.56 8.6 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.366 2.266 . . . . 0.0 114.108 -172.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.81 13.16 59.71 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.022 -1.049 . . . . 0.0 115.034 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -152.25 163.26 39.78 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.139 1.47 . . . . 0.0 110.004 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.04 -170.84 28.5 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.834 1.207 . . . . 0.0 112.954 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.45 153.71 47.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.68 127.6 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.088 1.355 . . . . 0.0 111.948 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -99.92 145.8 27.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.297 1.839 . . . . 0.0 113.558 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.38 154.5 37.62 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -67.91 -34.97 77.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.367 0.667 . . . . 0.0 112.299 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.7 t -140.24 143.37 35.94 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.017 1.327 . . . . 0.0 111.984 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.44 -19.19 64.56 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.093 -0.379 . . . . 0.0 111.364 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.07 -31.12 70.79 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.81 -42.85 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.938 -0.476 . . . . 0.0 110.195 170.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.28 -43.61 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.74 0.7 . . . . 0.0 110.025 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.849 0.859 . . . . 0.0 112.763 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.91 -48.5 79.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.443 1.097 . . . . 0.0 112.353 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.16 -45.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.778 1.631 . . . . 0.0 110.825 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 48.4 t -70.1 -31.27 68.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.192 -0.942 . . . . 0.0 112.925 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.8 -32.55 74.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.803 1.241 . . . . 0.0 112.818 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.22 -34.18 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.9 0.88 . . . . 0.0 111.064 171.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 66.22 -58.91 0.34 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.628 2.771 . . . . 0.0 115.026 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 56.0 m-85 -100.97 121.74 42.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -118.86 168.74 10.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.136 1.774 . . . . 0.0 111.118 -175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -126.68 135.65 51.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.229 1.012 . . . . 0.0 111.699 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.7 mt -140.78 129.08 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.877 1.671 . . . . 0.0 108.746 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 51.24 37.93 19.89 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.417 1.087 . . . . 0.0 113.799 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 64.74 1.15 1.31 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.519 2.328 . . . . 0.0 116.292 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -88.91 133.6 34.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.52 1.128 . . . . 0.0 110.473 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 27.1 ttm -84.1 137.53 33.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.686 0.794 . . . . 0.0 110.71 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 154.66 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.039 1.736 . . . . 0.0 111.589 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -102.93 131.73 49.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.408 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 78.5 m -111.87 134.8 53.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.014 1.326 . . . . 0.0 111.57 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.89 157.73 43.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.02 1.728 . . . . 0.0 110.228 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.92 138.7 58.62 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.168 1.349 . . . . 0.0 112.038 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 123.347 0.659 . . . . 0.0 111.959 178.622 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.8 mttt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -129.28 139.12 51.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.612 1.165 . . . . 0.0 113.846 -167.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -121.02 149.59 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.911 1.284 . . . . 0.0 112.081 173.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -87.11 139.43 30.58 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.054 2.542 . . . . 0.0 108.725 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.24 115.0 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.249 1.42 . . . . 0.0 109.452 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.07 147.63 16.62 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.278 0.942 . . . . 0.0 114.324 -173.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.81 18.34 48.06 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.054 1.312 . . . . 0.0 114.574 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.5 mt -58.44 144.44 42.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.948 1.299 . . . . 0.0 112.218 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 t -64.77 142.55 58.39 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.087 -0.383 . . . . 0.0 110.512 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.98 -14.83 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.64 -29.91 63.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.215 1.006 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.5 m -70.51 136.91 49.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.348 1.459 . . . . 0.0 114.753 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -116.84 164.08 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.516 1.527 . . . . 0.0 114.251 169.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -54.25 -35.5 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.23 -30.79 67.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.35 -44.67 86.94 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.824 0.738 . . . . 0.0 109.257 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.3 -47.03 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.963 1.305 . . . . 0.0 110.612 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.42 -51.02 71.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.694 0.798 . . . . 0.0 111.881 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -58.79 -43.95 90.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.843 0.857 . . . . 0.0 112.662 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.97 -42.7 94.33 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.349 63.6 m-85 -71.32 -28.25 63.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -59.88 -21.79 61.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.04 -33.92 74.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 112.199 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -72.0 -38.56 69.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 170.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.32 165.12 25.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 126.722 2.106 . . . . 0.0 111.497 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.13 134.28 52.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.277 1.037 . . . . 0.0 113.693 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.13 134.02 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.824 2.049 . . . . 0.0 108.237 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.17 -45.56 19.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.294 1.438 . . . . 0.0 113.419 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -161.81 158.82 26.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.426 1.091 . . . . 0.0 110.456 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.15 149.01 40.95 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.871 1.668 . . . . 0.0 111.346 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -154.95 130.76 10.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 0.0 112.513 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.5 mt -101.81 141.17 35.08 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.975 0.91 . . . . 0.0 110.488 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 34.8 mmt . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 121.248 0.547 . . . . 0.0 112.137 -170.583 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.3 p80 . . . . . 0 N--CA 1.468 0.452 0 CA-C-O 121.532 0.682 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -70.93 13.12 0.21 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.75 12.36 80.09 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.153 0.882 . . . . 0.0 114.058 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -150.26 164.38 35.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.841 1.32 . . . . 0.0 110.837 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.55 -168.19 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.041 1.305 . . . . 0.0 113.417 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.89 149.3 50.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.271 1.828 . . . . 0.0 115.158 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.14 130.14 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.162 1.385 . . . . 0.0 111.563 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -108.09 140.99 40.46 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.058 1.743 . . . . 0.0 113.49 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.53 153.72 28.28 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -169.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.49 -34.83 70.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.526 0.73 . . . . 0.0 112.314 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.6 t -132.91 140.95 48.11 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.981 1.312 . . . . 0.0 112.15 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -65.11 -25.62 67.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.247 1.019 . . . . 0.0 111.781 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.5 mm -70.26 -40.78 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.002 -0.436 . . . . 0.0 110.325 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.69 -42.91 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.787 0.721 . . . . 0.0 110.842 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -63.23 -46.98 84.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.599 0.636 . . . . 0.0 112.586 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -56.64 -46.12 81.19 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.393 1.477 . . . . 0.0 112.602 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.84 -47.41 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.059 1.744 . . . . 0.0 110.876 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 67.4 m -66.12 -30.75 71.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.25 -31.0 72.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.897 1.279 . . . . 0.0 112.832 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.54 -33.37 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.363 1.065 . . . . 0.0 111.337 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 64.27 -59.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.611 2.764 . . . . 0.0 115.225 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.334 39.2 m-85 -99.05 119.85 38.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -114.83 170.32 8.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.729 2.012 . . . . 0.0 111.312 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.85 122.98 20.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.55 0.74 . . . . 0.0 112.331 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 34.1 mt -138.26 130.08 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.0 1.72 . . . . 0.0 108.954 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 50.73 47.19 24.89 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.886 1.274 . . . . 0.0 113.914 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.8 t30 59.09 30.63 20.47 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.927 1.691 . . . . 0.0 114.101 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -145.61 156.34 43.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.06 1.744 . . . . 0.0 110.38 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 50.3 mtp -105.48 148.82 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.3 147.15 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.566 1.547 . . . . 0.0 111.737 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -88.85 129.78 35.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.598 0.759 . . . . 0.0 110.305 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.65 132.05 55.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.354 1.062 . . . . 0.0 111.391 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -153.43 151.46 29.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.102 1.361 . . . . 0.0 112.073 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 130.35 45.15 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.608 0.763 . . . . 0.0 111.647 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -170.164 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.34 140.91 43.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.279 1.431 . . . . 0.0 111.125 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.8 pt -117.9 150.66 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.64 1.176 . . . . 0.0 110.925 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -86.23 142.83 28.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.055 2.142 . . . . 0.0 107.23 165.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.64 106.53 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.505 1.522 . . . . 0.0 109.722 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.1 141.58 15.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.521 1.058 . . . . 0.0 114.763 -170.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.33 17.54 58.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.783 1.183 . . . . 0.0 114.924 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.82 122.64 15.33 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.694 1.197 . . . . 0.0 110.394 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.3 t -62.84 140.89 58.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.785 0.434 . . . . 0.0 110.795 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.299 0.3 OUTLIER -66.35 -10.27 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -168.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -77.8 -19.19 55.44 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.659 1.184 . . . . 0.0 112.862 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.8 m -71.32 138.87 49.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.291 1.436 . . . . 0.0 112.24 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 t -113.81 162.93 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 173.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.61 -34.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.414 1.485 . . . . 0.0 114.252 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.56 -34.51 75.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.305 0.642 . . . . 0.0 112.279 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.86 -44.09 97.54 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.017 0.826 . . . . 0.0 109.503 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.15 -46.69 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 111.336 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.31 -50.6 73.35 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.059 0.944 . . . . 0.0 112.054 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -64.71 -34.85 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -63.85 -53.34 52.22 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 51.9 m-85 -65.02 -22.2 66.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -63.16 -12.99 31.78 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.31 -29.22 69.95 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.525 1.057 . . . . 0.0 112.546 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -86.18 -31.61 21.67 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.346 1.058 . . . . 0.0 112.82 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.31 168.49 28.57 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 127.729 2.585 . . . . 0.0 110.33 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.61 134.7 54.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.166 0.984 . . . . 0.0 112.082 -169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.0 t -97.63 134.08 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.034 1.733 . . . . 0.0 108.169 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.4 -45.73 15.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.792 1.237 . . . . 0.0 113.764 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -162.89 164.06 26.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.731 1.212 . . . . 0.0 109.866 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.76 153.27 43.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.276 1.43 . . . . 0.0 111.579 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptm -152.03 136.45 16.81 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.706 1.202 . . . . 0.0 111.618 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.1 mt -107.85 153.52 22.9 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.83 0.852 . . . . 0.0 110.303 168.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.8 mmm . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.924 0.869 . . . . 0.0 111.317 -176.065 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 p80 . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.243 0.544 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -67.33 2.42 1.69 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.13 68.37 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.432 1.015 . . . . 0.0 114.888 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -153.09 168.74 24.91 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.345 1.072 . . . . 0.0 110.139 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.94 -167.77 27.08 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.455 1.026 . . . . 0.0 113.085 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -126.7 150.12 49.19 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.085 1.754 . . . . 0.0 114.976 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.58 122.08 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.017 1.327 . . . . 0.0 111.153 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m -93.54 143.08 26.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.492 1.917 . . . . 0.0 113.78 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -115.41 155.69 26.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -66.95 -36.06 81.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.327 0.651 . . . . 0.0 111.608 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -142.95 141.83 31.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 0.0 112.837 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -61.5 -20.59 63.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.007 1.323 . . . . 0.0 113.004 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.9 -25.73 67.29 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.9 -40.86 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.749 -0.594 . . . . 0.0 110.193 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -58.01 -45.39 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 110.191 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -66.11 -35.78 81.41 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.832 0.742 . . . . 0.0 112.784 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.0 -46.29 85.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.586 1.555 . . . . 0.0 111.977 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.74 -47.61 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.608 1.563 . . . . 0.0 110.699 175.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.1 m -65.08 -30.71 71.68 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -64.9 -26.64 68.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.695 1.198 . . . . 0.0 113.402 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.47 -32.25 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.112 0.965 . . . . 0.0 111.119 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 67.69 -49.82 0.51 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.867 2.867 . . . . 0.0 115.488 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.33 49.2 m-85 -114.5 123.83 50.39 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -121.27 157.07 31.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.783 2.033 . . . . 0.0 110.885 -171.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -117.18 114.81 24.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.981 -174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 38.5 mt -131.33 125.39 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.51 1.124 . . . . 0.0 109.634 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 49.7 37.09 12.12 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.448 1.099 . . . . 0.0 112.971 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.251 33.7 m120 61.41 4.66 1.0 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.806 2.442 . . . . 0.0 116.864 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -86.61 138.81 31.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.473 1.109 . . . . 0.0 110.105 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.2 mmm -82.6 131.62 35.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.518 0.727 . . . . 0.0 110.537 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.04 148.22 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.099 1.359 . . . . 0.0 111.748 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -96.11 125.39 40.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.721 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -89.87 135.44 33.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.179 0.592 . . . . 0.0 110.801 168.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -142.09 149.79 40.35 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.01 1.324 . . . . 0.0 109.666 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -61.61 135.35 57.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.515 1.052 . . . . 0.0 110.522 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -132.64 138.13 47.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.843 1.257 . . . . 0.0 112.569 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.7 pt -117.26 149.82 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.783 1.233 . . . . 0.0 111.604 172.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -85.87 138.93 31.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.911 2.084 . . . . 0.0 108.257 163.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.86 108.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 109.609 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.07 147.43 17.78 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.4 9.98 58.58 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.647 1.117 . . . . 0.0 114.206 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.24 134.95 57.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.121 1.461 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.0 t -61.57 143.27 56.3 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.206 -0.309 . . . . 0.0 111.367 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -60.78 -18.43 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -75.42 -25.78 57.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.827 1.251 . . . . 0.0 113.295 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.8 m -70.94 134.16 46.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.221 1.408 . . . . 0.0 113.271 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -106.49 158.4 16.94 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.191 1.396 . . . . 0.0 113.613 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -56.54 -32.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.87 -30.02 67.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -65.17 -47.11 78.12 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.641 0.777 . . . . 0.0 111.459 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -60.77 -45.82 92.85 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.835 -0.541 . . . . 0.0 112.287 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -59.85 -44.27 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.116 0.871 . . . . 0.0 113.307 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -58.98 -33.94 71.26 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 55.9 m-85 -85.65 -24.97 26.85 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 174.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -60.82 -16.25 38.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -42.11 87.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 112.375 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -79.07 -29.66 43.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.91 -173.96 38.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.975 1.75 . . . . 0.0 111.949 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.11 107.34 3.62 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.638 -0.919 . . . . 0.0 112.645 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.07 130.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.308 1.443 . . . . 0.0 109.609 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.38 -57.38 3.9 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.12 0.968 . . . . 0.0 112.727 173.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -157.48 164.74 37.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.953 0.901 . . . . 0.0 110.467 -170.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.03 41.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.481 1.512 . . . . 0.0 111.404 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -154.44 129.71 9.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.182 0.993 . . . . 0.0 113.136 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.78 144.62 26.51 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.476 1.11 . . . . 0.0 111.209 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 32.6 mmt . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 122.065 0.936 . . . . 0.0 111.551 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.6 p80 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -73.75 11.09 0.91 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.6 13.89 83.02 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.112 -0.826 . . . . 0.0 114.367 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -145.2 161.78 38.7 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.215 1.507 . . . . 0.0 112.052 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.9 -179.19 34.53 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.868 1.223 . . . . 0.0 112.471 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -116.79 149.14 40.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.563 1.545 . . . . 0.0 114.922 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.0 124.17 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.87 1.268 . . . . 0.0 111.523 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.52 142.67 33.88 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.691 1.997 . . . . 0.0 114.068 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.13 149.79 40.45 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.0 113.998 -172.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.55 -40.93 48.34 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.03 -0.419 . . . . 0.0 111.721 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 12.9 m -110.71 132.05 54.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 112.144 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -63.18 -34.09 76.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.476 1.111 . . . . 0.0 112.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -58.76 -28.33 65.81 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.3 mm -70.9 -39.76 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.753 -0.592 . . . . 0.0 110.465 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.94 -42.18 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.569 0.622 . . . . 0.0 110.25 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.4 -47.71 80.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.629 0.772 . . . . 0.0 111.84 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -57.32 -50.59 72.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.664 1.186 . . . . 0.0 112.234 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.7 -45.0 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 111.062 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 35.2 t -71.21 -32.37 68.74 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.415 -0.803 . . . . 0.0 112.643 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.25 -32.71 74.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.61 1.164 . . . . 0.0 112.723 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.4 -35.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.982 0.913 . . . . 0.0 111.18 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 66.7 -51.84 0.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.525 2.73 . . . . 0.0 115.06 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.261 74.5 m-85 -108.71 125.84 52.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 176.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -132.24 155.87 47.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.407 1.483 . . . . 0.0 112.376 -169.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -107.96 127.6 53.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.228 1.011 . . . . 0.0 111.408 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 44.6 mt -137.05 124.36 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.737 1.615 . . . . 0.0 109.035 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.46 36.11 12.65 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.225 1.01 . . . . 0.0 113.223 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.82 6.19 1.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.609 2.363 . . . . 0.0 116.765 -171.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.02 143.96 26.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.001 1.721 . . . . 0.0 109.992 169.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 41.5 tpp -85.15 133.89 34.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.374 1.07 . . . . 0.0 110.876 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.83 152.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.871 1.669 . . . . 0.0 113.703 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -104.27 123.78 47.97 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.831 1.252 . . . . 0.0 110.591 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 83.7 m -104.88 130.94 52.93 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.063 1.345 . . . . 0.0 111.072 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -153.28 145.35 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.026 1.33 . . . . 0.0 111.582 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.42 137.31 57.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.15 0.886 . . . . 0.0 112.265 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 122.963 0.505 . . . . 0.0 112.258 -176.092 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HE2' ' CD1' ' A' ' 154' ' ' PHE . 85.1 tttt -115.72 139.66 49.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.219 1.407 . . . . 0.0 112.099 -169.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.2 pt -121.94 150.15 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.12 1.368 . . . . 0.0 111.202 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -84.3 145.84 28.06 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.924 2.09 . . . . 0.0 107.379 166.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.12 117.28 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.736 1.614 . . . . 0.0 110.153 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.0 149.73 17.34 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.356 0.979 . . . . 0.0 114.037 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.0 55.48 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 124.951 1.262 . . . . 0.0 114.913 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.6 mt -68.38 135.39 51.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.881 1.273 . . . . 0.0 111.508 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.9 p -69.48 151.1 46.46 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.341 -0.849 . . . . 0.0 111.849 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -65.17 -16.23 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -79.77 -28.55 40.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.609 1.164 . . . . 0.0 112.941 171.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.8 m -71.22 136.99 48.31 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.486 1.115 . . . . 0.0 110.763 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.02 163.35 17.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.86 -36.58 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -173.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.06 -35.81 80.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.518 0.727 . . . . 0.0 112.468 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.14 -47.76 75.96 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.38 -42.25 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.049 0.539 . . . . 0.0 111.844 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -59.35 -53.05 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.603 0.638 . . . . 0.0 111.803 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -60.11 -38.74 83.87 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.282 33.3 m-85 -66.22 -16.48 64.03 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 52.5 m-85 -99.37 -26.76 14.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.55 -22.3 43.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.575 1.55 . . . . 0.0 114.234 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -62.77 -29.46 70.71 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -83.45 -27.44 29.5 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.82 169.19 21.92 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.355 2.407 . . . . 0.0 110.491 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -61.61 132.17 52.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.077 0.942 . . . . 0.0 113.279 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.45 124.46 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.667 1.987 . . . . 0.0 109.342 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.04 -56.25 7.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -146.54 160.01 42.69 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.24 40.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.777 1.231 . . . . 0.0 110.466 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptm -153.49 124.63 7.44 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.748 1.219 . . . . 0.0 111.159 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.8 mt -103.62 153.37 20.69 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.595 0.758 . . . . 0.0 111.413 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.438 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 37.6 mmt . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 125.072 1.349 . . . . 0.0 113.502 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 p80 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -68.62 3.38 1.88 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.59 14.55 75.66 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.217 -0.927 . . . . 0.0 114.712 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 32.1 p90 -148.6 168.09 23.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.051 0.926 . . . . 0.0 110.441 174.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -172.57 -166.62 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.984 1.278 . . . . 0.0 113.189 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.452 ' CD1' ' HE2' ' A' ' 110' ' ' LYS . 94.6 m-85 -128.6 154.05 46.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 115.186 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.95 140.31 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.756 1.622 . . . . 0.0 110.854 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -123.05 136.89 55.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.848 2.059 . . . . 0.0 114.358 -174.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -110.87 156.65 20.85 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -168.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -63.97 -41.72 97.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.271 1.028 . . . . 0.0 112.302 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.4 t -137.78 143.04 40.89 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.624 1.17 . . . . 0.0 112.414 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -62.62 -26.29 68.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.299 1.04 . . . . 0.0 111.903 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.08 -32.92 71.4 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.51 -42.02 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.389 171.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.16 -43.52 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.843 0.747 . . . . 0.0 110.697 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.95 -47.99 80.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.395 0.678 . . . . 0.0 112.828 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.83 -47.07 81.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.734 1.213 . . . . 0.0 112.345 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.46 -48.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.705 1.602 . . . . 0.0 110.617 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.54 -34.73 78.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -61.66 -27.22 68.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.997 1.319 . . . . 0.0 113.652 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.41 -33.15 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 0.0 111.321 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 65.73 -53.22 0.37 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 128.886 2.875 . . . . 0.0 115.32 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 57.3 m-85 -108.14 122.2 46.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -123.67 151.04 43.51 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.359 1.464 . . . . 0.0 112.606 -169.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -101.64 126.05 48.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.998 0.919 . . . . 0.0 110.903 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 10.4 mt -138.03 125.61 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.74 1.616 . . . . 0.0 108.811 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.27 37.01 13.97 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.395 1.078 . . . . 0.0 113.463 -173.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 61.96 7.1 1.93 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.044 2.138 . . . . 0.0 116.003 -171.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -95.34 163.01 13.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.87 1.668 . . . . 0.0 111.421 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -95.37 129.38 42.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.362 1.465 . . . . 0.0 111.061 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.1 165.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.589 1.556 . . . . 0.0 113.151 173.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -123.22 130.32 52.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.388 1.075 . . . . 0.0 111.762 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.72 144.44 25.51 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.982 0.913 . . . . 0.0 111.92 168.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -140.08 149.6 43.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.969 1.307 . . . . 0.0 108.591 170.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -64.56 131.18 46.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.983 1.265 . . . . 0.0 110.732 170.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.555 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.4 mttp . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 81.3 tttt -105.86 132.73 51.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.278 1.831 . . . . 0.0 111.583 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -120.3 150.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.918 1.287 . . . . 0.0 111.339 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -85.99 142.64 28.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.462 1.905 . . . . 0.0 109.441 165.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -126.6 100.55 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.519 1.528 . . . . 0.0 109.943 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.43 144.38 17.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.501 1.048 . . . . 0.0 113.952 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 19.72 54.09 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.41 1.005 . . . . 0.0 115.181 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.6 135.57 55.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.519 1.159 . . . . 0.0 111.379 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -66.81 144.0 56.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.024 0.53 . . . . 0.0 111.295 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 m -59.54 -16.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.98 -27.78 62.01 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.484 1.114 . . . . 0.0 113.303 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -77.11 131.24 38.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.637 1.575 . . . . 0.0 113.608 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.96 165.54 15.15 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.01 -34.98 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -71.46 -36.69 71.3 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 111.595 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -55.84 -51.67 66.69 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.411 0.551 . . . . 0.0 111.949 169.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.67 -42.58 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.9 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -57.59 -52.96 63.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.814 0.734 . . . . 0.0 111.123 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -62.48 -39.83 94.72 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.259 22.5 m-85 -63.67 -20.01 65.36 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 60.6 m-85 -97.3 -27.23 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 169.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.4 -23.51 38.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.223 1.409 . . . . 0.0 114.532 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -62.86 -29.78 71.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -85.75 -35.81 20.54 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.665 0.786 . . . . 0.0 111.628 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.69 163.04 24.97 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.179 2.799 . . . . 0.0 109.328 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -66.88 155.66 37.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -169.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.97 121.29 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.195 -1.82 . . . . 0.0 108.649 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -73.2 -39.6 65.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.746 1.218 . . . . 0.0 111.244 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.13 144.33 18.65 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.924 2.09 . . . . 0.0 115.206 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -132.16 148.17 52.46 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.621 1.168 . . . . 0.0 110.66 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -148.66 138.38 22.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.34 1.056 . . . . 0.0 111.564 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 46.1 mt -100.18 139.61 35.61 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.686 0.795 . . . . 0.0 110.444 170.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.7 mmm . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 122.892 0.477 . . . . 0.0 110.09 -179.48 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 121.578 0.704 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -79.16 11.8 2.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.594 2.358 . . . . 0.0 113.598 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.931 -1.106 . . . . 0.0 115.466 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.34 166.36 32.1 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.652 1.226 . . . . 0.0 112.329 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.25 -179.71 35.21 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.12 0.867 . . . . 0.0 113.529 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 95.7 m-85 -117.94 148.15 42.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.069 1.748 . . . . 0.0 115.248 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.8 t -137.03 126.83 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.918 1.287 . . . . 0.0 111.961 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -106.14 131.91 52.83 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.101 2.161 . . . . 0.0 114.479 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -102.54 159.49 15.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 120.33 3.455 . . . . 0.0 120.33 -167.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -58.32 -38.76 77.75 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.22 2.208 . . . . 0.0 113.501 170.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.9 t -155.26 153.42 30.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.408 1.483 . . . . 0.0 111.337 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -60.17 -32.3 70.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 111.25 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -61.96 -34.18 75.65 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.02 -42.93 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.179 -0.439 . . . . 0.0 110.195 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.95 -43.88 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.814 0.734 . . . . 0.0 110.511 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.31 -46.45 88.69 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.45 -45.5 88.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.59 1.156 . . . . 0.0 112.418 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.14 -48.91 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.002 1.721 . . . . 0.0 110.646 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.96 -30.58 71.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -64.55 -27.92 69.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 113.276 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.02 -33.27 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.208 1.003 . . . . 0.0 111.256 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 65.34 -58.84 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.543 2.737 . . . . 0.0 114.667 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 54.1 m-85 -104.3 116.97 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -112.15 152.69 28.04 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.91 1.684 . . . . 0.0 111.47 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.69 125.15 48.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.748 0.819 . . . . 0.0 110.495 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.04 122.46 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.545 1.538 . . . . 0.0 108.901 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 50.2 35.84 11.23 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.0 m120 63.03 2.12 0.98 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.427 2.291 . . . . 0.0 116.611 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -83.52 138.67 33.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.444 1.498 . . . . 0.0 109.112 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.8 mmm -86.43 129.82 34.72 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.833 -0.542 . . . . 0.0 110.78 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.13 152.2 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.526 1.53 . . . . 0.0 112.605 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -105.51 120.41 41.55 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.082 0.953 . . . . 0.0 111.654 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.33 141.86 28.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.151 0.58 . . . . 0.0 111.415 168.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -148.28 146.29 28.54 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 109.006 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.88 137.25 58.23 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.753 1.161 . . . . 0.0 110.155 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.577 0.703 . . . . 0.0 112.164 -174.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -142.08 138.92 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.789 -1.194 . . . . 0.0 113.041 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.69 151.91 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.932 1.293 . . . . 0.0 111.159 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.27 144.52 27.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.316 2.246 . . . . 0.0 106.546 165.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.08 108.9 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.806 1.642 . . . . 0.0 108.899 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.44 147.96 18.61 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.444 1.021 . . . . 0.0 114.531 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.56 19.96 36.25 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.896 1.236 . . . . 0.0 114.734 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.17 134.98 53.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.774 1.23 . . . . 0.0 111.466 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 t -63.24 152.39 37.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.928 0.891 . . . . 0.0 112.488 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 m -59.61 -20.08 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.625 1.17 . . . . 0.0 113.535 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -79.56 -25.91 41.51 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.572 1.149 . . . . 0.0 112.893 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 36.2 m -73.78 140.96 46.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.077 1.351 . . . . 0.0 113.713 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -122.87 164.13 19.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.736 1.614 . . . . 0.0 114.903 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.08 -35.84 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.17 -29.83 67.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.593 0.757 . . . . 0.0 112.775 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.41 -48.93 68.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.67 -43.01 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.821 0.848 . . . . 0.0 111.742 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.98 -46.54 90.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.156 0.582 . . . . 0.0 111.801 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -59.38 -45.26 91.95 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.986 0.914 . . . . 0.0 113.088 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -63.69 -35.33 80.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.346 62.3 m-85 -84.03 -25.82 29.58 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -59.37 -21.13 59.39 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.82 -31.81 73.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.119 1.367 . . . . 0.0 112.322 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -80.89 -26.54 36.78 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.0 165.0 15.18 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.993 2.235 . . . . 0.0 110.974 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.99 133.43 56.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.958 0.885 . . . . 0.0 112.638 -171.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.97 125.23 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.96 1.704 . . . . 0.0 108.093 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.99 -35.43 59.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -163.87 157.48 18.81 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.17 0.988 . . . . 0.0 110.435 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.9 150.49 43.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 111.218 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptm -153.88 133.73 13.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.633 1.173 . . . . 0.0 111.883 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.6 mt -103.9 147.66 27.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 170.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.9 mmm . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -171.506 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.0 p80 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 -72.76 9.85 1.02 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.42 22.16 77.83 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.122 -0.986 . . . . 0.0 113.853 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -150.34 166.27 30.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.518 1.151 . . . . 0.0 108.222 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.92 -170.33 23.35 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.79 1.186 . . . . 0.0 113.088 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.47 152.68 36.51 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.677 1.591 . . . . 0.0 114.486 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.79 127.41 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.13 1.372 . . . . 0.0 110.835 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.09 139.1 38.16 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.854 2.062 . . . . 0.0 113.759 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -112.09 155.34 24.02 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -66.87 -34.86 78.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.454 0.702 . . . . 0.0 112.087 172.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.5 t -141.64 143.51 33.67 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 112.206 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -67.01 -20.42 65.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.747 0.819 . . . . 0.0 111.976 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.62 -31.44 71.52 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.8 mm -72.84 -40.8 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.283 171.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.18 -44.85 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.941 0.791 . . . . 0.0 109.957 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -63.95 -45.0 91.11 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -56.91 -46.38 82.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.367 1.067 . . . . 0.0 111.868 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.88 -49.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.885 1.674 . . . . 0.0 110.651 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.15 -33.29 75.15 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.88 -27.38 68.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.462 1.105 . . . . 0.0 113.459 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.1 mt -72.56 -31.66 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.743 1.217 . . . . 0.0 111.754 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 66.04 -48.89 0.41 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 128.87 2.868 . . . . 0.0 115.607 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 51.8 m-85 -117.51 122.46 43.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -120.89 149.4 42.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 111.899 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -87.57 131.77 34.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.327 0.651 . . . . 0.0 111.846 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.8 mt -141.23 125.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.488 1.915 . . . . 0.0 108.74 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 51.27 41.36 27.88 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.726 1.211 . . . . 0.0 114.255 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 64.5 t30 60.27 21.13 10.57 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.13 1.772 . . . . 0.0 114.654 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -120.4 167.18 12.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.203 2.201 . . . . 0.0 110.318 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 95.9 mmm -105.52 141.19 37.43 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.928 0.891 . . . . 0.0 112.448 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.68 149.62 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.838 1.655 . . . . 0.0 112.29 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -94.78 127.76 41.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.023 0.929 . . . . 0.0 111.391 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.67 135.0 35.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.712 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -138.63 149.7 45.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.599 1.559 . . . . 0.0 109.585 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -61.15 136.29 58.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.959 1.254 . . . . 0.0 110.685 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 122.758 0.423 . . . . 0.0 110.838 -177.789 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -118.89 137.96 53.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.805 1.242 . . . . 0.0 112.761 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.3 pt -118.17 152.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.871 1.268 . . . . 0.0 111.065 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 182' ' ' LYS . 49.8 t80 -87.62 141.44 28.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.745 2.018 . . . . 0.0 108.098 165.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.81 114.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.227 1.411 . . . . 0.0 109.347 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.11 144.37 18.41 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.423 1.011 . . . . 0.0 114.334 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.59 20.56 50.9 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.523 1.058 . . . . 0.0 114.562 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.0 mt -61.91 141.42 58.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.6 1.2 . . . . 0.0 111.103 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.32 141.7 58.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.888 -0.508 . . . . 0.0 111.128 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.01 -17.34 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.44 -25.85 50.99 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.543 1.137 . . . . 0.0 112.876 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 140.06 55.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.112 1.365 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -113.67 161.1 17.88 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.004 1.322 . . . . 0.0 114.42 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -54.7 -34.51 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.48 -31.35 68.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -64.6 -42.19 95.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.897 0.772 . . . . 0.0 109.25 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.7 -48.83 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.585 1.154 . . . . 0.0 111.3 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -60.26 -48.29 82.37 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.629 0.65 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -58.53 -41.17 84.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.672 0.789 . . . . 0.0 112.796 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.7 -47.01 82.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 57.5 m-85 -70.2 -25.89 63.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -60.48 -43.66 96.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.622 1.169 . . . . 0.0 112.784 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.46 -35.63 70.94 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 113.04 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.62 166.12 26.17 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.123 2.297 . . . . 0.0 110.731 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.072 0.939 . . . . 0.0 112.978 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.6 t -106.79 129.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.556 1.943 . . . . 0.0 108.395 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.89 -56.59 5.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 112.163 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -155.46 161.46 40.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.048 0.939 . . . . 0.0 110.319 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.44 152.63 38.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.47 1.508 . . . . 0.0 111.044 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -154.17 132.0 11.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.975 0.91 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.5 mt -100.59 137.49 38.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.27 1.028 . . . . 0.0 111.087 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.3 mmt . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 122.885 0.474 . . . . 0.0 112.264 -174.803 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.2 p80 . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.277 0.561 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -77.78 19.22 0.4 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.218 1.407 . . . . 0.0 114.709 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.42 22.52 76.44 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.128 -0.982 . . . . 0.0 113.824 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -151.7 164.0 37.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.559 1.179 . . . . 0.0 109.224 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.34 -167.57 29.18 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.279 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.62 150.1 44.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.916 1.686 . . . . 0.0 114.337 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.95 128.66 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.191 1.397 . . . . 0.0 110.815 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -108.54 134.22 51.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.209 1.803 . . . . 0.0 114.079 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -105.82 160.04 15.55 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -69.12 -33.68 73.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.933 0.893 . . . . 0.0 112.753 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t -142.66 147.07 35.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.707 1.203 . . . . 0.0 112.316 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.21 -30.09 67.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.517 1.127 . . . . 0.0 111.765 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.75 -35.27 72.46 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.65 -40.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.562 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.95 -44.21 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.994 0.816 . . . . 0.0 110.138 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -62.15 -48.07 81.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.44 -46.46 76.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.023 1.329 . . . . 0.0 112.547 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.85 -45.14 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.358 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.9 t -67.62 -36.13 80.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.699 0.799 . . . . 0.0 112.846 -176.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.54 -22.64 67.02 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.8 -33.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.803 0.841 . . . . 0.0 111.051 172.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 67.11 -51.32 0.48 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.838 2.855 . . . . 0.0 115.42 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.332 59.2 m-85 -110.28 123.57 50.06 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -123.86 170.36 10.64 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.281 2.232 . . . . 0.0 110.578 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -142.47 122.54 13.71 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.816 -1.178 . . . . 0.0 112.939 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.88 128.84 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.77 1.628 . . . . 0.0 108.989 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.72 39.64 18.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.65 1.18 . . . . 0.0 113.294 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 62.22 9.02 2.97 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.118 2.167 . . . . 0.0 116.231 -174.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -98.68 134.06 42.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.16 1.384 . . . . 0.0 110.42 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 18.7 ttm -82.53 137.24 34.65 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.757 0.823 . . . . 0.0 110.784 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.17 157.52 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.171 1.788 . . . . 0.0 112.259 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -106.47 128.77 54.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.065 0.946 . . . . 0.0 111.913 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.1 p -90.7 138.62 31.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.093 0.557 . . . . 0.0 110.632 167.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 112' ' ' PHE . 46.6 mtmt -140.36 146.44 38.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.828 1.251 . . . . 0.0 109.518 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -62.79 128.1 34.36 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.218 0.917 . . . . 0.0 110.781 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 120.867 0.365 . . . . 0.0 111.945 -172.578 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.2 mttp . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.174 0.035 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -133.55 139.8 46.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -167.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 pt -121.07 153.07 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.192 1.397 . . . . 0.0 111.032 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.55 143.9 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.211 2.604 . . . . 0.0 105.009 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.58 103.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.949 1.7 . . . . 0.0 109.263 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -104.29 142.44 15.49 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.568 1.08 . . . . 0.0 114.264 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.13 54.69 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.747 1.165 . . . . 0.0 114.997 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 mt -62.54 145.16 55.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.757 1.223 . . . . 0.0 112.475 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 t -66.93 137.69 56.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 110.719 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.76 -9.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.28 -20.29 28.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.098 0.959 . . . . 0.0 113.071 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.8 m -72.22 129.92 39.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.725 1.21 . . . . 0.0 111.37 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -103.01 163.95 11.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.72 -38.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.56 -29.64 68.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.276 0.63 . . . . 0.0 112.616 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -65.75 -45.73 81.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.308 0.958 . . . . 0.0 110.172 173.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.52 -48.21 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.576 1.15 . . . . 0.0 110.812 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -56.64 -51.13 69.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.149 1.38 . . . . 0.0 112.377 173.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -62.42 -36.86 83.7 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.872 0.869 . . . . 0.0 112.934 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -65.97 -45.38 81.92 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 58.3 m-85 -71.14 -25.51 62.6 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 176.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -56.83 -22.38 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.532 1.533 . . . . 0.0 114.631 170.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.79 -43.53 97.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.57 -33.28 68.94 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.52 170.8 30.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.336 1.922 . . . . 0.0 112.049 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -60.62 132.08 52.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.22 1.008 . . . . 0.0 112.188 -171.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.62 134.95 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.161 1.784 . . . . 0.0 108.431 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.93 -45.6 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.437 1.095 . . . . 0.0 113.703 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.73 162.35 23.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.911 1.285 . . . . 0.0 109.73 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.43 153.09 42.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.287 1.435 . . . . 0.0 111.71 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -156.33 134.72 11.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.53 1.132 . . . . 0.0 112.276 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 18.4 mt -101.49 147.07 26.81 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.864 0.866 . . . . 0.0 110.839 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.492 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 33.4 mmt . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 112.91 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.6 p80 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 121.624 0.726 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 ttp85 -72.88 17.41 0.12 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.88 2.072 . . . . 0.0 114.489 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.29 15.35 69.34 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.198 1.38 . . . . 0.0 114.766 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.492 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 27.4 p90 -156.02 168.47 27.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.219 1.51 . . . . 0.0 111.237 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.87 -167.74 25.92 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.829 1.204 . . . . 0.0 113.573 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.71 150.83 50.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.268 1.827 . . . . 0.0 115.014 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.48 128.52 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.29 1.436 . . . . 0.0 111.498 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -100.72 146.51 27.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.735 2.014 . . . . 0.0 113.687 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.8 151.94 38.97 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.41 -27.76 63.53 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.926 0.891 . . . . 0.0 112.948 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.8 t -141.68 142.34 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.995 1.318 . . . . 0.0 112.148 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -64.23 -26.52 68.54 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.125 . . . . 0.0 111.754 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.76 -32.82 72.1 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.9 -42.34 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.336 172.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.56 -44.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.666 0.666 . . . . 0.0 110.514 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -64.23 -47.3 80.19 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.84 -46.58 74.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.403 1.081 . . . . 0.0 111.946 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.91 -49.62 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.827 1.651 . . . . 0.0 110.872 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.61 -33.31 75.63 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -65.67 -21.6 66.56 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.68 -31.77 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.021 0.928 . . . . 0.0 111.304 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 66.1 -52.75 0.4 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.828 2.851 . . . . 0.0 115.535 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.337 49.6 m-85 -111.41 121.5 45.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 173.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -118.42 165.65 13.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.117 2.167 . . . . 0.0 110.849 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -131.14 113.9 14.46 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.276 -0.89 . . . . 0.0 112.14 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.75 129.24 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.776 1.23 . . . . 0.0 109.314 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 48.1 45.12 19.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.648 1.179 . . . . 0.0 112.686 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.297 0.9 OUTLIER 52.81 31.79 11.18 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.448 2.299 . . . . 0.0 115.748 -174.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -130.84 142.2 50.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.78 1.632 . . . . 0.0 110.344 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.3 mmm -84.11 135.1 34.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.312 1.045 . . . . 0.0 111.79 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.71 153.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.834 1.254 . . . . 0.0 111.892 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.38 127.63 46.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.651 0.78 . . . . 0.0 111.933 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -89.79 136.38 33.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.846 0.458 . . . . 0.0 110.432 167.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -140.76 148.11 40.17 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.974 1.309 . . . . 0.0 108.744 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.45 135.5 55.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.897 1.226 . . . . 0.0 110.879 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 122.742 0.417 . . . . 0.0 111.29 -175.676 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.2 mttp . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.55 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 80.2 tttt -136.63 138.33 41.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.346 1.458 . . . . 0.0 111.72 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.0 149.29 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.592 1.157 . . . . 0.0 111.333 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -83.97 145.22 28.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.251 1.82 . . . . 0.0 107.534 165.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.82 108.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.977 1.711 . . . . 0.0 109.984 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.74 147.63 18.66 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.594 1.092 . . . . 0.0 114.5 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.8 17.42 63.57 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.243 0.925 . . . . 0.0 114.61 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.1 mt -61.66 144.68 54.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.841 1.256 . . . . 0.0 111.494 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.5 t -69.36 137.0 52.49 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.061 -0.399 . . . . 0.0 110.133 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.4 m -64.52 -12.2 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -27.63 42.11 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.75 1.22 . . . . 0.0 113.145 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.2 m -67.4 132.39 47.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 111.974 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.49 161.46 20.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -35.02 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -71.6 -37.35 70.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.489 0.716 . . . . 0.0 111.685 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.51 -50.26 72.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.539 0.609 . . . . 0.0 111.787 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.81 -43.49 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.84 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.94 -52.57 64.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.053 0.842 . . . . 0.0 111.647 174.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -59.55 -39.79 85.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.27 24.4 m-85 -64.32 -16.24 61.82 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 118.309 2.707 . . . . 0.0 118.309 170.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 58.3 m-85 -101.5 -25.61 13.85 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.72 -21.87 56.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.159 1.384 . . . . 0.0 113.824 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.19 -29.92 71.17 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.31 -28.55 31.61 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.72 169.19 24.7 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.496 2.474 . . . . 0.0 110.079 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -63.27 130.23 43.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.843 0.83 . . . . 0.0 112.589 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.44 132.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.193 1.797 . . . . 0.0 108.938 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.94 -57.91 3.6 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.174 0.989 . . . . 0.0 112.743 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -157.47 166.99 31.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.271 1.029 . . . . 0.0 109.883 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.39 157.72 43.66 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.398 1.479 . . . . 0.0 111.315 174.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -152.16 125.02 8.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.421 1.088 . . . . 0.0 111.391 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.36 146.97 25.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.305 0.642 . . . . 0.0 110.568 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.44 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 36.8 mmt . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 112.114 -172.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.4 p80 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -70.7 -15.67 62.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.303 1.441 . . . . 0.0 114.081 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 114.9 22.27 5.04 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.509 1.052 . . . . 0.0 114.841 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.44 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 41.6 p90 -153.46 166.04 33.93 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.778 1.289 . . . . 0.0 111.237 171.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.3 -169.58 33.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.614 1.102 . . . . 0.0 114.289 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.55 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 92.8 m-85 -124.11 152.57 42.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.875 2.07 . . . . 0.0 115.979 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -137.86 133.65 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.412 1.485 . . . . 0.0 111.807 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.58 140.89 39.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.328 2.251 . . . . 0.0 114.934 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -117.2 155.61 29.12 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -168.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -72.24 -31.29 65.68 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.866 0.866 . . . . 0.0 113.095 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.7 t -144.37 145.99 32.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.65 1.18 . . . . 0.0 112.633 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.32 -25.07 66.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.88 0.872 . . . . 0.0 111.872 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.12 -32.52 72.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.7 mm -72.33 -42.56 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.312 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.51 -44.68 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.772 0.715 . . . . 0.0 110.23 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.75 -49.7 76.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -55.76 -47.39 77.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.513 1.125 . . . . 0.0 112.301 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.32 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.749 1.62 . . . . 0.0 110.725 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 61.6 m -65.7 -33.27 75.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.24 -23.03 66.95 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.8 mt -72.98 -33.03 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.914 0.885 . . . . 0.0 111.251 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 65.7 -48.94 0.39 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.032 2.933 . . . . 0.0 115.531 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.301 46.9 m-85 -115.7 124.14 50.1 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -123.56 139.32 54.12 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.665 1.586 . . . . 0.0 111.816 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -86.05 124.62 32.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.072 0.949 . . . . 0.0 111.222 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.1 mt -138.76 124.75 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.213 1.805 . . . . 0.0 108.729 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 48.29 44.72 20.04 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.313 0.8 OUTLIER 53.45 29.22 8.58 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.688 1.995 . . . . 0.0 115.947 -172.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -127.53 136.06 51.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.318 2.247 . . . . 0.0 109.819 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 88.0 mtp -86.25 132.72 33.93 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.776 -0.578 . . . . 0.0 111.207 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.2 m -127.37 153.27 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.625 1.57 . . . . 0.0 112.712 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -101.25 125.98 47.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.781 0.833 . . . . 0.0 111.982 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.11 139.31 30.75 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.392 0.677 . . . . 0.0 111.462 167.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -136.37 145.3 45.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.72 1.208 . . . . 0.0 109.237 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.72 130.28 45.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.367 0.985 . . . . 0.0 109.758 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -172.699 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.0 mttt . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 84.0 tttt -137.86 140.1 40.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.877 1.271 . . . . 0.0 111.178 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt -124.82 150.62 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.489 1.116 . . . . 0.0 111.922 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -85.12 144.14 28.39 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.09 117.09 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.613 1.565 . . . . 0.0 109.762 172.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.0 145.81 16.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.269 0.938 . . . . 0.0 114.267 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.02 11.9 58.26 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.855 1.217 . . . . 0.0 115.121 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -59.63 142.78 52.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 111.275 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t -67.83 144.71 55.21 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.63 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.25 1.4 p -65.07 -13.57 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -72.75 -26.85 61.71 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 112.545 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.2 m -72.22 135.37 46.06 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 112.832 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 t -106.15 160.05 15.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 171.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.89 -34.42 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.435 1.494 . . . . 0.0 114.564 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.29 -34.88 75.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.235 0.614 . . . . 0.0 112.598 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -61.2 -42.37 98.47 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.222 0.919 . . . . 0.0 109.85 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.85 -47.81 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.74 1.216 . . . . 0.0 111.244 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -60.85 -48.48 81.61 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.664 0.665 . . . . 0.0 112.156 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -59.83 -37.02 78.04 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.67 -48.37 72.32 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 54.4 m-85 -68.99 -25.0 64.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -59.79 -18.65 45.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -59.43 -45.0 92.8 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.633 1.173 . . . . 0.0 112.82 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -73.01 -36.85 67.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.963 1.305 . . . . 0.0 112.535 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.68 165.88 29.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.097 1.808 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -59.09 126.22 26.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.963 0.905 . . . . 0.0 112.432 -169.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.97 128.67 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.756 1.622 . . . . 0.0 108.593 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.37 -57.2 4.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.195 0.998 . . . . 0.0 113.093 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -156.19 165.56 36.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 110.039 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.8 155.81 41.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.571 1.549 . . . . 0.0 111.272 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -154.86 134.88 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.373 1.069 . . . . 0.0 112.347 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.2 mt -103.25 142.45 34.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 111.236 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.438 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 38.3 mmt . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 121.863 0.84 . . . . 0.0 111.611 -175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.7 p80 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.763 0.316 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.06 2.65 6.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.03 58.27 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.059 -1.025 . . . . 0.0 113.952 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 14.9 p90 -152.39 165.15 35.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.562 1.181 . . . . 0.0 109.234 172.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.65 -167.88 33.94 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.477 1.037 . . . . 0.0 113.668 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.517 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.5 m-85 -124.79 151.73 44.78 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.988 1.715 . . . . 0.0 114.974 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.15 132.91 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.288 1.435 . . . . 0.0 111.526 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.14 142.76 37.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.942 2.097 . . . . 0.0 114.647 -178.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.21 156.88 30.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -168.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.37 -32.92 73.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.796 0.838 . . . . 0.0 112.99 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.9 t -144.41 145.96 32.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.795 1.238 . . . . 0.0 112.377 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -60.18 -31.13 69.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.838 0.855 . . . . 0.0 111.638 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -59.69 -30.34 68.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.3 mm -72.36 -44.66 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 122.06 -0.4 . . . . 0.0 110.086 169.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.25 -41.33 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.639 0.654 . . . . 0.0 110.504 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -58.19 -51.37 70.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.291 0.636 . . . . 0.0 112.631 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.17 -46.38 88.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.639 1.176 . . . . 0.0 112.435 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.33 -46.87 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.806 1.642 . . . . 0.0 110.791 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.48 -38.52 91.46 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.622 0.769 . . . . 0.0 112.988 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -63.45 -19.46 64.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 73.4 mt -71.87 -33.71 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.28 -0.888 . . . . 0.0 111.464 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 65.08 -55.39 0.31 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.851 2.86 . . . . 0.0 115.179 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.359 46.3 m-85 -107.6 109.55 21.22 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -100.15 168.95 9.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.602 2.361 . . . . 0.0 111.353 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -132.45 118.41 19.28 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.362 -0.836 . . . . 0.0 111.889 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.91 127.95 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.787 1.235 . . . . 0.0 109.262 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.5 43.21 19.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.758 1.223 . . . . 0.0 112.939 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.301 0.7 OUTLIER 53.92 20.58 2.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.76 2.424 . . . . 0.0 116.352 -173.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -106.43 138.74 42.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.697 1.599 . . . . 0.0 110.24 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.1 mmm -80.7 133.56 35.71 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.896 0.878 . . . . 0.0 110.457 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.86 147.67 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.792 1.237 . . . . 0.0 112.84 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -97.35 124.63 41.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.225 1.01 . . . . 0.0 111.987 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.2 p -90.55 147.64 23.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.05 0.54 . . . . 0.0 111.426 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -143.34 151.02 39.98 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.927 1.291 . . . . 0.0 109.128 170.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.49 126.81 29.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.016 0.825 . . . . 0.0 109.149 168.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 121.435 0.636 . . . . 0.0 112.161 -175.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.8 mttt . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -124.0 138.49 54.45 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.543 1.065 . . . . 0.0 113.027 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.5 pt -118.66 153.04 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.894 1.278 . . . . 0.0 111.537 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -88.54 139.46 30.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.783 2.433 . . . . 0.0 108.12 165.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.4 t -130.73 111.13 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.31 1.444 . . . . 0.0 109.809 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.58 17.6 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.536 1.065 . . . . 0.0 113.807 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.52 12.76 37.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.917 1.246 . . . . 0.0 114.534 -177.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.02 139.23 58.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.429 1.092 . . . . 0.0 110.876 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -66.85 142.12 57.44 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.868 -0.52 . . . . 0.0 110.029 169.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.92 -14.61 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -74.18 -21.7 59.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.303 1.441 . . . . 0.0 113.744 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -71.24 145.48 49.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.404 1.481 . . . . 0.0 112.448 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -118.59 159.36 23.72 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.897 1.279 . . . . 0.0 114.113 169.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.54 -34.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.269 1.427 . . . . 0.0 114.847 -173.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.57 -28.82 65.19 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.56 0.744 . . . . 0.0 112.942 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -64.88 -51.59 61.14 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 t -58.83 -44.81 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.148 0.979 . . . . 0.0 111.489 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -59.21 -48.01 83.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.929 0.492 . . . . 0.0 111.952 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -62.71 -40.08 96.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -58.57 -30.38 67.12 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.262 59.7 m-85 -88.42 -24.1 23.13 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.13 -14.07 22.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -59.19 -42.58 91.19 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 112.523 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -80.51 -32.98 36.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.06 172.87 35.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.39 1.948 . . . . 0.0 111.058 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.16 125.5 24.08 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.134 0.967 . . . . 0.0 112.391 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 38.3 t -97.66 128.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.516 1.527 . . . . 0.0 110.107 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -75.05 -50.68 15.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.973 1.309 . . . . 0.0 112.906 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -160.9 164.25 31.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.18 0.992 . . . . 0.0 110.471 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.62 154.56 39.88 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.546 1.539 . . . . 0.0 111.383 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -151.71 136.71 17.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.697 1.199 . . . . 0.0 111.67 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.75 146.83 34.28 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 111.396 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 124.287 1.035 . . . . 0.0 112.363 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.8 p80 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -67.23 7.96 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.204 1.802 . . . . 0.0 115.751 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.84 65.73 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.581 1.086 . . . . 0.0 114.208 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -153.7 167.6 29.04 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.719 1.26 . . . . 0.0 111.21 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.78 -164.7 22.88 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.102 0.858 . . . . 0.0 113.41 170.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -120.89 150.58 40.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.104 1.762 . . . . 0.0 114.892 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.17 127.77 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.066 1.346 . . . . 0.0 111.159 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.66 136.34 48.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.432 1.893 . . . . 0.0 114.62 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -109.76 158.68 17.88 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.141 1.776 . . . . 0.0 115.643 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.32 -28.44 63.07 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.2 t -141.85 144.84 34.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.169 1.388 . . . . 0.0 112.459 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -60.58 -31.67 70.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 111.684 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.62 -31.46 70.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.75 -42.04 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 110.134 171.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.9 -43.19 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.834 0.743 . . . . 0.0 110.248 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -59.94 -47.15 86.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 173.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -58.67 -51.21 70.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.189 0.995 . . . . 0.0 112.466 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.0 t -64.19 -43.18 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.703 1.601 . . . . 0.0 110.809 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 46.7 t -70.23 -35.52 73.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -64.28 -26.58 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.923 -1.111 . . . . 0.0 113.781 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.5 mt -71.07 -39.43 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.844 0.858 . . . . 0.0 110.874 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 65.45 -43.15 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.973 2.909 . . . . 0.0 115.969 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.283 53.2 m-85 -111.69 123.36 50.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 174.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -129.52 159.84 35.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.502 1.521 . . . . 0.0 112.356 -169.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -106.41 127.08 53.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.129 0.972 . . . . 0.0 111.282 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.74 123.79 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.327 1.451 . . . . 0.0 108.998 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.58 37.48 16.28 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.279 1.032 . . . . 0.0 113.298 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.83 12.92 4.07 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 127.339 2.256 . . . . 0.0 115.7 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -97.86 145.57 26.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.082 1.753 . . . . 0.0 110.584 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.67 128.96 34.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.368 1.467 . . . . 0.0 110.205 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.39 147.31 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.702 1.201 . . . . 0.0 113.318 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -94.18 129.18 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.549 1.139 . . . . 0.0 110.187 171.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.85 126.58 54.14 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.754 1.222 . . . . 0.0 110.388 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -148.88 148.69 30.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.025 1.33 . . . . 0.0 111.296 -171.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.31 138.94 58.25 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.411 -0.806 . . . . 0.0 111.817 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.674 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.382 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 112.103 -0.399 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.8 m -66.61 -23.54 66.2 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -148.84 153.44 38.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.755 1.622 . . . . 0.0 111.66 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 50.1 tpp -86.36 157.33 19.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.833 0.853 . . . . 0.0 110.41 168.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -75.76 46.48 0.37 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.522 1.529 . . . . 0.0 112.048 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -150.71 147.61 27.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.937 2.495 . . . . 0.0 109.797 -168.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.6 pt -108.65 152.2 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.837 . . . . 0.0 111.307 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -85.41 144.54 27.95 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 164.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.71 110.34 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.44 1.496 . . . . 0.0 109.74 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.65 150.94 18.46 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.421 1.01 . . . . 0.0 113.908 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.62 15.52 54.68 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.316 0.96 . . . . 0.0 114.51 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.87 134.86 55.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.655 1.182 . . . . 0.0 111.66 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t -62.47 148.69 44.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.299 0.639 . . . . 0.0 111.842 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t -58.73 -25.76 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.504 1.122 . . . . 0.0 113.885 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -74.26 -27.83 60.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.274 1.03 . . . . 0.0 112.476 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.4 m -72.75 127.38 32.38 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -94.42 165.76 12.4 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.9 p -59.48 -34.52 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -73.84 -37.43 64.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.403 0.681 . . . . 0.0 111.878 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -54.08 -46.08 71.93 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.851 0.75 . . . . 0.0 112.795 169.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.61 -48.53 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.624 1.17 . . . . 0.0 109.801 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -61.34 -42.98 99.59 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.027 0.931 . . . . 0.0 112.715 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -72.98 -28.8 62.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -69.11 -50.49 47.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.317 67.3 m-85 -65.83 -20.27 66.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -56.57 -18.03 10.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 170.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.63 -29.32 69.89 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.958 -1.089 . . . . 0.0 112.817 176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -87.32 -34.55 18.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.005 0.922 . . . . 0.0 112.609 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.02 171.58 35.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.027 2.251 . . . . 0.0 110.576 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -66.67 133.47 50.29 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.709 0.766 . . . . 0.0 112.282 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.65 127.02 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.286 1.834 . . . . 0.0 109.296 -176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.84 -52.61 16.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -164.24 173.85 11.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.672 0.789 . . . . 0.0 110.011 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -138.59 157.33 46.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.197 1.399 . . . . 0.0 111.899 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptm -150.53 133.42 15.97 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.01 1.324 . . . . 0.0 111.049 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.36 150.61 25.07 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.563 -0.711 . . . . 0.0 110.622 169.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 45.1 mmm -80.39 72.72 7.28 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.166 0.508 . . . . 0.0 111.904 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.287 53.4 m-85 -61.85 137.99 58.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -118.81 112.04 19.2 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.967 1.707 . . . . 0.0 113.181 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -64.31 -18.08 64.27 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -25.38 64.94 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 170.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.3 p -130.56 -14.79 3.63 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 65.68 11.65 7.68 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.125 2.17 . . . . 0.0 114.444 -171.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.28 167.77 9.77 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.907 1.683 . . . . 0.0 111.716 169.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -91.97 156.65 17.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.969 0.908 . . . . 0.0 113.064 172.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 21.23 0.07 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.491 2.316 . . . . 0.0 113.428 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 73.66 6.23 71.04 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.045 -1.66 . . . . 0.0 115.25 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -146.76 167.35 24.08 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.887 1.344 . . . . 0.0 110.13 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.19 -165.33 22.32 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.223 1.392 . . . . 0.0 112.676 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.56 152.23 50.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.191 1.796 . . . . 0.0 114.92 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.54 119.08 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.075 1.35 . . . . 0.0 112.058 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -89.11 144.76 25.9 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.502 1.921 . . . . 0.0 113.763 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -116.6 162.33 17.8 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.53 -40.9 76.62 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.829 -0.544 . . . . 0.0 111.137 168.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t -139.51 144.39 37.89 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.262 1.425 . . . . 0.0 112.406 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -65.5 -18.12 65.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.44 -32.63 71.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 18.9 mm -75.87 -41.75 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.751 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.27 -44.56 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 119.085 0.857 . . . . 0.0 109.888 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -60.82 -49.91 75.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 113.165 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.32 -45.44 80.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.158 1.383 . . . . 0.0 112.531 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.35 -46.07 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.611 1.565 . . . . 0.0 111.225 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.5 m -66.2 -31.15 71.8 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -63.93 -31.38 72.55 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.151 1.38 . . . . 0.0 112.834 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.7 mt -68.82 -33.79 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.286 1.034 . . . . 0.0 111.319 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 65.19 -58.51 0.27 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 128.547 2.739 . . . . 0.0 114.884 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 46.1 m-85 -102.25 116.37 32.52 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 170.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -109.57 173.61 6.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.148 2.179 . . . . 0.0 110.709 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -140.84 123.22 15.88 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.07 -1.019 . . . . 0.0 112.505 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 18.7 mt -137.38 133.01 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.987 1.715 . . . . 0.0 108.983 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 50.6 41.51 25.73 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.894 1.278 . . . . 0.0 114.025 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.15 24.7 14.78 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.049 1.74 . . . . 0.0 114.163 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -129.35 153.18 48.12 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.467 1.507 . . . . 0.0 110.713 169.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 37.8 mtp -94.47 144.47 25.54 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.39 144.97 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.426 1.491 . . . . 0.0 111.677 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -95.36 121.57 37.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.205 1.002 . . . . 0.0 110.646 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 72.6 m -105.89 131.07 53.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.334 1.053 . . . . 0.0 111.809 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.356 1.862 . . . . 0.0 110.14 -173.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.49 135.07 57.64 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.82 1.191 . . . . 0.0 111.094 170.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.51 118.08 12.86 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.274 0.559 . . . . 0.0 110.871 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -66.82 147.66 99.0 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.676 1.191 . . . . 0.0 111.479 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.78 36.13 0.47 Allowed 'Trans proline' 0 CA--C 1.547 1.16 1 C-N-CA 125.713 4.275 . . . . 0.0 117.948 -166.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 59.98 -15.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 129.409 3.084 . . . . 0.0 118.32 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.27 -31.02 71.55 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.016 -1.053 . . . . 0.0 111.617 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.4 m -67.99 -5.03 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.124 1.77 . . . . 0.0 115.173 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 81.3 mtp -70.25 -12.18 61.41 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.177 0.898 . . . . 0.0 112.825 169.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.2 t -56.9 148.92 46.61 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.925 1.29 . . . . 0.0 112.068 170.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -54.83 -20.97 24.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.474 2.783 . . . . 0.0 115.345 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.7 p -70.11 -15.95 63.05 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 171.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -137.47 -11.54 0.99 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.023 1.297 . . . . 0.0 116.157 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 89.1 p -62.06 -21.17 64.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.777 1.788 . . . . 0.0 114.53 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.62 54.66 1.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.283 1.433 . . . . 0.0 111.87 169.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 48.65 32.74 3.69 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.941 2.496 . . . . 0.0 114.681 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.04 171.71 48.81 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.493 1.521 . . . . 0.0 115.334 -171.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 149.81 49.79 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.916 2.086 . . . . 0.0 111.222 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.547 1.539 . . . . 0.0 113.748 -178.844 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.154 1 O4'-C1'-N19 112.946 4.746 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.434 1 O4'-C1'-N19 112.623 4.423 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.308 1 O4'-C1'-N19 112.606 4.406 . 0.089 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.205 1 O4'-C1'-N19 113.181 4.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.171 0 O4'-C1'-N19 111.702 3.502 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.076 -0.409 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.2 p -153.46 163.08 40.57 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.163 1.385 . . . . 0.0 112.362 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -153.07 175.05 13.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.693 1.597 . . . . 0.0 111.632 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.65 35.92 4.74 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.576 1.55 . . . . 0.0 111.324 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -75.0 -1.64 23.62 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -174.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -105.15 133.65 49.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.349 1.06 . . . . 0.0 112.772 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.8 pt -112.46 154.58 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.205 1.402 . . . . 0.0 111.359 169.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.66 142.31 28.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.281 2.232 . . . . 0.0 107.843 165.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 t -133.56 110.43 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.131 1.372 . . . . 0.0 110.135 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.06 153.85 16.68 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.459 1.028 . . . . 0.0 113.921 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.47 9.4 56.68 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.225 1.393 . . . . 0.0 115.249 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.0 mt -63.39 141.16 58.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.998 1.319 . . . . 0.0 110.931 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 t -66.85 142.98 57.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.972 -0.455 . . . . 0.0 110.838 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.79 -11.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -86.37 -13.36 46.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.807 1.243 . . . . 0.0 114.151 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.5 m -73.88 132.82 42.9 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.59 1.156 . . . . 0.0 111.676 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.88 161.63 17.38 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 175.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -60.29 -33.65 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 169.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -74.22 -34.25 63.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.697 0.799 . . . . 0.0 112.068 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -56.25 -46.05 79.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.081 0.855 . . . . 0.0 112.135 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.64 -47.92 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.077 0.951 . . . . 0.0 110.649 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.11 -47.28 86.54 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.66 0.664 . . . . 0.0 111.735 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -62.87 -38.82 92.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.196 0.998 . . . . 0.0 112.992 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -64.68 -51.0 64.8 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 57.0 m-85 -64.44 -21.24 66.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -66.61 0.02 2.55 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 170.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.49 -29.47 63.66 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.389 -1.444 . . . . 0.0 111.862 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -88.95 -21.13 23.72 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.13 -158.3 25.82 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 126.681 2.086 . . . . 0.0 110.49 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -97.95 147.52 24.39 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.484 1.142 . . . . 0.0 110.791 170.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 95.8 t -117.32 129.92 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.412 1.485 . . . . 0.0 109.302 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -71.08 -47.09 60.28 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.774 1.63 . . . . 0.0 114.738 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -162.69 161.07 26.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.156 0.983 . . . . 0.0 110.241 -173.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.34 153.72 40.85 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.566 1.546 . . . . 0.0 111.271 170.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -152.75 132.35 13.06 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.425 1.09 . . . . 0.0 111.794 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.0 mt -103.98 146.97 27.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.71 0.804 . . . . 0.0 110.752 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.1 mmt -87.15 85.24 7.2 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 149' ' ' HIS . 40.9 m-85 -69.61 136.63 51.45 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 118.41 2.744 . . . . 0.0 118.41 174.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -94.17 129.39 40.78 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.218 1.407 . . . . 0.0 113.414 168.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.5 -38.01 89.51 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -171.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -76.99 -52.5 9.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.063 1.345 . . . . 0.0 109.028 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 p -69.32 -19.67 63.87 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.322 9.1 p30 51.2 26.66 3.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.109 2.163 . . . . 0.0 114.841 -172.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -131.64 160.91 34.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.3 2.24 . . . . 0.0 111.119 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 35.7 p80 -86.43 157.88 19.72 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 173.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -68.69 5.94 0.96 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.59 18.62 67.95 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.751 -1.218 . . . . 0.0 114.286 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -144.2 161.66 38.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.289 1.045 . . . . 0.0 112.48 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.85 27.08 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.632 0.634 . . . . 0.0 113.451 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.61 150.63 39.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.235 1.814 . . . . 0.0 114.343 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.72 127.35 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.421 1.488 . . . . 0.0 111.527 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -110.26 125.92 53.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.321 1.449 . . . . 0.0 114.394 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -91.48 162.09 14.7 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -170.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -60.7 -45.41 94.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.246 1.018 . . . . 0.0 111.605 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -136.73 142.66 43.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.572 1.549 . . . . 0.0 111.612 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.04 -24.67 67.79 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.509 1.124 . . . . 0.0 112.039 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -63.01 -28.9 70.42 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 172.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.7 -42.48 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 121.954 -0.467 . . . . 0.0 110.539 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.09 -41.29 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.236 0.614 . . . . 0.0 110.359 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.47 -47.23 82.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.985 0.514 . . . . 0.0 112.364 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -64.35 -45.97 85.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.307 1.043 . . . . 0.0 112.157 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.26 -41.33 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.144 1.377 . . . . 0.0 111.405 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.31 -33.92 70.13 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.983 0.913 . . . . 0.0 112.716 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -26.94 68.03 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.8 mt -67.32 -36.62 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.421 -0.799 . . . . 0.0 110.313 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 65.19 -60.27 0.25 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 128.826 2.85 . . . . 0.0 114.233 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 64.9 m-85 -100.03 123.51 44.36 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 174.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -124.17 176.01 6.66 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.741 2.416 . . . . 0.0 110.124 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -139.6 129.24 24.48 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.426 -1.421 . . . . 0.0 112.783 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 39.5 mt -138.15 131.99 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.296 1.438 . . . . 0.0 109.278 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.7 41.17 25.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.177 1.391 . . . . 0.0 114.543 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.3 t30 60.55 33.19 20.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.032 1.733 . . . . 0.0 113.794 -176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -133.97 143.62 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.05 1.74 . . . . 0.0 111.456 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 7.2 ttm -85.17 133.58 34.19 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.785 0.834 . . . . 0.0 110.723 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.32 156.72 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.571 1.548 . . . . 0.0 112.787 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -118.42 112.3 19.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.812 0.845 . . . . 0.0 112.097 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.6 t -78.72 131.21 36.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.785 0.834 . . . . 0.0 111.458 168.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -150.18 146.77 27.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.927 1.691 . . . . 0.0 110.709 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -64.79 135.15 55.47 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.448 -0.783 . . . . 0.0 112.493 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.0 122.5 18.81 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -129.67 155.63 80.05 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 126.407 1.883 . . . . 0.0 111.896 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.84 151.05 86.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.3 2.667 . . . . 0.0 114.237 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -66.05 -16.43 63.91 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -65.61 -41.66 92.46 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.858 1.263 . . . . 0.0 112.487 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.268 1.0 OUTLIER -77.12 -31.86 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 178.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 22.4 mmt -79.46 -17.05 55.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.712 1.205 . . . . 0.0 113.489 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.0 t 63.86 133.7 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.876 2.87 . . . . 0.0 114.316 -168.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -66.33 -21.35 54.39 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.873 2.382 . . . . 0.0 113.565 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.268 1.0 OUTLIER -81.99 158.46 23.85 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -177.43 167.99 39.4 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.419 1.009 . . . . 0.0 113.608 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 91.9 p -156.21 163.71 39.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.547 1.539 . . . . 0.0 111.915 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 54.83 31.75 16.29 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.73 1.612 . . . . 0.0 114.939 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -62.44 141.42 58.38 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.319 1.448 . . . . 0.0 111.505 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.67 -10.51 50.14 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 116.541 1.376 . . . . 0.0 116.541 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -113.89 9.26 17.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.499 1.92 . . . . 0.0 114.014 174.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.254 1.337 0 C-N-CA 125.407 1.483 . . . . 0.0 112.217 178.137 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.38 0 O4'-C1'-N19 110.497 2.297 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 0 O4'-C1'-N19 111.557 3.357 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.123 0 O4'-C4'-C3' 109.314 2.725 . 0.55 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.375 0 O4'-C1'-N19 111.464 3.264 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.498 2 O4'-C1'-N19 113.574 5.374 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 80.4 p -153.1 160.27 42.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.183 1.393 . . . . 0.0 112.691 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -76.7 177.75 7.3 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.078 1.351 . . . . 0.0 113.09 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 20.7 ptp -130.12 41.23 3.44 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.952 1.301 . . . . 0.0 112.811 174.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -71.08 30.19 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.15 137.91 43.2 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.475 -1.391 . . . . 0.0 112.667 -169.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.8 pt -123.58 148.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.94 1.296 . . . . 0.0 112.456 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -85.96 139.49 31.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.919 2.088 . . . . 0.0 109.908 164.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.1 t -127.32 113.66 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.945 1.298 . . . . 0.0 109.521 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -119.09 154.12 16.6 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.8 1.191 . . . . 0.0 114.115 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.88 13.31 75.3 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.458 1.028 . . . . 0.0 114.506 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.06 144.17 46.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.963 1.305 . . . . 0.0 111.95 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -65.61 139.74 58.46 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.23 -13.04 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.891 0.877 . . . . 0.0 112.528 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -22.09 27.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.63 1.172 . . . . 0.0 111.954 171.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 82.9 m -75.44 139.95 42.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.88 1.272 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -114.8 163.85 14.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.405 1.482 . . . . 0.0 114.745 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.7 p -54.47 -36.65 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.37 -30.49 69.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.557 0.743 . . . . 0.0 112.619 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.59 -47.29 67.12 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.89 -42.54 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.46 0.704 . . . . 0.0 111.298 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -60.76 -48.16 83.03 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.545 0.738 . . . . 0.0 112.051 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -60.54 -39.08 86.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.444 1.098 . . . . 0.0 113.679 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -68.07 -39.22 82.99 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.322 47.9 m-85 -81.21 -24.9 37.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 118.513 2.783 . . . . 0.0 118.513 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -57.72 -29.25 64.58 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.62 -26.03 68.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.367 1.467 . . . . 0.0 112.712 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -75.22 -20.78 59.08 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 116.436 2.014 . . . . 0.0 116.436 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.54 -93.6 0.09 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.033 1.302 . . . . 0.0 111.439 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -157.65 137.53 12.35 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.312 1.445 . . . . 0.0 111.809 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.1 136.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.409 1.484 . . . . 0.0 108.457 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -92.64 -30.71 15.45 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -162.23 153.84 18.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.283 1.033 . . . . 0.0 110.273 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.51 152.78 44.45 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.005 1.322 . . . . 0.0 111.757 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.8 ptm -154.21 134.89 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.013 1.325 . . . . 0.0 112.004 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.4 mt -109.46 145.12 36.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.178 0.991 . . . . 0.0 111.26 173.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 47.7 mmm -85.79 74.91 10.13 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.287 40.9 m-85 -58.49 137.43 57.37 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 171.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -118.09 119.17 33.96 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.567 1.547 . . . . 0.0 113.341 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -57.07 -26.31 60.15 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.316 1.446 . . . . 0.0 113.321 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.42 -24.91 67.79 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.499 2.036 . . . . 0.0 116.499 173.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 p -128.71 -16.98 4.13 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.6 t30 56.58 30.96 18.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 126.079 1.752 . . . . 0.0 113.116 -172.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -135.35 163.75 29.3 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.192 2.197 . . . . 0.0 110.11 172.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -79.36 154.47 29.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.642 0.734 . . . . 0.0 112.368 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -70.89 15.01 0.11 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.319 1.848 . . . . 0.0 115.246 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.9 12.6 82.49 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.431 1.015 . . . . 0.0 114.494 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -152.09 167.8 27.31 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.607 1.204 . . . . 0.0 110.457 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.87 -167.84 27.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.383 1.468 . . . . 0.0 113.182 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -125.93 149.62 48.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.349 1.86 . . . . 0.0 115.256 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.7 t -135.77 130.61 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 111.404 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.8 m -107.83 138.17 44.55 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.548 1.939 . . . . 0.0 113.203 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -109.89 157.95 18.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -67.17 -32.09 72.95 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.437 0.695 . . . . 0.0 112.477 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.0 t -146.24 143.52 29.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.797 1.239 . . . . 0.0 112.428 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -67.82 -17.55 64.55 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.93 -24.94 67.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.7 mm -78.24 -45.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.4 -44.55 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.592 0.757 . . . . 0.0 110.935 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.0 -37.06 86.05 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.857 0.753 . . . . 0.0 112.564 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -67.84 -47.56 68.66 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.697 1.199 . . . . 0.0 111.73 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.97 -47.01 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.984 1.314 . . . . 0.0 110.525 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 27.4 t -69.19 -32.83 72.39 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.704 0.802 . . . . 0.0 112.116 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.74 -30.27 71.28 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.77 1.228 . . . . 0.0 113.296 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 69.0 mt -64.98 -33.52 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.647 0.779 . . . . 0.0 111.099 171.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 66.84 -56.22 0.42 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.69 2.796 . . . . 0.0 114.93 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.279 63.3 m-85 -106.57 125.25 50.77 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -125.21 161.53 26.7 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.903 1.681 . . . . 0.0 111.3 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -109.58 135.15 51.02 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.372 1.069 . . . . 0.0 111.49 172.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 43.5 mt -141.93 124.76 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.362 1.865 . . . . 0.0 108.509 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 51.06 34.66 11.27 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.316 1.046 . . . . 0.0 113.425 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.275 3.6 m120 63.62 3.88 1.65 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.683 2.393 . . . . 0.0 116.298 -172.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -86.71 142.3 28.28 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.416 1.486 . . . . 0.0 108.821 168.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 29.2 ttm -88.82 135.93 33.27 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.578 -0.701 . . . . 0.0 111.201 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.66 158.89 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.143 1.777 . . . . 0.0 112.329 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -110.54 133.04 53.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.43 1.092 . . . . 0.0 111.428 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.7 p -97.73 145.76 26.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.019 0.928 . . . . 0.0 112.204 168.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -143.37 152.1 41.21 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.044 1.738 . . . . 0.0 108.843 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.76 136.43 56.92 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 120.334 1.425 . . . . 0.0 110.818 169.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -77.99 104.68 8.71 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -90.61 149.8 41.36 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.471 1.508 . . . . 0.0 110.859 169.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.25 151.46 71.96 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.473 2.115 . . . . 0.0 111.619 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -61.56 -14.71 32.15 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -59.75 -29.54 68.23 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.579 1.551 . . . . 0.0 113.514 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.255 1.4 m -76.15 -4.9 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 24.3 mmt -122.97 115.27 21.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.954 1.702 . . . . 0.0 109.798 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.2 m -57.02 146.54 59.69 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.183 1.393 . . . . 0.0 113.439 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -64.23 -26.68 64.36 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.972 2.448 . . . . 0.0 115.658 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.251 1.5 t -71.27 144.97 49.84 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 69.34 179.07 21.72 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.99 1.281 . . . . 0.0 114.888 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 79.9 p -159.22 150.2 19.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.044 1.338 . . . . 0.0 112.218 177.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.15 149.72 40.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.172 0.589 . . . . 0.0 111.56 170.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 155.8 30.19 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.478 1.511 . . . . 0.0 111.737 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 170.8 -166.86 40.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.39 1.472 . . . . 0.0 112.128 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.6 133.92 16.29 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.082 1.353 . . . . 0.0 111.549 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 126.049 1.74 . . . . 0.0 113.741 179.152 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.572 0 O4'-C1'-N19 111.015 2.815 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.291 0 O4'-C1'-N19 111.868 3.668 . 0.062 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.596 0 O4'-C1'-N19 111.828 3.628 . 0.166 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.569 0 C4'-C3'-C2' 99.5 -3.2 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.098 1 O4'-C1'-N19 112.465 4.265 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.0 m -64.45 149.85 47.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.889 1.275 . . . . 0.0 113.91 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -80.42 169.33 17.85 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.869 0.868 . . . . 0.0 110.909 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 77.5 mtm -60.1 125.48 23.81 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.235 -0.915 . . . . 0.0 110.945 173.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -74.98 37.52 0.12 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.981 1.312 . . . . 0.0 114.46 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -130.59 137.55 49.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.626 1.17 . . . . 0.0 112.436 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 pt -113.24 152.68 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 111.024 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -86.04 144.04 27.78 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.8 t -127.04 106.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.556 1.542 . . . . 0.0 109.279 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -107.1 150.84 16.83 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.988 1.28 . . . . 0.0 114.225 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.48 19.79 65.57 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.376 0.988 . . . . 0.0 114.569 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.7 mt -65.19 137.78 57.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.489 1.116 . . . . 0.0 111.391 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.8 t -69.35 142.42 54.0 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.751 0.82 . . . . 0.0 111.641 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 p -61.21 -17.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -73.02 -29.03 62.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.937 0.895 . . . . 0.0 112.331 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.4 m -73.12 137.15 45.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.587 1.555 . . . . 0.0 112.927 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 t -112.11 161.99 15.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.05 1.34 . . . . 0.0 114.41 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 p -53.89 -34.92 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.4 -31.13 69.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.574 0.75 . . . . 0.0 112.837 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -66.41 -43.54 85.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.895 0.77 . . . . 0.0 109.425 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.1 -45.73 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.614 1.165 . . . . 0.0 111.564 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.92 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.717 0.807 . . . . 0.0 111.776 172.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -57.52 -41.57 81.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.954 0.901 . . . . 0.0 112.942 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.87 -46.92 73.48 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.327 54.8 m-85 -70.92 -23.72 62.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -59.68 -29.91 68.4 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 171.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -64.24 -26.9 68.7 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.934 0.894 . . . . 0.0 112.906 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -72.76 -26.67 61.64 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -175.89 -94.21 0.09 OUTLIER Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.04 1.305 . . . . 0.0 112.006 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -157.29 133.6 9.72 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.437 1.495 . . . . 0.0 111.667 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.51 134.91 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.351 1.46 . . . . 0.0 108.666 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -80.9 -44.74 17.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.992 1.317 . . . . 0.0 113.915 170.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -161.9 160.76 28.36 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.09 1.356 . . . . 0.0 109.915 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.05 148.88 39.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.184 1.394 . . . . 0.0 111.707 174.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -153.3 132.47 12.67 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 112.53 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -96.57 145.94 25.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.691 0.796 . . . . 0.0 110.042 169.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.9 mmt -83.33 127.34 33.58 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.118 -0.364 . . . . 0.0 110.049 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.288 64.2 m-85 -103.64 139.69 38.58 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -174.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -96.86 110.0 22.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.381 1.472 . . . . 0.0 113.567 171.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.12 -16.07 58.81 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.49 -35.97 82.2 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 174.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.281 0.7 OUTLIER -136.55 -2.98 2.14 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 65.08 12.59 8.07 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.974 2.11 . . . . 0.0 114.638 -171.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -71.35 156.48 39.45 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.75 1.22 . . . . 0.0 110.937 168.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -87.08 156.14 19.85 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.283 0.563 . . . . 0.0 110.506 167.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -76.2 8.06 3.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.369 2.267 . . . . 0.0 114.695 -169.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.16 6.1 84.91 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.992 1.282 . . . . 0.0 114.46 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.33 168.56 26.68 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.413 1.106 . . . . 0.0 111.218 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.37 -167.73 23.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.808 1.194 . . . . 0.0 113.337 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.8 149.99 50.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.27 1.828 . . . . 0.0 114.77 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -136.76 123.05 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.918 1.287 . . . . 0.0 111.609 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.06 148.94 21.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.829 2.052 . . . . 0.0 114.168 175.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.9 155.63 35.05 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 -169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -66.1 -36.38 83.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.209 0.604 . . . . 0.0 112.201 172.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -141.25 144.25 34.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.053 1.341 . . . . 0.0 112.485 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -64.5 -20.7 66.36 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.39 0.676 . . . . 0.0 112.557 171.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -61.78 -33.72 74.6 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.4 mm -72.5 -40.62 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.008 -0.433 . . . . 0.0 110.434 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 83.4 t -57.14 -43.8 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.073 0.851 . . . . 0.0 110.288 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -60.66 -48.43 81.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.328 0.651 . . . . 0.0 112.699 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.01 -47.55 80.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.321 1.448 . . . . 0.0 112.703 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.67 -43.5 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.916 1.686 . . . . 0.0 111.159 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.63 -35.75 79.49 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.515 0.726 . . . . 0.0 112.482 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.15 -29.34 70.28 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.041 1.336 . . . . 0.0 113.161 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.83 -35.13 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.272 1.029 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 65.75 -55.04 0.36 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.739 2.816 . . . . 0.0 115.238 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.314 59.9 m-85 -105.93 124.55 49.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 174.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -126.61 171.18 11.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.205 2.202 . . . . 0.0 110.734 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -137.65 132.48 33.02 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.828 -1.17 . . . . 0.0 112.919 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mt -140.99 127.41 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.509 1.523 . . . . 0.0 108.762 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 50.9 38.81 21.05 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.65 1.18 . . . . 0.0 113.746 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.05 -0.66 1.01 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.465 2.306 . . . . 0.0 116.195 -173.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -85.31 131.1 34.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.843 1.257 . . . . 0.0 109.631 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 12.3 ttm -80.17 132.97 36.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.164 0.586 . . . . 0.0 110.196 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.64 159.27 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.78 1.632 . . . . 0.0 111.806 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -114.96 126.22 54.52 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.268 1.027 . . . . 0.0 111.639 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.1 p -87.17 147.8 25.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.389 0.614 . . . . 0.0 111.605 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -143.49 151.78 40.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.387 1.475 . . . . 0.0 108.169 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.24 132.74 48.37 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.913 1.233 . . . . 0.0 109.922 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.94 136.38 48.48 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.089 0.404 . . . . 0.0 110.603 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -137.18 158.19 72.99 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.435 1.094 . . . . 0.0 111.8 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.97 156.12 51.26 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.667 2.911 . . . . 0.0 114.354 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -61.78 -20.65 63.81 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 59.8 mp0 -63.73 -21.92 66.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.87 1.668 . . . . 0.0 113.189 170.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.256 1.0 OUTLIER -118.31 -9.36 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.265 1.826 . . . . 0.0 115.209 175.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 26.2 mmt -127.26 103.27 7.31 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.837 2.055 . . . . 0.0 110.862 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.7 t -144.09 135.25 12.52 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.917 1.287 . . . . 0.0 110.982 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.65 165.08 27.45 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.822 3.014 . . . . 0.0 113.239 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.267 0.6 OUTLIER -69.63 161.0 30.53 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 169.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -77.21 -0.95 72.81 Favored Glycine 0 CA--C 1.54 1.594 0 N-CA-C 115.335 0.894 . . . . 0.0 115.335 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 23.1 t -71.76 133.33 45.5 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 118.977 1.389 . . . . 0.0 112.693 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.97 158.87 26.47 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.737 1.215 . . . . 0.0 112.723 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 32.1 ttt-85 -65.44 141.57 58.47 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.937 0.895 . . . . 0.0 111.057 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.28 138.55 34.47 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.35 0.5 . . . . 0.0 112.692 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 53.2 tpt85 -84.22 -27.63 27.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.242 1.417 . . . . 0.0 113.652 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.6 1.96 . . . . 0.0 112.403 -173.352 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.314 0 O4'-C1'-N19 111.765 3.565 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 O4'-C1'-N19 112.01 3.81 . 0.071 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 0 O4'-C1'-N19 111.07 2.87 . 0.041 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.49 1 O4'-C1'-N19 112.967 4.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.411 0 O4'-C1'-N19 111.662 3.462 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.1 p -76.35 166.98 22.66 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.231 1.012 . . . . 0.0 113.085 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -71.14 -6.29 38.22 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 86.5 mtp -76.89 39.21 0.22 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.103 1.761 . . . . 0.0 113.954 -174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -76.89 38.65 0.21 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.464 1.506 . . . . 0.0 113.019 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -149.69 147.15 27.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.214 2.206 . . . . 0.0 110.024 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.8 pt -123.54 152.35 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.45 1.1 . . . . 0.0 111.91 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -87.8 140.93 29.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.749 2.02 . . . . 0.0 105.849 164.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -128.9 110.11 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.195 1.398 . . . . 0.0 110.038 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.15 147.65 18.2 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.958 1.266 . . . . 0.0 114.475 -172.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.19 14.55 58.78 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.784 1.183 . . . . 0.0 114.671 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.79 135.01 57.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.734 1.267 . . . . 0.0 110.321 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 p -67.1 150.79 48.69 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.599 -0.688 . . . . 0.0 111.275 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.01 -20.89 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.16 -27.49 42.73 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.899 1.28 . . . . 0.0 113.664 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 83.2 m -68.93 138.84 54.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.454 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.251 2.1 t -118.13 165.29 13.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.63 -34.75 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.76 -30.04 66.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 112.625 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.11 -47.37 71.35 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.02 -45.57 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.817 0.847 . . . . 0.0 110.144 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -58.72 -48.79 79.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.627 0.771 . . . . 0.0 111.937 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -59.33 -50.34 74.33 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.978 0.911 . . . . 0.0 113.035 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.25 26.4 m-85 -59.81 -31.91 70.15 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.342 51.3 m-85 -85.25 -24.28 27.86 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -63.95 -20.2 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -62.81 -34.64 77.72 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.071 0.948 . . . . 0.0 111.948 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -74.94 -25.67 59.05 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 179.67 -94.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.709 1.147 . . . . 0.0 112.195 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -154.87 136.16 14.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.072 1.349 . . . . 0.0 112.239 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 65.9 t -87.31 137.18 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.593 1.557 . . . . 0.0 108.847 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.87 -46.32 12.28 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.019 1.328 . . . . 0.0 113.056 169.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -160.57 155.17 23.75 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.983 1.313 . . . . 0.0 109.929 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.8 145.97 47.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.538 1.535 . . . . 0.0 111.461 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -154.12 127.83 8.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.168 0.987 . . . . 0.0 113.014 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.6 mt -88.24 143.96 26.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.749 0.82 . . . . 0.0 110.929 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 36.6 mmt -91.43 141.92 28.23 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.374 0.669 . . . . 0.0 112.207 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.305 40.2 m-85 -109.2 142.31 40.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 118.768 2.877 . . . . 0.0 118.768 -169.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.61 118.93 23.18 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.58 1.552 . . . . 0.0 114.272 169.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -67.07 -19.44 65.66 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -43.82 55.48 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 p -126.18 -0.31 7.09 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 60.76 22.42 12.39 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.522 1.929 . . . . 0.0 115.546 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -101.2 162.76 12.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.27 1.828 . . . . 0.0 111.063 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -74.36 150.52 40.04 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.614 -0.679 . . . . 0.0 111.69 174.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -77.2 10.92 2.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.356 1.862 . . . . 0.0 115.044 -174.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.8 79.56 Favored Glycine 0 CA--C 1.532 1.156 0 O-C-N 121.281 -0.887 . . . . 0.0 114.121 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -152.3 165.49 34.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.742 1.271 . . . . 0.0 110.317 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.64 176.7 37.26 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.022 0.82 . . . . 0.0 113.829 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.38 146.59 28.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.19 116.09 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.882 1.273 . . . . 0.0 111.779 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.7 m -89.25 144.34 26.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.777 1.631 . . . . 0.0 113.001 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.54 163.44 14.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -69.58 -40.37 76.77 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.274 0.63 . . . . 0.0 111.849 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.6 t -140.33 145.42 37.15 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.172 1.389 . . . . 0.0 112.861 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.69 -25.99 68.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.709 1.203 . . . . 0.0 111.897 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.71 -35.9 79.38 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.27 -42.41 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.22 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 79.4 t -54.55 -45.67 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 118.657 0.662 . . . . 0.0 110.301 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.34 -39.03 74.95 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.82 -48.3 75.67 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.624 1.102 . . . . 0.0 111.685 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.13 -49.45 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 126.104 1.762 . . . . 0.0 110.797 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 33.1 m -66.54 -30.52 70.85 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -67.99 -25.68 65.53 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.555 1.07 . . . . 0.0 113.587 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 70.2 mt -71.28 -32.9 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.77 0.828 . . . . 0.0 111.079 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 65.36 -59.65 0.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 128.5 2.72 . . . . 0.0 114.923 173.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 47.3 m-85 -100.41 123.12 44.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 171.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -121.04 147.32 45.68 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.676 1.59 . . . . 0.0 112.232 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -95.25 124.5 39.32 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.897 0.879 . . . . 0.0 110.738 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.67 129.38 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.828 1.651 . . . . 0.0 108.715 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 50.54 35.51 11.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.194 0.998 . . . . 0.0 113.223 -173.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 28.3 m120 59.37 26.46 15.34 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.595 1.958 . . . . 0.0 115.758 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -125.81 148.06 49.24 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.151 1.78 . . . . 0.0 110.223 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.9 mmm -90.75 134.37 34.47 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.837 0.855 . . . . 0.0 112.408 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.16 153.68 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.439 1.496 . . . . 0.0 112.245 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -102.06 122.05 43.36 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.306 1.043 . . . . 0.0 112.107 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 74.0 m -98.31 135.6 39.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.402 1.081 . . . . 0.0 112.318 173.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -140.04 145.83 38.23 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.724 1.609 . . . . 0.0 110.769 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.46 137.77 57.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.889 1.222 . . . . 0.0 111.06 171.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.01 94.43 0.86 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.733 0.777 . . . . 0.0 113.091 -174.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -80.86 156.35 72.55 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.516 1.926 . . . . 0.0 111.334 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.96 -179.93 4.3 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.475 3.45 . . . . 0.0 114.411 -169.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -68.85 66.53 0.14 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.611 1.565 . . . . 0.0 111.764 168.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -146.16 -41.54 0.21 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.767 2.427 . . . . 0.0 110.32 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 15.4 m -76.9 34.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 127.005 2.122 . . . . 0.0 113.531 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 69.2 mtm -71.05 -4.74 26.61 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -167.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.2 m -59.83 127.67 85.65 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.9 0.88 . . . . 0.0 112.179 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.73 147.65 45.29 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.198 2.599 . . . . 0.0 112.261 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.1 p -77.97 158.94 29.11 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -67.43 129.39 28.28 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 121.501 -0.749 . . . . 0.0 113.675 -175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.4 p -138.57 -1.92 1.82 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.174 1.39 . . . . 0.0 114.66 -174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.63 -7.13 52.22 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -173.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.84 134.64 20.06 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.719 1.208 . . . . 0.0 111.596 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.63 -155.45 30.74 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.986 1.279 . . . . 0.0 113.353 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -23.16 67.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.604 1.161 . . . . 0.0 113.126 173.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 C--O 1.253 1.239 0 C-N-CA 127.011 2.124 . . . . 0.0 110.056 174.033 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.223 0 O4'-C1'-N19 111.032 2.832 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.232 0 O5'-C5'-C4' 113.715 2.511 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.4 0 C1'-O4'-C4' 106.43 -3.522 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.611 0 O4'-C1'-N19 111.083 2.883 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.014 1 O4'-C1'-N19 112.241 4.041 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.585 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.0 m -59.75 -22.55 62.25 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -61.2 -23.49 65.64 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.173 0.989 . . . . 0.0 113.168 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 53.2 tpp -63.08 -21.04 65.91 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.225 1.01 . . . . 0.0 112.778 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -77.61 -0.98 28.58 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.476 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 83.2 tttt -107.36 138.11 44.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.108 1.363 . . . . 0.0 112.082 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.0 pt -123.39 151.78 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.225 1.41 . . . . 0.0 111.826 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -87.18 143.66 27.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.594 1.958 . . . . 0.0 108.064 165.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.72 125.98 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.834 1.653 . . . . 0.0 109.995 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.56 156.79 23.77 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.057 0.844 . . . . 0.0 114.48 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.89 10.5 58.72 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.712 1.149 . . . . 0.0 114.373 -174.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.3 mt -66.2 140.2 58.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.351 1.46 . . . . 0.0 111.327 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 86.8 p -75.23 152.15 38.35 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.757 -0.589 . . . . 0.0 111.372 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 m -65.92 -16.72 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -73.65 -34.81 65.12 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.651 1.18 . . . . 0.0 112.168 169.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.0 m -67.09 136.36 55.06 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.165 0.986 . . . . 0.0 111.698 173.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.5 t -119.0 163.79 16.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 p -53.65 -36.2 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.45 -31.26 68.35 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.34 -43.63 90.33 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.884 0.765 . . . . 0.0 109.078 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.15 -47.77 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.485 1.114 . . . . 0.0 111.141 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -60.36 -50.07 75.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.45 0.7 . . . . 0.0 112.07 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -61.43 -38.37 86.88 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.56 0.744 . . . . 0.0 112.964 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -64.58 -46.99 80.38 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.297 47.2 m-85 -67.83 -27.09 66.41 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -58.71 -19.5 40.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -61.93 -45.16 94.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.873 1.269 . . . . 0.0 112.881 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.01 -38.13 82.24 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.619 1.168 . . . . 0.0 112.802 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.44 158.64 14.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 127.2 2.333 . . . . 0.0 110.226 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.16 138.11 57.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.636 1.208 . . . . 0.0 112.885 -168.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.5 t -97.63 136.64 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.882 2.073 . . . . 0.0 109.222 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -78.89 -49.72 12.4 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.697 1.599 . . . . 0.0 112.471 173.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -159.3 159.94 34.58 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.335 1.054 . . . . 0.0 110.498 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.95 151.19 36.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.556 1.542 . . . . 0.0 111.464 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 21.0 ptt? -153.94 133.73 13.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.468 1.107 . . . . 0.0 112.231 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.1 mt -102.41 143.23 32.41 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.083 0.953 . . . . 0.0 111.201 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.4 mmt -87.6 103.96 16.06 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.334 32.8 m-85 -72.17 147.21 46.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 118.589 2.811 . . . . 0.0 118.589 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -117.73 111.74 19.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.349 1.46 . . . . 0.0 111.488 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.1 mttp -64.6 -21.53 66.73 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 m -70.85 -27.6 63.97 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 171.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.5 p -106.59 -19.06 13.78 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.8 t30 56.75 32.83 21.92 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.139 1.775 . . . . 0.0 112.985 -172.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -136.15 165.68 25.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.048 2.139 . . . . 0.0 110.447 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -74.65 152.64 39.17 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.409 0.623 . . . . 0.0 111.554 169.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -75.28 16.1 0.37 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.83 1.652 . . . . 0.0 114.825 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.47 13.11 83.89 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.462 1.029 . . . . 0.0 114.405 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -147.47 162.71 38.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.998 1.399 . . . . 0.0 111.594 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.85 -168.32 30.73 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.446 1.498 . . . . 0.0 113.538 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.476 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.0 m-85 -125.03 151.02 46.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.153 1.781 . . . . 0.0 115.124 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.8 t -137.0 134.17 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.497 1.519 . . . . 0.0 110.414 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.6 m -114.89 134.42 55.16 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.69 1.596 . . . . 0.0 114.087 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -103.51 159.79 15.28 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.961 1.704 . . . . 0.0 115.471 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -72.46 -29.02 63.29 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.0 t -139.76 145.3 38.07 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.473 1.109 . . . . 0.0 112.867 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -62.5 -28.65 69.98 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.181 0.993 . . . . 0.0 111.782 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.92 -31.73 72.86 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.5 -43.2 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 119.228 -0.415 . . . . 0.0 109.977 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.73 -42.39 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 118.636 0.653 . . . . 0.0 110.577 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -60.0 -48.5 81.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.755 0.707 . . . . 0.0 112.668 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -58.19 -44.85 88.28 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.526 1.13 . . . . 0.0 112.118 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.8 t -67.65 -48.1 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.024 1.729 . . . . 0.0 111.019 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.23 -34.17 77.49 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.51 -21.47 66.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.6 mt -74.81 -30.91 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.099 0.96 . . . . 0.0 111.703 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 64.61 -62.21 0.19 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.297 2.639 . . . . 0.0 114.609 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.343 47.6 m-85 -101.5 120.2 39.93 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -115.66 154.72 29.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 111.747 -173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -112.85 108.28 17.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.585 0.754 . . . . 0.0 111.996 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.31 123.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.554 1.141 . . . . 0.0 109.467 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 51.17 37.01 17.16 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.075 0.95 . . . . 0.0 113.031 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 61.99 4.25 1.12 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 127.291 2.236 . . . . 0.0 115.646 -170.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -83.82 140.91 31.73 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -82.64 128.49 34.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 110.547 171.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.81 150.77 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.266 1.426 . . . . 0.0 112.497 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -104.98 123.83 48.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.869 1.267 . . . . 0.0 111.327 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -89.66 147.95 23.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.676 0.791 . . . . 0.0 111.896 169.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -147.08 151.09 36.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.733 1.613 . . . . 0.0 108.786 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -64.56 135.18 55.73 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.051 1.296 . . . . 0.0 110.739 168.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.51 137.14 42.29 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.2 152.78 80.14 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.428 1.491 . . . . 0.0 111.645 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.95 150.89 84.48 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.558 2.839 . . . . 0.0 114.247 -171.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -64.28 -20.6 66.17 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -69.0 -22.55 64.07 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.518 1.927 . . . . 0.0 113.041 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.3 m -107.98 -36.01 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.406 1.483 . . . . 0.0 113.832 170.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 86.9 mmm -91.53 71.91 5.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.086 1.754 . . . . 0.0 110.83 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 71.7 p -81.29 144.24 53.56 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.644 0.778 . . . . 0.0 111.334 169.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.59 149.72 74.24 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.181 2.588 . . . . 0.0 113.038 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.9 p -78.98 -2.97 42.7 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 82.53 -152.34 30.47 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.73 1.157 . . . . 0.0 112.702 -172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.8 p -66.04 130.83 44.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.775 0.83 . . . . 0.0 112.554 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -154.02 156.94 38.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.23 1.412 . . . . 0.0 112.186 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -76.78 -23.1 52.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.943 1.297 . . . . 0.0 114.086 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 118.39 -145.87 18.41 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.758 1.647 . . . . 0.0 112.023 -173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 12.7 mmp_? -68.01 149.36 49.8 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.817 0.809 . . . . 0.0 111.707 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.73 1.612 . . . . 0.0 113.678 -178.638 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.242 0 O4'-C1'-N19 111.692 3.492 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.166 1 O4'-C1'-N19 112.336 4.136 . 0.342 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.544 2.644 0 O4'-C1'-N19 110.996 2.796 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.894 0 C4'-C3'-C2' 99.932 -2.768 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.289 0 O4'-C1'-N19 112.083 3.883 . 0.06 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.4 m 52.98 29.61 8.15 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 115.454 1.649 . . . . 0.0 115.454 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.9 m80 56.96 22.44 7.22 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.163 1.785 . . . . 0.0 115.54 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.1 mmt -64.0 -26.8 68.73 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -83.89 8.35 15.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -118.03 143.53 46.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.902 1.281 . . . . 0.0 112.066 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 pt -112.04 149.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.662 1.185 . . . . 0.0 110.51 169.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -86.63 141.75 28.75 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.744 2.018 . . . . 0.0 106.945 166.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.95 118.26 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.695 1.598 . . . . 0.0 109.529 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.69 146.69 16.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.139 0.876 . . . . 0.0 113.764 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.18 19.44 33.3 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.592 1.092 . . . . 0.0 114.493 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 mt -70.4 134.7 48.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.988 1.315 . . . . 0.0 112.122 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.5 t -64.04 141.99 58.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.894 -0.504 . . . . 0.0 111.637 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.2 p -62.83 -16.87 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.44 -32.66 66.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.821 0.848 . . . . 0.0 112.071 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 m -69.29 135.43 50.45 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.552 1.541 . . . . 0.0 113.132 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -111.73 164.46 13.02 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.169 1.388 . . . . 0.0 114.598 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.35 -36.83 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.7 -33.89 75.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 112.417 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -63.98 -48.6 75.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.79 -43.2 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.376 0.671 . . . . 0.0 111.485 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.19 -50.64 72.86 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.801 0.84 . . . . 0.0 112.036 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.46 -38.76 92.37 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -63.13 -48.14 79.77 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 52.4 m-85 -69.18 -24.35 64.05 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -61.79 -14.23 30.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.85 -27.94 69.21 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.576 1.08 . . . . 0.0 112.4 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -85.54 -30.31 23.49 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.397 1.079 . . . . 0.0 113.647 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 164.55 173.05 32.77 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.917 2.199 . . . . 0.0 111.026 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.13 131.71 45.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 122.266 1.031 . . . . 0.0 113.011 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.7 t -99.27 133.67 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.63 1.972 . . . . 0.0 108.211 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.64 -48.67 16.25 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.172 1.389 . . . . 0.0 113.507 174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -162.43 163.4 27.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.483 1.113 . . . . 0.0 110.153 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.86 151.84 40.4 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.447 1.499 . . . . 0.0 111.553 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -153.77 134.18 13.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.198 0.999 . . . . 0.0 112.317 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.88 0.872 . . . . 0.0 110.556 172.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.4 mmt -85.05 140.89 30.67 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.771 0.428 . . . . 0.0 111.358 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.334 42.9 m-85 -106.15 150.3 25.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 118.734 2.864 . . . . 0.0 118.734 -173.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.63 120.33 37.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.009 1.724 . . . . 0.0 113.325 168.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -74.25 -14.05 60.86 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -42.47 68.56 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.2 p -123.23 -4.63 8.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.062 1.745 . . . . 0.0 115.703 -175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 60.65 13.51 4.33 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.748 2.019 . . . . 0.0 115.297 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -85.45 159.43 19.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.299 1.84 . . . . 0.0 111.492 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -75.15 153.17 38.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.723 -0.61 . . . . 0.0 111.004 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -78.69 8.62 5.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.531 1.532 . . . . 0.0 114.872 -171.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.36 15.13 81.72 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.512 -0.742 . . . . 0.0 114.276 -174.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -150.76 163.68 38.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.444 1.116 . . . . 0.0 109.478 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -171.37 -162.81 24.31 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.988 1.28 . . . . 0.0 113.166 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -133.8 151.56 51.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.941 1.696 . . . . 0.0 115.241 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.66 123.74 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.243 1.417 . . . . 0.0 111.385 171.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -98.09 140.17 32.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.104 1.762 . . . . 0.0 114.066 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -111.84 151.77 28.69 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.047 1.339 . . . . 0.0 114.043 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -76.7 -40.57 48.35 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.0 t -110.73 135.21 51.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.327 1.051 . . . . 0.0 111.775 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.27 -23.67 66.44 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.196 0.998 . . . . 0.0 112.213 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -62.02 -31.48 71.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.4 mm -69.53 -38.21 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.843 -0.536 . . . . 0.0 110.574 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.05 -43.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 118.614 0.643 . . . . 0.0 110.883 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -64.01 -49.16 73.53 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.905 0.882 . . . . 0.0 112.232 174.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.75 -45.15 78.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.617 1.567 . . . . 0.0 112.587 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.48 -49.43 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.731 1.612 . . . . 0.0 110.918 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.84 -32.74 74.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.1 0.56 . . . . 0.0 112.462 -174.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.47 -28.81 68.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.227 1.411 . . . . 0.0 113.453 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.05 -30.6 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.431 1.092 . . . . 0.0 111.78 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 66.65 -51.15 0.45 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 128.863 2.865 . . . . 0.0 115.77 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.31 39.2 m-85 -112.92 124.22 52.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -123.13 153.83 39.47 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.124 1.77 . . . . 0.0 111.271 -173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -105.71 128.81 53.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.184 0.994 . . . . 0.0 110.95 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 33.2 mt -139.4 123.76 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.733 1.613 . . . . 0.0 108.758 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 50.46 35.07 10.32 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.015 0.926 . . . . 0.0 113.358 -174.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 25.6 m120 63.17 1.58 0.93 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.596 2.358 . . . . 0.0 116.957 -170.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -83.47 142.52 30.88 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.166 1.387 . . . . 0.0 109.416 168.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 94.2 mmm -86.52 137.27 32.66 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.753 -0.592 . . . . 0.0 111.094 172.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.06 150.55 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.25 1.42 . . . . 0.0 111.771 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -98.99 130.8 45.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.622 0.769 . . . . 0.0 111.282 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.9 p -94.39 139.19 31.42 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.361 0.664 . . . . 0.0 110.797 167.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -136.92 154.22 50.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.266 1.426 . . . . 0.0 108.653 170.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.7 137.05 57.58 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.723 1.147 . . . . 0.0 110.276 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.81 114.18 12.96 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.254 0.55 . . . . 0.0 111.673 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -66.25 148.97 98.27 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 166.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -60.36 151.3 75.3 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.843 2.362 . . . . 0.0 112.849 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -60.12 -17.38 39.82 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -78.57 -17.0 56.77 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.505 1.522 . . . . 0.0 114.052 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.0 p -65.61 -45.91 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -171.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.2 mmt 50.64 48.87 21.95 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 127.351 2.261 . . . . 0.0 112.868 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.7 m -60.83 151.14 74.34 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.443 1.097 . . . . 0.0 112.515 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -57.4 139.82 91.27 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.12 2.547 . . . . 0.0 113.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.8 p -71.98 157.44 37.81 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -174.5 126.29 1.18 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.301 0.953 . . . . 0.0 112.629 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 52.5 p -70.9 149.39 46.79 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -160.56 138.23 9.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.799 1.64 . . . . 0.0 111.209 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 28.7 ttt-85 -81.34 -30.53 33.77 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.194 -0.941 . . . . 0.0 113.349 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.94 -169.79 40.8 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.974 1.273 . . . . 0.0 113.414 -169.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.5 mmm-85 -70.11 -18.99 63.26 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 34.1 p . . . . . 0 C--O 1.254 1.304 0 C-N-CA 126.46 1.904 . . . . 0.0 112.998 174.227 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.118 0 O4'-C1'-N19 112.058 3.858 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.132 0 O4'-C1'-N19 112.192 3.992 . 0.24 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.921 0 O4'-C1'-N19 110.113 1.913 . 0.352 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.455 1 O4'-C1'-N19 113.284 5.084 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.245 1 O4'-C1'-N19 112.225 4.025 . 0.184 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 N-CA-C 112.167 -0.373 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.2 t -155.79 -48.28 0.08 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.454 1.102 . . . . 0.0 112.781 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 50.7 m-70 -71.15 94.01 1.11 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.694 1.198 . . . . 0.0 112.622 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 50.0 ttm -78.41 53.51 1.29 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.265 1.426 . . . . 0.0 111.48 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -75.92 30.57 0.11 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.541 1.536 . . . . 0.0 114.474 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -137.78 139.04 39.83 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.89 -1.131 . . . . 0.0 112.159 -173.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 pt -117.24 151.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.81 1.244 . . . . 0.0 111.593 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -89.75 136.83 32.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.35 2.66 . . . . 0.0 108.119 165.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.54 110.3 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.415 . . . . 0.0 110.136 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -118.8 142.78 17.07 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.255 0.931 . . . . 0.0 114.366 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.3 13.5 28.46 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.487 1.518 . . . . 0.0 115.027 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.4 mt -63.72 151.43 42.01 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.264 1.426 . . . . 0.0 112.478 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.4 t -68.81 139.83 55.26 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 122.052 -0.405 . . . . 0.0 110.453 168.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.4 -14.44 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.538 0.735 . . . . 0.0 112.331 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -83.64 -19.55 35.22 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.914 1.285 . . . . 0.0 113.11 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 84.9 m -69.37 134.37 48.96 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.806 1.242 . . . . 0.0 111.759 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.5 t -102.28 157.97 16.52 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.39 -33.67 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.223 1.409 . . . . 0.0 114.608 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -71.35 -29.58 65.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.69 -43.89 95.3 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.162 0.892 . . . . 0.0 109.466 172.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -66.54 -47.62 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.109 1.364 . . . . 0.0 110.96 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -60.99 -45.25 95.59 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.845 -0.534 . . . . 0.0 112.057 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -60.34 -43.71 96.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 112.273 176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.01 -43.88 97.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 61.5 m-85 -72.54 -27.49 62.26 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -62.01 -14.75 38.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -61.74 -44.64 96.52 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.689 1.196 . . . . 0.0 112.711 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.68 -36.15 70.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.675 1.19 . . . . 0.0 113.769 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.87 164.82 24.22 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.004 2.24 . . . . 0.0 110.547 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.83 134.13 56.78 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.224 1.012 . . . . 0.0 113.258 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -101.97 127.38 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.599 1.96 . . . . 0.0 109.228 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -72.5 -50.0 29.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.916 1.287 . . . . 0.0 112.875 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -160.09 160.45 33.08 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.487 1.115 . . . . 0.0 109.91 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.6 153.67 42.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.473 1.509 . . . . 0.0 111.115 174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -153.16 133.89 13.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.408 1.083 . . . . 0.0 111.991 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 19.2 mt -102.25 142.76 32.97 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.135 0.974 . . . . 0.0 110.448 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.487 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 30.2 mmt -80.67 86.53 5.89 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.956 -0.465 . . . . 0.0 111.554 -169.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.349 53.5 m-85 -61.76 123.84 19.08 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -76.01 -43.11 45.78 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.971 0.891 . . . . 0.0 110.938 168.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -152.59 123.02 7.22 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.053 2.141 . . . . 0.0 108.255 168.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.3 p -63.25 -30.11 71.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.466 1.506 . . . . 0.0 111.876 -169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 p -75.68 -8.21 56.25 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -127.37 -71.56 0.67 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.08 1.352 . . . . 0.0 114.399 -169.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -163.29 159.9 23.19 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -169.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -103.86 167.33 9.85 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.842 1.657 . . . . 0.0 112.01 169.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -70.24 7.8 0.92 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.953 1.701 . . . . 0.0 115.245 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.66 15.96 76.62 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.551 1.072 . . . . 0.0 114.41 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.487 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 35.4 p90 -152.18 164.58 37.04 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.795 1.298 . . . . 0.0 110.977 176.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.42 32.89 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.365 0.983 . . . . 0.0 113.871 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -120.13 147.7 44.55 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.132 1.773 . . . . 0.0 114.675 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.66 124.09 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.016 1.326 . . . . 0.0 111.366 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.2 m -105.34 137.62 42.84 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.531 1.933 . . . . 0.0 114.459 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.62 155.87 23.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -168.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -67.15 -34.58 77.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.839 0.855 . . . . 0.0 112.197 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 48.3 t -141.39 143.15 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.827 1.251 . . . . 0.0 112.517 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -66.37 -20.16 66.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.44 0.696 . . . . 0.0 112.597 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.34 -31.32 71.93 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 170.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.0 mm -73.89 -42.55 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.116 170.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.34 -44.02 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.801 0.728 . . . . 0.0 109.858 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -59.82 -48.18 82.73 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -57.0 -49.48 75.64 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.145 0.978 . . . . 0.0 112.285 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.4 -43.26 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.826 1.65 . . . . 0.0 110.987 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.2 m -69.23 -32.47 71.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -67.21 -27.79 67.54 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.239 0.927 . . . . 0.0 113.322 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.3 mt -68.91 -36.36 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.569 0.748 . . . . 0.0 110.688 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 66.42 -53.36 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.796 2.838 . . . . 0.0 115.07 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.317 59.0 m-85 -106.19 125.89 51.54 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -127.92 169.36 14.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.716 2.007 . . . . 0.0 111.074 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -131.03 130.58 43.48 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.244 -0.91 . . . . 0.0 112.51 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 56.8 mt -139.77 127.45 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.396 1.478 . . . . 0.0 108.969 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 49.53 43.04 23.7 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.001 1.321 . . . . 0.0 113.784 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 66.29 0.03 1.6 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.544 2.338 . . . . 0.0 116.459 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.61 143.68 26.08 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.664 1.12 . . . . 0.0 111.551 168.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 17.5 ttm -89.05 136.36 33.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.674 0.79 . . . . 0.0 111.029 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.42 149.04 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.502 1.521 . . . . 0.0 112.559 -176.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -95.24 128.25 41.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.864 0.866 . . . . 0.0 110.39 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 82.1 m -108.02 129.6 55.12 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.639 1.176 . . . . 0.0 111.012 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -152.21 153.12 33.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.227 1.411 . . . . 0.0 111.715 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.78 133.66 56.31 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.119 0.872 . . . . 0.0 112.58 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.72 127.48 32.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.186 0.595 . . . . 0.0 111.438 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -130.01 156.74 78.68 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.343 1.457 . . . . 0.0 112.339 -175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.16 141.03 81.17 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.022 2.481 . . . . 0.0 112.345 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -62.97 -21.29 66.01 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -63.54 -29.76 70.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.231 1.413 . . . . 0.0 113.439 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.259 0.9 OUTLIER -77.2 -27.24 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 173.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 25.5 mmt -86.67 -29.72 22.27 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.059 1.344 . . . . 0.0 113.077 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.7 t 51.43 57.08 16.84 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 126.369 1.868 . . . . 0.0 113.621 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.43 -13.91 20.39 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.149 3.232 . . . . 0.0 114.497 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.52 130.27 42.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 -170.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -77.39 168.28 54.43 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.507 1.051 . . . . 0.0 114.449 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.2 p -67.78 153.95 42.6 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.945 1.298 . . . . 0.0 113.405 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.37 134.2 56.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.181 0.992 . . . . 0.0 112.186 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -152.39 29.27 0.55 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.107 1.363 . . . . 0.0 114.028 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -170.19 -175.08 38.81 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.049 1.309 . . . . 0.0 113.429 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -148.68 164.39 34.47 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.688 1.595 . . . . 0.0 112.789 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.808 1.643 . . . . 0.0 112.784 171.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 1 O4'-C1'-N19 113.432 5.232 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.082 1 O4'-C1'-N19 112.396 4.196 . 0.084 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 0 O4'-C1'-N19 111.103 2.903 . 0.189 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . 0.417 " H1'" ' SD ' ' A' ' 141' ' ' MET . . . . . . . . 0 O4'--C4' 1.416 -3.089 0 O4'-C1'-N19 111.61 3.41 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.389 0 O4'-C1'-N19 111.356 3.156 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 112.109 -0.396 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.0 p -76.54 -28.99 56.52 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.434 1.094 . . . . 0.0 112.932 172.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -73.55 161.53 30.24 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.176 1.791 . . . . 0.0 112.542 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 57.4 21.59 7.03 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -70.69 33.2 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.151 1.38 . . . . 0.0 114.342 170.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -145.75 133.75 21.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.99 1.316 . . . . 0.0 111.305 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.19 151.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.381 1.086 . . . . 0.0 111.168 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -93.73 136.17 34.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.238 2.615 . . . . 0.0 106.939 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 t -126.13 116.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.863 1.265 . . . . 0.0 110.478 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.29 148.29 18.89 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.666 1.127 . . . . 0.0 114.1 -173.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.82 18.91 58.94 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.256 1.408 . . . . 0.0 114.49 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 22.1 mt -65.47 135.69 55.5 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.699 1.2 . . . . 0.0 111.66 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.5 t -64.58 142.72 58.33 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.84 -0.538 . . . . 0.0 112.03 173.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.78 -14.67 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 169.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -73.42 -31.56 63.92 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.71 0.804 . . . . 0.0 112.169 169.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -71.91 125.47 27.27 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.476 . . . . 0.0 113.625 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.15 166.13 16.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.8 -32.6 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -73.08 -35.5 66.66 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.017 0.927 . . . . 0.0 111.545 174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.91 -49.19 78.76 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.498 0.59 . . . . 0.0 112.016 169.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.75 -48.24 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.435 0.694 . . . . 0.0 109.929 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.64 -49.16 77.36 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.665 0.666 . . . . 0.0 111.967 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -60.66 -46.67 89.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 113.037 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.26 19.0 m-85 -64.72 -21.97 66.87 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.903 2.557 . . . . 0.0 117.903 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.321 61.0 m-85 -92.94 -23.58 18.69 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -62.6 -18.43 62.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -63.52 -28.95 70.3 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.359 -0.838 . . . . 0.0 113.058 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -83.75 -27.0 29.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 160.37 175.37 31.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 127.072 2.272 . . . . 0.0 110.973 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -65.89 132.64 49.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.453 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.11 133.72 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.633 1.973 . . . . 0.0 107.73 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -81.63 -46.58 14.18 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.786 1.234 . . . . 0.0 113.773 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -162.71 162.7 26.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 109.836 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.42 153.51 46.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.726 1.61 . . . . 0.0 111.482 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 23.6 ptm -155.52 151.0 27.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.505 1.122 . . . . 0.0 112.425 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.4 mt -119.29 144.52 46.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.539 1.536 . . . . 0.0 110.381 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 28.9 mmm -95.98 127.61 42.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.786 0.435 . . . . 0.0 110.751 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.426 62.1 m-85 -83.0 143.76 30.42 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 119.503 3.149 . . . . 0.0 119.503 -169.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -97.32 -52.43 3.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.78 0.832 . . . . 0.0 109.871 168.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -135.12 108.37 7.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.928 2.091 . . . . 0.0 108.071 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -28.5 65.09 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 -169.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.4 p -81.63 -6.61 59.17 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -135.61 -54.66 0.78 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -157.93 151.04 23.07 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.194 1.361 . . . . 0.0 113.742 -172.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 25.4 p80 -84.45 161.45 20.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.084 0.954 . . . . 0.0 112.063 170.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 8.56 8.6 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.366 2.266 . . . . 0.0 114.108 -172.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.81 13.16 59.71 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 121.022 -1.049 . . . . 0.0 115.034 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -152.25 163.26 39.78 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.139 1.47 . . . . 0.0 110.004 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.04 -170.84 28.5 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.834 1.207 . . . . 0.0 112.954 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.45 153.71 47.69 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.68 127.6 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.088 1.355 . . . . 0.0 111.948 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -99.92 145.8 27.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.297 1.839 . . . . 0.0 113.558 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.38 154.5 37.62 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -67.91 -34.97 77.64 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.367 0.667 . . . . 0.0 112.299 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.7 t -140.24 143.37 35.94 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.017 1.327 . . . . 0.0 111.984 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.44 -19.19 64.56 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.093 -0.379 . . . . 0.0 111.364 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -61.07 -31.12 70.79 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.81 -42.85 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.938 -0.476 . . . . 0.0 110.195 170.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.28 -43.61 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.74 0.7 . . . . 0.0 110.025 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.849 0.859 . . . . 0.0 112.763 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -57.91 -48.5 79.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.443 1.097 . . . . 0.0 112.353 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.16 -45.63 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.778 1.631 . . . . 0.0 110.825 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 48.4 t -70.1 -31.27 68.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.192 -0.942 . . . . 0.0 112.925 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.8 -32.55 74.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.803 1.241 . . . . 0.0 112.818 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.1 mt -67.22 -34.18 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.9 0.88 . . . . 0.0 111.064 171.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 66.22 -58.91 0.34 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.628 2.771 . . . . 0.0 115.026 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.287 56.0 m-85 -100.97 121.74 42.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 170.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -118.86 168.74 10.48 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.136 1.774 . . . . 0.0 111.118 -175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -126.68 135.65 51.43 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.229 1.012 . . . . 0.0 111.699 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.7 mt -140.78 129.08 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.877 1.671 . . . . 0.0 108.746 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 51.24 37.93 19.89 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.417 1.087 . . . . 0.0 113.799 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 64.74 1.15 1.31 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 127.519 2.328 . . . . 0.0 116.292 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -88.91 133.6 34.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.52 1.128 . . . . 0.0 110.473 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 27.1 ttm -84.1 137.53 33.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.686 0.794 . . . . 0.0 110.71 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.5 154.66 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 126.039 1.736 . . . . 0.0 111.589 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -102.93 131.73 49.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.408 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 78.5 m -111.87 134.8 53.19 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.014 1.326 . . . . 0.0 111.57 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.89 157.73 43.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.02 1.728 . . . . 0.0 110.228 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -62.92 138.7 58.62 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.168 1.349 . . . . 0.0 112.038 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.99 133.24 41.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.347 0.659 . . . . 0.0 111.959 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -64.61 146.53 98.25 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 122.992 0.517 . . . . 0.0 109.988 168.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.73 -36.85 10.11 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.688 2.259 . . . . 0.0 116.853 -165.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -156.05 44.94 0.44 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -169.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 55.32 48.8 18.42 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 122.823 1.297 . . . . 0.0 110.752 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.16 -1.78 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -168.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 20.4 mmt -62.02 -33.8 75.03 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.03 1.332 . . . . 0.0 112.428 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.4 t -162.76 139.7 5.98 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.372 1.469 . . . . 0.0 111.458 169.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.62 -14.3 43.41 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.074 2.516 . . . . 0.0 113.164 170.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.341 0.2 OUTLIER -116.97 19.44 14.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.944 2.098 . . . . 0.0 115.999 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 78.78 -20.33 4.52 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.835 1.683 . . . . 0.0 115.899 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 91.2 p -155.03 157.69 37.99 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.938 1.695 . . . . 0.0 111.04 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -64.67 132.12 48.8 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.546 -0.721 . . . . 0.0 111.756 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 156.17 39.71 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.519 1.128 . . . . 0.0 112.322 174.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -172.9 175.22 45.92 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.487 1.041 . . . . 0.0 113.732 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 95.0 mtm-85 -69.96 154.69 41.63 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.901 1.28 . . . . 0.0 113.045 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.7 p . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.762 1.625 . . . . 0.0 114.433 174.574 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.332 1 O4'-C1'-N19 114.637 6.437 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.138 0 O4'-C1'-N19 111.53 3.33 . 0.666 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.018 0 N19-C1'-C2' 116.561 1.976 . 0.221 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.511 1 O4'-C1'-N19 114.463 6.263 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.12 0 O4'-C1'-N19 111.123 2.923 . 0.143 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 72.1 m -139.45 147.89 41.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.699 1.6 . . . . 0.0 111.806 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -149.9 -51.57 0.14 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.11 0.964 . . . . 0.0 113.166 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 98.4 mmm -69.41 -11.56 60.92 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -76.33 46.08 0.4 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.464 1.906 . . . . 0.0 112.285 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -129.28 139.12 51.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.612 1.165 . . . . 0.0 113.846 -167.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -121.02 149.59 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.911 1.284 . . . . 0.0 112.081 173.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -87.11 139.43 30.58 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.054 2.542 . . . . 0.0 108.725 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.24 115.0 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.249 1.42 . . . . 0.0 109.452 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.07 147.63 16.62 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.278 0.942 . . . . 0.0 114.324 -173.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.81 18.34 48.06 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.054 1.312 . . . . 0.0 114.574 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.5 mt -58.44 144.44 42.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.948 1.299 . . . . 0.0 112.218 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.3 t -64.77 142.55 58.39 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.087 -0.383 . . . . 0.0 110.512 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.98 -14.83 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -72.64 -29.91 63.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.215 1.006 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.5 m -70.51 136.91 49.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.348 1.459 . . . . 0.0 114.753 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 t -116.84 164.08 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.516 1.527 . . . . 0.0 114.251 169.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -54.25 -35.5 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -174.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.23 -30.79 67.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -65.35 -44.67 86.94 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.824 0.738 . . . . 0.0 109.257 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.3 -47.03 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.963 1.305 . . . . 0.0 110.612 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -58.42 -51.02 71.59 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.694 0.798 . . . . 0.0 111.881 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -58.79 -43.95 90.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.843 0.857 . . . . 0.0 112.662 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.97 -42.7 94.33 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.349 63.6 m-85 -71.32 -28.25 63.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -59.88 -21.79 61.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.04 -33.92 74.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 112.199 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -72.0 -38.56 69.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 170.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.32 165.12 25.19 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 126.722 2.106 . . . . 0.0 111.497 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.13 134.28 52.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.277 1.037 . . . . 0.0 113.693 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.13 134.02 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.824 2.049 . . . . 0.0 108.237 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -79.17 -45.56 19.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.294 1.438 . . . . 0.0 113.419 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -161.81 158.82 26.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.426 1.091 . . . . 0.0 110.456 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.15 149.01 40.95 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.871 1.668 . . . . 0.0 111.346 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -154.95 130.76 10.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.178 0.991 . . . . 0.0 112.513 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.5 mt -101.81 141.17 35.08 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.975 0.91 . . . . 0.0 110.488 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 34.8 mmt -84.18 86.54 7.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.248 0.547 . . . . 0.0 112.137 -170.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.26 37.4 m-85 -66.9 136.23 55.05 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 118.275 2.694 . . . . 0.0 118.275 174.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -97.03 121.55 39.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.6 1.16 . . . . 0.0 113.193 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -63.04 -33.62 75.82 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.25 -50.94 16.89 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -23.86 65.91 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.254 30.7 m-80 58.54 33.02 22.77 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.7 1.6 . . . . 0.0 114.219 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -150.25 164.11 36.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.29 2.236 . . . . 0.0 110.74 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 34.3 p80 -77.35 153.47 33.75 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.532 0.682 . . . . 0.0 112.099 169.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.2 mtm-85 -70.93 13.12 0.21 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.75 12.36 80.09 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.153 0.882 . . . . 0.0 114.058 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -150.26 164.38 35.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.841 1.32 . . . . 0.0 110.837 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.55 -168.19 27.33 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.041 1.305 . . . . 0.0 113.417 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.89 149.3 50.83 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.271 1.828 . . . . 0.0 115.158 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 t -136.14 130.14 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.162 1.385 . . . . 0.0 111.563 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -108.09 140.99 40.46 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.058 1.743 . . . . 0.0 113.49 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.53 153.72 28.28 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -169.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.49 -34.83 70.49 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.526 0.73 . . . . 0.0 112.314 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.6 t -132.91 140.95 48.11 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.981 1.312 . . . . 0.0 112.15 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -65.11 -25.62 67.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.247 1.019 . . . . 0.0 111.781 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 16.5 mm -70.26 -40.78 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.002 -0.436 . . . . 0.0 110.325 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.69 -42.91 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.787 0.721 . . . . 0.0 110.842 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -63.23 -46.98 84.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.599 0.636 . . . . 0.0 112.586 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -56.64 -46.12 81.19 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.393 1.477 . . . . 0.0 112.602 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.84 -47.41 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.059 1.744 . . . . 0.0 110.876 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 67.4 m -66.12 -30.75 71.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.25 -31.0 72.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.897 1.279 . . . . 0.0 112.832 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.54 -33.37 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.363 1.065 . . . . 0.0 111.337 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 64.27 -59.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.611 2.764 . . . . 0.0 115.225 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.334 39.2 m-85 -99.05 119.85 38.49 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 169.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -114.83 170.32 8.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.729 2.012 . . . . 0.0 111.312 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -136.85 122.98 20.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.55 0.74 . . . . 0.0 112.331 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 34.1 mt -138.26 130.08 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.0 1.72 . . . . 0.0 108.954 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 50.73 47.19 24.89 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.886 1.274 . . . . 0.0 113.914 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.8 t30 59.09 30.63 20.47 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.927 1.691 . . . . 0.0 114.101 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -145.61 156.34 43.6 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.06 1.744 . . . . 0.0 110.38 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 50.3 mtp -105.48 148.82 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.3 147.15 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.566 1.547 . . . . 0.0 111.737 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -88.85 129.78 35.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.598 0.759 . . . . 0.0 110.305 172.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.65 132.05 55.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.354 1.062 . . . . 0.0 111.391 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -153.43 151.46 29.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.102 1.361 . . . . 0.0 112.073 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 130.35 45.15 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.608 0.763 . . . . 0.0 111.647 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.04 130.94 42.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -170.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -129.75 151.55 78.32 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 126.774 2.03 . . . . 0.0 111.303 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.11 142.53 38.32 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.852 2.368 . . . . 0.0 112.971 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -60.25 -22.85 63.56 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -64.7 -27.41 68.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.565 1.546 . . . . 0.0 113.1 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.7 m -98.1 -24.9 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 25.9 mmt -73.57 -27.78 61.5 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.9 t 52.0 56.19 15.62 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 126.32 1.848 . . . . 0.0 113.848 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.77 0.87 8.25 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.216 3.277 . . . . 0.0 114.356 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.5 p -65.36 -16.77 63.95 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.117 2.266 . . . . 0.0 117.117 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -77.93 -174.77 43.17 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.7 1.143 . . . . 0.0 114.518 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 53.3 m -69.75 -3.72 16.68 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.25 -4.87 32.08 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -57.89 149.45 22.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.992 1.317 . . . . 0.0 114.225 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -85.23 -99.58 0.69 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.173 1.368 . . . . 0.0 112.097 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 56.71 39.33 29.75 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.288 2.235 . . . . 0.0 113.858 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.794 0.838 . . . . 0.0 111.784 168.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.43 0 O5'-C5'-C4' 113.621 2.444 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.043 0 O4'-C1'-N19 111.612 3.412 . 0.568 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.648 0 O4'-C1'-N19 110.501 2.301 . 0.081 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.474 1 O4'-C1'-N19 112.831 4.631 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 0 O4'-C1'-N19 111.381 3.181 . 0.149 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.2 m -76.83 -18.12 58.58 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -83.44 168.63 16.35 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.658 1.183 . . . . 0.0 112.548 176.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.66 154.25 34.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.142 1.377 . . . . 0.0 109.406 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -105.59 6.27 32.01 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 170.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -136.34 140.91 43.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.279 1.431 . . . . 0.0 111.125 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.8 pt -117.9 150.66 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.64 1.176 . . . . 0.0 110.925 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -86.23 142.83 28.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.055 2.142 . . . . 0.0 107.23 165.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.64 106.53 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.505 1.522 . . . . 0.0 109.722 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.1 141.58 15.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.521 1.058 . . . . 0.0 114.763 -170.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.33 17.54 58.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.783 1.183 . . . . 0.0 114.924 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.82 122.64 15.33 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.694 1.197 . . . . 0.0 110.394 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.3 t -62.84 140.89 58.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.785 0.434 . . . . 0.0 110.795 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.299 0.3 OUTLIER -66.35 -10.27 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -168.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -77.8 -19.19 55.44 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.659 1.184 . . . . 0.0 112.862 169.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.8 m -71.32 138.87 49.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.291 1.436 . . . . 0.0 112.24 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 t -113.81 162.93 15.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 173.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.61 -34.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.414 1.485 . . . . 0.0 114.252 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.56 -34.51 75.95 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.305 0.642 . . . . 0.0 112.279 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.86 -44.09 97.54 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.017 0.826 . . . . 0.0 109.503 175.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.15 -46.69 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 111.336 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -59.31 -50.6 73.35 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.059 0.944 . . . . 0.0 112.054 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -64.71 -34.85 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -63.85 -53.34 52.22 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 173.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 51.9 m-85 -65.02 -22.2 66.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -63.16 -12.99 31.78 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.31 -29.22 69.95 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.525 1.057 . . . . 0.0 112.546 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -86.18 -31.61 21.67 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.346 1.058 . . . . 0.0 112.82 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.31 168.49 28.57 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 127.729 2.585 . . . . 0.0 110.33 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.61 134.7 54.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.166 0.984 . . . . 0.0 112.082 -169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.0 t -97.63 134.08 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.034 1.733 . . . . 0.0 108.169 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.4 -45.73 15.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.792 1.237 . . . . 0.0 113.764 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -162.89 164.06 26.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.731 1.212 . . . . 0.0 109.866 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -142.76 153.27 43.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.276 1.43 . . . . 0.0 111.579 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptm -152.03 136.45 16.81 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.706 1.202 . . . . 0.0 111.618 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.1 mt -107.85 153.52 22.9 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.83 0.852 . . . . 0.0 110.303 168.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 35.8 mmm -82.47 71.67 9.54 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.924 0.869 . . . . 0.0 111.317 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -70.6 155.48 40.67 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -172.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -119.66 105.07 10.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.417 2.287 . . . . 0.0 110.976 167.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -65.06 -9.38 21.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -33.7 76.02 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 169.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -139.4 -3.53 1.52 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.277 76.4 m-20 62.16 12.61 5.19 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.097 2.159 . . . . 0.0 115.497 -170.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.27 169.39 16.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.793 1.237 . . . . 0.0 110.182 167.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -142.76 168.54 19.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.192 0.997 . . . . 0.0 112.446 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -67.33 2.42 1.69 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.13 68.37 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.432 1.015 . . . . 0.0 114.888 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -153.09 168.74 24.91 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 118.345 1.072 . . . . 0.0 110.139 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -165.94 -167.77 27.08 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.455 1.026 . . . . 0.0 113.085 174.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -126.7 150.12 49.19 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.085 1.754 . . . . 0.0 114.976 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.58 122.08 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.017 1.327 . . . . 0.0 111.153 173.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m -93.54 143.08 26.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.492 1.917 . . . . 0.0 113.78 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -115.41 155.69 26.95 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -170.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -66.95 -36.06 81.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.327 0.651 . . . . 0.0 111.608 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.1 t -142.95 141.83 31.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 0.0 112.837 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -61.5 -20.59 63.36 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.007 1.323 . . . . 0.0 113.004 169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.9 -25.73 67.29 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.9 -40.86 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.749 -0.594 . . . . 0.0 110.193 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -58.01 -45.39 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.026 0.83 . . . . 0.0 110.191 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -66.11 -35.78 81.41 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.832 0.742 . . . . 0.0 112.784 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.0 -46.29 85.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.586 1.555 . . . . 0.0 111.977 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.74 -47.61 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.608 1.563 . . . . 0.0 110.699 175.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 68.1 m -65.08 -30.71 71.68 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -64.9 -26.64 68.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.695 1.198 . . . . 0.0 113.402 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.47 -32.25 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.112 0.965 . . . . 0.0 111.119 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 67.69 -49.82 0.51 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.867 2.867 . . . . 0.0 115.488 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.33 49.2 m-85 -114.5 123.83 50.39 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -121.27 157.07 31.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.783 2.033 . . . . 0.0 110.885 -171.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -117.18 114.81 24.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.53 -0.731 . . . . 0.0 111.981 -174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 38.5 mt -131.33 125.39 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.51 1.124 . . . . 0.0 109.634 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 49.7 37.09 12.12 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.448 1.099 . . . . 0.0 112.971 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.251 33.7 m120 61.41 4.66 1.0 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.806 2.442 . . . . 0.0 116.864 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -86.61 138.81 31.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.473 1.109 . . . . 0.0 110.105 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 91.2 mmm -82.6 131.62 35.21 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.518 0.727 . . . . 0.0 110.537 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.04 148.22 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.099 1.359 . . . . 0.0 111.748 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -96.11 125.39 40.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.587 0.755 . . . . 0.0 111.721 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -89.87 135.44 33.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.179 0.592 . . . . 0.0 110.801 168.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -142.09 149.79 40.35 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.01 1.324 . . . . 0.0 109.666 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -61.61 135.35 57.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.515 1.052 . . . . 0.0 110.522 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.95 137.51 49.24 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -134.82 148.91 69.06 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 124.968 1.307 . . . . 0.0 111.604 169.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.33 149.48 88.27 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.327 2.685 . . . . 0.0 113.862 -172.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -67.14 -16.64 64.44 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 173.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -72.6 -22.78 60.92 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.987 1.315 . . . . 0.0 112.894 169.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.63 -49.2 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.381 1.473 . . . . 0.0 110.602 169.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 70.7 mtp -82.37 60.22 4.95 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.034 1.734 . . . . 0.0 112.02 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.1 m -59.78 -37.06 45.73 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.58 137.17 53.45 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.224 2.616 . . . . 0.0 113.134 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.23 -14.43 62.96 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 75.03 -34.1 1.07 Allowed Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.789 1.662 . . . . 0.0 115.591 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.6 t -64.65 153.52 39.23 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.547 1.539 . . . . 0.0 113.091 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -146.37 151.42 37.44 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.702 1.601 . . . . 0.0 112.091 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 29.9 ptt-85 -81.16 -8.25 59.72 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.99 154.2 52.82 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 124.38 0.991 . . . . 0.0 114.349 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -149.87 135.71 18.59 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.901 1.68 . . . . 0.0 110.942 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.201 1.4 . . . . 0.0 111.369 174.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.724 0 O5'-C5'-C4' 114.314 2.938 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.339 0 O4'-C1'-N19 112.095 3.895 . 0.024 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.503 0 O4'-C1'-N19 111.803 3.603 . 0.241 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.429 0 C4'-C3'-C2' 99.517 -3.183 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.431 -1.851 1 O4'-C1'-N19 113.857 5.657 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.6 p -72.37 160.66 31.99 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.74 1.216 . . . . 0.0 113.908 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -66.2 163.37 17.92 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.881 1.673 . . . . 0.0 112.817 171.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 77.7 mtm -59.24 142.1 52.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.57 0.748 . . . . 0.0 112.081 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -75.93 39.87 0.19 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.476 1.11 . . . . 0.0 112.848 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -132.64 138.13 47.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.843 1.257 . . . . 0.0 112.569 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.7 pt -117.26 149.82 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.783 1.233 . . . . 0.0 111.604 172.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -85.87 138.93 31.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.911 2.084 . . . . 0.0 108.257 163.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.86 108.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 109.609 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.07 147.43 17.78 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.4 9.98 58.58 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.647 1.117 . . . . 0.0 114.206 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 39.2 mt -62.24 134.95 57.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.121 1.461 . . . . 0.0 111.037 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.0 t -61.57 143.27 56.3 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.206 -0.309 . . . . 0.0 111.367 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -60.78 -18.43 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 170.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -75.42 -25.78 57.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.827 1.251 . . . . 0.0 113.295 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.8 m -70.94 134.16 46.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.221 1.408 . . . . 0.0 113.271 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -106.49 158.4 16.94 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.191 1.396 . . . . 0.0 113.613 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.0 p -56.54 -32.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.87 -30.02 67.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -65.17 -47.11 78.12 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.92 -48.06 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.641 0.777 . . . . 0.0 111.459 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -60.77 -45.82 92.85 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.835 -0.541 . . . . 0.0 112.287 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -59.85 -44.27 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.116 0.871 . . . . 0.0 113.307 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -58.98 -33.94 71.26 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.307 55.9 m-85 -85.65 -24.97 26.85 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 174.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -60.82 -16.25 38.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 172.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.62 -42.11 87.47 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.053 1.341 . . . . 0.0 112.375 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -79.07 -29.66 43.52 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.91 -173.96 38.32 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.975 1.75 . . . . 0.0 111.949 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -70.11 107.34 3.62 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.638 -0.919 . . . . 0.0 112.645 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.07 130.99 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.308 1.443 . . . . 0.0 109.609 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.38 -57.38 3.9 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.12 0.968 . . . . 0.0 112.727 173.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -157.48 164.74 37.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.953 0.901 . . . . 0.0 110.467 -170.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.01 155.03 41.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.481 1.512 . . . . 0.0 111.404 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -154.44 129.71 9.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.182 0.993 . . . . 0.0 113.136 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.78 144.62 26.51 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.476 1.11 . . . . 0.0 111.209 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 32.6 mmt -93.96 82.63 4.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.065 0.936 . . . . 0.0 111.551 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.294 50.9 m-85 -60.2 137.45 58.11 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 178.026 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -81.08 -54.32 5.64 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.712 0.805 . . . . 0.0 110.839 168.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.2 114.72 11.09 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.624 1.97 . . . . 0.0 107.608 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -27.71 66.62 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.287 2.329 . . . . 0.0 117.287 -169.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 t -76.56 -9.99 59.06 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -129.25 -64.01 0.92 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -169.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -157.41 156.27 31.92 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -168.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 32.6 p80 -113.54 161.64 17.15 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.231 1.413 . . . . 0.0 112.848 171.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -73.75 11.09 0.91 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.6 13.89 83.02 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.112 -0.826 . . . . 0.0 114.367 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -145.2 161.78 38.7 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.215 1.507 . . . . 0.0 112.052 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.9 -179.19 34.53 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.868 1.223 . . . . 0.0 112.471 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -116.79 149.14 40.45 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.563 1.545 . . . . 0.0 114.922 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.0 124.17 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.87 1.268 . . . . 0.0 111.523 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.52 142.67 33.88 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.691 1.997 . . . . 0.0 114.068 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.13 149.79 40.45 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.0 113.998 -172.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.55 -40.93 48.34 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.03 -0.419 . . . . 0.0 111.721 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 12.9 m -110.71 132.05 54.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 112.144 177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -63.18 -34.09 76.88 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.476 1.111 . . . . 0.0 112.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -58.76 -28.33 65.81 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.3 mm -70.9 -39.76 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.753 -0.592 . . . . 0.0 110.465 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.94 -42.18 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.569 0.622 . . . . 0.0 110.25 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -63.4 -47.71 80.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.629 0.772 . . . . 0.0 111.84 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -57.32 -50.59 72.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.664 1.186 . . . . 0.0 112.234 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.7 -45.0 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 111.062 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 35.2 t -71.21 -32.37 68.74 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.415 -0.803 . . . . 0.0 112.643 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.25 -32.71 74.4 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.61 1.164 . . . . 0.0 112.723 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.4 -35.61 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.982 0.913 . . . . 0.0 111.18 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 66.7 -51.84 0.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.525 2.73 . . . . 0.0 115.06 173.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.261 74.5 m-85 -108.71 125.84 52.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 176.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -132.24 155.87 47.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.407 1.483 . . . . 0.0 112.376 -169.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -107.96 127.6 53.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.228 1.011 . . . . 0.0 111.408 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 44.6 mt -137.05 124.36 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.737 1.615 . . . . 0.0 109.035 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.46 36.11 12.65 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.225 1.01 . . . . 0.0 113.223 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.82 6.19 1.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.609 2.363 . . . . 0.0 116.765 -171.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.02 143.96 26.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.001 1.721 . . . . 0.0 109.992 169.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 41.5 tpp -85.15 133.89 34.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.374 1.07 . . . . 0.0 110.876 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 4.2 m -129.83 152.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.871 1.669 . . . . 0.0 113.703 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -104.27 123.78 47.97 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.831 1.252 . . . . 0.0 110.591 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 83.7 m -104.88 130.94 52.93 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.063 1.345 . . . . 0.0 111.072 174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -153.28 145.35 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.026 1.33 . . . . 0.0 111.582 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.42 137.31 57.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.15 0.886 . . . . 0.0 112.265 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.01 131.38 45.73 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 122.963 0.505 . . . . 0.0 112.258 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -129.68 155.49 80.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.911 1.685 . . . . 0.0 111.834 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -62.6 145.0 95.22 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.311 2.674 . . . . 0.0 115.318 -170.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -61.74 -28.28 69.32 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -78.9 -27.92 43.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.531 1.532 . . . . 0.0 113.315 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.71 -28.5 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 58.3 mtp -99.93 17.14 21.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.772 1.629 . . . . 0.0 114.539 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.4 p -60.55 145.87 86.43 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 121.108 -0.995 . . . . 0.0 113.138 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.96 143.78 61.73 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.287 2.658 . . . . 0.0 112.775 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.3 p -79.72 -17.42 53.59 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 168.8 -162.06 35.8 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.106 1.336 . . . . 0.0 113.177 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.2 t -65.9 155.36 36.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.259 1.024 . . . . 0.0 112.668 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.69 -15.17 63.51 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.819 1.248 . . . . 0.0 114.178 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -148.99 156.24 41.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.781 1.632 . . . . 0.0 112.417 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 169.33 174.05 37.45 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.712 1.149 . . . . 0.0 113.555 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -70.04 124.09 23.21 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.064 1.346 . . . . 0.0 111.403 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.917 1.687 . . . . 0.0 113.179 178.625 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.27 0 C5'-C4'-C3' 110.101 -3.599 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.665 1 C5'-C4'-C3' 108.207 -4.862 . 0.432 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.325 0 O4'-C1'-N19 112.191 3.991 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . 0.413 ' N3 ' " H5'" ' B' ' 204' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.427 -2.162 1 O4'-C1'-N19 113.277 5.077 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.525 1 O4'-C1'-N19 113.297 5.097 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.36 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.2 t -67.24 120.62 14.08 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.683 1.193 . . . . 0.0 112.673 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -75.32 -28.99 59.87 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.875 0.87 . . . . 0.0 111.783 169.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 96.4 mtp -66.94 -36.08 81.42 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.463 1.105 . . . . 0.0 113.301 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt 50.61 39.59 21.78 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.36 1.464 . . . . 0.0 113.732 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HE2' ' CD1' ' A' ' 154' ' ' PHE . 85.1 tttt -115.72 139.66 49.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.219 1.407 . . . . 0.0 112.099 -169.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.2 pt -121.94 150.15 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.12 1.368 . . . . 0.0 111.202 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -84.3 145.84 28.06 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.924 2.09 . . . . 0.0 107.379 166.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -132.12 117.28 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.736 1.614 . . . . 0.0 110.153 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -121.0 149.73 17.34 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.356 0.979 . . . . 0.0 114.037 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.77 16.0 55.48 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 124.951 1.262 . . . . 0.0 114.913 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.6 mt -68.38 135.39 51.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.881 1.273 . . . . 0.0 111.508 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.9 p -69.48 151.1 46.46 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.341 -0.849 . . . . 0.0 111.849 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -65.17 -16.23 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -79.77 -28.55 40.34 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.609 1.164 . . . . 0.0 112.941 171.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 80.8 m -71.22 136.99 48.31 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.486 1.115 . . . . 0.0 110.763 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.6 t -119.02 163.35 17.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.86 -36.58 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -173.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.06 -35.81 80.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.518 0.727 . . . . 0.0 112.468 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.14 -47.76 75.96 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.38 -42.25 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.049 0.539 . . . . 0.0 111.844 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -59.35 -53.05 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.603 0.638 . . . . 0.0 111.803 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -60.11 -38.74 83.87 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.282 33.3 m-85 -66.22 -16.48 64.03 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 52.5 m-85 -99.37 -26.76 14.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.55 -22.3 43.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.575 1.55 . . . . 0.0 114.234 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -62.77 -29.46 70.71 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -83.45 -27.44 29.5 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.82 169.19 21.92 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 127.355 2.407 . . . . 0.0 110.491 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -61.61 132.17 52.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.077 0.942 . . . . 0.0 113.279 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.45 124.46 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.667 1.987 . . . . 0.0 109.342 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.04 -56.25 7.43 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -146.54 160.01 42.69 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -170.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.4 153.24 40.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.777 1.231 . . . . 0.0 110.466 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptm -153.49 124.63 7.44 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.748 1.219 . . . . 0.0 111.159 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.8 mt -103.62 153.37 20.69 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.595 0.758 . . . . 0.0 111.413 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.438 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 37.6 mmt -76.71 62.47 2.0 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.072 1.349 . . . . 0.0 113.502 -173.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -65.78 136.53 56.34 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -99.25 113.19 25.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.178 1.391 . . . . 0.0 112.423 169.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -59.16 -18.67 38.21 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -25.13 63.57 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 172.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -134.84 -16.45 1.98 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.886 2.18 . . . . 0.0 116.886 -173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 61.3 12.8 4.45 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.718 2.007 . . . . 0.0 115.318 -170.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -94.65 163.48 13.36 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.276 1.43 . . . . 0.0 109.994 168.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -114.6 163.84 14.85 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.857 0.863 . . . . 0.0 113.13 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -68.62 3.38 1.88 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.59 14.55 75.66 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.217 -0.927 . . . . 0.0 114.712 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 32.1 p90 -148.6 168.09 23.71 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.051 0.926 . . . . 0.0 110.441 174.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -172.57 -166.62 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.984 1.278 . . . . 0.0 113.189 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.452 ' CD1' ' HE2' ' A' ' 110' ' ' LYS . 94.6 m-85 -128.6 154.05 46.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 115.186 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.95 140.31 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.756 1.622 . . . . 0.0 110.854 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -123.05 136.89 55.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.848 2.059 . . . . 0.0 114.358 -174.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -110.87 156.65 20.85 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 -168.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -63.97 -41.72 97.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.271 1.028 . . . . 0.0 112.302 170.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.4 t -137.78 143.04 40.89 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.624 1.17 . . . . 0.0 112.414 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -62.62 -26.29 68.54 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.299 1.04 . . . . 0.0 111.903 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.08 -32.92 71.4 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.51 -42.02 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.389 171.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.16 -43.52 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.843 0.747 . . . . 0.0 110.697 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -62.95 -47.99 80.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.395 0.678 . . . . 0.0 112.828 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.83 -47.07 81.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.734 1.213 . . . . 0.0 112.345 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.46 -48.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.705 1.602 . . . . 0.0 110.617 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 47.7 t -65.54 -34.73 78.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -61.66 -27.22 68.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.997 1.319 . . . . 0.0 113.652 176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.41 -33.15 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 0.0 111.321 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 65.73 -53.22 0.37 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 128.886 2.875 . . . . 0.0 115.32 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.272 57.3 m-85 -108.14 122.2 46.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 175.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -123.67 151.04 43.51 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.359 1.464 . . . . 0.0 112.606 -169.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -101.64 126.05 48.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.998 0.919 . . . . 0.0 110.903 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 10.4 mt -138.03 125.61 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.74 1.616 . . . . 0.0 108.811 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 50.27 37.01 13.97 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.395 1.078 . . . . 0.0 113.463 -173.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 61.96 7.1 1.93 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.044 2.138 . . . . 0.0 116.003 -171.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -95.34 163.01 13.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.87 1.668 . . . . 0.0 111.421 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -95.37 129.38 42.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.362 1.465 . . . . 0.0 111.061 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.1 165.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.589 1.556 . . . . 0.0 113.151 173.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -123.22 130.32 52.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.388 1.075 . . . . 0.0 111.762 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.72 144.44 25.51 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.982 0.913 . . . . 0.0 111.92 168.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -140.08 149.6 43.3 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.969 1.307 . . . . 0.0 108.591 170.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -64.56 131.18 46.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.983 1.265 . . . . 0.0 110.732 170.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.83 150.62 37.64 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -144.78 150.66 47.32 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.504 1.521 . . . . 0.0 110.313 170.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.83 159.18 38.85 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.169 2.579 . . . . 0.0 115.832 -169.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -54.69 -28.82 50.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.408 2.283 . . . . 0.0 114.898 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -78.2 -25.63 47.16 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.707 1.603 . . . . 0.0 113.743 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.84 -34.02 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -169.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -158.18 163.03 37.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.706 1.602 . . . . 0.0 110.847 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 90.3 p -144.71 159.67 50.0 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 128.463 2.705 . . . . 0.0 111.003 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.73 147.93 45.8 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.67 2.247 . . . . 0.0 112.225 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.5 t -151.24 157.49 42.65 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 162.69 -173.39 38.92 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.41 1.481 . . . . 0.0 113.168 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 30.0 p -65.46 148.91 50.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.311 1.044 . . . . 0.0 112.995 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -71.69 -19.04 62.12 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -60.77 151.23 30.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.106 1.762 . . . . 0.0 113.008 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.63 161.43 54.1 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.094 0.854 . . . . 0.0 113.609 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 -72.14 139.81 48.5 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.605 1.162 . . . . 0.0 111.633 174.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.539 1.936 . . . . 0.0 112.493 -178.794 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.103 1 O4'-C1'-N19 112.419 4.219 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.204 0 O4'-C1'-N19 111.224 3.024 . 0.605 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.708 0 O4'-C1'-N19 111.591 3.391 . 0.282 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.733 0 C5'-C4'-C3' 110.109 -3.594 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.219 0 O4'-C1'-N19 111.376 3.176 . 0.497 2z . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.938 -0.465 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.2 m -76.18 68.73 2.65 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.949 1.3 . . . . 0.0 113.089 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.79 -32.26 73.43 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.865 1.266 . . . . 0.0 113.295 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.39 144.37 57.12 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.776 1.231 . . . . 0.0 111.617 175.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -116.88 17.46 15.04 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -170.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 81.3 tttt -105.86 132.73 51.61 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.278 1.831 . . . . 0.0 111.583 -172.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -120.3 150.37 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.918 1.287 . . . . 0.0 111.339 172.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -85.99 142.64 28.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.462 1.905 . . . . 0.0 109.441 165.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.6 t -126.6 100.55 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.519 1.528 . . . . 0.0 109.943 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.43 144.38 17.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.501 1.048 . . . . 0.0 113.952 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 19.72 54.09 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.41 1.005 . . . . 0.0 115.181 174.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.6 135.57 55.24 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.519 1.159 . . . . 0.0 111.379 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -66.81 144.0 56.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.024 0.53 . . . . 0.0 111.295 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 m -59.54 -16.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.98 -27.78 62.01 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.484 1.114 . . . . 0.0 113.303 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 31.2 m -77.11 131.24 38.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.637 1.575 . . . . 0.0 113.608 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.96 165.54 15.15 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -62.01 -34.98 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -71.46 -36.69 71.3 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 111.595 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -55.84 -51.67 66.69 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.411 0.551 . . . . 0.0 111.949 169.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.1 t -61.67 -42.58 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.9 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -57.59 -52.96 63.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 118.814 0.734 . . . . 0.0 111.123 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -62.48 -39.83 94.72 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.259 22.5 m-85 -63.67 -20.01 65.36 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 117.882 2.549 . . . . 0.0 117.882 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 60.6 m-85 -97.3 -27.23 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 169.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.4 -23.51 38.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.223 1.409 . . . . 0.0 114.532 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -62.86 -29.78 71.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -85.75 -35.81 20.54 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.665 0.786 . . . . 0.0 111.628 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.69 163.04 24.97 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 128.179 2.799 . . . . 0.0 109.328 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -66.88 155.66 37.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -169.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.9 t -113.97 121.29 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 113.195 -1.82 . . . . 0.0 108.649 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -73.2 -39.6 65.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.746 1.218 . . . . 0.0 111.244 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.13 144.33 18.65 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.924 2.09 . . . . 0.0 115.206 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -132.16 148.17 52.46 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.621 1.168 . . . . 0.0 110.66 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -148.66 138.38 22.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.34 1.056 . . . . 0.0 111.564 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 46.1 mt -100.18 139.61 35.61 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.686 0.795 . . . . 0.0 110.444 170.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.7 mmm -89.49 138.9 31.05 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 122.892 0.477 . . . . 0.0 110.09 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.321 22.4 m-85 -102.46 145.35 29.68 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -175.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -69.83 126.82 30.86 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 168.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -70.1 3.22 2.9 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -169.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.7 p -70.76 -20.59 62.6 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.963 1.705 . . . . 0.0 109.057 164.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.522 0.3 OUTLIER 71.3 22.54 4.28 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.97 2.508 . . . . 0.0 116.277 -168.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.58 -59.43 2.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -149.02 168.98 21.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.723 2.009 . . . . 0.0 111.437 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -68.34 147.74 51.7 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.578 0.704 . . . . 0.0 110.987 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -79.16 11.8 2.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.594 2.358 . . . . 0.0 113.598 -169.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.43 76.66 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.931 -1.106 . . . . 0.0 115.466 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.34 166.36 32.1 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.652 1.226 . . . . 0.0 112.329 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.25 -179.71 35.21 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.12 0.867 . . . . 0.0 113.529 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 95.7 m-85 -117.94 148.15 42.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.069 1.748 . . . . 0.0 115.248 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.8 t -137.03 126.83 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.918 1.287 . . . . 0.0 111.961 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -106.14 131.91 52.83 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.101 2.161 . . . . 0.0 114.479 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -102.54 159.49 15.39 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 120.33 3.455 . . . . 0.0 120.33 -167.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -58.32 -38.76 77.75 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.22 2.208 . . . . 0.0 113.501 170.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.9 t -155.26 153.42 30.6 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.408 1.483 . . . . 0.0 111.337 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -60.17 -32.3 70.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 111.25 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -61.96 -34.18 75.65 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.02 -42.93 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.179 -0.439 . . . . 0.0 110.195 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.95 -43.88 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.814 0.734 . . . . 0.0 110.511 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.31 -46.45 88.69 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -58.45 -45.5 88.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.59 1.156 . . . . 0.0 112.418 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.14 -48.91 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.002 1.721 . . . . 0.0 110.646 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.96 -30.58 71.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -64.55 -27.92 69.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 113.276 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.02 -33.27 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.208 1.003 . . . . 0.0 111.256 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 65.34 -58.84 0.28 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.543 2.737 . . . . 0.0 114.667 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.307 54.1 m-85 -104.3 116.97 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 173.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -112.15 152.69 28.04 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.91 1.684 . . . . 0.0 111.47 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.69 125.15 48.3 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.748 0.819 . . . . 0.0 110.495 174.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.04 122.46 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.545 1.538 . . . . 0.0 108.901 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 50.2 35.84 11.23 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.0 m120 63.03 2.12 0.98 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.427 2.291 . . . . 0.0 116.611 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -83.52 138.67 33.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.444 1.498 . . . . 0.0 109.112 168.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 92.8 mmm -86.43 129.82 34.72 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.833 -0.542 . . . . 0.0 110.78 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.13 152.2 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.526 1.53 . . . . 0.0 112.605 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -105.51 120.41 41.55 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.082 0.953 . . . . 0.0 111.654 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.33 141.86 28.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.151 0.58 . . . . 0.0 111.415 168.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -148.28 146.29 28.54 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 109.006 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.88 137.25 58.23 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.753 1.161 . . . . 0.0 110.155 168.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.12 133.81 49.53 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.577 0.703 . . . . 0.0 112.164 -174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -142.49 156.63 63.51 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.312 2.245 . . . . 0.0 111.855 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.0 167.87 26.15 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.276 2.651 . . . . 0.0 112.522 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -57.59 -12.15 2.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.321 1.848 . . . . 0.0 115.086 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -62.88 -26.46 68.79 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.155 1.382 . . . . 0.0 113.374 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.334 2.2 m -81.88 15.98 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -177.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 91.6 mtp -75.19 46.53 0.32 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.691 1.596 . . . . 0.0 113.568 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.6 p -68.79 152.86 96.52 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.441 1.096 . . . . 0.0 112.094 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.68 138.69 38.69 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.069 2.513 . . . . 0.0 112.703 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.306 1.3 p -130.67 15.62 5.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.33 1.852 . . . . 0.0 115.905 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 83.89 172.89 49.37 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.752 1.168 . . . . 0.0 113.372 -169.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 39.7 t -68.97 -40.78 78.66 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -158.71 168.04 27.91 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.652 1.581 . . . . 0.0 111.791 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -67.01 -16.45 64.37 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 79.98 173.82 46.16 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.308 1.432 . . . . 0.0 114.389 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -78.86 91.66 4.79 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.169 1.387 . . . . 0.0 111.786 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.785 1.634 . . . . 0.0 112.37 169.589 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.124 0 O4'-C1'-N19 111.524 3.324 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.419 0 O5'-C5'-C4' 113.624 2.445 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.369 1 C1'-O4'-C4' 105.286 -4.793 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.626 0 C5'-C4'-C3' 109.855 -3.763 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.28 0 O4'-C1'-N19 110.967 2.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 54.5 p -69.21 159.05 33.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.916 1.286 . . . . 0.0 113.694 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -136.36 -73.04 0.44 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.548 1.539 . . . . 0.0 112.002 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 52.8 tpp -164.49 145.47 8.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.878 1.271 . . . . 0.0 111.687 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -74.79 36.28 0.11 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.367 1.467 . . . . 0.0 114.714 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -142.08 138.92 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.789 -1.194 . . . . 0.0 113.041 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.69 151.91 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.932 1.293 . . . . 0.0 111.159 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -86.27 144.52 27.37 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.316 2.246 . . . . 0.0 106.546 165.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.08 108.9 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.806 1.642 . . . . 0.0 108.899 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.44 147.96 18.61 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 124.444 1.021 . . . . 0.0 114.531 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.56 19.96 36.25 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.896 1.236 . . . . 0.0 114.734 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.17 134.98 53.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.774 1.23 . . . . 0.0 111.466 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.9 t -63.24 152.39 37.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.928 0.891 . . . . 0.0 112.488 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.2 m -59.61 -20.08 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.625 1.17 . . . . 0.0 113.535 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -79.56 -25.91 41.51 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.572 1.149 . . . . 0.0 112.893 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 36.2 m -73.78 140.96 46.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.077 1.351 . . . . 0.0 113.713 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.3 t -122.87 164.13 19.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.736 1.614 . . . . 0.0 114.903 173.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.08 -35.84 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -69.17 -29.83 67.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.593 0.757 . . . . 0.0 112.775 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.41 -48.93 68.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.67 -43.01 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.821 0.848 . . . . 0.0 111.742 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.98 -46.54 90.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.156 0.582 . . . . 0.0 111.801 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -59.38 -45.26 91.95 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.986 0.914 . . . . 0.0 113.088 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -63.69 -35.33 80.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.346 62.3 m-85 -84.03 -25.82 29.58 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -59.37 -21.13 59.39 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.82 -31.81 73.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.119 1.367 . . . . 0.0 112.322 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -80.89 -26.54 36.78 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 159.0 165.0 15.18 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.993 2.235 . . . . 0.0 110.974 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.99 133.43 56.09 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.958 0.885 . . . . 0.0 112.638 -171.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.97 125.23 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.96 1.704 . . . . 0.0 108.093 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.99 -35.43 59.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -163.87 157.48 18.81 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.17 0.988 . . . . 0.0 110.435 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -140.9 150.49 43.25 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.234 1.414 . . . . 0.0 111.218 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptm -153.88 133.73 13.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.633 1.173 . . . . 0.0 111.883 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.6 mt -103.9 147.66 27.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 170.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.9 mmm -97.94 108.17 20.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -171.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.287 53.9 m-85 -80.84 149.4 29.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -90.7 169.05 11.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.042 1.737 . . . . 0.0 114.048 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -69.22 5.29 1.29 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 18.4 p -66.36 -21.88 66.25 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.395 1.078 . . . . 0.0 108.702 164.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.434 0.8 OUTLIER 62.91 14.23 7.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.322 2.249 . . . . 0.0 114.765 -169.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -140.8 -18.28 0.84 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -167.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -127.87 144.44 51.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.958 1.303 . . . . 0.0 112.148 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -101.26 159.57 15.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.612 1.165 . . . . 0.0 112.633 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 -72.76 9.85 1.02 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.42 22.16 77.83 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.122 -0.986 . . . . 0.0 113.853 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -150.34 166.27 30.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.518 1.151 . . . . 0.0 108.222 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.92 -170.33 23.35 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.79 1.186 . . . . 0.0 113.088 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -119.47 152.68 36.51 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.677 1.591 . . . . 0.0 114.486 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.79 127.41 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.13 1.372 . . . . 0.0 110.835 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.09 139.1 38.16 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.854 2.062 . . . . 0.0 113.759 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -112.09 155.34 24.02 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -66.87 -34.86 78.73 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.454 0.702 . . . . 0.0 112.087 172.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.5 t -141.64 143.51 33.67 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 112.206 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -67.01 -20.42 65.87 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.747 0.819 . . . . 0.0 111.976 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.62 -31.44 71.52 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 19.8 mm -72.84 -40.8 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.283 171.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.18 -44.85 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.941 0.791 . . . . 0.0 109.957 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -63.95 -45.0 91.11 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -56.91 -46.38 82.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.367 1.067 . . . . 0.0 111.868 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 99.3 t -67.88 -49.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.885 1.674 . . . . 0.0 110.651 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.15 -33.29 75.15 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -61.88 -27.38 68.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.462 1.105 . . . . 0.0 113.459 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.1 mt -72.56 -31.66 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.743 1.217 . . . . 0.0 111.754 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 66.04 -48.89 0.41 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 128.87 2.868 . . . . 0.0 115.607 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.305 51.8 m-85 -117.51 122.46 43.78 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -120.89 149.4 42.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 111.899 -172.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -87.57 131.77 34.28 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.327 0.651 . . . . 0.0 111.846 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.8 mt -141.23 125.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.488 1.915 . . . . 0.0 108.74 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 51.27 41.36 27.88 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.726 1.211 . . . . 0.0 114.255 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 64.5 t30 60.27 21.13 10.57 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.13 1.772 . . . . 0.0 114.654 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -120.4 167.18 12.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.203 2.201 . . . . 0.0 110.318 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 95.9 mmm -105.52 141.19 37.43 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.928 0.891 . . . . 0.0 112.448 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.68 149.62 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.838 1.655 . . . . 0.0 112.29 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -94.78 127.76 41.01 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.023 0.929 . . . . 0.0 111.391 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.67 135.0 35.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.233 0.613 . . . . 0.0 110.712 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -138.63 149.7 45.48 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.599 1.559 . . . . 0.0 109.585 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -61.15 136.29 58.02 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.959 1.254 . . . . 0.0 110.685 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -72.89 115.65 12.44 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.758 0.423 . . . . 0.0 110.838 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -102.68 153.48 38.17 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.546 1.138 . . . . 0.0 111.517 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.21 147.79 93.66 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.164 2.576 . . . . 0.0 112.903 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -66.28 -20.36 66.08 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.213 -0.93 . . . . 0.0 113.466 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -67.98 -28.57 67.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.92 1.688 . . . . 0.0 112.779 169.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.14 -46.32 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.249 1.42 . . . . 0.0 111.09 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 93.1 mmm -74.66 -19.64 60.19 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 22.8 t 65.52 126.51 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 128.431 2.692 . . . . 0.0 113.022 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.0 132.85 38.53 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.666 2.244 . . . . 0.0 111.414 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.7 t -161.71 176.0 11.41 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -169.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -169.79 156.0 26.45 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.592 1.091 . . . . 0.0 112.665 172.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 38.0 t -58.08 133.67 55.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.359 0.664 . . . . 0.0 112.325 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.32 -29.85 64.22 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -155.99 142.67 18.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.509 1.524 . . . . 0.0 111.427 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -168.38 168.0 40.63 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.13 1.347 . . . . 0.0 112.451 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.04 -55.81 0.17 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 128.434 2.693 . . . . 0.0 115.277 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 C--O 1.252 1.205 0 C-N-CA 126.585 1.954 . . . . 0.0 113.135 176.178 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.562 0 O5'-C5'-C4' 114.012 2.723 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.179 0 O4'-C1'-N19 111.639 3.439 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.142 0 O4'-C1'-N19 111.727 3.527 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.276 0 O4'-C1'-N19 111.689 3.489 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.067 1 O4'-C1'-N19 112.437 4.237 . 0.019 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 41.7 t -153.95 146.14 23.77 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.968 1.307 . . . . 0.0 111.583 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 64.67 -31.15 0.12 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.082 2.953 . . . . 0.0 116.606 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 35.3 mmt -73.72 53.99 0.46 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.807 2.043 . . . . 0.0 112.984 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.07 32.19 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.192 2.197 . . . . 0.0 114.736 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -118.89 137.96 53.09 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.805 1.242 . . . . 0.0 112.761 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.3 pt -118.17 152.02 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.871 1.268 . . . . 0.0 111.065 170.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 182' ' ' LYS . 49.8 t80 -87.62 141.44 28.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.745 2.018 . . . . 0.0 108.098 165.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.81 114.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.227 1.411 . . . . 0.0 109.347 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -116.11 144.37 18.41 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.423 1.011 . . . . 0.0 114.334 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.59 20.56 50.9 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.523 1.058 . . . . 0.0 114.562 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 34.0 mt -61.91 141.42 58.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.6 1.2 . . . . 0.0 111.103 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.32 141.7 58.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.888 -0.508 . . . . 0.0 111.128 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.01 -17.34 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.44 -25.85 50.99 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.543 1.137 . . . . 0.0 112.876 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 140.06 55.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.112 1.365 . . . . 0.0 112.45 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 t -113.67 161.1 17.88 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.004 1.322 . . . . 0.0 114.42 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -54.7 -34.51 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.48 -31.35 68.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -64.6 -42.19 95.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.897 0.772 . . . . 0.0 109.25 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.7 -48.83 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.585 1.154 . . . . 0.0 111.3 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -60.26 -48.29 82.37 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.629 0.65 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -58.53 -41.17 84.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.672 0.789 . . . . 0.0 112.796 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.7 -47.01 82.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.312 57.5 m-85 -70.2 -25.89 63.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -60.48 -43.66 96.74 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.622 1.169 . . . . 0.0 112.784 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.46 -35.63 70.94 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.848 1.259 . . . . 0.0 113.04 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.62 166.12 26.17 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.123 2.297 . . . . 0.0 110.731 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.46 136.46 57.5 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.072 0.939 . . . . 0.0 112.978 -169.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.6 t -106.79 129.65 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.556 1.943 . . . . 0.0 108.395 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -71.89 -56.59 5.44 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 112.163 173.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -155.46 161.46 40.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.048 0.939 . . . . 0.0 110.319 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -147.44 152.63 38.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.47 1.508 . . . . 0.0 111.044 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -154.17 132.0 11.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.975 0.91 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.5 mt -100.59 137.49 38.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.27 1.028 . . . . 0.0 111.087 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.3 mmt -87.42 121.8 30.32 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.885 0.474 . . . . 0.0 112.264 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.378 25.2 m-85 -83.87 145.28 28.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -68.28 136.83 54.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.492 1.517 . . . . 0.0 109.067 169.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -64.38 -18.2 64.46 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -168.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -3.48 9.56 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 167.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.475 0.7 OUTLIER 63.67 19.19 11.59 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.723 2.009 . . . . 0.0 115.28 -169.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -77.94 -51.8 9.84 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -168.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.3 167.45 25.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.467 1.907 . . . . 0.0 111.405 -172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -79.58 150.7 30.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.56 0.618 . . . . 0.0 110.779 168.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -77.78 19.22 0.4 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.218 1.407 . . . . 0.0 114.709 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.42 22.52 76.44 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 121.128 -0.982 . . . . 0.0 113.824 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -151.7 164.0 37.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.559 1.179 . . . . 0.0 109.224 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -168.34 -167.57 29.18 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.279 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.62 150.1 44.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.916 1.686 . . . . 0.0 114.337 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.95 128.66 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.191 1.397 . . . . 0.0 110.815 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -108.54 134.22 51.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.209 1.803 . . . . 0.0 114.079 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -105.82 160.04 15.55 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 -169.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -69.12 -33.68 73.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.933 0.893 . . . . 0.0 112.753 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t -142.66 147.07 35.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.707 1.203 . . . . 0.0 112.316 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.21 -30.09 67.98 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.517 1.127 . . . . 0.0 111.765 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.75 -35.27 72.46 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 20.5 mm -72.65 -40.34 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 119.174 -0.441 . . . . 0.0 110.562 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.95 -44.21 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.994 0.816 . . . . 0.0 110.138 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -62.15 -48.07 81.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.44 -46.46 76.75 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.023 1.329 . . . . 0.0 112.547 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.85 -45.14 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.358 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 45.9 t -67.62 -36.13 80.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.699 0.799 . . . . 0.0 112.846 -176.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -64.54 -22.64 67.02 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.8 -33.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.803 0.841 . . . . 0.0 111.051 172.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 67.11 -51.32 0.48 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.838 2.855 . . . . 0.0 115.42 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.332 59.2 m-85 -110.28 123.57 50.06 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -123.86 170.36 10.64 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.281 2.232 . . . . 0.0 110.578 -170.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -142.47 122.54 13.71 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.816 -1.178 . . . . 0.0 112.939 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.88 128.84 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.77 1.628 . . . . 0.0 108.989 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 49.72 39.64 18.19 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.65 1.18 . . . . 0.0 113.294 -173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 62.22 9.02 2.97 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.118 2.167 . . . . 0.0 116.231 -174.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -98.68 134.06 42.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.16 1.384 . . . . 0.0 110.42 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 18.7 ttm -82.53 137.24 34.65 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.757 0.823 . . . . 0.0 110.784 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.17 157.52 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.171 1.788 . . . . 0.0 112.259 -174.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -106.47 128.77 54.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.065 0.946 . . . . 0.0 111.913 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.1 p -90.7 138.62 31.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.093 0.557 . . . . 0.0 110.632 167.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 112' ' ' PHE . 46.6 mtmt -140.36 146.44 38.42 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.828 1.251 . . . . 0.0 109.518 176.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -62.79 128.1 34.36 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.218 0.917 . . . . 0.0 110.781 172.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.71 125.24 26.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.867 0.365 . . . . 0.0 111.945 -172.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -126.11 134.85 26.35 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.496 1.519 . . . . 0.0 110.922 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -60.47 138.66 81.88 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.001 2.468 . . . . 0.0 112.807 174.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -60.66 -21.93 63.32 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -67.76 -21.24 65.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.457 1.903 . . . . 0.0 113.797 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.77 -30.5 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.439 ' HG3' ' H ' ' A' ' 191' ' ' SER . 6.3 ptm -84.8 -70.69 0.56 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.051 0.841 . . . . 0.0 112.923 173.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.439 ' H ' ' HG3' ' A' ' 190' ' ' MET . 32.5 t -166.23 136.53 2.71 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.507 1.523 . . . . 0.0 110.773 176.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.77 149.91 78.72 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.118 2.545 . . . . 0.0 112.299 175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.9 t -68.34 156.74 37.15 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -145.39 16.89 1.87 Allowed Glycine 0 CA--C 1.538 1.475 0 C-N-CA 126.041 1.782 . . . . 0.0 113.658 172.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.0 t -66.46 131.97 47.24 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.307 1.054 . . . . 0.0 112.366 -175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.02 154.19 38.12 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.519 1.127 . . . . 0.0 113.519 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -74.38 -21.79 59.49 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.55 1.14 . . . . 0.0 113.583 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.45 -98.63 0.07 OUTLIER Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.911 1.719 . . . . 0.0 112.936 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 50.31 56.33 8.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.407 1.483 . . . . 0.0 111.477 177.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.924 2.09 . . . . 0.0 113.129 -169.668 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.282 1 O4'-C1'-N19 112.233 4.033 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.057 0 O4'-C1'-N19 111.757 3.557 . 0.264 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.515 0 O4'-C1'-N19 111.619 3.419 . 0.093 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.771 0 C5'-C4'-C3' 111.858 -2.428 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.746 0 O5'-C5'-C4' 106.933 -2.333 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.1 t -68.31 144.93 54.63 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.123 0.969 . . . . 0.0 113.029 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -80.9 14.17 2.33 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.808 1.643 . . . . 0.0 113.855 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -58.89 152.19 19.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.438 1.495 . . . . 0.0 113.59 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.15 60.55 1.7 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.937 1.695 . . . . 0.0 111.026 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -133.55 139.8 46.81 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -167.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 pt -121.07 153.07 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.192 1.397 . . . . 0.0 111.032 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.55 143.9 26.45 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.211 2.604 . . . . 0.0 105.009 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.58 103.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.949 1.7 . . . . 0.0 109.263 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -104.29 142.44 15.49 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.568 1.08 . . . . 0.0 114.264 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.66 21.13 54.69 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.747 1.165 . . . . 0.0 114.997 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 mt -62.54 145.16 55.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.757 1.223 . . . . 0.0 112.475 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.0 t -66.93 137.69 56.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.074 0.55 . . . . 0.0 110.719 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.76 -9.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -86.28 -20.29 28.62 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.098 0.959 . . . . 0.0 113.071 169.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.8 m -72.22 129.92 39.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.725 1.21 . . . . 0.0 111.37 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.7 t -103.01 163.95 11.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.72 -38.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.56 -29.64 68.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.276 0.63 . . . . 0.0 112.616 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -65.75 -45.73 81.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.308 0.958 . . . . 0.0 110.172 173.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.52 -48.21 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.576 1.15 . . . . 0.0 110.812 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -56.64 -51.13 69.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.149 1.38 . . . . 0.0 112.377 173.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -62.42 -36.86 83.7 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.872 0.869 . . . . 0.0 112.934 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -65.97 -45.38 81.92 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.315 58.3 m-85 -71.14 -25.51 62.6 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 176.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -56.83 -22.38 36.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.532 1.533 . . . . 0.0 114.631 170.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.79 -43.53 97.98 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.57 -33.28 68.94 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 165.52 170.8 30.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.336 1.922 . . . . 0.0 112.049 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -60.62 132.08 52.77 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.22 1.008 . . . . 0.0 112.188 -171.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.62 134.95 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 126.161 1.784 . . . . 0.0 108.431 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -81.93 -45.6 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.437 1.095 . . . . 0.0 113.703 174.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -163.73 162.35 23.91 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.911 1.285 . . . . 0.0 109.73 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.43 153.09 42.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.287 1.435 . . . . 0.0 111.71 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -156.33 134.72 11.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.53 1.132 . . . . 0.0 112.276 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 18.4 mt -101.49 147.07 26.81 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.864 0.866 . . . . 0.0 110.839 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.492 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 33.4 mmt -81.45 75.89 8.4 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 112.91 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.271 53.4 m-85 -62.94 141.68 58.62 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 178.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -103.02 123.49 46.71 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.873 1.669 . . . . 0.0 113.349 168.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -62.06 -25.95 67.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.479 1.112 . . . . 0.0 113.362 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -67.86 0.5 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 175.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -19.9 62.31 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 177.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . 0.269 37.9 m-80 57.66 32.89 22.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.506 1.522 . . . . 0.0 113.684 -174.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -132.09 159.11 39.83 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.49 2.716 . . . . 0.0 109.633 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 32.6 p80 -84.18 156.29 22.13 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.624 0.726 . . . . 0.0 112.427 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.8 ttp85 -72.88 17.41 0.12 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.88 2.072 . . . . 0.0 114.489 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.29 15.35 69.34 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.198 1.38 . . . . 0.0 114.766 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.492 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 27.4 p90 -156.02 168.47 27.16 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.219 1.51 . . . . 0.0 111.237 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.87 -167.74 25.92 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.829 1.204 . . . . 0.0 113.573 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -129.71 150.83 50.86 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.268 1.827 . . . . 0.0 115.014 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.1 t -136.48 128.52 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.29 1.436 . . . . 0.0 111.498 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -100.72 146.51 27.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.735 2.014 . . . . 0.0 113.687 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.8 151.94 38.97 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -169.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -71.41 -27.76 63.53 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.926 0.891 . . . . 0.0 112.948 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.8 t -141.68 142.34 33.35 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.995 1.318 . . . . 0.0 112.148 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -64.23 -26.52 68.54 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.125 . . . . 0.0 111.754 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -60.76 -32.82 72.1 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.4 mm -70.9 -42.34 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.336 172.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.56 -44.55 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.666 0.666 . . . . 0.0 110.514 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -64.23 -47.3 80.19 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.84 -46.58 74.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.403 1.081 . . . . 0.0 111.946 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.91 -49.62 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.827 1.651 . . . . 0.0 110.872 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 64.7 m -64.61 -33.31 75.63 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -65.67 -21.6 66.56 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.68 -31.77 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.021 0.928 . . . . 0.0 111.304 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 66.1 -52.75 0.4 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.828 2.851 . . . . 0.0 115.535 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.337 49.6 m-85 -111.41 121.5 45.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 173.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -118.42 165.65 13.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.117 2.167 . . . . 0.0 110.849 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -131.14 113.9 14.46 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.276 -0.89 . . . . 0.0 112.14 -173.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.75 129.24 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.776 1.23 . . . . 0.0 109.314 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 48.1 45.12 19.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.648 1.179 . . . . 0.0 112.686 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.297 0.9 OUTLIER 52.81 31.79 11.18 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.448 2.299 . . . . 0.0 115.748 -174.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -130.84 142.2 50.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.78 1.632 . . . . 0.0 110.344 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.3 mmm -84.11 135.1 34.53 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.312 1.045 . . . . 0.0 111.79 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.71 153.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.834 1.254 . . . . 0.0 111.892 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.38 127.63 46.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.651 0.78 . . . . 0.0 111.933 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -89.79 136.38 33.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.846 0.458 . . . . 0.0 110.432 167.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -140.76 148.11 40.17 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.974 1.309 . . . . 0.0 108.744 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -65.45 135.5 55.27 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.897 1.226 . . . . 0.0 110.879 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.52 117.36 15.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 122.742 0.417 . . . . 0.0 111.29 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -73.51 149.53 88.67 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.323 0.649 . . . . 0.0 111.56 170.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.59 148.65 92.52 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.929 2.419 . . . . 0.0 112.915 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -60.73 -22.87 64.45 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.366 -0.834 . . . . 0.0 113.21 169.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -66.03 -26.57 67.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.732 1.613 . . . . 0.0 113.509 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . 0.269 1.2 m -87.37 -7.64 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 7.1 ptm -156.39 76.0 0.88 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.335 1.454 . . . . 0.0 112.353 -171.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.8 p -147.52 150.94 38.51 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.154 1.381 . . . . 0.0 112.328 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -71.93 161.14 45.8 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.645 2.897 . . . . 0.0 113.459 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.75 138.63 44.5 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.741 1.616 . . . . 0.0 115.351 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 76.43 174.57 38.73 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.624 1.106 . . . . 0.0 114.805 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.6 t -76.82 160.18 29.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.547 1.139 . . . . 0.0 112.384 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.17 154.19 40.39 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.662 1.185 . . . . 0.0 112.963 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -149.75 147.75 28.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.639 1.576 . . . . 0.0 111.342 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.07 53.19 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.256 0.932 . . . . 0.0 113.985 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -133.45 155.62 49.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.154 1.782 . . . . 0.0 112.385 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.933 1.693 . . . . 0.0 113.581 179.159 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.173 1 O4'-C1'-N19 112.891 4.691 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.343 0 O4'-C1'-N19 111.66 3.46 . 0.266 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.754 0 C4'-C3'-C2' 100.679 -2.021 . 0.282 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.303 1 O4'-C1'-N19 114.004 5.804 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.225 0 O4'-C1'-N19 111.553 3.353 . 0.035 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.1 m -65.92 157.17 31.38 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.756 1.222 . . . . 0.0 113.28 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -144.5 170.43 16.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.916 1.286 . . . . 0.0 112.391 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 73.3 mtm -55.41 137.29 48.44 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.697 0.799 . . . . 0.0 111.522 171.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -77.01 43.22 0.35 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.33 1.452 . . . . 0.0 112.86 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.55 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 80.2 tttt -136.63 138.33 41.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.346 1.458 . . . . 0.0 111.72 -168.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.0 149.29 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.592 1.157 . . . . 0.0 111.333 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -83.97 145.22 28.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.251 1.82 . . . . 0.0 107.534 165.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.82 108.8 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.977 1.711 . . . . 0.0 109.984 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.74 147.63 18.66 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 124.594 1.092 . . . . 0.0 114.5 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.8 17.42 63.57 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.243 0.925 . . . . 0.0 114.61 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.1 mt -61.66 144.68 54.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.841 1.256 . . . . 0.0 111.494 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.5 t -69.36 137.0 52.49 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.061 -0.399 . . . . 0.0 110.133 168.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.4 m -64.52 -12.2 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 114.233 1.198 . . . . 0.0 114.233 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -79.32 -27.63 42.11 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.75 1.22 . . . . 0.0 113.145 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.2 m -67.4 132.39 47.56 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 111.974 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.49 161.46 20.25 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -35.02 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 169.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -71.6 -37.35 70.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.489 0.716 . . . . 0.0 111.685 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.51 -50.26 72.33 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.539 0.609 . . . . 0.0 111.787 170.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.81 -43.49 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 119.021 -0.514 . . . . 0.0 110.84 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -57.94 -52.57 64.97 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.053 0.842 . . . . 0.0 111.647 174.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -59.55 -39.79 85.15 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . 0.27 24.4 m-85 -64.32 -16.24 61.82 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 118.309 2.707 . . . . 0.0 118.309 170.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.31 58.3 m-85 -101.5 -25.61 13.85 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -58.72 -21.87 56.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.159 1.384 . . . . 0.0 113.824 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.19 -29.92 71.17 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -82.31 -28.55 31.61 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 161.72 169.19 24.7 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.496 2.474 . . . . 0.0 110.079 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -63.27 130.23 43.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.843 0.83 . . . . 0.0 112.589 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.44 132.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.193 1.797 . . . . 0.0 108.938 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.94 -57.91 3.6 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.174 0.989 . . . . 0.0 112.743 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -157.47 166.99 31.5 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.271 1.029 . . . . 0.0 109.883 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.39 157.72 43.66 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.398 1.479 . . . . 0.0 111.315 174.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -152.16 125.02 8.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.421 1.088 . . . . 0.0 111.391 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.36 146.97 25.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.305 0.642 . . . . 0.0 110.568 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.44 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 36.8 mmt -82.29 82.33 7.83 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 112.114 -172.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.363 10.8 m-85 -54.68 138.71 41.0 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 118.221 2.675 . . . . 0.0 118.221 174.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -75.61 148.75 38.54 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.436 ' H ' ' HD3' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -70.4 -1.77 11.69 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 116.183 1.919 . . . . 0.0 116.183 -169.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.2 p -69.23 -17.87 63.82 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.394 1.477 . . . . 0.0 109.305 166.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.501 0.5 OUTLIER 67.18 17.81 10.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.339 2.256 . . . . 0.0 114.967 -168.677 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -84.88 -58.44 2.7 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.025 0.93 . . . . 0.0 113.066 -170.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -148.64 166.76 27.35 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 128.038 2.535 . . . . 0.0 111.507 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 28.4 p80 -87.23 161.59 17.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.281 1.032 . . . . 0.0 112.954 169.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -70.7 -15.67 62.72 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.303 1.441 . . . . 0.0 114.081 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 114.9 22.27 5.04 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.509 1.052 . . . . 0.0 114.841 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.44 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 41.6 p90 -153.46 166.04 33.93 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.778 1.289 . . . . 0.0 111.237 171.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.3 -169.58 33.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.614 1.102 . . . . 0.0 114.289 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.55 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 92.8 m-85 -124.11 152.57 42.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.875 2.07 . . . . 0.0 115.979 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.1 t -137.86 133.65 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.412 1.485 . . . . 0.0 111.807 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.58 140.89 39.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.328 2.251 . . . . 0.0 114.934 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -117.2 155.61 29.12 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -168.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -72.24 -31.29 65.68 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.866 0.866 . . . . 0.0 113.095 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.7 t -144.37 145.99 32.27 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.65 1.18 . . . . 0.0 112.633 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.32 -25.07 66.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.88 0.872 . . . . 0.0 111.872 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -61.12 -32.52 72.21 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 12.7 mm -72.33 -42.56 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.312 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.51 -44.68 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.772 0.715 . . . . 0.0 110.23 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.75 -49.7 76.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -55.76 -47.39 77.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.513 1.125 . . . . 0.0 112.301 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.32 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.749 1.62 . . . . 0.0 110.725 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 61.6 m -65.7 -33.27 75.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.24 -23.03 66.95 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.8 mt -72.98 -33.03 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.914 0.885 . . . . 0.0 111.251 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 65.7 -48.94 0.39 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 129.032 2.933 . . . . 0.0 115.531 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.301 46.9 m-85 -115.7 124.14 50.1 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -123.56 139.32 54.12 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.665 1.586 . . . . 0.0 111.816 -170.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -86.05 124.62 32.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.072 0.949 . . . . 0.0 111.222 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.1 mt -138.76 124.75 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.213 1.805 . . . . 0.0 108.729 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 48.29 44.72 20.04 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.313 0.8 OUTLIER 53.45 29.22 8.58 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.688 1.995 . . . . 0.0 115.947 -172.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -127.53 136.06 51.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 127.318 2.247 . . . . 0.0 109.819 174.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 88.0 mtp -86.25 132.72 33.93 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.776 -0.578 . . . . 0.0 111.207 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.2 m -127.37 153.27 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.625 1.57 . . . . 0.0 112.712 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -101.25 125.98 47.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.781 0.833 . . . . 0.0 111.982 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.11 139.31 30.75 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.392 0.677 . . . . 0.0 111.462 167.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -136.37 145.3 45.21 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.72 1.208 . . . . 0.0 109.237 170.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.72 130.28 45.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.367 0.985 . . . . 0.0 109.758 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.87 140.9 53.25 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -172.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -139.31 154.33 71.8 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.533 1.933 . . . . 0.0 110.941 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.85 153.88 73.06 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.063 2.509 . . . . 0.0 114.622 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -62.04 -19.65 63.11 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 172.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -71.61 -33.63 69.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.398 1.479 . . . . 0.0 112.415 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.14 -36.59 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.762 1.225 . . . . 0.0 111.221 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 19.7 mmt -80.55 83.2 6.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.747 1.219 . . . . 0.0 111.79 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.1 m -54.68 144.25 45.91 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.066 1.346 . . . . 0.0 114.211 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.91 -8.43 17.84 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.964 3.109 . . . . 0.0 114.902 -173.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.273 1.2 p -65.14 153.8 39.82 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 75.01 -177.72 47.7 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.502 1.048 . . . . 0.0 114.116 -174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.3 t -157.4 156.17 31.78 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.896 1.278 . . . . 0.0 111.58 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.23 157.3 37.92 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.636 1.174 . . . . 0.0 113.066 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -150.21 162.94 39.5 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.704 1.601 . . . . 0.0 112.194 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -176.34 -171.79 40.43 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.929 1.252 . . . . 0.0 113.406 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -63.5 139.26 58.75 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.841 1.256 . . . . 0.0 112.055 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.973 1.709 . . . . 0.0 114.281 178.533 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.308 0 C4'-C3'-C2' 99.432 -3.268 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.247 0 O4'-C1'-N19 111.682 3.482 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.015 0 C3'-C2'-C1' 98.221 -3.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 1.991 1 O4'-C1'-N19 114.009 5.809 . 0.011 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.331 0 O4'-C1'-N19 111.515 3.315 . 0.181 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.2 m -86.06 -9.52 56.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.8 m80 60.14 34.8 21.17 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.194 1.798 . . . . 0.0 115.273 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.26 88.54 0.45 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.196 -0.94 . . . . 0.0 112.251 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -96.36 22.03 8.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.861 1.664 . . . . 0.0 113.405 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 154' ' ' PHE . 84.0 tttt -137.86 140.1 40.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.877 1.271 . . . . 0.0 111.178 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt -124.82 150.62 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.489 1.116 . . . . 0.0 111.922 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -85.12 144.14 28.39 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 166.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.09 117.09 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.613 1.565 . . . . 0.0 109.762 172.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.0 145.81 16.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.269 0.938 . . . . 0.0 114.267 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.02 11.9 58.26 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.855 1.217 . . . . 0.0 115.121 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -59.63 142.78 52.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 111.275 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t -67.83 144.71 55.21 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.63 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.25 1.4 p -65.07 -13.57 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -72.75 -26.85 61.71 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.207 1.003 . . . . 0.0 112.545 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.2 m -72.22 135.37 46.06 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 112.832 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 t -106.15 160.05 15.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 171.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.89 -34.42 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.435 1.494 . . . . 0.0 114.564 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.29 -34.88 75.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.235 0.614 . . . . 0.0 112.598 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -61.2 -42.37 98.47 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.222 0.919 . . . . 0.0 109.85 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.85 -47.81 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 124.74 1.216 . . . . 0.0 111.244 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -60.85 -48.48 81.61 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.664 0.665 . . . . 0.0 112.156 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -59.83 -37.02 78.04 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.67 -48.37 72.32 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.314 54.4 m-85 -68.99 -25.0 64.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 117.206 2.298 . . . . 0.0 117.206 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -59.79 -18.65 45.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 174.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -59.43 -45.0 92.8 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.633 1.173 . . . . 0.0 112.82 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -73.01 -36.85 67.07 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.963 1.305 . . . . 0.0 112.535 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.68 165.88 29.56 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.097 1.808 . . . . 0.0 111.471 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -59.09 126.22 26.81 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.963 0.905 . . . . 0.0 112.432 -169.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.97 128.67 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.756 1.622 . . . . 0.0 108.593 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.37 -57.2 4.67 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.195 0.998 . . . . 0.0 113.093 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -156.19 165.56 36.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 110.039 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.8 155.81 41.45 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.571 1.549 . . . . 0.0 111.272 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -154.86 134.88 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.373 1.069 . . . . 0.0 112.347 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.2 mt -103.25 142.45 34.15 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 111.236 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.438 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 38.3 mmt -83.7 90.08 7.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.863 0.84 . . . . 0.0 111.611 -175.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . 0.308 57.9 m-85 -61.23 138.32 58.23 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 175.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -88.06 -47.21 8.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.735 1.214 . . . . 0.0 110.538 168.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.97 112.17 8.04 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.924 2.089 . . . . 0.0 108.355 168.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.54 -27.05 64.18 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 -169.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.3 p -80.6 -10.04 59.75 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.786 1.634 . . . . 0.0 114.71 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -138.03 -58.99 0.65 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -168.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -144.8 149.59 35.73 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -168.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -123.1 159.97 27.39 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.045 1.738 . . . . 0.0 111.832 169.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.06 2.65 6.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 -176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.03 58.27 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.059 -1.025 . . . . 0.0 113.952 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 14.9 p90 -152.39 165.15 35.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.562 1.181 . . . . 0.0 109.234 172.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.65 -167.88 33.94 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.477 1.037 . . . . 0.0 113.668 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.517 ' CD2' ' HE2' ' A' ' 110' ' ' LYS . 96.5 m-85 -124.79 151.73 44.78 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.988 1.715 . . . . 0.0 114.974 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.5 t -137.15 132.91 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.288 1.435 . . . . 0.0 111.526 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.14 142.76 37.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.942 2.097 . . . . 0.0 114.647 -178.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.21 156.88 30.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -168.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.37 -32.92 73.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.796 0.838 . . . . 0.0 112.99 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.9 t -144.41 145.96 32.22 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.795 1.238 . . . . 0.0 112.377 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -60.18 -31.13 69.83 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.838 0.855 . . . . 0.0 111.638 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -59.69 -30.34 68.71 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 23.3 mm -72.36 -44.66 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 122.06 -0.4 . . . . 0.0 110.086 169.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.2 t -57.25 -41.33 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.639 0.654 . . . . 0.0 110.504 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -58.19 -51.37 70.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.291 0.636 . . . . 0.0 112.631 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.17 -46.38 88.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.639 1.176 . . . . 0.0 112.435 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.33 -46.87 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.806 1.642 . . . . 0.0 110.791 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 52.9 t -63.48 -38.52 91.46 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.622 0.769 . . . . 0.0 112.988 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -63.45 -19.46 64.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 73.4 mt -71.87 -33.71 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.28 -0.888 . . . . 0.0 111.464 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 65.08 -55.39 0.31 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.851 2.86 . . . . 0.0 115.179 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.359 46.3 m-85 -107.6 109.55 21.22 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -100.15 168.95 9.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.602 2.361 . . . . 0.0 111.353 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -132.45 118.41 19.28 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.362 -0.836 . . . . 0.0 111.889 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.6 mt -134.91 127.95 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.787 1.235 . . . . 0.0 109.262 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.5 43.21 19.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.758 1.223 . . . . 0.0 112.939 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . 0.301 0.7 OUTLIER 53.92 20.58 2.44 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.76 2.424 . . . . 0.0 116.352 -173.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -106.43 138.74 42.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.697 1.599 . . . . 0.0 110.24 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 93.1 mmm -80.7 133.56 35.71 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.896 0.878 . . . . 0.0 110.457 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.86 147.67 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.792 1.237 . . . . 0.0 112.84 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -97.35 124.63 41.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.225 1.01 . . . . 0.0 111.987 -176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.2 p -90.55 147.64 23.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.05 0.54 . . . . 0.0 111.426 168.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -143.34 151.02 39.98 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.927 1.291 . . . . 0.0 109.128 170.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.49 126.81 29.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.016 0.825 . . . . 0.0 109.149 168.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.66 141.67 36.25 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.435 0.636 . . . . 0.0 112.161 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -63.22 157.66 61.63 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.787 0.835 . . . . 0.0 111.085 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.27 -23.36 17.9 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.019 1.813 . . . . 0.0 113.214 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -162.6 -155.02 0.33 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.045 2.538 . . . . 0.0 107.783 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -74.82 28.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.944 2.098 . . . . 0.0 114.606 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.5 m -60.77 -12.47 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 95.4 mmm -66.24 -25.53 66.94 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.468 1.507 . . . . 0.0 112.327 172.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 t -153.77 85.8 3.96 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.701 1.2 . . . . 0.0 111.138 173.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.4 157.61 53.71 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.573 2.849 . . . . 0.0 113.36 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.0 t -149.5 162.02 40.96 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 168.24 -145.79 9.92 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.309 1.433 . . . . 0.0 112.446 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.0 m -68.33 -8.04 36.42 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -143.61 174.87 10.4 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.976 2.111 . . . . 0.0 111.045 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -60.46 163.35 5.34 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.752 1.221 . . . . 0.0 113.135 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.4 130.09 48.21 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 123.911 0.767 . . . . 0.0 113.287 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 -157.49 161.79 38.87 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.004 1.722 . . . . 0.0 111.455 -176.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.247 1.819 . . . . 0.0 112.556 -177.222 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.127 2.927 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 0 O4'-C4'-C3' 108.893 2.424 . 0.113 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.939 0 O4'-C1'-N19 110.061 1.861 . 0.364 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.615 2.153 1 O4'-C1'-N19 115.453 7.253 . 0.062 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.329 0 O4'-C1'-N19 111.76 3.56 . 0.173 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.9 m 61.13 164.61 0.08 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.507 1.923 . . . . 0.0 115.282 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -76.67 37.51 0.18 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.117 1.767 . . . . 0.0 114.371 -174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 47.5 tpp -70.9 115.21 9.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.864 -1.148 . . . . 0.0 111.777 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -114.0 12.01 17.9 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -124.0 138.49 54.45 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.543 1.065 . . . . 0.0 113.027 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.5 pt -118.66 153.04 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.894 1.278 . . . . 0.0 111.537 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -88.54 139.46 30.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.783 2.433 . . . . 0.0 108.12 165.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.4 t -130.73 111.13 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.31 1.444 . . . . 0.0 109.809 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.73 146.58 17.6 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.536 1.065 . . . . 0.0 113.807 -174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.52 12.76 37.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.917 1.246 . . . . 0.0 114.534 -177.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.6 mt -62.02 139.23 58.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.429 1.092 . . . . 0.0 110.876 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.1 t -66.85 142.12 57.44 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.868 -0.52 . . . . 0.0 110.029 169.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.92 -14.61 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -74.18 -21.7 59.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.303 1.441 . . . . 0.0 113.744 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 91.5 m -71.24 145.48 49.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.404 1.481 . . . . 0.0 112.448 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.2 t -118.59 159.36 23.72 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.897 1.279 . . . . 0.0 114.113 169.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 p -54.54 -34.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.269 1.427 . . . . 0.0 114.847 -173.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -70.57 -28.82 65.19 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.56 0.744 . . . . 0.0 112.942 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -64.88 -51.59 61.14 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 t -58.83 -44.81 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.148 0.979 . . . . 0.0 111.489 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -59.21 -48.01 83.19 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.929 0.492 . . . . 0.0 111.952 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -62.71 -40.08 96.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -58.57 -30.38 67.12 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 172.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.262 59.7 m-85 -88.42 -24.1 23.13 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.13 -14.07 22.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 173.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -59.19 -42.58 91.19 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 112.523 169.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -80.51 -32.98 36.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.06 172.87 35.51 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.39 1.948 . . . . 0.0 111.058 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.16 125.5 24.08 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.134 0.967 . . . . 0.0 112.391 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 38.3 t -97.66 128.38 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.516 1.527 . . . . 0.0 110.107 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -75.05 -50.68 15.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.973 1.309 . . . . 0.0 112.906 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -160.9 164.25 31.36 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.18 0.992 . . . . 0.0 110.471 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.62 154.56 39.88 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.546 1.539 . . . . 0.0 111.383 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -151.71 136.71 17.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.697 1.199 . . . . 0.0 111.67 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.75 146.83 34.28 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.213 1.005 . . . . 0.0 111.396 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.25 78.48 8.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.287 1.035 . . . . 0.0 112.363 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 149' ' ' HIS 0.285 53.6 m-85 -64.26 134.5 54.85 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 118.128 2.64 . . . . 0.0 118.128 176.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.32 121.19 14.26 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.592 1.157 . . . . 0.0 112.57 169.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.46 -16.05 53.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.097 1.359 . . . . 0.0 114.304 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -1.87 7.89 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 167.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . 0.497 0.2 OUTLIER 70.33 31.81 2.97 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -177.264 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -85.83 -78.87 0.26 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.017 0.927 . . . . 0.0 113.364 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.69 166.46 20.0 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.097 2.559 . . . . 0.0 110.266 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 142' ' ' PHE . 34.8 p80 -74.99 158.36 33.38 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -67.23 7.96 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.204 1.802 . . . . 0.0 115.751 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.84 65.73 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.581 1.086 . . . . 0.0 114.208 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -153.7 167.6 29.04 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.719 1.26 . . . . 0.0 111.21 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.78 -164.7 22.88 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.102 0.858 . . . . 0.0 113.41 170.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -120.89 150.58 40.84 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.104 1.762 . . . . 0.0 114.892 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.17 127.77 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.066 1.346 . . . . 0.0 111.159 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -108.66 136.34 48.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.432 1.893 . . . . 0.0 114.62 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -109.76 158.68 17.88 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.141 1.776 . . . . 0.0 115.643 -169.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.32 -28.44 63.07 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 172.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.2 t -141.85 144.84 34.07 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.169 1.388 . . . . 0.0 112.459 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -60.58 -31.67 70.8 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 111.684 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.62 -31.46 70.64 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.75 -42.04 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 110.134 171.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.9 -43.19 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 118.834 0.743 . . . . 0.0 110.248 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -59.94 -47.15 86.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 173.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -58.67 -51.21 70.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.189 0.995 . . . . 0.0 112.466 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 63.0 t -64.19 -43.18 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.703 1.601 . . . . 0.0 110.809 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 46.7 t -70.23 -35.52 73.92 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -64.28 -26.58 68.55 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.923 -1.111 . . . . 0.0 113.781 173.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 68.5 mt -71.07 -39.43 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.844 0.858 . . . . 0.0 110.874 170.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.4 t60 65.45 -43.15 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.973 2.909 . . . . 0.0 115.969 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . 0.283 53.2 m-85 -111.69 123.36 50.08 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 174.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -129.52 159.84 35.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.502 1.521 . . . . 0.0 112.356 -169.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -106.41 127.08 53.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.129 0.972 . . . . 0.0 111.282 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 35.8 mt -135.74 123.79 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.327 1.451 . . . . 0.0 108.998 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 50.58 37.48 16.28 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.279 1.032 . . . . 0.0 113.298 -176.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 60.83 12.92 4.07 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 127.339 2.256 . . . . 0.0 115.7 -172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -97.86 145.57 26.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.082 1.753 . . . . 0.0 110.584 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.67 128.96 34.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.368 1.467 . . . . 0.0 110.205 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.39 147.31 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.702 1.201 . . . . 0.0 113.318 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -94.18 129.18 40.88 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.549 1.139 . . . . 0.0 110.187 171.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.0 m -115.85 126.58 54.14 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.754 1.222 . . . . 0.0 110.388 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -148.88 148.69 30.16 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.025 1.33 . . . . 0.0 111.296 -171.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.31 138.94 58.25 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.411 -0.806 . . . . 0.0 111.817 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.05 134.98 51.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -123.55 150.39 61.1 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.429 1.492 . . . . 0.0 111.365 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -57.08 149.04 65.26 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.391 2.727 . . . . 0.0 115.751 -171.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -58.55 -28.12 65.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.101 1.76 . . . . 0.0 113.778 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -70.56 -26.84 63.72 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.204 1.802 . . . . 0.0 113.565 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.3 m -114.0 4.54 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -172.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 27.2 mmt -122.55 113.13 18.88 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.448 1.899 . . . . 0.0 110.674 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.6 t -129.2 137.83 31.85 Favored Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 126.124 1.77 . . . . 0.0 111.282 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.46 -13.78 18.34 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.129 2.552 . . . . 0.0 113.209 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . 0.422 0.2 OUTLIER 61.47 -21.11 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 119.132 3.012 . . . . 0.0 119.132 -176.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -165.01 141.52 7.11 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.055 1.788 . . . . 0.0 111.935 171.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 43.4 m -85.97 129.21 34.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.18 -27.57 48.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.183 0.993 . . . . 0.0 112.828 169.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.0 mtm105 -64.82 170.96 3.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.21 2.204 . . . . 0.0 112.864 176.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 89.37 27.44 22.73 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.014 0.816 . . . . 0.0 114.666 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.03 161.73 36.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.466 1.906 . . . . 0.0 112.32 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.08 1.752 . . . . 0.0 113.53 -175.862 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.671 0 O4'-C4'-C3' 108.587 2.205 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.354 0 O5'-C5'-C4' 113.915 2.654 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.819 0 C4'-C3'-C2' 99.563 -3.137 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.274 2 O4'-C1'-N19 112.564 4.364 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.054 2 O4'-C1'-N19 113.851 5.651 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 stop_ save_